Zepto Life Technology Introduces FungiFlex® Pneumocystis jirovecii and FungiFlex® Mold Plus 2026-07-15 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/zepto-life-technology-introduces-fungiflex-pneumocystis-jirovecii-and-fungiflex-mold-plus-302825991.html New targeted plasma cfDNA liquid biopsy testing options expand the FungiFlex ®menu, allowing clinicians to order targeted Pneumocystis jirovecii testing or combined mold and P. jirovecii detection based on the clinical question. ST. PAUL, Minn., July 15, 2026 /PRNewswire/ -- Zepto Life... ———————————————————————————————————————————————————————————— Elsevier Foundation and The Lancet Announce Winners of Inaugural Evidence to Impact Awards 2026-07-15 · WebWire · Healthcare https://www.webwire.com/ViewPressRel.asp?aId=357704 The Elsevier Foundation and The Lancet announced the three winning teams of the inaugural edition of The Lancet –Elsevier Foundation Evidence to Impact Awards. The Awards recognize research teams that go beyond publishing experimental findings: teams that have put implementation science to work, with communities, to change how health care is actually delivered. Today's health landscape faces complex challenges: from rising non-communicable diseases and infectious diseases to malnutr... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357704 ———————————————————————————————————————————————————————————— NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome 2026-07-15 · NewMediaWire · Healthcare, Education https://www.newmediawire.com/news/neurothera-labs-announces-initiation-of-phase-iib-clinical-trial-at-hannover-medical-school-in-germany-for-innovative-treatment-of-tourette-syndrome-7087727 TORONTO, ONTARIO - July 15, 2026 ( NEWMEDIAWIRE ) - NeuroThera Labs Inc. (TSXV: NTLX) (the " Company " or " NeuroThera "), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd., today announced the initiation of its Phase IIb clinical trial site at Hannover Medical School, Hanover (“MHH”), Germany, for SCI-110, its proprietary cannabinoid-based treatment candidate for Tourette Syndrome (TS) in adults. The trial, which previously received regulatory clearance from Germany’s Federal Institute for Drugs and Medical Devices and MHH's ethics committee, is now advancing towards the next stage at Hannover Medical School, one of the key clinical sites of the study. SCI-110 combines dronabinol with the endocannabinoid-like palmitoylethanolamide in an innovative one dosag ———————————————————————————————————————————————————————————— Befriending Networks launches free Dementia and Social Connection CPD training for third sector 2026-07-15 · Pressat · Healthcare https://pressat.co.uk/releases/befriending-networks-launches-free-dementia-and-social-connection-cpd-training-for-third-sector-858401ae84e5e76270439ec2dabd4a5b/ Wednesday 15 July, 2026 Booking is now live for the Connected Lives training programme, with events in 20 locations across Scotland and online. The new training programme from Befriending Networks kicks off in Edinburgh on Tuesday 11 August and will continue until February 2027, visiting 20 towns and cities across Scotland. Four online sessions will also be available for those who are unable to attend in person. Connected Lives training is free and open to staff and volunteers at third sector organisations based in Scotland who want to feel more confident supporting people living with dementia. Research suggests that social isolation is a key risk factor for developing dementia. Alzheimer’s Research UK estimates that if everyone kept socially connected, there would be five fewer cases of d ———————————————————————————————————————————————————————————— England football legend David Seaman supporting Tesco and British Heart Foundation campaign to get fans on the ball with checking their blood pressure 2026-07-15 · WebWire · Healthcare https://www.webwire.com/ViewPressRel.asp?aId=357699 David Seaman, the ex-England goalkeeper nicknamed 'Safe Hands', is encouraging football fans across the UK to put their heart health first by popping to their local Tesco Pharmacy for a free blood pressure check. - - The supermarket has teamed up with the British Heart Foundation to offer more than 50,000 blood pressure check appointments per week across over 350 Tesco Pharmacies so fans can get themselves checked as they shop for their big match essentials. - - The quick and simple test tha... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357699 ———————————————————————————————————————————————————————————— Mitsui Chemicals Integrates Dental 3D Printing Business in Japan into Sun Medical 2026-07-15 · WebWire · Healthcare https://www.webwire.com/ViewPressRel.asp?aId=357695 Mitsui Chemicals, Inc. (Tokyo:4183; President & CEO: ICHIMURA Satoshi; “Mitsui Chemicals”) has decided to integrate its dental 3D printing business and some dental materials business in Japan into its subsidiary, Sun Medical Co., Ltd. (Head Office: Moriyama City, Shiga; President & CEO: SUZUKI Takefumi; “Sun Medical”). Mitsui Chemicals positions Sun Medical as the core of its dental 3D printing business and will continue to strengthen its capabilities. - - Kulzer Japan Co., Ltd. (Head Offic... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357695 ———————————————————————————————————————————————————————————— Ankle & Foot Centers of America Shares Why Work-from-Home Habits Are ... 2026-07-15 · PR-Inside · Healthcare https://pr-inside.com/ankle-foot-centers-of-america-shares-why-work-from-home-habits-are-r5201327.htm (PR-inside.com) ATLANTA, GA / ACCESS Newswire / July 15, 2026 / While remote work has become a permanent part of life for many professionals,Ankle & Foot Centers of Americais encouraging employees to pay closer attention to their foot health. Years after the work-from-home boom, podiatrists continue to see patients experiencing foot pain and other lower extremity issues related to prolonged sitting, reduced activity, and unsupportive footwear. Working from home often means spending long hours at a desk while barefoot or wearing slippers that lack proper arch support. Combined with hard flooring and decreased daily movement, these habits can contribute to conditions such .. ———————————————————————————————————————————————————————————— NYSE Content Update: Women's Health Equity Funding Up 41% in 2025 Report 2026-07-15 · PR Newswire · Finance, Healthcare, Media https://www.prnewswire.com/news-releases/nyse-content-update-womens-health-equity-funding-up-41-in-2025-report-302826431.html NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, July 15, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before... ———————————————————————————————————————————————————————————— Ractigen Therapeutics Announces Landmark Publication in Nature Medicine Highlighting Unprecedented Preclinical Efficacy and Positive First-in-Human Clinical Data for RAG-17 in SOD1-ALS 2026-07-15 · PR Newswire · SaaS, Healthcare https://www.prnewswire.com/news-releases/ractigen-therapeutics-announces-landmark-publication-in-nature-medicine-highlighting-unprecedented-preclinical-efficacy-and-positive-first-in-human-clinical-data-for-rag-17-in-sod1-als-302826429.html — Peer-reviewed publication details RAG-17's robust translation from "bench to bedside," validating the proprietary SCAD™ delivery platform for CNS-targeted RNAi therapies — — First-in-Human trial met primary safety endpoints with no Serious Adverse Events (SAEs); demonstrated mean... ———————————————————————————————————————————————————————————— As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22 2026-07-15 · PR Newswire · Finance, AI, Healthcare https://www.prnewswire.com/news-releases/as-ai-rewrites-drug-discovery-this-bio-native-ai-company-just-joined-the-russell-3000e-and-reports-earnings-july-22-302826193.html Issued on behalf of MindWalk Holdings Corp. MindWalk Holdings Corp. (NASDAQ: HYFT) heads into its fourth-quarter and full-year results with fresh index inclusion, an expanded patent estate, and AI-designed programs aimed at two of medicine's biggest frontiers: GLP-1 metabolic health and... ———————————————————————————————————————————————————————————— Intiveo Publishes the Most Comprehensive Benchmark Report for Dental and Oral Surgery Practices 2026-07-15 · PR Newswire · SaaS, Healthcare https://www.prnewswire.com/news-releases/intiveo-publishes-the-most-comprehensive-benchmark-report-for-dental-and-oral-surgery-practices-302826194.html VANCOUVER, BC, July 15, 2026 /PRNewswire/ -- Intiveo, the patient engagement platform built for dental and oral surgery practices, today released its 2026 Dental Patient Engagement Report, a benchmark study drawn from communication and engagement data across more than 2,500 practices... ———————————————————————————————————————————————————————————— SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome 2026-07-15 · GlobeNewswire · Finance, Healthcare, Education https://www.globenewswire.com/news-release/2026/07/15/3327736/0/en/SciSparc-NeuroThera-Labs-Announces-Initiation-of-Phase-IIb-Clinical-Trial-at-Hannover-Medical-School-in-Germany-for-Innovative-Treatment-of-Tourette-Syndrome.html TEL AVIV, Israel, July 15, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its subsidiary NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, announced the initiation of its Phase IIb clinical trial site at Hannover Medical School, Hanover, Germany (“MHH”), for SCI-110, its proprietary cannabinoid-based treatment candidate for Tourette Syndrome (TS) in adults. ———————————————————————————————————————————————————————————— Aimwell Partners Inc. (OTC:AIMN) Confirms Advanced Discussions With ... 2026-07-15 · PR-Inside · Healthcare https://pr-inside.com/aimwell-partners-inc-otc-aimn-confirms-advanced-discussions-with-r5201320.htm (PR-inside.com) MIAMI, FL / ACCESS Newswire / July 15, 2026 / Aimwell Partners Inc. (OTCID:AIMN), parent company of AimwellBio, today confirmed it is engaged in advanced discussions with an exclusive, referral-based life sciences capital markets network that connects biotechnology companies with institutional investors, banking relationships, strategic advisors, and other participants across the biotech investment ecosystem. The introduction originated through Christopher A. Jones, PhD, FRSM, Strategic Advisor to AimwellBio and one of the founding credentialed contributors to the company's Federated Health Intelligence Network. The company expects negotiations to conclude next week, at which time the counterparty and the scope of the relationship are anticipated .. ———————————————————————————————————————————————————————————— enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive ... 2026-07-15 · PR-Inside · Finance, Healthcare, Real Estate, Media https://pr-inside.com/envveno-medical-highlights-newly-issued-u-s-patent-strengthening-competitive-r5201313.htm (PR-inside.com) CEO Explains How Broad Patent Protection, Combined with First-Ever FDA IDE Approval, Positions enVVe® to Own a Multi-Billion-Dollar Venous Disease Market Watch the "What This Means" video here IRVINE, CA / ACCESS Newswire / July 15, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company"), today announced that Robert Berman, Chief Executive Officer of enVVeno Medical participated in a Virtual Investor "What This Means" segment. As part of the segment, Mr. Berman discussed the Company's recent news announcing the issuance of the first U.S. Patent covering the company's enVVe system, further expanding its intellectual property portfolio and laying the groundwork to .. ———————————————————————————————————————————————————————————— Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center 2026-07-15 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/15/3327707/0/en/Alpha-Tau-Successfully-Treats-First-Immunocompromised-Patient-with-Recurrent-Cutaneous-Squamous-Cell-Carcinoma-in-its-ADMIRE-Study-at-Banner-MD-Anderson-Cancer-Center.html Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson ———————————————————————————————————————————————————————————— Foot & Ankle Center Warns Southern Utah Residents of Overlooked Summer Heat Risks 2026-07-15 · PRUnderground · Healthcare https://www.prunderground.com/foot-ankle-center-warns-southern-utah-residents-of-overlooked-summer-heat-risks/00388703/ As Southern Utah temperatures climb, St. George foot and ankle clinic highlights how extreme heat can affect foot and ankle health and ways to lower risk. The post Foot & Ankle Center Warns Southern Utah Residents of Overlooked Summer Heat Risks first appeared on ———————————————————————————————————————————————————————————— Ascelia Pharma Announces Organizational Changes and a Reduced Cost ... 2026-07-15 · PR-Inside · Healthcare https://pr-inside.com/ascelia-pharma-announces-organizational-changes-and-a-reduced-cost-r5201307.htm (PR-inside.com) MALMÖ, SE / ACCESS Newswire / July 15, 2026 / Ascelia Pharma (STO:ACE), a biotech company focused on improving the lives of people with rare cancer conditions, today announces that CFO Anton Hansson will be leaving the Company. In connection with this change and cost reduction initiatives, Ascelia Pharma is reducing its cost base while focusing on the path forward for Orviglance®. The changes support alignment of resources with Ascelia Pharma's current priorities, including regulatory interactions with the U.S. Food and Drug Administration ("FDA") and bringing Orviglance to patients. "Our focus is on the upcoming Type A meeting with the FDA where .. ———————————————————————————————————————————————————————————— SlicedHealth Introduces GROW: A New Operational Platform Built to Help ... 2026-07-15 · PR-Inside · SaaS, Healthcare https://pr-inside.com/slicedhealth-introduces-grow-a-new-operational-platform-built-to-help-r5201300.htm (PR-inside.com) WOODSTOCK, GA / ACCESS Newswire / July 15, 2026 / SlicedHealth has launched GROW, an operational platform designed to give small and mid-sized hospitals the same clarity and control over contracts, credentialing, and compliance that has traditionally only been available to much larger health systems. GROW connects agreements to the day to day activity they are supposed to govern, so a hospital can see not just what a contract says, but whether it is actually being honored in practice. For years, the advice to rural and community hospitals was simple. Protect your margin, control your costs, and keep the doors open. .. ———————————————————————————————————————————————————————————— Modular Medical Receives Research Demonstrating Positive Payor Reception ... 2026-07-15 · PR-Inside · Finance, Healthcare https://pr-inside.com/modular-medical-receives-research-demonstrating-positive-payor-reception-r5201295.htm (PR-inside.com) Completed Independent Study Strongly Supports Favorable Payor Receptivity to Pivot's Differentiated Design and Simplified User Experience, and provides further validation of significant progress towards goal of achieving broad market access for Pivot SAN DIEGO, CA / ACCESS Newswire / July 15, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company that is commercializing the next generation of insulin delivery technology, today released findings from an independent market research study demonstrating positive receptivity to its FDA-cleared Pivot™ tubeless patch pump due to its differentiated design, streamlined user experience, and potential for reimbursement through the pharmacy .. ———————————————————————————————————————————————————————————— LataMed AI Corp. Announces Effectiveness of 5-for-1 Forward Stock Split 2026-07-15 · NewMediaWire · Finance, AI, Retail, Healthcare https://www.newmediawire.com/news/latamed-ai-corp-announces-effectiveness-of-5-for-1-forward-stock-split-7087720 CARACAS, VENEZUELA - July 15, 2026 ( NEWMEDIAWIRE ) - LataMed AI Corp. (OTC: LMEDD) (the “Company”) today announced that its previously announced 5-for-1 forward stock split has become effective at the opening of trading following publication of the corporate action on the FINRA Daily List dated July 14, 2026. In connection with the forward stock split, the Company's common stock will begin trading today under the temporary trading symbol LMEDD . The temporary "D" designation is a standard FINRA identifier used in connection with certain corporate actions and is expected to remain in place for approximately twenty (20) business days, after which the trading symbol is expected to revert to LMED . The forward stock split has also been implemented in conjunction with the Company's mandatory s ———————————————————————————————————————————————————————————— Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump 2026-07-15 · Newswire.com · Healthcare https://www.newswire.com/news/modular-medical-receives-research-demonstrating-positive-payor-reception-of Completed Independent Study Strongly Supports Favorable Payor Receptivity to Pivot's Differentiated Design and Simplified User Experience, and provides further validation of significant progress towards goal of achieving broad market access for Pivot ———————————————————————————————————————————————————————————— Wheel Launches Clinical Infrastructure for Medicare's Next Era of Cardiometabolic Care 2026-07-15 · PRWeb · Healthcare https://www.prweb.com/releases/wheel-launches-clinical-infrastructure-for-medicares-next-era-of-cardiometabolic-care-302825843.html Company expands support for CMS' ACCESS Model and the Medicare GLP-1 Bridge, helping healthcare organizations operationalize technology-enabled, longitudinal care at scale AUSTIN, Texas, July 15, 2026 /PRNewswire-PRWeb/ -- Wheel, the leading clinical infrastructure company powering... ———————————————————————————————————————————————————————————— InnoCare Announces Phase III Study Results of TYK2 Inhibitor Soficitinib Meet Primary Endpoint in Patients with Atomic Dermatitis 2026-07-15 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/15/3327622/0/en/InnoCare-Announces-Phase-III-Study-Results-of-TYK2-Inhibitor-Soficitinib-Meet-Primary-Endpoint-in-Patients-with-Atomic-Dermatitis.html BEIJING, July 15, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that registrational phase III clinical study results of novel TYK2 (Tyrosine Kinase 2) inhibitor soficitinib (ICP-332) met the primary endpoint in patients with moderate-to-severe atopic dermatitis (AD). ———————————————————————————————————————————————————————————— Ernexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry 2026-07-15 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/15/3327620/0/en/Ernexa-Therapeutics-Receives-Independent-Validation-of-ERNA-101-with-Complete-Tumor-Clearance-and-Durable-Survival-in-Ovarian-Cancer-Models-Ahead-of-Planned-Clinical-Entry.html Independent CRO Successfully Reproduces ERNA-101 Combination Data in Larger Preclinical Study, Significantly Strengthening Confidence as Company Advances Toward IND ———————————————————————————————————————————————————————————— Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 Study) 2026-07-15 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/intensity-therapeutics-inc-restarts-patient-treatment-in-the-randomized-presurgical-triple-negative-breast-cancer-phase-2-clinical-trial-invincible-4-study-302825854.html First patients dosed in Switzerland SHELTON, Conn., July 15, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that... ———————————————————————————————————————————————————————————— Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026 2026-07-15 · GlobeNewswire · Finance, AI, Healthcare https://www.globenewswire.com/news-release/2026/07/15/3327615/33471/en/Profound-Medical-Autonomous-Robotics-and-Incisionless-Surgery-to-Have-Exceptional-Presence-at-SRS2026.html TORONTO, July 15, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that its MRI-guided, AI-powered, Robotically-Driven and Incisionless TULSA Procedure™ will be highlighted in several presentations by leading physicians at the upcoming Society of Robotic Surgery (“SRS”) Annual Meeting to be held in Fort Lauderdale, FL, July 23-26, 2026.* ———————————————————————————————————————————————————————————— Wellgistics Health Appoints Brett Thompson as Chief Technology Officer ... 2026-07-15 · PR-Inside · Finance, AI, SaaS, Healthcare https://pr-inside.com/wellgistics-health-appoints-brett-thompson-as-chief-technology-officer-r5201288.htm (PR-inside.com) Experienced Healthcare Information Technology Specialist Joins Leading Pharmaceutical IT Company TAMPA, FL / ACCESS Newswire / July 15, 2026 /Wellgistics Health, Inc. (the "Company" or "Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that it appointed healthcare information technology executive Brett Thompson as the Company's consulting Chief Technology Officer (CTO). Mr. Thompson has more than thirty years of experience designing, developing, and leading enterprise software solutions, including more than seventeen years focused on healthcare and pharmacy technology. Throughout his career, he has structured and delivered commercial softwar ———————————————————————————————————————————————————————————— Wellgistics Health Appoints Brett Thompson as Chief Technology Officer 2026-07-15 · Newswire.com · Healthcare https://www.newswire.com/news/wellgistics-health-appoints-brett-thompson-as-chief-technology-officer Experienced Healthcare Information Technology Specialist Joins Leading Pharmaceutical IT Company ———————————————————————————————————————————————————————————— Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026 2026-07-15 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/15/3327603/0/en/Acumen-Pharmaceuticals-Highlights-Enhanced-Brain-Delivery-EBD-Program-Data-and-Early-Alzheimer-s-Disease-Insights-at-the-Alzheimer-s-Association-International-Conference-AAIC-2026.html NEWTON, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen), a clinical-stage biopharmaceutical company developing novel therapeutics that target soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today announced new findings presented at the Alzheimer's Association International Conference (AAIC ® ) 2026 in London. Following collaboration with JCR Pharmaceuticals Co., Ltd. (JCR) on EBD candidate development, studies demonstrated improved brain penetration of anti-AβO antibodies through transferrin receptor-mediated delivery across both mouse and non-human primate models. Additionally, research from early symptomatic AD patients highlighted the lived experience among ALTITUDE-AD trial participants and their study p ———————————————————————————————————————————————————————————— BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™ 2026-07-15 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/15/3327609/0/en/BriaCell-Arranges-Scalable-Manufacturing-with-FUJIFILM-Biotechnologies-for-Bria-IMT.html PHILADELPHIA and VANCOUVER, British Columbia, July 15, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, announces a manufacturing arrangement with FUJIFILM Biotechnologies California, a leading contract development and manufacturing organization (CDMO) specializing in cell therapies, to support the ongoing pivotal Phase 3 clinical development and potential future commercial supply of BriaCell’s lead clinical candidate, Bria-IMT, an off-the-shelf allogenic cell therapy. ———————————————————————————————————————————————————————————— Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers 2026-07-15 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/15/3327602/29076/en/Cellectar-Biosciences-Announces-Publication-of-Phase-1-Study-of-Iopofosine-I-131-in-Peer-Reviewed-Journal-Cancers.html Demonstrated Favorable Safety Profile and Preliminary Clinical Activity in Relapsed/Refractory Multiple Myeloma ———————————————————————————————————————————————————————————— XRHealth Acquires Swing Therapeutics, Expanding Its Platform to Mobile Digital Therapeutics 2026-07-15 · PRWeb · AI, SaaS, Healthcare https://www.prweb.com/releases/xrhealth-acquires-swing-therapeutics-expanding-its-platform-to-mobile-digital-therapeutics-302822708.html XRHealth acquires Swing Therapeutics to expand its AI-powered digital health platform beyond XR into mobile apps, wearables, and FDA-authorized digital therapeutics for chronic pain and fibromyalgia, creating a comprehensive, reimbursable care platform BOSTON, July 15, 2026... ———————————————————————————————————————————————————————————— Aduro launches Aduro Mental Health & Resilience, a dedicated therapy benefit that connects mental and physical health. 2026-07-15 · PRWeb · Healthcare https://www.prweb.com/releases/aduro-launches-aduro-mental-health--resilience-a-dedicated-therapy-benefit-that-connects-mental-and-physical-health-302825756.html A different kind of mental health benefit for self-insured employers: a dedicated, employed team of therapists, care that sees the whole person across mental and physical health, and the workforce intelligence to prove it. SEATTLE, July 15, 2026 /PRNewswire-PRWeb/ -- For thirty years, the... ———————————————————————————————————————————————————————————— MedPR Pro Launches Distribution Service to Enhance Medical Spa Marketing Visibility 2026-07-15 · PressReleaseNews · AI, Healthcare https://pressreleasenews.org/pressroom/medpr-pro-launches-distribution-service-to-enhance-medical-spa-marketing-visibility MedPR Pro today launched a press release distribution service designed to support med spa marketing by improving visibility across traditional search engines and emerging artificial intelligence platforms. The service aims to address the challenges independent medical aesthetics clinics face in acquiring new patients amid rising ———————————————————————————————————————————————————————————— Zomedica Announces "Fourth Friday at Four" Webinar on July 24, 2026: ... 2026-07-15 · PR-Inside · Finance, Healthcare https://pr-inside.com/zomedica-announces-fourth-friday-at-four-webinar-on-july-r5201190.htm (PR-inside.com) July session to spotlight the specialized, coordinated commercial organization that turns product innovation into clinical adoption, sustained utilization, and long-term recurring revenue ANN ARBOR, MI / ACCESS Newswire / July 15, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the next installment of its "Fourth Friday at Four" investor webinar series, scheduled for Friday, July 24 at 4:00 p.m. Eastern Time. The July program, titled " Fourth Friday at Four - Zomedica's Sales Organization: From Strategy to the Clinic ," will give current .. ———————————————————————————————————————————————————————————— Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation 2026-07-15 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/15/3327527/0/en/Fractyl-Health-Reports-Positive-Randomized-Data-from-REMAIN-1-Midpoint-Cohort-Demonstrating-Durable-Weight-Maintenance-One-Year-After-GLP-1-Discontinuation.html Up to 84% of GLP-1 induced weight loss retained with Revita® versus 46% with sham at one year in patients receiving complete duodenal ablations ———————————————————————————————————————————————————————————— Recent Release, "I Was A Therapist," from Page Publishing Author Lila Karoub, Explores the Harrowing True Cases That Shaped Her Three-Decade Career in Mental Health 2026-07-15 · PR.com · Healthcare https://www.pr.com/press-release/973248 Lila Karoub has completed a new book, "I Was A Therapist": True Case Studies of Child Abuse, Attempted Murder, and Marital Torture, a candid examination of the most challenging and transformative moments from her decades as a practicing psychotherapist. Drawing from her clinical experience, Karoub recounts pivotal cases involving attempted homicide, severe childhood trauma, and intimate partner [PR.com] ———————————————————————————————————————————————————————————— First Vet Brings Trusted Veterinary Lab Testing in Doha for Better Pet Health 2026-07-15 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/15/1762759 Doha, Qatar – , 2026-07-15 — /EPR Network/ — First Vet is happy to offer trusted Veterinary Lab Testing in Doha for pets. The clinic [read full press release...] ———————————————————————————————————————————————————————————— Nxera Pharma Webinar for Financial Results Presentation - 2Q2026 2026-07-15 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/15/3327513/0/en/Nxera-Pharma-Webinar-for-Financial-Results-Presentation-2Q2026.html Tokyo, Japan and Cambridge and London, UK, 15 July 2026 – Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) will announce its earnings results and present operational highlights for 2Q 2026 on Friday, 7 August 2026. The Company will host a live webinar presentation with Chris Cargill (President, CEO), Hironoshin Nomura (CFO), Toshi Maeda (COO) and Patrik Foerch (CSO and President of Nxera Pharma UK), at 5:00 pm JST (9:00 am GMT) on Friday, 7 August 2026. The webinar is open to all existing and potential investors as well as sell-/buy-side analysts and will consist of a presentation followed by a Q&A session. Please click here to pre-register, which will provide a link to access the webinar. Presentation slides will be made available by 4:30 pm JST (8:30 am GMT) on 7 August 2026 through the inve ———————————————————————————————————————————————————————————— Cumulus Neuroscience Presents Data at AAIC 2026 Annual Meeting Showing a Two-Minute Digital Task Matches or Outperforms Clinical Benchmarks for Alzheimer's Trial Pre-enrichment 2026-07-15 · PR Newswire · SaaS, Healthcare https://www.prnewswire.com/news-releases/cumulus-neuroscience-presents-data-at-aaic-2026-annual-meeting-showing-a-two-minute-digital-task-matches-or-outperforms-clinical-benchmarks-for-alzheimers-trial-pre-enrichment-302826250.html Across three independent studies, the NeuLogiq® Platform two-minute tablet-based Symbol Swap task delivered clinically meaningful discrimination between control, MCI and Alzheimer's dementia groups and detected blood-biomarker-defined pathology — including in clinically normal individuals... ———————————————————————————————————————————————————————————— Are Survival Rates for Adults With Congenital Heart Disease Linked to Specialized Cardiac Care Access? 2026-07-15 · NewMediaWire · Healthcare, Retail https://www.newmediawire.com/news/are-survival-rates-for-adults-with-congenital-heart-disease-linked-to-specialized-cardiac-care-access-7087718 Research Highlights: In an analysis of the Global Burden of Disease Study compared with U.S. Census data from 1990-2021, researchers found that people with congenital heart disease living in states with lower average household incomes and fewer people with health insurance had higher rates of death and disability. The research authors hypothesize that this difference may be due to easier access to specialized care and treatment from adult congenital heart disease cardiologists in communities with higher income levels and more residents with health insurance. Congenital heart disease requires lifelong, regular access to specialized cardiac care. Expanding access to expert care, particularly in under-resourced regions of the U.S., could play a profound role in improving survival and quality ———————————————————————————————————————————————————————————— Form 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc 2026-07-15 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/15/3327503/0/en/Form-8-5-EPT-RI-Advanced-Medical-Solutions-Group-Plc.html FORM 8.5 (EPT/RI) ———————————————————————————————————————————————————————————— Luxury Spa in Norwalk CT Introduces Premium Facial & Skincare Treatments 2026-07-15 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/15/1762729 Norwalk, USA, 2026-07-15 — /EPR Network/ — Beautiful skin is more than a trend. It is a reflection of healthy care and self-confidence. Lzur Day [read full press release...] ———————————————————————————————————————————————————————————— Dr. David B. Hardin Honored as a Professional of the Year for Healthcare, Rehabilitation, and Wound Care by Strathmore's Who's Who Worldwide Publication 2026-07-15 · PR.com · Healthcare https://www.pr.com/press-release/973750 Dr. David B. Hardin of Noblesville, Indiana has been named Professional of the Year for Healthcare, Rehabilitation, and Wound Care by Strathmore's Who's Who Worldwide for his outstanding contributions and achievements in his field. About Dr. David B. Hardin Dr. David B. Hardin is a physician serving patients through his medical practice in Indiana, offering patient care and related services. With more than four decades [PR.com] ———————————————————————————————————————————————————————————— Pennington Biomedical, Our Lady of the Lake and Metamor Institute Show Promising Outcomes for Bariatric Surgery in Adolescents and Young Adults with Severe Obesity 2026-07-15 · PR.com · Healthcare https://www.pr.com/press-release/973631 Research collaboration highlights safe surgical outcomes and significant health improvements in young patients in Louisiana [PR.com] ———————————————————————————————————————————————————————————— NATIONAL UNIVERSITY HOSPITAL TO EXPAND WEARABLE TECHNOLOGY FOR PATIENT MONITORING FOLLOWING SUCCESSFUL PILOT 2026-07-15 · PR Newswire · Healthcare, Education https://www.prnewswire.com/news-releases/national-university-hospital-to-expand-wearable-technology-for-patient-monitoring-following-successful-pilot-302826140.html Continuous smartwatch monitoring shown to safely support post-surgical care, reducing disruptions for patients and easing nursing time for direct patient care SINGAPORE, July 14, 2026 /PRNewswire/ -- The National University Hospital (NUH) is set to expand the use of wearable technology... ———————————————————————————————————————————————————————————— Förderung einer kohlenstoffarmen Fertigung und globaler Nachhaltigkeitsverpflichtungen 2026-07-15 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/forderung-einer-kohlenstoffarmen-fertigung-und-globaler-nachhaltigkeitsverpflichtungen-302826054.html Der Bericht hebt saubere Energie, Innovation und ESG-Anerkennung hervor ZIBO, China, 15. Juli 2026 /PRNewswire/ -- INTCO Medical („das Unternehmen"), ein weltweit führender Hersteller von Einweghandschuhen, hat seinen ESG-Bericht (Umwelt, Soziales und Unternehmensführung) für 2025... ———————————————————————————————————————————————————————————— FDA grants Priority Review to Roche’s Gazyva/Gazyvaro for adults with primary membranous nephropathy 2026-07-15 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/15/3327447/0/en/FDA-grants-Priority-Review-to-Roche-s-Gazyva-Gazyvaro-for-adults-with-primary-membranous-nephropathy.html Basel, 15 July 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has granted Priority Review to the company’s supplemental Biologics License Application (sBLA) for Gazyva®/Gazyvaro® (obinutuzumab) for the treatment of primary membranous nephropathy (pMN). The priority review is based on the positive phase III MAJESTY results, which show superiority of Gazyva/Gazyvaro over an immunosuppressive therapy, tacrolimus, in adults with pMN. 1 The FDA has already granted Breakthrough Therapy Designation (BTD) to Gazyva/Gazyvaro in pMN and is expected to make a decision on approval by November 2026. This is the second indication in recent months for which the US FDA has granted priority review to Gazyva/Gazyvaro, following idiopathic nephrotic s ———————————————————————————————————————————————————————————— Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference 2026-07-15 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/15/3327452/0/en/Molecular-Partners-Showcases-Bispecific-Radio-DARPins-at-Gordon-Research-Conference.html ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today highlights its approaches to overcoming target limitations in radioligand therapy (RLT) through Radio-DARPins, in a presentation at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer in Newry, Maine, US. ———————————————————————————————————————————————————————————— Lake Park Dental Celebrates Gorgeous Grandma Day With a Toast to Milwaukee Smiles 2026-07-15 · PRUnderground · Healthcare https://www.prunderground.com/lake-park-dental-celebrates-gorgeous-grandma-day-with-a-toast-to-milwaukee-smiles/00388662/ This Gorgeous Grandma Day, Lake Park Dental in Milwaukee spotlights how modern, metal-free implants help women 55 and up smile with confidence again. The post Lake Park Dental Celebrates Gorgeous Grandma Day With a Toast to Milwaukee Smiles first appeared on ———————————————————————————————————————————————————————————— Closing of Previously Announced Restructuring Transaction in Connection with CCAA Proceedings 2026-07-15 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/15/3327442/0/en/Closing-of-Previously-Announced-Restructuring-Transaction-in-Connection-with-CCAA-Proceedings.html MONTREAL, July 14, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“ Premier Health” or the “Company” ) announces that, in connection with the restructuring proceedings initiated on June 23, 2026 by the Royal Bank of Canada (the “ Applicant ”) in its capacity as a secured creditor (the “ CCAA Proceedings ”) and the Court-approved restructuring transaction announced on July 3, 2026, Polar Valley Investments Limited (“ Polar ”) has successfully closed the acquisition of all of the equity interests in three affiliates of the Company, namely Solutions Staffing Inc. (“ SSI ”), Canadian Health Care Agency Ltd. (“ CHCA ”) and Premier Soin Nordik Inc. / Premier Health Nordik Inc. (“ Nordik Québec ”) (the “ Transaction ”). ———————————————————————————————————————————————————————————— Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants 2026-07-15 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/q32-bio-announces-pricing-of-200-million-public-offering-of-common-stock-and-pre-funded-warrants-302825849.html WALTHAM, Mass., July 14, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB), ("Q32 Bio") a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases, today announced the pricing of an underwritten... ———————————————————————————————————————————————————————————— QUINT Reviews 2026: Why Q.SCALP and Q.FACE Are Winning Over Buyers Seeking a Smarter Monthly Routine 2026-07-15 · Newswire.com · Healthcare https://www.newswire.com/news/quint-reviews-2026-why-q-scalp-and-q-face-are-winning-over-buyers-seeking-a As consumers look beyond demanding daily hair and skincare regimens, this QUINT review explores why Q.SCALP and Q.FACE are attracting attention, how the brand positions its once-monthly exosome-serum systems, and what buyers should confirm about pricing, subscriptions, FDA status, and guarantee terms before ordering. ———————————————————————————————————————————————————————————— Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants 2026-07-15 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/15/3327429/0/en/Crescent-Biopharma-Announces-Pricing-of-Public-Offering-of-Ordinary-Shares-and-Pre-Funded-Warrants.html WALTHAM, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced the pricing of its underwritten public offering of 8,094,793 ordinary shares and in lieu of ordinary shares to certain investors, pre-funded warrants to purchase up to 525,897 ordinary shares. The ordinary shares are being sold to the public at a price of $14.50 per share and the pre-funded warrants are being sold at a price to the public of $14.499 per pre-funded warrant, which represents the per ordinary share price less the $0.001 per share exercise price for each such pre-funded warrant. The gross proceeds to Crescent from the offering ———————————————————————————————————————————————————————————— Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) 2026-07-15 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/15/3327426/0/en/Tenaya-Therapeutics-Reports-Inducement-Grants-under-NASDAQ-Listing-Rule-5635-c-4.html SOUTH SAN FRANCISCO, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that it granted stock options to purchase 1,650,000 shares of Tenaya common stock to Eric Hyllengren, its newly appointed Chief Financial Officer, and an aggregate of 187,200 shares of Tenaya common stock to two new non-executive employees in connection with the commencement of their employment. ———————————————————————————————————————————————————————————— Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development 2026-07-15 · PR Newswire · AI, SaaS, Healthcare https://www.prnewswire.com/news-releases/insilico-medicine-and-bora-pharmaceuticals-announce-strategic-alliance-for-ai-driven-drug-discovery-and-development-302824911.html Combines Insilico's Pharma.AI platform with Bora's global development, manufacturing, quality, and commercialization capabilities to explore a next-generation drug innovation model CAMBRIDGE, Mass. and TAIPEI, July 14, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"; HKEX: 3696), a... ———————————————————————————————————————————————————————————— Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis 2026-07-15 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announces-completion-of-patient-enrollment-in-phase-iii-clinical-trial-of-zemprocitinib-for-ankylosing-spondylitis-302825302.html HANGZHOU, China and SHANGHAI and BOSTON, July 14, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that patient enrollment was completed on July 9... ———————————————————————————————————————————————————————————— Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/kelun-biotech-announces-phase-iii-study-of-sacituzumab-tirumotecan-sac-tmt-in-combination-with-pembrolizumab-as-first-line-treatment-for-pd-l1-negative-non-squamous-nsclc-met-primary-endpoint-302825316.html As a head-to-head Phase III trial comparing sac-TMT plus pembrolizumab with the first-line standard of care (immunotherapy plus chemotherapy), OptiTROP-Lung06 demonstrated the superiority of replacing conventional pemetrexed/platinum chemotherapy with sac-TMT, with significantly prolonged... ———————————————————————————————————————————————————————————— United Kingdom Digital Health Market Size to Reach USD 43.98 Billion by 2031, Driven by NHS Digitalization 2026-07-14 · GetNews · Healthcare https://www.getnews.info/story/2026/07/14/united-kingdom-digital-health-market-size-to-reach-usd-4398-billion-by-2031-driven-by-nhs-digitalization/?source=barchart ———————————————————————————————————————————————————————————— BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600 2026-07-14 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/brightspring-health-services-set-to-join-sp-midcap-400-and-karman-holdings-to-join-sp-smallcap-600-302825665.html NEW YORK, July 14, 2026 /PRNewswire/ -- S&P SmallCap 600 constituent BrightSpring Health Services Inc. (NASD: BTSG) will replace Chart Industries Inc. (NYSE: GTLS) in the S&P MidCap 400, and Karman Holdings Inc. (NYSE: KRMN) will replace BrightSpring Health Services in the S&P SmallCap... ———————————————————————————————————————————————————————————— AI Search Engineers Reports That Professional Service Businesses Using ... 2026-07-14 · PR-Inside · AI, Healthcare https://pr-inside.com/ai-search-engineers-reports-that-professional-service-businesses-using-r5201092.htm (PR-inside.com) The No. 1 AI certified agency and only AEO Verified agency in the United States releases comparative data showing that the integrated deployment of AI chatbots and Answer Engine Optimization produces three times more qualified leads for law firms, financial advisors, and medical practices than either system deployed independently. AMHERST, NY / ACCESS Newswire / July 14, 2026 / AI Search Engineers, the #1 AI certified agency and the only AEO Verified agency in the United States meeting all Tier 1 requirements under the AEO Differentiation Standard, today released comparative data documenting that professional service businesses deploying AI chatbots alongside Answer .. ———————————————————————————————————————————————————————————— AI Search Engineers Reports That Professional Service Businesses Using AI Chatbots Alongside Answer Engine Optimization See 3X More Qualified Leads Than Businesses Using Either System Alone 2026-07-14 · Newswire.com · AI, Healthcare https://www.newswire.com/news/ai-search-engineers-reports-that-professional-service-businesses-using-ai The No. 1 AI certified agency and only AEO Verified agency in the United States releases comparative data showing that the integrated deployment of AI chatbots and Answer Engine Optimization produces three times more qualified leads for law firms, financial advisors, and medical practices than either system deployed independently. ———————————————————————————————————————————————————————————— Cora Launches First Commercial, Raising the Standards for a New Generation 2026-07-14 · PR Newswire · Healthcare, Education https://www.prnewswire.com/news-releases/cora-launches-first-commercial-raising-the-standards-for-a-new-generation-302825649.html The clean period care brand launches its Back to School campaign, reimagining period care for Gen Z and Gen Alpha. NEW YORK, July 14, 2026 /PRNewswire/ -- For millions of people, health class was the introduction to period care and the message was clear: discomfort was just part of the... ———————————————————————————————————————————————————————————— Cardiovascular Logistics Names Dr. Gary Kirsh Chief Executive Officer 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/cardiovascular-logistics-names-dr-gary-kirsh-chief-executive-officer-302825509.html Veteran physician executive and former Solaris Health CEO to lead one of the nation's largest cardiology platforms NASHVILLE, Tenn., July 14, 2026 /PRNewswire/ -- Cardiovascular Logistics ("CVL" or the "Company"), one of the nation's leading cardiology management services organizations,... ———————————————————————————————————————————————————————————— Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer 2026-07-14 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/14/3327323/0/en/Celcuity-Announces-FDA-Approval-of-REVTORPYK-gedatolisib-for-the-Treatment-of-HR-HER2-PIK3CA-Wild-Type-Locally-Advanced-or-Metastatic-Breast-Cancer.html MINNEAPOLIS, July 14, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for multiple solid tumor indications, today announced that the U.S. Food and Drug Administration (“FDA”) approved REVTORPYK™ (gedatolisib) for the treatment of patients with hormone receptor positive (“HR+”), human epidermal growth factor receptor 2 negative (“HER2-”), locally advanced or metastatic breast cancer without a PIK3CA mutation detected following progression on or after treatment with at least one line of endocrine therapy in the metastatic setting. REVTORPYK is the only inhibitor of class I PI3K isoforms (α, β, δ, γ) and mTOR complexes mTORC1 and mTORC2 to receive FDA approval. ———————————————————————————————————————————————————————————— Public Health Groups, Pediatricians and Parents Sue FDA Over Policy Allowing the Marketing of Unauthorized E-Cigarettes and Nicotine Pouches 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/public-health-groups-pediatricians-and-parents-sue-fda-over-policy-allowing-the-marketing-of-unauthorized-e-cigarettes-and-nicotine-pouches-302825624.html WASHINGTON, July 14, 2026 /PRNewswire/ -- A coalition of public health organizations, pediatricians and parents today filed a federal lawsuit challenging the Food and Drug Administration's new enforcement policy that allows e-cigarette and nicotine pouch products to be marketed and sold... ———————————————————————————————————————————————————————————— Jack and Jill of America Opens Its Doors: 47th National Convention Brings Baltimore a Town Hall with Laura Coates and a Free Community Health & Resource Fair 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/jack-and-jill-of-america-opens-its-doors-47th-national-convention-brings-baltimore-a-town-hall-with-laura-coates-and-a-free-community-health--resource-fair-302825616.html National convening will connect families, uplift Baltimore leaders and strengthen pathways for the next generation through two free public events WASHINGTON, July 14, 2026 /PRNewswire/ -- Thousands of families will arrive in Baltimore from July 21–26 as Jack and Jill of America,... ———————————————————————————————————————————————————————————— Formycon AG and OneSource Specialty Pharma Announce Strategic Manufacturing Partnership for Biosimilars 2026-07-14 · NewMediaWire · Healthcare https://www.newmediawire.com/news/formycon-ag-and-onesource-specialty-pharma-announce-strategic-manufacturing-partnership-for-biosimilars-7087710 MUNICH, GERMANY and BANGALORE, INDIA - July 14, 2026 ( NEWMEDIAWIRE ) - Formycon AG (FSE: FYB, Prime Standard, “Formycon”) and OneSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE, “OneSource”), a multi-modality specialty pharma CDMO, today announced a strategic manufacturing partnership for biosimilars. Under the partnership, OneSource will serve as a strategic manufacturing partner for Formycon and provide integrated Drug Substance (DS) and Drug Product (DP) manufacturing capabilities from its state-of-the-art biologics’ facility in Bangalore, India. The collaboration brings together Formycon’s biosimilar development excellence with OneSource’s end-to-end biologics manufacturing expertise to support Formycon’s biosimilar programs for global markets. Dr. Stefan Glombitza, Chief ———————————————————————————————————————————————————————————— Chris Long Named President of Micross North America 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/chris-long-named-president-of-micross-north-america-302825611.html MELVILLE, N.Y., July 14, 2026 /PRNewswire/ -- Micross Components, Inc. ("Micross" or the "Company"), a global provider of high-reliability microelectronic products and services for aerospace, defense, space, medical, and industrial applications, and a portfolio company of Behrman Capital,... ———————————————————————————————————————————————————————————— Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call 2026-07-14 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/astrana-health-inc-schedules-2026-second-quarter-financial-results-release-and-conference-call-302825414.html ALHAMBRA, Calif., July 14, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality,... ———————————————————————————————————————————————————————————— Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test 2026-07-14 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/castle-biosciences-announces-new-york-state-department-of-health-approval-of-its-advancead-tx-test-302825462.html Approval expands access to Castle's precision medicine test designed to guide systemic treatment decision making in patients with moderate-to-severe atopic dermatitis FRIENDSWOOD, Texas, July 14, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health... ———————————————————————————————————————————————————————————— Clinical Based Evidence of Eminent Spine's 3D Printed Titanium Pedicle Screw 2026-07-14 · PR.com · Healthcare https://www.pr.com/press-release/973662 Eminent Spine, a leader in advanced 3D implant technology, releases the early clinical and implant results of the world's first FDA 510(k) approved 3D printed titanium pedicle screw. The proprietary 3D printed pedicle screw, designed and manufactured by Eminent Spine received FDA 501(k) clearance on April 28, 2025. The new novel 3D titanium printing cutting edge technology surpassed the FDA biomechanical testing critria. [PR.com] ———————————————————————————————————————————————————————————— Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy 2026-07-14 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/14/3327284/0/en/Mobia-Medical-Announces-Publication-of-Two-Year-Data-from-VNS-REHAB-Trial-Demonstrating-Durable-and-Continued-Stroke-Recovery-with-Vivistim-Paired-VNS-Therapy.html Findings published in Neurology® show improvements in upper-limb motor function, activities of daily living, and quality of life were sustained for at least two years Findings published in Neurology® show improvements in upper-limb motor function, activities of daily living, and quality of life were sustained for at least two years ———————————————————————————————————————————————————————————— SS Innovations International (SSII) CEO Outlines Strategy to Expand Affordable Robotic Surgery 2026-07-14 · NewMediaWire · Finance, AI, SaaS, Healthcare, Retail https://www.newmediawire.com/news/ss-innovations-international-ssii-ceo-outlines-strategy-to-expand-affordable-robotic-surgery-7087705 LOS ANGELES, CA - July 14, 2026 ( NEWMEDIAWIRE ) - For investors evaluating emerging medical technology companies, the competitive advantages behind a product can be as important as financial results. That was the focus of a recent Medsider interview with Dr. Sudhir Srivastava, founder, chairman and CEO of SS Innovations International (NASDAQ: SSII) , a developer of innovative surgical robotic technologies, who discussed the company’s strategy to broaden access to robotic surgery through lower-cost technology, physician training and remote surgical capabilities. Affordability and accessibility remain the company’s core priorities as it expands its surgical robotics platform globally, with artificial intelligence, automation, and new robotic platforms, remaining central to the company’s lon ———————————————————————————————————————————————————————————— Children's Hospital of Philadelphia Initiative Substantially Increases Naloxone Co-Prescribing when Outpatient Opioids Are Prescribed 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/childrens-hospital-of-philadelphia-initiative-substantially-increases-naloxone-co-prescribing-when-outpatient-opioids-are-prescribed-302825528.html Multidisciplinary initiative increased naloxone co-prescribing with outpatient opioid prescriptions from ———————————————————————————————————————————————————————————— Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases 2026-07-14 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/14/3327211/0/en/Cosmos-Health-Share-Buyback-Expands-to-4-49-Million-Shares-Continues-Open-Market-Repurchases.html Cosmos Health has now repurchased a total of approximately 4,488,000 shares for approximately $941,000. ———————————————————————————————————————————————————————————— Intermountain Health Dermatologist Discusses New FDA-Approved Sunscreen Ingredient 2026-07-14 · PRUnderground · Healthcare https://www.prunderground.com/intermountain-health-dermatologist-discusses-new-fda-approved-sunscreen-ingredient/00388638/ No matter the ingredient, Intermountain Health Dermatologists still emphasize importance of broad-spectrum sunscreens to protect from both UVA and UVB rays. The post Intermountain Health Dermatologist Discusses New FDA-Approved Sunscreen Ingredient first appeared on ———————————————————————————————————————————————————————————— Skilled Nursing Care Explained in HelloNation Article Featuring Senior Care Expert Rachel Baker 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/skilled-nursing-care-explained-in-hellonation-article-featuring-senior-care-expert-rachel-baker-302825492.html The article outlines key signs families should recognize when home care support is no longer enough for a loved one's safety and health. MASSILLON, Ohio, July 14, 2026 /PRNewswire/ -- What are the clear signs that a loved one may need skilled nursing care rather than continuing home care... ———————————————————————————————————————————————————————————— Savings of Up to 80% Drive Record Dental Travel to Mexico, 660,000 Monthly Border Crossings, MexicoSmile Finds 2026-07-14 · PR Newswire · Healthcare, Automotive https://www.prnewswire.com/news-releases/savings-of-up-to-80-drive-record-dental-travel-to-mexico-660-000-monthly-border-crossings-mexicosmile-finds-302825485.html Cost savings of 50% to 80% are the dominant driver of dental tourism per a 2025 Journal of International Oral Health systematic review; 660,000 crossing in December 2023 (Statista). MERIDA, Yucatan, July 14, 2026 /PRNewswire/ -- MexicoSmile Dental Tourism Clinic , a popular dental center... ———————————————————————————————————————————————————————————— From GLP-1 skepticism and skin health to Apple Watch and Oura loyalty -- 1,400 young consumers talk Health & Wellness on Cafeteria 2026-07-14 · PRWeb · SaaS, Healthcare, Retail https://www.prweb.com/releases/from-glp-1-skepticism-and-skin-health-to-apple-watch-and-oura-loyalty--1-400-young-consumers-talk-health--wellness-on-cafeteria-302825386.html The interactive report pulled together 240 hours of in-app, private text and voice notes about what Gen Next spends, what (and who) they trust, and which products start to feel like a scam. NEW YORK, July 14, 2026 /PRNewswire-PRWeb/ -- Cafeteria, the only consumer intelligence platform... ———————————————————————————————————————————————————————————— As Superintendents Return to Office, Avel eCare Highlights the School ... 2026-07-14 · PR-Inside · Healthcare, Education https://pr-inside.com/as-superintendents-return-to-office-avel-ecare-highlights-the-school-r5201029.htm (PR-inside.com) Avel eCare's Virtual Health System Connects School Staff to Experienced Nurses in Real Time, Closing Coverage Gaps for Students SIOUX FALLS, SD / ACCESS Newswire / July 14, 2026 / As superintendents and administrators return to their offices to prepare for the coming school year, many are once again confronting a persistent and often under-discussed problem: the majority of schools do not have consistent access to a school nurse. In their absence, office staff, teachers, and administrators are frequently left to manage health situations they are not trained or equipped to handle. Avel eCare, the Virtual Health System that has set the .. ———————————————————————————————————————————————————————————— AMRADNET UK now in the UK! 2026-07-14 · Pressat · Healthcare https://pressat.co.uk/releases/amradnet-uk-now-in-the-uk-c970fd76f9743f23b5890e52411fb777/ Tuesday 14 July, 2026 The UK does not need another teleradiology vendor. It needs diagnostic capacity partners who can help NHS Trusts and hospitals move patients from scan to answer faster.AMRADNET is launching in the UK with a different radiology offering that goes beyond teleradiology reporting and encompasses scanning, interventional support, and CDC partnership pathways to help reduce delays and deliver better outcomes. With 22 years of U.S. and international radiology experience, the company has supported care across a wide range of clinical settings, including hospitals, imaging centres, urgent care, nursing and rehabilitation facilities, outpatient practices, and complex care environments. Having completed several million studies across multiple modalities and exam types, it unders ———————————————————————————————————————————————————————————— Spinogenix Reports Positive Data on Alzheimer's Patients Who Continued Treatment With Tazbentetol For Up To 84 Weeks 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/spinogenix-reports-positive-data-on-alzheimers-patients-who-continued-treatment-with-tazbentetol-for-up-to-84-weeks-302825473.html Tazbentetol, a First-in-Class, Oral Synaptic Regenerative Investigational Therapy, Demonstrated Favorable Safety Profile and Durable Therapeutic Benefits Clinical Case Study Presented at AAIC Highlights Caregiver Report of Rapid Cognitive Improvement with Supporting Clinical Outcome... ———————————————————————————————————————————————————————————— Sandiola Introduces Sandpiper™, a Purpose-Built Clinical Documentation Integrity AI for Community Hospitals and Health Systems 2026-07-14 · PR Newswire · AI, Healthcare https://www.prnewswire.com/news-releases/sandiola-introduces-sandpiper-a-purpose-built-clinical-documentation-integrity-ai-for-community-hospitals-and-health-systems-302823399.html The optimal combination of technology and expert talent to ensure no patient acuity, earned reimbursement, or quality credit slips through the cracks. ENCINITAS, Calif., July 14, 2026 /PRNewswire/ -- Under the Inpatient Prospective Payment System, documentation is the payment. Every... ———————————————————————————————————————————————————————————— Royal Canin® Launches Its First Fresh Therapeutic Diet Portfolio Available Exclusively Through Veterinarians 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/royal-canin-launches-its-first-fresh-therapeutic-diet-portfolio-available-exclusively-through-veterinarians-302825457.html New portfolio combines fresh, fully-cooked ingredients with science-backed therapeutic nutrition, giving veterinarians an innovative option for dogs with unique needs ST. LOUIS, July 14, 2026 /PRNewswire/ -- Royal Canin®, a global leader in pet health nutrition and one of the... ———————————————————————————————————————————————————————————— Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe 2026-07-14 · PR.com · Healthcare https://www.pr.com/press-release/973561 Slimshot® recognized in Medical Devices & Technology Concept category; product selected for display at Red Dot Design Museum in Singapore. [PR.com] ———————————————————————————————————————————————————————————— Aguirre Medical Group Returns with a New Focus on Revenue Forecasting for Med Spas 2026-07-14 · PR.com · Finance, Healthcare https://www.pr.com/press-release/973356 Dallas-based Aguirre Medical Group returns with a new business model hyper-focused on revenue forecasting for medspas. Following the closure of its previous management services organization, founder AJ Aguirre is relaunching the company with a single service designed to make medical spa revenue more predictable. Cancer survivor and sobriety advocate, Aguirre will have a strong focus on not only company culture, but also [PR.com] ———————————————————————————————————————————————————————————— Veterinary Referral Center of Central Oregon Expands Access to Advanced ... 2026-07-14 · PR-Inside · Healthcare https://pr-inside.com/veterinary-referral-center-of-central-oregon-expands-access-to-advanced-r5201014.htm (PR-inside.com) BEND, OR / ACCESS Newswire / July 14, 2026 / The Veterinary Referral Center of Central Oregon (VRCCO) is proud to announce the expansion of its personalized medical travel program, designed to break down geographical barriers and streamline access to advanced, life-saving veterinary specialty and emergency care for families across the Pacific Northwest and beyond. Seeking advanced medical care for a pet often requires traveling significant distances. Recognizing the challenges of long-distance medical travel, VRCCO has built a comprehensive support system that accommodates the logistics of travel, allowing pet parents to focus entirely on their animal's recovery and well-being. "When a pet .. ———————————————————————————————————————————————————————————— Veterinary Referral Center of Central Oregon Expands Access to Advanced Care with Enhanced Medical Travel Program 2026-07-14 · Newswire.com · Healthcare https://www.newswire.com/news/veterinary-referral-center-of-central-oregon-expands-access-to-22823017 ———————————————————————————————————————————————————————————— Dr. Patrick Ojo, Author of FREEDOM FOR PHARMACY, Signs Publishing Agreement With Brick Tower Press as Negotiated by Creative Management Partners (CMP) Agent Alan Morell 2026-07-14 · NewMediaWire · Retail, Education, Healthcare https://www.newmediawire.com/news/dr-patrick-ojo-author-of-freedom-for-pharmacy-signs-publishing-agreement-with-brick-tower-press-as-negotiated-by-creative-management-partners-cmp-agent-alan-morell-7087700 - CMP Will Represent Dr. Ojo's Commercial Rights Across All Platforms BEVERLY HILLS, CA - July 14, 2026 ( NEWMEDIAWIRE ) - Announced today, Dr. Patrick Ojo, Author of FREEDOM FOR PHARMACY, signs Publishing Agreement with Brick Tower Press as Negotiated by Creative Management Partners (CMP) Agent Alan Morell signs with Creative Management Partners (CMP) Agent Alan Morell. CMP will represent Dr. Ojo Commercial Rights Across All Platforms. These include literary works, including a sequel to FREEDOM FOR PHARMACY , broadcast, adaptation of his book to a docuseries, speaking engagements, endorsements, advisory roles with online courses, and licensing. ABOUT DR. PATRICK OJO: Dr. Patrick Ojo was born and brought up in Benin City, Nigeria, Africa. He attended Benin Baptist Model Primary School, Evb ———————————————————————————————————————————————————————————— Vadzo Introduces Falcon-821CRS as AI Patient Monitoring Camera with 4K HDR for Contactless Vital Sign Monitoring Under Variable Clinical Lighting 2026-07-14 · Newswire.com · AI, SaaS, Healthcare https://www.newswire.com/news/vadzo-introduces-falcon-821crs-as-ai-patient-monitoring-camera-with-4k-22825233 The Falcon-821CRS is an 8MP color camera built on the Onsemi AR0821 sensor for contactless patient monitoring in hospitals and care facilities. It captures native 4K resolution with HDR and auto exposure across a single USB 3.2 GEN 1 connection for AI based on vital sign extraction and fall detection. It supports Windows, Linux, and Android through native UVC drivers in a compact S-Mount form factor suited for ceiling, wall, and bedside cart integration. ———————————————————————————————————————————————————————————— Coming Soon: A New AI-Powered Health Companion on Your Wrist 2026-07-14 · WebWire · AI, Healthcare https://www.webwire.com/ViewPressRel.asp?aId=357662 AI Summary - - - • Samsung will unveil the next evolution of Galaxy Watch at Galaxy Unpacked on July 22, expanding AI-powered health support across the ecosystem. - - - - - - • The new Galaxy Watch delivers AI-driven insights in real time, supporting Samsung's vision for a health-first, always-on device for personalized AI and connected wellness. - - - - As AI becomes an integral part of daily life, mobile devices serve as the primary entry point for unlocking its full potential. What... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357662 ———————————————————————————————————————————————————————————— Doceree Unveils Semmelweis: The First AI Model Purpose-Built for Pharma Commercialization 2026-07-14 · PR Newswire · AI, Healthcare https://www.prnewswire.com/news-releases/doceree-unveils-semmelweis-the-first-ai-model-purpose-built-for-pharma-commercialization-302825341.html General AI is built to be right about everything. Semmelweis is built to be right about the next prescription. The first-generation model is the intelligence layer beneath Daily Command and the Doceree product suite — and the first in a series named for the unsung pioneers of medicine.... ———————————————————————————————————————————————————————————— MNA: Baystate Franklin Nurses Cite Safety Risks in DPH Complaint Over Cuts to Patient Transport Services, Will Hold Press Conference July 16 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/mna-baystate-franklin-nurses-cite-safety-risks-in-dph-complaint-over-cuts-to-patient-transport-services-will-hold-press-conference-july-16-302825344.html Following their DPH complaint, nurses will hold a press conference on July 16 highlighting the need for safe staffing and contractual patient care protection GREENFIELD, Mass., July 14, 2026 /PRNewswire/ -- Registered nurses at Baystate Franklin Medical Center (BFMC), represented by the... ———————————————————————————————————————————————————————————— /C O R R E C T I O N -- O Positiv Health/ 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/o-positiv-health-introduces-new-gummy-format-of-1-best-selling-uro-vaginal-probiotic-302824151.html /C O R R E C T I O N – O Positiv Health/ In the news release, O Positiv Health Introduces New Gummy Format Of #1 Best-Selling URO Vaginal Probiotic, issued July 14, 2026 by O Positiv Health over PR Newswire, we are advised by the company that changes have been made. The complete,... ———————————————————————————————————————————————————————————— bioMérieux to Showcase Company's Latest in Diagnostic Innovations at ADLM 2026 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/biomerieux-to-showcase-companys-latest-in-diagnostic-innovations-at-adlm-2026-302825334.html ANAHEIM, Calif., July 14, 2026 /PRNewswire/ -- bioMérieux, a global leader in in vitro diagnostics, today announced it will showcase its latest diagnostic solutions and innovations at the 2026 Association for Diagnostics & Laboratory Medicine (ADLM) Annual Conference & Clinical Lab Expo,... ———————————————————————————————————————————————————————————— Doceree Launches Daily Command: The First Commercial Operating System for Pharma, Powered by Semmelweis 2026-07-14 · PR Newswire · AI, Healthcare https://www.prnewswire.com/news-releases/doceree-launches-daily-command-the-first-commercial-operating-system-for-pharma-powered-by-semmelweis-302825330.html Built by 75. Proven by 5. Launched to the industry. Daily Command orchestrates the entire commercialization journey — physician awareness to filled prescription, every channel and format, including generative AI — and closes the loop from activation to outcome, all from a single... ———————————————————————————————————————————————————————————— LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment 2026-07-14 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/14/3327109/0/en/LEQEMBI-Real-World-LEADER-Study-Presented-at-AAIC-2026-Finds-Over-75-of-Early-Alzheimer-s-Patients-Enrolled-in-the-Study-Remained-Stable-and-Nearly-7-Improved-Over-an-Average-of-17.html Real-World Findings Support Long-Term Benefits of Continuous Treatment with LEQEMBI and Provide Important Insights into Treatment Experience Outside of a Clinical Trial Setting Real-World Findings Support Long-Term Benefits of Continuous Treatment with LEQEMBI and Provide Important Insights into Treatment Experience Outside of a Clinical Trial Setting ———————————————————————————————————————————————————————————— Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ... 2026-07-14 · PR-Inside · Finance, Healthcare https://pr-inside.com/bronstein-gewirtz-grossman-llc-announces-an-investigation-against-r5200955.htm (PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 14, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE:HIMS). Investors who purchased Hims & Hers securities prior to April 1, 2025, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/HIMS. Hims & Hers Investigation Details The investigation concerns whether Hims & Hers and certain of its officers and/or directors have engaged in corporate wrongdoing. What's Next for Hims & Hers Investors? If .. ———————————————————————————————————————————————————————————— Renew Labs Receives Accreditation from the College of American Pathologists 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/renew-labs-receives-accreditation-from-the-college-of-american-pathologists-302824973.html PLEASANT GROVE, Utah, July 14, 2026 /PRNewswire/ -- Renew Labs, the clinical laboratory division of Renew Biotechnologies, has been awarded accreditation by the College of American Pathologists (CAP) Accreditation Committee based on the results of a recent on-site inspection. CAP... ———————————————————————————————————————————————————————————— AIAI Holdings' MediGuide Enters the State-of-the-Art Medicine Market ... 2026-07-14 · PR-Inside · Finance, AI, Healthcare https://pr-inside.com/aiai-holdings-mediguide-enters-the-state-of-the-art-medicine-market-r5200940.htm (PR-inside.com) Leveraging Advanced Diagnostics and Screenings to Provide Personalized Proactive Care DALLAS, TX / ACCESS Newswire / July 14, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today announced that its portfolio company, MediGuide, has launched a state of the art (SOTA) precision healthcare solution that combines advanced medical intelligence, expert clinical review, and AI-enabled diagnostic support to enable more personalized, data-driven medical decision-making. The launch represents another milestone in MediGuide's innovation roadmap and reflects AIAI Holdings' strategy of supporting portfolio companies that responsibly integrate advanced ———————————————————————————————————————————————————————————— Solutech Helps Radiation Oncology Practices Lower Equipment Service ... 2026-07-14 · PR-Inside · Healthcare https://pr-inside.com/solutech-helps-radiation-oncology-practices-lower-equipment-service-r5200913.htm (PR-inside.com) Independent service model helps providers reduce linear accelerator maintenance expenses while protecting uptime and patient access PLANO, TX / ACCESS Newswire / July 14, 2026 / Radiation oncology providers are facing new financial pressure following 2026 Medicare coding and reimbursement changes and the steadily rising OEM service and maintenance costs, forcing many practices to examine operating costs while trying to preserve access to cancer care in their communities. Effective Jan. 1, the Centers for Medicare & Medicaid Services, or CMS, implemented significant changes to radiation treatment delivery and image guidance codes. The American Society for Radiation Oncology, or ASTRO, reported in a .. ———————————————————————————————————————————————————————————— MPAI Publishes “AI for Health” and “Neural Network Watermarking- Technologies” 2026-07-14 · PR.com · AI, SaaS, Healthcare https://www.pr.com/press-release/969092 MPAI has concluded its 68th General Assembly (MPAI-68) publishing AI for Health (MPAI-AIH) – Health Secure Platform (AIH-HSP) and Neural Network Watermarking (MPAI-NNW) – Technologies (TEC)” as MPAI Standards. [PR.com] ———————————————————————————————————————————————————————————— Marquis Who's Who Interviews and Honors Timothy P. Lantz for Leadership ... 2026-07-14 · PR-Inside · Healthcare, Retail https://pr-inside.com/marquis-who-s-who-interviews-and-honors-timothy-p-lantz-for-leadership-r5200905.htm (PR-inside.com) MEQUON, WI / ACCESS Newswire / July 14, 2026 / Marquis Who's Who is proud to interview and honor Timothy P. Lantz for his distinguished contributions to health care technology, e-commerce, business leadership, entrepreneurship and community impact. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility and prominence in a field are all taken into account during the selection process. In Mr. Lantz's case, that recognition reflects a career defined by people-first leadership, strategic growth, innovation and a commitment to building businesses that .. ———————————————————————————————————————————————————————————— Marquis Who's Who Interviews and Honors Theresa Porcaro for Leadership ... 2026-07-14 · PR-Inside · Finance, Healthcare, Education https://pr-inside.com/marquis-who-s-who-interviews-and-honors-theresa-porcaro-for-leadership-r5200903.htm (PR-inside.com) NORTH KINGSTOWN, RI / ACCESS Newswire / July 14, 2026 / Marquis Who's Who is proud to interview and honor Theresa Porcaro for her distinguished contributions to strategic healthcare marketing, growth leadership, patient acquisition and women's health advocacy. Ms. Porcaro's recognition reflects a career defined by adaptability, continuous learning, empathy and a powerful commitment to helping patients feel seen, heard and supported. Ms. Porcaro currently serves as vice president of growth and marketing at Pelvic Rehabilitation Medicine (PRM), where she leads national growth, patient acquisition and digital transformation for one of the nation's leading specialty healthcare organizations focused exclusively on pelvic .. ———————————————————————————————————————————————————————————— Freedom Rhymer Poetry Event Inspires Community of Healing and Powerful Self-Expression 2026-07-14 · PR.com · Healthcare https://www.pr.com/press-release/969297 Local poets take center stage in an intimate slam competition celebrating creative triumph, art, and poetry as a vital public health initiative for community mental health and healing. [PR.com] ———————————————————————————————————————————————————————————— VSee Health Vision for AI-Enabled Enterprise Infrastructure as the ... 2026-07-14 · PR-Inside · Finance, AI, SaaS, Healthcare https://pr-inside.com/vsee-health-vision-for-ai-enabled-enterprise-infrastructure-as-the-r5200895.htm (PR-inside.com) VSEE's Telehealth Platform is Positioned at the Center of Healthcare's AI Transformation HOUSTON, TX / ACCESS Newswire / July 14, 2026 / VSee Health, Inc. (Nasdaq:VSEE) ("VSee" or the "Company"), a leading provider of enterprise telehealth solutions for hospitals and health systems, today shared its strategic initiatives and perspective on the role of artificial intelligence in healthcare and why enterprise telehealth platforms are well positioned to serve as the infrastructure layer for that transformation. "We believe healthcare is entering a new technology cycle in which artificial intelligence becomes an operating layer, rather than simply another application," said Dr. Imoigele Aisiku, Chairman and .. ———————————————————————————————————————————————————————————— VSee Health Vision for AI-Enabled Enterprise Infrastructure as the Next Frontier of Hospital Operations 2026-07-14 · Newswire.com · AI, SaaS, Healthcare https://www.newswire.com/news/vsee-health-vision-for-ai-enabled-enterprise-infrastructure-as-the-next VSEE's Telehealth Platform is Positioned at the Center of Healthcare's AI Transformation ———————————————————————————————————————————————————————————— Clinicians Have Become Healthcare's Human Middleware, New Vendor-Agnostic ... 2026-07-14 · PR-Inside · AI, Healthcare https://pr-inside.com/clinicians-have-become-healthcare-s-human-middleware-new-vendor-agnostic-r5200885.htm (PR-inside.com) EHR fragmentation, payer demands and unproven AI efficiencies are adding hidden labor across clinical workflows CHICAGO, IL / ACCESS Newswire / July 14, 2026 / Black Book Research today releasedThe Work That Didn't Disappear: The Black Book Clinician Reality Index , a nine-month national study finding that healthcare technology is frequently shifting work to clinicians rather than eliminating it. The vendor-agnostic survey of 1,919 clinicians found that 80.7% use at least one workaround every day, while 65.2% lose 30 minutes or more per day or shift to avoidable digital work. Clinicians reported repeatedly re-entering information, reconciling external records, monitoring disconnected queues, checking payer .. ———————————————————————————————————————————————————————————— Clinicians Have Become Healthcare's Human Middleware, New Vendor-Agnostic Report Finds from Black Book Research 2026-07-14 · Newswire.com · AI, Healthcare https://www.newswire.com/news/clinicians-have-become-healthcares-human-middleware-new-vendor-agnostic-report EHR fragmentation, payer demands and unproven AI efficiencies are adding hidden labor across clinical workflows ———————————————————————————————————————————————————————————— Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform 2026-07-14 · GlobeNewswire · Finance, AI, SaaS, Healthcare https://www.globenewswire.com/news-release/2026/07/14/3326873/0/en/Silo-Pharma-s-QwikAgents-Joins-AMD-AI-Developer-Program-to-Advance-Enterprise-AI-Agent-Platform.html Access to AMD Developer Cloud credits, AI development tools and technical resources to support next-generation enterprise AI agents Access to AMD Developer Cloud credits, AI development tools and technical resources to support next-generation enterprise AI agents ———————————————————————————————————————————————————————————— New Research Reveals Major Communication Gap Between Health Plans and New Mothers 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/new-research-reveals-major-communication-gap-between-health-plans-and-new-mothers-302824037.html More than half of new mothers don't fully understand their care plans, while health plan leaders rank member engagement and navigation as a top maternal health priority BALTIMORE, July 14, 2026 /PRNewswire/ -- More communication doesn't necessarily mean better communication for pregnant... ———————————————————————————————————————————————————————————— MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer’s Disease and Dementia 2026-07-14 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/14/3326864/0/en/MediPharm-Labs-Announces-Positive-Phase-II-LiBBY-Trial-Results-Demonstrating-Significant-Reduction-in-Agitation-Associated-With-Advanced-Alzheimer-s-Disease-and-Dementia.html TORONTO, July 14, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specializing in precision-based cannabinoids, today announced positive results from the Phase II LiBBY (Life’s End Benefits of Cannabidiol and Tetrahydrocannabinol) clinical trial evaluating the Company’s proprietary oral cannabinoid formulation for the treatment of agitation in patients with advanced dementia. The results were presented by the LiBBY team at AAIC in London, United Kingdom on July 14, 2026. ———————————————————————————————————————————————————————————— SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI) 2026-07-14 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/14/3326859/0/en/SeaStar-Medical-Supports-Advances-in-Critical-Care-of-Pediatric-Patients-with-Acute-Kidney-Injury-AKI.html Sponsors educational summit of leading pediatric AKI health care experts ———————————————————————————————————————————————————————————— Vitalist to Participate in a Fireside Chat at the Health, Wellness & Longevity Conference Presented by Maxim Group 2026-07-14 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/14/3326840/0/en/Vitalist-to-Participate-in-a-Fireside-Chat-at-the-Health-Wellness-Longevity-Conference-Presented-by-Maxim-Group.html CALGARY, Alberta, July 14, 2026 (GLOBE NEWSWIRE) -- Vitalist Inc. ( TSX-V: VITA.V ; OTCQB: VTLSF ) (" Vitalist "), is pleased to announce that Company CEO Kalvie Legat and CSO Charles Herman will participate in a virtual fireside chat at the Health, Wellness & Longevity Conference presented by Maxim Group on Wednesday, July 22. ———————————————————————————————————————————————————————————— Medical Care Technologies Inc. (OTC PINK:MDCE) Snapshot Recipes AI ... 2026-07-14 · PR-Inside · AI, Healthcare, Retail https://pr-inside.com/medical-care-technologies-inc-otc-pink-mdce-snapshot-recipes-ai-r5200876.htm (PR-inside.com) First 24 Hours of Performance Ads Match Lifetime Downloads - Positioning for Accelerated Consumer Growth MESA, AZ / ACCESS Newswire / July 14, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a major evolution for its popular AI-powered mobile app, Snapshot Recipes, introducing a new freemium model designed to dramatically expand user access while accelerating growth. Download Snapshot Recipes for free now: https://snapshotrecipes.app/get/ Snapshot Recipes empowers users to create instant, personalized recipes by simply snapping a photo of their groceries, open fridge, ingredients, a saved meal image, or even a screenshot from social media. The app instantly delivers chef-inspired recipes with .. ———————————————————————————————————————————————————————————— Medical Care Technologies Inc. (OTC PINK:MDCE) Snapshot Recipes AI Powered Mobile App Hits New Milestone with Freemium Model and Strong Marketing Results 2026-07-14 · Newswire.com · AI, Healthcare, Retail https://www.newswire.com/news/medical-care-technologies-inc-otc-pink-mdce-snapshot-recipes-ai-powered-mobile First 24 Hours of Performance Ads Match Lifetime Downloads - Positioning for Accelerated Consumer Growth ———————————————————————————————————————————————————————————— Ensysce Biosciences Awarded $5.3 Million Installment in NIDA Funding ... 2026-07-14 · PR-Inside · Finance, Healthcare https://pr-inside.com/ensysce-biosciences-awarded-5-3-million-installment-in-nida-funding-r5200872.htm (PR-inside.com) Funds Advance FDA-Designated Breakthrough Therapy First-in-Class Opioid with Oral Overdose-Protection SAN DIEGO, CA / ACCESS Newswire / July 14, 2026 /Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company pioneering next-generation pain and central nervous system therapeutics engineered to minimize abuse and overdose risk, today announced receipt of a Notice of Award for $5.3 million from the National Institutes on Drug Abuse (NIDA)1 to support the development of its novel MPAR® (Multi-Pill Abuse Resistance) overdose-protection technology, and the lead agent, PF614-MPAR. This marks the third consecutive year of NIDA funding under this award, reflecting sustained institutional confidence in .. ———————————————————————————————————————————————————————————— Modular Medical Announces Completion of Research Initiative Indicating ... 2026-07-14 · PR-Inside · Finance, Healthcare, Education https://pr-inside.com/modular-medical-announces-completion-of-research-initiative-indicating-r5200870.htm (PR-inside.com) 97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved Outcomes Conducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tubeless Insulin Patch Pump Company to Showcase Pivot at Association of Diabetes Care & Education Specialists (ADCES) Annual Conference, August 7-10, 2026 SAN DIEGO, CA / ACCESS Newswire / July 14, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company that is commercializing the next generation of insulin delivery technology, today announced positive findings from a new comprehensive diabetes patient research initiative further supporting its commercialization strategy. The .. ———————————————————————————————————————————————————————————— Ensysce Biosciences Awarded $5.3 Million Installment in NIDA Funding Completing Multi-Year $15 Million Federal Grant 2026-07-14 · Newswire.com · Finance, Healthcare https://www.newswire.com/news/ensysce-biosciences-awarded-5-3-million-installment-in-nida-funding-completing Funds Advance FDA-Designated Breakthrough Therapy First-in-Class Opioid with Oral Overdose-Protection ———————————————————————————————————————————————————————————— ESS Clinical Launches MSP Program to Help Districts Manage Coverage and Compliance for Critical Student Services 2026-07-14 · PRWeb · Healthcare, Education https://www.prweb.com/releases/ess-clinical-launches-msp-program-to-help-districts-manage-coverage-and-compliance-for-critical-student-services-302823207.html ESS has launched ESS Clinical MSP, a Managed Service Provider program that helps K-12 school districts simplify the management of clinical and related services. The program serves as a single point of contact for sourcing licensed specialists, coordinating vendors, tracking credentials... ———————————————————————————————————————————————————————————— Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery 2026-07-14 · Newswire.com · Healthcare, Education https://www.newswire.com/news/modular-medical-announces-completion-of-research-initiative-indicating-strong 97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved Outcomes Conducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tubeless Insulin Patch Pump Company to Showcase Pivot at Association of Diabetes Care & Education Specialists (ADCES) Annual Conference, August 7-10, 2026 ———————————————————————————————————————————————————————————— SONATA Launches as a New Doctor-Led Preventive Healthcare Membership Bridging the Gap Between Deep Testing and Personalized Care 2026-07-14 · PR Newswire · AI, Healthcare https://www.prnewswire.com/news-releases/sonata-launches-as-a-new-doctor-led-preventive-healthcare-membership-bridging-the-gap-between-deep-testing-and-personalized-care-302824195.html Launching in New York, San Francisco, and Los Angeles, SONATA combines deep clinical testing, dedicated physicians, and clinical AI to help members build a fuller picture of their health and take action before disease starts. NEW YORK, July 14, 2026 /PRNewswire/ -- SONATA, offering a... ———————————————————————————————————————————————————————————— Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress 2026-07-14 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/14/3326747/0/en/Hemab-Therapeutics-Presents-Clinical-and-Preclinical-Data-from-Sutacimig-in-Glanzmann-Thrombasthenia-and-Factor-VII-Deficiency-at-the-ISTH-2026-Congress.html Sutacimig Phase 2 long-term extension (LTE) data show sustained bleed reduction and manageable safety and tolerability; Phase 3 initiation planned 2H 2026 ———————————————————————————————————————————————————————————— Médunik Canada becomes exclusive distributor of INCRELEX® in Canada, strengthening support for children with a rare growth disorder 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/medunik-canada-becomes-exclusive-distributor-of-increlex-in-canada-strengthening-support-for-children-with-a-rare-growth-disorder-302824220.html BLAINVILLE, QC, July 14, 2026 /PRNewswire/ - Médunik Canada, a Canadian owned and operated pharmaceutical company dedicated to improving the health and quality of life of people living with rare and debilitating diseases, part of Duchesnay Pharmaceutical Group, is pleased to announce that... ———————————————————————————————————————————————————————————— CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB) 2026-07-14 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/14/3326737/0/en/CervoMed-Announces-New-Clinical-Plasma-Biomarker-and-Imaging-Data-at-AAIC-2026-for-Neflamapimod-in-the-Treatment-of-Dementia-with-Lewy-Bodies-DLB.html BOSTON, July 14, 2026 (GLOBE NEWSWIRE) -- CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB) ———————————————————————————————————————————————————————————— Fistula Foundation Delivers More Than 5,500 Life-Changing Surgeries to Women Across 23 Provinces in the Democratic Republic of Congo in One Year 2026-07-14 · PRWeb · Healthcare https://www.prweb.com/releases/fistula-foundation-delivers-more-than-5-500-life-changing-surgeries-to-women-across-23-provinces-in-the-democratic-republic-of-congo-in-one-year-302823205.html Expanded program increases access to care, strengthens local health systems across more than 40 hospitals nationwide SAN JOSE, Calif., July 14, 2026 /PRNewswire-PRWeb/ -- Fistula Foundation today announced impressive, countrywide results one year into an expanded effort to reach women... ———————————————————————————————————————————————————————————— Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring 2026-07-14 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/14/3326729/0/en/Plus-Therapeutics-Highlights-NCCN-CNS-Cancers-Guidelines-Update-and-Reinforces-Clinical-Role-of-CNSide-in-Leptomeningeal-Metastases-Monitoring.html Updated NCCN language continues to support CSF analysis in the diagnosis and management of leptomeningeal metastases, including CSF cytology follow-up every 4 to 8 weeks for patients receiving intrathecal therapy, to enable longitudinal patient monitoring Updated NCCN language continues to support CSF analysis in the diagnosis and management of leptomeningeal metastases, including CSF cytology follow-up every 4 to 8 weeks for patients receiving intrathecal therapy, to enable longitudinal patient monitoring ———————————————————————————————————————————————————————————— Cypress Health Partners Releases 2025 DPT Student Experience Survey Highlighting Rising Debt Concerns, Career Pressures, and Long-Term Opportunities in Physical Therapy 2026-07-14 · PRWeb · Healthcare, Education https://www.prweb.com/releases/cypress-health-partners-releases-2025-dpt-student-experience-survey-highlighting-rising-debt-concerns-career-pressures-and-long-term-opportunities-in-physical-therapy-302823203.html Survey of 673 DPT students across 23 programs reveals growing concerns about PT school ROI, student debt, mentorship, and career growth pathways BOSTON, July 14, 2026 /PRNewswire-PRWeb/ -- Cypress Health Partners, today released the findings of its 2025 DPT Student Experience Survey, a... ———————————————————————————————————————————————————————————— Was My Pet Treated as Promised? APPCC Urges Owners to Ask Before Arranging Cremation 2026-07-14 · Pressat · Healthcare https://pressat.co.uk/releases/was-my-pet-treated-as-promised-appcc-urges-owners-to-ask-before-arranging-cremation-fd6999d29a57b955b029c2fc2b189339/ Tuesday 14 July, 2026 Distressing social media images & subsequent investigation prompt calls for greater transparency over how pets are collected, stored, identified and cremated. Pet owners and veterinary practices are being urged to ask tougher questions about what really happens after a pet is handed over for cremation. The Association of Private Pet Cemeteries and Crematoria, APPCC, says recent distressing images shared widely on social media have caused understandable horror among pet owners. The APPCC will not comment on any individual business, person or unverified circumstances, but says the public reaction highlights a much bigger issue. Herefordshire Council has confirmed that a multi-agency inquiry is under way. The council says it is working with the Animal and Plant Health Ag ———————————————————————————————————————————————————————————— Syngenta and Groundwork BioAg enter partnership to bring innovation in biologicals and soil carbon solutions to farmers 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/syngenta-and-groundwork-bioag-enter-partnership-to-bring-innovation-in-biologicals-and-soil-carbon-solutions-to-farmers-302824931.html New strategic partnership combines advanced biological crop performance and soil health solution with carbon credit program Carbon program to be launched in Latin America and Europe Product distribution to include multiple other markets MAZOR, Israel, July 14, 2026 /PRNewswire/ --... ———————————————————————————————————————————————————————————— Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/atrium-therapeutics-announces-fda-clearance-of-investigational-new-drug-application-for-atr-1072-for-treatment-of-prkag2-syndrome-302824844.html -- ATR 1072 is the company's first precision cardiology program to enter the clinic -- -- Corventis™ will be the first clinical trial for people living with PRKAG2 syndrome that evaluates a potential treatment for the underlying cause of the disease -- SAN DIEGO, July 14, 2026... ———————————————————————————————————————————————————————————— Haoxi Health Technology Limited Announces Strategic Cooperation Framework with NOVA MEDIA to Develop An AI Digital Marketing System 2026-07-14 · GlobeNewswire · Finance, AI, Healthcare https://www.globenewswire.com/news-release/2026/07/14/3326680/0/en/Haoxi-Health-Technology-Limited-Announces-Strategic-Cooperation-Framework-with-NOVA-MEDIA-to-Develop-An-AI-Digital-Marketing-System.html BEIJING, July 14, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), a Beijing-headquartered online marketing solutions provider specializing in one-stop digital marketing services for the health and wellness industry, today announced the signing of a strategic cooperation framework agreement with NOVA MEDIA, a technology company with expertise in AI digital humans and generative AI. ———————————————————————————————————————————————————————————— Medical Imaging Market Future Demand Analysis 2026-07-14 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/14/1762647 The global medical imaging market was valued at USD 43.5 billion in 2025 and is projected to grow from USD 45.5 billion in 2026 to USD 64.7 [read full press release...] ———————————————————————————————————————————————————————————— Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties 2026-07-14 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/14/3326666/0/en/Spero-Therapeutics-Announces-105-Million-Non-Recourse-Non-Dilutive-Financing-Backed-by-a-Portion-of-Utebzi-Milestones-Royalties.html CAMBRIDGE, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, today announced a $105 million non-recourse non-dilutive royalty financing transaction with affiliates of Healthcare Royalty, a business of KKR (HCRx). Under the agreement, HCRx will receive a portion of future milestone and royalty payments associated with sales of Utebzi™ (tebipenem pivoxil). The proceeds will primarily be used to support advancement of Spero’s lead immunology drug candidate, SP001, a Phase 2-ready, Fc-silent, third-generation anti-CD40L monoclonal antibody with potential for development across a range of immune-mediated diseases. ———————————————————————————————————————————————————————————— "Nursing is for Me, Mom - What's Next?" from LA Fridlington Introduces Young Readers to the Diverse Career Pathways Available Within the Nursing Profession 2026-07-14 · PR.com · Healthcare, Education https://www.pr.com/press-release/973150 LA Fridlington has completed a new book, "Nursing is for Me, Mom - What's Next?: Teddy Learns about the Many Roles of a Nurse," which follows Teddy's journey through a school career fair where an engaging nurse mentor reveals the breadth of opportunities in healthcare. Through this narrative, readers discover that nursing extends far beyond hospital walls—into community settings, traveling positions, and [PR.com] ———————————————————————————————————————————————————————————— Legacy Youth Zone Golf Day Raises Over £80,000 for Young People Across Croydon 2026-07-14 · Pressat · Healthcare, Education https://pressat.co.uk/releases/legacy-youth-zone-golf-day-raises-over-80000-for-young-people-across-croydon-b2efe860a69156de010c089a375d3ec0/ Tuesday 14 July, 2026 Legacy Youth Zone Croydon is delighted to announce that its annual Golf Day, organised by Trustee Indy Chatwal, Managing Director of I See Apps, has raised more than £80,000 to support thousands of local young people. Held on Wednesday 24 June at the prestigious The Addington Golf Course, the event brought together more than 100 golfers, local business leaders, supporters and sponsors for a day of sport, networking and fundraising in aid of Legacy Youth Zone’s life-changing work. The headline sponsor was from Modern Health Group for the day alongside other sponsors including: BootBuddy, Roasting Party, Bradley & Sons, Whisky Brokers Associates, Live Mauritius, Quilter, Namos Solutions, PMJ Risk Solutions, Sherrards, Roley’s, HotBoss, TW Drainage and Mobsta. The event ———————————————————————————————————————————————————————————— HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction 2026-07-14 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/hitgen-partner-bioage-labs-doses-first-participant-in-phase-2-trial-of-bge-102-a-novel-oral-nlrp3-inhibitor-for-cardiovascular-risk-reduction-302824804.html CHENGDU, China, July 14, 2026 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH), congratulates its partner BioAge Labs, Inc. ("BioAge", NASDAQ: BIOA), a clinical-stage biopharmaceutical company developing therapeutic product candidates for... ———————————————————————————————————————————————————————————— Phase II Trial of Cadonilimab(PD-1/CTLA-4) Combination Regimen Launches in the United States for Perioperative Treatment of Gastric Cancer 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/phase-ii-trial-of-cadonilimabpd-1ctla-4-combination-regimen-launches-in-the-united-states-for-perioperative-treatment-of-gastric-cancer-302824817.html HONG KONG, July 14, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that it has entered into a collaboration with Memorial Sloan Kettering Cancer Center (MSKCC) to advance a Phase II clinical study evaluating a cadonilimab-based combination regimen... ———————————————————————————————————————————————————————————— RWS launches new linguistic validation service to significantly reduce clinical trial timelines 2026-07-14 · PR Newswire · AI, Healthcare https://www.prnewswire.com/news-releases/rws-launches-new-linguistic-validation-service-to-significantly-reduce-clinical-trial-timelines-302824011.html New service brings critical eCOA trial services together under one program team to speed global studies MAIDENHEAD, England, July 14, 2026 /PRNewswire/ -- RWS (AIM: RWS.L), a global AI solutions company, today launched a new tech-enabled eCOA translation and linguistic validation service... ———————————————————————————————————————————————————————————— Hennick Humber Hospital in Canada has selected Sectra One Cloud to speed up patient diagnostics with improved radiology workflows 2026-07-14 · PR Newswire · SaaS, Healthcare https://www.prnewswire.com/news-releases/hennick-humber-hospital-in-canada-has-selected-sectra-one-cloud-to-speed-up-patient-diagnostics-with-improved-radiology-workflows-302824777.html LINKÖPING, Sweden and MISSISSAUGA, ON, July 14, 2026 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its fully managed, cloud enterprise imaging solution, Sectra One Cloud, to Hennick Humber Hospital (HHH) in Canada. This SaaS... ———————————————————————————————————————————————————————————— Biovica Receives Ninth Work Order From a Leading Global Pharmaceutical ... 2026-07-14 · PR-Inside · Healthcare https://pr-inside.com/biovica-receives-ninth-work-order-from-a-leading-global-pharmaceutical-r5200793.htm (PR-inside.com) UPPSALA, SE / ACCESS Newswire / July 14, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a company specializing in blood-based cancer monitoring, today announced that it has received a new work order from a current customer, one of the world's leading pharmaceutical companies with a strong oncology pipeline. This marks the ninth work order received from the same customer, further strengthening the ongoing collaboration. The work order covers DiviTum® TKa testing services for a clinical breast cancer study evaluating a next-generation CDK inhibitor in combination with endocrine therapy. The study includes serial TKa testing over a period of up to four .. ———————————————————————————————————————————————————————————— Breakout Wellness UK Empowers the Next Generation of Wellness Innovators 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/breakout-wellness-uk-empowers-the-next-generation-of-wellness-innovators-302823849.html A new accelerator programme from Growth Studio will support ambitious founders building the UK's next generation of health and wellness brands. LONDON, July 14, 2026 /PRNewswire/ -- Growth Studio has today announced the launch of Breakout Wellness UK - a new accelerator programme designed... ———————————————————————————————————————————————————————————— People in the UK fear cancer and heart disease – but overlook one of the biggest killers of working-age adults 2026-07-14 · Pressat · Finance, Healthcare https://pressat.co.uk/releases/people-in-the-uk-fear-cancer-and-heart-disease-but-overlook-one-of-the-biggest-killers-of-working-age-adults-20627a86397f052890eaae27e1b1a97a/ Tuesday 14 July, 2026 **EMBARGOED UNTIL 00:01 14th July 2026** New data released today has revealed that just 9% of people actively think about or monitor their liver health despite liver disease being one of the leading causes of premature death among working-age adults. Liver disease is largely absent from the UK's biggest health concerns according to a major new survey published today and commissioned by Liver UK, the new charity formed by the merger of the British Liver Trust and Children's Liver Disease Foundation. When asked to name the three health conditions they worry about most, respondents overwhelmingly identified cancer, heart disease, stroke and mental health. Liver disease barely featured, even though it caused more than 12,300 deaths across the UK in 2023 and remains one of ———————————————————————————————————————————————————————————— Americans for Ibogaine Welcomes Milestone as Federal Government Mobilizes ... 2026-07-14 · PR-Inside · Healthcare https://pr-inside.com/americans-for-ibogaine-welcomes-milestone-as-federal-government-mobilizes-r5200789.htm (PR-inside.com) HHS announcement marks the latest milestone in a movement led by Americans for Ibogaine. HHS, VA, FDA, NIH, ARPA-H and HRSA announce coordinated actions implementing Executive Order, accelerating research, clinical readiness and the pathway toward future FDA-approved psychedelic therapies. WASHINGTON, D.C. / ACCESS Newswire / July 14, 2026 / Americans for Ibogaine (AFI) today welcomed the coordinated, government-wide implementation of the Executive Order advancing psychedelic medicine, including a landmark HHS-VA partnership, new federal actions to accelerate ibogaine research, and efforts to prepare the healthcare system for the responsible deployment of future FDA-approved psychedelic therapies. Just 18 months ago, ibogaine and psychedelic medicine .. ———————————————————————————————————————————————————————————— XRP Healthcare, the First AI Healthcare Platform Built on the XRP Ledger, Announces BitMart Listing of XRPHAI 2026-07-14 · PR Newswire · Crypto, AI, SaaS, Healthcare https://www.prnewswire.com/news-releases/xrp-healthcare-the-first-ai-healthcare-platform-built-on-the-xrp-ledger-announces-bitmart-listing-of-xrphai-302824243.html Trading of XRPHAI/USDT begins on BitMart on 14 July 2026 at 10:00 UTC as XRP Healthcare expands its AI healthcare ecosystem with intelligent healthcare agents, Proof of Health™ and blockchain-powered healthcare engagement. DUBAI, UAE, July 14, 2026 /PRNewswire/ -- XRP Healthcare, the... ———————————————————————————————————————————————————————————— IGC Pharma (NYSE: IGC) Showcasing 7 AI Breakthroughs Advancing Alzheimer’s Drug Discovery at AAIC 2026 2026-07-14 · GetNews · Finance, AI, Healthcare https://www.getnews.info/story/2026/07/14/igc-pharma-nyse-igc-showcasing-7-ai-breakthroughs-advancing-alzheimers-drug-discovery-at-aaic-2026/?source=barchart ———————————————————————————————————————————————————————————— ALZHEIMER'S BLOOD TEST COULD BRING HIGHLY ACCURATE DIAGNOSIS INTO EVERYDAY CLINICAL CARE 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/alzheimers-blood-test-could-bring-highly-accurate-diagnosis-into-everyday-clinical-care-302824484.html A blood test for Alzheimer's disease biomarkers helped improve diagnostic accuracy among specialists and primary care physicians in a real-world study. In a head-to-head comparison after reviewing blood test results, primary care physicians and specialists both had a diagnostic accuracy... ———————————————————————————————————————————————————————————— Erasca Announces Pricing of Upsized Public Offering of Common Stock 2026-07-14 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/14/3326554/0/en/Erasca-Announces-Pricing-of-Upsized-Public-Offering-of-Common-Stock.html SAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of an upsized public offering of 31,428,572 shares of its common stock. The shares of common stock are being sold to the public at a price of $17.50 per share. All of the shares of common stock to be sold in the public offering are to be sold by Erasca. The gross proceeds to Erasca from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be approximately $550.0 million. In addition, Erasca has granted the underwriters a 30-day option to purchase up to an ———————————————————————————————————————————————————————————— FDA approves Leqembi Iqlik® (lecanemab-irmb) subcutaneous injection as a starting dose for early Alzheimer's disease 2026-07-14 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/fda-approves-leqembi-iqlik-lecanemab-irmb-subcutaneous-injection-as-a-starting-dose-for-early-alzheimers-disease-302824479.html STOCKHOLM, July 14, 2026 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the US Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for a once weekly lecanemab irmb subcutaneous injection... ———————————————————————————————————————————————————————————— Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules 2026-07-14 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/14/3326547/0/en/Autonomix-Medical-Enters-into-2-6-Million-Warrant-Inducement-Priced-At-the-Market-Under-Nasdaq-Rules.html THE WOODLANDS, TX, July 13, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it has entered into a warrant inducement agreement with an investor (“Investor”) for the immediate exercise of certain outstanding warrants that the Company issued on November 19, 2025 (the “November 2025 Warrants”). Pursuant to a warrant inducement agreement, the Investor has agreed to exercise the outstanding November 2025 Warrants to purchase an aggregate of 428,731 shares of the Company’s common stock at the amended and reduced exercise price of $6.00. The resale of the shares of common stock issuable upon exercise of the November 2025 Warrants has been registered ———————————————————————————————————————————————————————————— Reynolds Road Surgical Center Notice of Data Privacy Incident 2026-07-14 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/reynolds-road-surgical-center-notice-of-data-privacy-incident-302824361.html TOLEDO, Ohio, July 13, 2026 /PRNewswire/ -- Reynolds Road Surgical Center LLC, doing business as Wildwood Surgical Center ("Wildwood"), writes to notify you of a data security incident involving personal information of certain members of our health care community. What Happened: On June... ———————————————————————————————————————————————————————————— ADDF Statement: FDA Approval of Subcutaneous Starting Dose for Leqembi Advances Alzheimer's Care Toward Combination Therapy Future 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/addf-statement-fda-approval-of-subcutaneous-starting-dose-for-leqembi-advances-alzheimers-care-toward-combination-therapy-future-302824323.html Initiation of treatment with subcutaneous administration opens the door to fully at-home dosing, similar to injectable diabetes and GLP-1 weight loss therapies NEW YORK, July 13, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today approved a weekly subcutaneous starting... ———————————————————————————————————————————————————————————— MemorialCare Requests Correction to Inaccurate Employment Information Published in Recent News Story 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/memorialcare-requests-correction-to-inaccurate-employment-information-published-in-recent-news-story-302824297.html FOUNTAIN VALLEY, Calif., July 13, 2026 /PRNewswire/ -- A Fox News Digital article published on July 13, 2026, identified Robert Acuna-Bagshaw as a current employee of MemorialCare Long Beach Medical Center. Mr. Acuna-Bagshaw has not been employed by MemorialCare since July 2025.... ———————————————————————————————————————————————————————————— FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease 2026-07-13 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326503/0/en/FDA-Approves-LEQEMBI-IQLIK-lecanemab-irmb-Subcutaneous-Injection-as-an-Initiation-Dose-for-Early-Alzheimer-s-Disease.html LEQEMBI IQLIK is a first-of-its-kind anti-amyloid treatment worldwide, offering at-home dosing for initiation and maintenance (approved in the U.S.) ———————————————————————————————————————————————————————————— CoreViva Named One of Orange County's Best Places to Work in 2026 2026-07-13 · PRWeb · Healthcare https://www.prweb.com/releases/coreviva-named-one-of-orange-countys-best-places-to-work-in-2026-302824230.html CoreViva, an innovative preventive health company providing whole-body MRI exams to improve health span and lifespan, is named one the 2026 Best Places to Work in Orange County by the Orange County Business Journal. NEWPORT BEACH, Calif., July 13, 2026 /PRNewswire-PRWeb/ -- CoreViva, a... ———————————————————————————————————————————————————————————— Birdsong Health Literacy Center of Excellence Appoints Jacqueline Schillereff ... 2026-07-13 · PR-Inside · Healthcare https://pr-inside.com/birdsong-health-literacy-center-of-excellence-appoints-jacqueline-schillereff-r5200672.htm (PR-inside.com) NORFOLK, VA / ACCESS Newswire / July 13, 2026 /The Birdsong Health Literacy Center of Excellence is pleased to announce the appointment of Jacqueline Schillereff as its new Executive Director. Schillereff, who has been serving as Director of Business Development and Communications for the Center, brings a dynamic combination of leadership, communications expertise, relationship-building ability, operational discipline, and a deep commitment to advancing health literacy and community well-being. In her new role, Schillereff will lead the Center's growing efforts to improve health literacy, reduce health inequities, and empower individuals and families with the knowledge, confidence, and access they need to make .. ———————————————————————————————————————————————————————————— Birdsong Health Literacy Center of Excellence Appoints Jacqueline Schillereff as Executive Director 2026-07-13 · Newswire.com · Healthcare https://www.newswire.com/news/birdsong-health-literacy-center-of-excellence-appoints-jacqueline-22825117 ———————————————————————————————————————————————————————————— Brayton Purcell LLP Calls Attention to New Medical Report Highlighting Severe Risks of Artificial Stone Silicosis and Limitations of Conventional Controls 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/brayton-purcell-llp-calls-attention-to-new-medical-report-highlighting-severe-risks-of-artificial-stone-silicosis-and-limitations-of-conventional-controls-302824206.html American Thoracic Society workshop report underscores rapid disease progression and identifies elimination of the hazard as the most effective means of protection NOVATO, Calif., July 13, 2026 /PRNewswire/ -- A newly released medical report from the American Thoracic Society is bringing... ———————————————————————————————————————————————————————————— Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth 2026-07-13 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/astrana-health-strengthens-leadership-team-to-accelerate-long-term-growth-302824153.html Names Daniel Rothman President of Physician Enterprise and Vishal Gupta Senior Vice President of Enterprise Transformation ALHAMBRA, Calif., July 13, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:... ———————————————————————————————————————————————————————————— Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance 2026-07-13 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326468/20998/en/Sanuwave-Health-Reports-Preliminary-Q2-2026-Revenue-of-9-6-9-8-Million-Above-High-End-of-Revised-Guidance.html Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance ———————————————————————————————————————————————————————————— Elk Grove Foot & Ankle Clinic Opens Aug. 1 in Historic Old Town; Bringing Specialized Medical Foot Care and Same-Day Appointments to the Community 2026-07-13 · PR.com · Healthcare https://www.pr.com/press-release/973084 Elk Grove Foot and Ankle Clinic announces its grand opening on Aug. 1, 2026, at 9075 Elk Grove Blvd., Suite 220A, in Old Town Elk Grove. Founded by Dr. Christina Garvin, AACFAS, the practice brings specialized medical foot care and a patient-first model to the community. The clinic offers comprehensive conservative care, streamlined digital check-ins, and convenient same-day appointments. [PR.com] ———————————————————————————————————————————————————————————— Cleveland Medical Devices Reports Favorable PTAB Outcomes in Five of Six ResMed IPR Challenges 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/cleveland-medical-devices-reports-favorable-ptab-outcomes-in-five-of-six-resmed-ipr-challenges-302824198.html CLEVELAND, July 13, 2026 /PRNewswire/ -- Cleveland Medical Devices Inc. announced that proceedings before the Patent Trial and Appeal Board have now produced favorable outcomes for Cleveland Medical Devices in five of the six inter partes review petitions filed by ResMed against patents... ———————————————————————————————————————————————————————————— Erasca Announces Proposed Public Offering of $500 Million of Common Stock 2026-07-13 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326465/0/en/Erasca-Announces-Proposed-Public-Offering-of-500-Million-of-Common-Stock.html SAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that it intends to offer and sell, subject to market and other conditions, $500.0 million of shares of its common stock in a proposed underwritten public offering. All of the shares of common stock to be sold in the proposed offering are being offered by Erasca. In addition, Erasca intends to grant the underwriters a 30-day option to purchase up to an additional $75.0 million of shares of its common stock. There can be no assurance as to whether or when the proposed public offering may be completed, or as to the actual size or terms ———————————————————————————————————————————————————————————— MBX Biosciences Announces Executive Leadership Transition to Support the Company’s Next Phase of Growth 2026-07-13 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326463/0/en/MBX-Biosciences-Announces-Executive-Leadership-Transition-to-Support-the-Company-s-Next-Phase-of-Growth.html CARMEL, Ind. and BURLINGTON, Mass., July 13, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that its Board of Directors has appointed Steve Hoerter, current Executive Chairman of the Board, as its new Chairman and Chief Executive Officer. Mr. Hoerter succeeds Kent Hawryluk, who will step down as President, Chief Executive Officer and a member of the Board of Directors. In addition, the Board has appointed John Smither, current Interim Chief Financial Officer, as the Company’s new Chief Financial Officer. All leadership changes are effective immediately. ———————————————————————————————————————————————————————————— Eupraxia Pharmaceuticals Strengthens Executive Leadership Team to Support Next Phase of Growth 2026-07-13 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326453/0/en/Eupraxia-Pharmaceuticals-Strengthens-Executive-Leadership-Team-to-Support-Next-Phase-of-Growth.html VANCOUVER, British Columbia, July 13, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“ Eupraxia ” or the “ Company ”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, announced updates to its executive leadership and operating structure as the Company continues to prepare for its next stage of clinical and commercial development. ———————————————————————————————————————————————————————————— Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth 2026-07-13 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326452/0/en/Tarsus-Pharmaceuticals-Announces-Executive-Leadership-Transition-as-Company-Advances-Next-Phase-of-Growth.html IRVINE, Calif., July 13, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) today announced that Aziz Mottiwala, Chief Commercial Officer, is departing the Company to pursue a new opportunity as Chief Executive Officer of a public medical device company. Effective immediately, Neera Clase, formerly Senior Vice President of Market Access, will serve as Interim Chief Commercial Officer while Tarsus conducts a search for a permanent successor. ———————————————————————————————————————————————————————————— Peptide Stacking is the Newest Wellness Obsession. California Trim Clinic Breaks Down the Compounded Peptide Trend Patients Cannot Stop Searching 2026-07-13 · PRUnderground · Healthcare, Energy, Education https://www.prunderground.com/peptide-stacking-is-the-newest-wellness-obsession-california-trim-clinic-breaks-down-the-compounded-peptide-trend-patients-cannot-stop-searching/00388514/ Peptide stacking has moved from bodybuilding forums and biohacker circles into everyday wellness searches. Patients are now hearing about combinations for weight loss, recovery, muscle support, skin, energy, longevity, inflammation, and metabolic health. The problem is not that patients are curious. The problem is that many people are learning about peptide stacks from TikTok clips, influencer protocols, private message sellers, and vials labeled "research use only." California Trim Clinic offers a different pathway. The clinic does not sell R&D peptides, gray-market peptides, or black-market vials. It provides doctor-prescribed, patient-specific compounded peptide care through licensed pharmacy partners when medically appropriate and legally permitted. Patients interested in learning ———————————————————————————————————————————————————————————— Promouvoir les engagements mondiaux en matière de production à faibles émissions de carbone et de développement durable 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/promouvoir-les-engagements-mondiaux-en-matiere-de-production-a-faibles-emissions-de-carbone-et-de-developpement-durable-302824140.html Un rapport met en avant l'énergie propre, l'innovation et la reconnaissance des critères ESG ZIBO, Chine, 13 juillet 2026 /PRNewswire/ -- INTCO Medical (« la Société »), l'un des principaux fabricants mondiaux de gants jetables, a publié son rapport 2025 sur les enjeux environnementaux,... ———————————————————————————————————————————————————————————— VERAXA Biotech (VRXA) Partners With Ardigen to Advance AI-Driven Cancer Drug Development 2026-07-13 · NewMediaWire · Finance, AI, SaaS, Healthcare, Retail https://www.newmediawire.com/news/veraxa-biotech-vrxa-partners-with-ardigen-to-advance-ai-driven-cancer-drug-development-7087678 LOS ANGELES, CA - July 13, 2026 ( NEWMEDIAWIRE ) - VERAXA Biotech (NASDAQ: VRXA) announced a collaboration with AI-driven bioinformatics company Ardigen S.A. to support development of its BiTAC(R) pipeline of T-cell engagers and future antibody-drug conjugates. The partnership will initially focus on developing AI-enabled tools to identify and prioritize synergistic dual-target combinations for VERAXA’s BiTAC platform, which is designed to improve tumor targeting while reducing off-target toxicity. VERAXA said integrating artificial intelligence into its research and development strategy could enhance target selection by analyzing large preclinical and clinical datasets, including programs that demonstrated efficacy but failed because of toxicity. The company believes the collaboration wil ———————————————————————————————————————————————————————————— NicholsMD Launches The Hair Lab™: A Dedicated Destination for Dermatologist-Led Hair Restoration, Scalp Health, and Hair Removal 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/nicholsmd-launches-the-hair-lab-a-dedicated-destination-for-dermatologist-led-hair-restoration-scalp-health-and-hair-removal-302824134.html GREENWICH, Conn., July 13, 2026 /PRNewswire/ -- NicholsMD of Greenwich, founded in 2013 as the first boutique dermatology practice in Greenwich, Connecticut, is proud to introduce The Hair Lab™ at its new flagship location at 32 Field Point Road in Greenwich's Central Business District.... ———————————————————————————————————————————————————————————— Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases 2026-07-13 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326424/0/en/Cosmos-Health-Share-Buyback-Reaches-4-36-Million-Shares-Continues-Open-Market-Repurchases.html Cosmos Health has now repurchased a total of 4,355,000 shares for approximately $901,000. ———————————————————————————————————————————————————————————— Synexis, LLC and Penn Veterinary Supply Collaborate to offer DHP(R) ... 2026-07-13 · PR-Inside · Healthcare https://pr-inside.com/synexis-llc-and-penn-veterinary-supply-collaborate-to-offer-dhp-r-r5200634.htm (PR-inside.com) OVERLAND PARK, KS / ACCESS Newswire / July 13, 2026 / Synexis®, LLC, the leader in touchless, continuous pathogen control technology, today announced a strategic collaboration with Penn Veterinary Supply to expand access to Synexis DHP® technology for veterinary and animal health professionals nationwide. The Synexis and Penn Veterinary Supply collaboration reflects a growing shift across veterinary medicine and animal care toward more proactive, science-based biosecurity strategies designed to address the continuous nature of pathogen exposure in indoor environments. Through Penn Veterinary Supply's long-standing relationships with veterinary professionals and animal care facilities, customers will gain expanded access to Synexis DHP technology .. ———————————————————————————————————————————————————————————— Synexis, LLC and Penn Veterinary Supply Collaborate to offer DHP(R) Technology Across Animal Health Facilities Nationwide 2026-07-13 · Newswire.com · Healthcare https://www.newswire.com/news/synexis-llc-and-penn-veterinary-supply-collaborate-to-offer-dhp-r-technology Penn Vet and Synexis advance continuous indoor pathogen control through veterinary research that supports biosecurity, animal health, and infection prevention. ———————————————————————————————————————————————————————————— New Autism Clinic for Young Children Prepares to Open its Doors in Johnson County 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/new-autism-clinic-for-young-children-prepares-to-open-its-doors-in-johnson-county-302824024.html OLATHE, Kan., July 13, 2026 /PRNewswire/ -- Caravel Autism Health, a leader in the diagnosis and treatment of young children on the autism spectrum, is hosting a ribbon-cutting on Tuesday, July 14 to celebrate the grand opening of a new, state-of-the-art autism therapy clinic. The clinic,... ———————————————————————————————————————————————————————————— Asian‑Led NutriWorks® Elevates Holistic Health Power of Passion Fruit Seed Extract in Newly-Debuting RejuvenAge NMN 18000 Capsules 2026-07-13 · PRUnderground · Healthcare https://www.prunderground.com/asian-led-nutriworks-elevates-holistic-health-power-of-passion-fruit-seed-extract-in-newly-debuting-rejuvenage-nmn-18000-capsules/00388469/ With global lifespans continuing to increase, consumers are overwhelmingly seeking products that not only improve their health, but return strength, youth, and vitality. Working to accomplish this goal through innovation and use of 'tried and true' ingredients is NutriWorks, an Asian beauty leader lauded for their modernization of Traditional Chinese Medicine (TCM) values and knowledge... Read more » The post Asian‑Led NutriWorks® Elevates Holistic Health Power of Passion Fruit Seed Extract in Newly-Debuting RejuvenAge NMN 18000 Capsules first appeared on ———————————————————————————————————————————————————————————— Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece 2026-07-13 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326385/0/en/Cosmos-Health-Accelerates-Prescription-Medicine-Strategy-with-Libytec-Partnership-to-Commercialize-DIABIT-IS-X-in-Greece.html Cosmos Health accelerates prescription medicine strategy with Libytec partnership to commercialize DIABIT-IS X in Greece. ———————————————————————————————————————————————————————————— Quankang Launches UES140 140W GaN Medical Power Supply for Medical and ITE Applications 2026-07-13 · GetNews · Healthcare https://www.getnews.info/story/2026/07/13/quankang-launches-ues140-140w-gan-medical-power-supply-for-medical-and-ite-applications/?source=barchart ———————————————————————————————————————————————————————————— OSR Health, A Message From the CEO 2026-07-13 · Newswire.com · Healthcare https://www.newswire.com/news/osr-health-a-message-from-the-ceo-22825204 Read the CEO’s letter outlining OSR Health’s proposed Shareholder Loyalty CVR Program, VXM01 progress, Woori IO and the company’s long-term strategy ———————————————————————————————————————————————————————————— What Is an Aortic Dissection? 2026-07-13 · NewMediaWire · Healthcare, Retail https://www.newmediawire.com/news/what-is-an-aortic-dissection-7087671 DALLAS - July 13, 2026 ( NEWMEDIAWIRE ) - Following the sudden death of U.S. Senator Lindsey Graham of South Carolina, widespread news reports indicate he suffered from an aortic dissection. An aortic dissection is a tear in the inner layer of the aorta, the body's largest artery. Blood surges through the tear, causing the layers of the aortic wall to separate (dissect). Aortic dissection is a medical emergency that can be rapidly fatal if not diagnosed and treated promptly, according to the American Heart Association. Key Facts The aorta, the largest artery in the body, carries oxygen-rich blood from the heart to the rest of the body. Aortic disease can occur when the aortic wall is weakened and either bulges (aneurysm) or tears (dissection). A tear in the wall of the aorta allows blood t ———————————————————————————————————————————————————————————— Family Care Center Opens North Peoria Behavioral Health Clinic 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/family-care-center-opens-north-peoria-behavioral-health-clinic-302823931.html PEORIA, Ariz., July 13, 2026 /PRNewswire/ -- Family Care Center has opened a new outpatient behavioral health clinic in North Peoria, expanding integrated mental health services in one of Arizona's fastest-growing communities. The clinic improves access to in-network care in the West... ———————————————————————————————————————————————————————————— Zelluna doses first solid tumour patient with ZI-MA4-1 in the ZIMA-101 Phase 1 trial 2026-07-13 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326342/0/en/Zelluna-doses-first-solid-tumour-patient-with-ZI-MA4-1-in-the-ZIMA-101-Phase-1-trial.html July 13 2026 – Zelluna ASA (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today announced that the first patient has been given the first dose in ZIMA-101, the Company’s first-in-human Phase 1 clinical trial evaluating ZI-MA4-1, Zelluna’s lead TCR-NK product candidate. ———————————————————————————————————————————————————————————— Amazfit Launches Its HYBRID TRAINING Ecosystem in Malaysia, Powered ... 2026-07-13 · PR-Inside · Healthcare https://pr-inside.com/amazfit-launches-its-hybrid-training-ecosystem-in-malaysia-powered-r5200610.htm (PR-inside.com) KUALA LUMPUR, MY / ACCESS Newswire / July 13, 2026 / Amazfit , a leading global smart wearable brand owned by Zepp Health, officially launched its Hybrid Training ecosystem in Malaysia, bringing together intelligent training guidance, official HYROX tools and advanced performance tracking to help athletes train smarter across strength, endurance and recovery. The ecosystem is powered by the new Amazfit Balance 3 and Amazfit Balance Ultra, with the Balance 3 now available in Malaysia. Amazfit Balance 3 Stainless Steel Designed for the growing community of Malaysians embracing hybrid fitness and active lifestyles, the Amazfit Hybrid Training ecosystem combines the intelligence of .. ———————————————————————————————————————————————————————————— Dr. Albert H. Yurvati's Four Books Receive National Spotlight in the New York Times Book Review 2026-07-13 · WebWire · Healthcare https://www.webwire.com/ViewPressRel.asp?aId=357446 Writers' Branding and Reading Glass Books proudly celebrate the successful feature of Dr. Albert H. Yurvati's four books in the July 12, 2026 issue of the New York Times Book Review. The national feature introduced “Wet My Hands,” “This to Me,” “30 Degrees on Bypass,” and “Bride and Blades” to one of the publishing industry's most respected literary audiences, recognizing a body of work shaped by decades of medical excellence, military service, and personal perseverance. - - Each fe... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357446 ———————————————————————————————————————————————————————————— Zealand Pharma - Transactions related to share buy-back program (week 28, 2026) 2026-07-13 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326336/0/en/Zealand-Pharma-Transactions-related-to-share-buy-back-program-week-28-2026.html Company announcement No. 32 / 2026 ———————————————————————————————————————————————————————————— Metastatic Castration-resistant Prostate Cancer Market Poised for Strong Growth by 2036, Due to the Launch of Drug Classes Such as Anti-B7-H3 ADC, PROTAC Protein Degrader, NTD AR Inhibitor, Radionuclide Therapy, and Several Others | DelveInsight 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/metastatic-castration-resistant-prostate-cancer-market-poised-for-strong-growth-by-2036-due-to-the-launch-of-drug-classes-such-as-anti-b7-h3-adc-protac-protein-degrader-ntd-ar-inhibitor-radionuclide-therapy-and-several-others-302823584.html The metastatic castration-resistant prostate cancer market is poised for substantial growth over the coming years, driven by the rising prevalence of advanced prostate cancer and continuous innovation in treatment options. Additionally, the ongoing late-stage clinical development of... ———————————————————————————————————————————————————————————— FedEx Launches Dedicated Life Sciences Organization to Support the Next Generation of Healthcare Delivery 2026-07-13 · WebWire · Finance, Healthcare https://www.webwire.com/ViewPressRel.asp?aId=357559 FedEx Corp. (NYSE: FDX) announced the launch of FedEx Life Sciences, a dedicated organization created to support the increasingly complex movement of pharmaceuticals, medical devices, biologics, clinical trials, and other critical healthcare shipments. - - As medicine becomes more specialized, global, and time-sensitive, life sciences companies need logistics networks built for precision, visibility, and reliability. From temperature-sensitive therapies and clinical trial materials to me... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357559 ———————————————————————————————————————————————————————————— Atrium Health and OrthoCarolina join forces to build nationally recognized orthopedic destination 2026-07-13 · PRWeb · Healthcare, Education https://www.prweb.com/releases/atrium-health-and-orthocarolina-join-forces-to-build-nationally-recognized-orthopedic-destination-302823200.html Expanded collaboration builds on a longstanding relationship to advance access, coordinated care, education and innovation CHARLOTTE, N.C., July 13, 2026 /PRNewswire-PRWeb/ -- Atrium Health, part of Advocate Health, and OrthoCarolina announced they are strengthening and expanding their... ———————————————————————————————————————————————————————————— Desert Oasis Healthcare Uses AI Technology to Help Detect Heart Rhythm Conditions Earlier 2026-07-13 · Newswire.com · AI, Healthcare https://www.newswire.com/news/desert-oasis-healthcare-uses-ai-technology-to-help-detect-heart-rhythm New program helps identify patients who may benefit from heart monitoring before a serious medical event occurs ———————————————————————————————————————————————————————————— IPANY Partners With ExtensisHR to Deliver Enterprise-Level Benefits and HR Solutions to New York Providers 2026-07-13 · PRWeb · Healthcare https://www.prweb.com/releases/ipany-partners-with-extensishr-to-deliver-enterprise-level-benefits-and-hr-solutions-to-new-york-providers-302822878.html Partnership gives 3,500+ independent providers access to preferred health insurance pricing and comprehensive HR support SMITHTOWN, N.Y., July 13, 2026 /PRNewswire-PRWeb/ -- The Independent Practice Association of New York (IPANY), the largest Independent Practice Association in New York... ———————————————————————————————————————————————————————————— AtlantiCare First in Region to Offer Robotic Nipple-Sparing Mastectomy Using da Vinci Single Port System 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/atlanticare-first-in-region-to-offer-robotic-nipple-sparing-mastectomy-using-da-vinci-single-port-system-302823383.html Innovative, minimally invasive approach advances breast cancer care and enhances patient experience EGG HARBOR TOWNSHIP, N.J., July 13, 2026 /PRNewswire/ -- AtlantiCare today announced that it is the first healthcare system in the tri-state region to offer robotic nipple-sparing... ———————————————————————————————————————————————————————————— In HelloNation, Health Insurance Expert David Wiley Explains Georgia Life Insurance Options for Families 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/in-hellonation-health-insurance-expert-david-wiley-explains-georgia-life-insurance-options-for-families-302745652.html The article outlines how term and permanent life insurance differ in cost, coverage length, and long-term financial planning. WATKINSVILLE, Ga., July 13, 2026 /PRNewswire/ -- How can families in Georgia decide between term life insurance and permanent life insurance? Licensed insurance... ———————————————————————————————————————————————————————————— As Ebola Spreads in Two More Provinces, NanoViricides Has Received ... 2026-07-13 · PR-Inside · Finance, Healthcare, Education https://pr-inside.com/as-ebola-spreads-in-two-more-provinces-nanoviricides-has-received-r5200563.htm (PR-inside.com) SHELTON, CT / ACCESS Newswire / July 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that it has received National Ethics Committee approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus in the Democratic Republic of Congo (DRC). The Company is now getting ready to file a Clinical Trial Application to ACOREP, the regulatory agency in DRC. NanoViricides has already put together a team with a renowned Principal Investigator and with support from a well known University in .. ———————————————————————————————————————————————————————————— As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo 2026-07-13 · Newswire.com · Healthcare https://www.newswire.com/news/as-ebola-spreads-in-two-more-provinces-nanoviricides-has-received-national ———————————————————————————————————————————————————————————— Patel Orthopedics in Beverly Hills Advances Whole-Patient Orthopedic Care With Integrated Surgical, Regenerative, and Recovery Solutions 2026-07-13 · PRWeb · Healthcare, Automotive https://www.prweb.com/releases/patel-orthopedics-in-beverly-hills-advances-whole-patient-orthopedic-care-with-integrated-surgical-regenerative-and-recovery-solutions-302823197.html Under the leadership of dual board-certified orthopedic surgeon Dr. Rajan M. Patel, the Beverly Hills practice combines robotic-assisted surgery, regenerative therapies, and advanced recovery technologies in a unified care model designed to restore function, mobility, and long-term... ———————————————————————————————————————————————————————————— iFabric Corp. Announces Launch of Aura Scrubs at U.S. National Mass ... 2026-07-13 · PR-Inside · SaaS, Healthcare, Retail https://pr-inside.com/ifabric-corp-announces-launch-of-aura-scrubs-at-u-s-national-mass-r5200561.htm (PR-inside.com) Third major retailer to adopt IFTNA's technology-enhanced scrub platform New Brand Expands Commercial Reach of PROTX2® and ecoPEL™, the Company's Proprietary Antimicrobial and Durable Water Repellant Technologies MARKHAM, ON / ACCESS Newswire / July 13, 2026 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF) is pleased to announce that its wholly owned subsidiary, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), is launching Aura, a new performance medical apparel scrubs line developed, branded, and manufactured by IFTNA, in cooperation with a leading U.S. national mass retailer. The Aura scrubs collection is launching in approximately 400 brick-and-mortar stores across the United States, together with availability .. ———————————————————————————————————————————————————————————— U.S. Food and Drug Administration Accepts BioMarin's Supplemental New Drug Application for Full Approval of VOXZOGO® (vosoritide) for Children With Achondroplasia 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/us-food-and-drug-administration-accepts-biomarins-supplemental-new-drug-application-for-full-approval-of-voxzogo-vosoritide-for-children-with-achondroplasia-302823072.html Application based on long-term safety and efficacy data from three ongoing studies, including adult height and additional clinical outcomes beyond linear growth, including body proportionality and arm span evaluated over long-term follow-up FDA PDUFA target action date of Feb. 28, 2027... ———————————————————————————————————————————————————————————— Health Insurance Private Plans Reach Households Above the Subsidy Line ... 2026-07-13 · PR-Inside · Healthcare https://pr-inside.com/health-insurance-private-plans-reach-households-above-the-subsidy-line-r5200555.htm (PR-inside.com) Health Insurance Now offers private options to middle-income families squeezed by the 2026 subsidy cliff. BOCA RATON, FL / ACCESS Newswire / July 13, 2026 / Health Insurance Now is reaching middle-income households hit hardest by the 2026 changes to health insurance subsidies, a group earning just above the eligibility threshold that has left the Marketplace in disproportionate numbers. For these families,health insurance private planshave become the practical path to coverage once premium tax credits fall away. Reporting on early 2026 enrollment found that people with incomes between 400 percent and 500 percent of the federal poverty level accounted for about 27 .. ———————————————————————————————————————————————————————————— Bavarian Nordic’s Chikungunya Vaccine Submitted for Regulatory Approval in Brazil 2026-07-13 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326208/0/en/Bavarian-Nordic-s-Chikungunya-Vaccine-Submitted-for-Regulatory-Approval-in-Brazil.html COPENHAGEN, Denmark, July 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that its partner, Eurofarma, has submitted a marketing authorization application to the Brazilian Health Regulatory Agency (Anvisa) for Bavarian Nordic’s chikungunya vaccine, CHIKV VLP, for the prevention of disease caused by chikungunya virus in individuals 12 years of age and older. ———————————————————————————————————————————————————————————— Cadrenal Therapeutics’ Late-Breaking Phase 2 Data Demonstrate Greater Than 25% Reduction in Thrombotic Events in HIT for First-in-Class 12-LOX Inhibitor CAD-1005 at ISTH 2026 Congress 2026-07-13 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326228/0/en/Cadrenal-Therapeutics-Late-Breaking-Phase-2-Data-Demonstrate-Greater-Than-25-Reduction-in-Thrombotic-Events-in-HIT-for-First-in-Class-12-LOX-Inhibitor-CAD-1005-at-ISTH-2026-Congres.html PARIS, July 13, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing novel therapies for rare immunothrombotic conditions, announced today that late-breaking clinical data from the Phase 2 study of the first-in-class 12-lipoxygenase (12-LOX) inhibitor CAD-1005 were featured in a highly anticipated late-breaking oral presentation at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris. ———————————————————————————————————————————————————————————— Health Insurance Private Plans Reach Households Above the Subsidy Line 2026-07-13 · Newswire.com · Healthcare https://www.newswire.com/news/health-insurance-private-plans-reach-households-above-the-subsidy-line Health Insurance Now offers private options to middle-income families squeezed by the 2026 subsidy cliff. ———————————————————————————————————————————————————————————— Magna Legal Services and Naegeli Deposition & Trial Combine to Expand Presence in the Pacific Northwest 2026-07-13 · PRWeb · Healthcare https://www.prweb.com/releases/magna-legal-services-and-naegeli-deposition--trial-combine-to-expand-presence-in-the-pacific-northwest-302823734.html Magna Legal Services, a nationwide leader in court reporting, medical record retrieval, litigation consulting, investigations and service of process, has combined with Naegeli Deposition & Trial. The transaction became effective on Thursday, July 9 and was led by John Brownschidle, Head... ———————————————————————————————————————————————————————————— Omada Health to Participate in Canaccord Genuity’s 46th Annual Growth Conference 2026-07-13 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326215/0/en/Omada-Health-to-Participate-in-Canaccord-Genuity-s-46th-Annual-Growth-Conference.html Omada Health (Nasdaq: OMDA) announced that members of senior management will participate in Canaccord Genuity’s 46th annual Growth Conference. ———————————————————————————————————————————————————————————— Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial 2026-07-13 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326226/0/en/Oncolytics-Biotech-Reports-FDA-Regulatory-Milestone-and-Strong-Clinical-Progress-in-Randomized-RAS-Mutant-MSS-Colorectal-Cancer-Trial.html Oncolytics announced more than 20 patients pre-identified for REO 033 colorectal cancer trial and scheduled Type D meeting with the FDA. ———————————————————————————————————————————————————————————— PDS Optical Launches National Survey to Discover the Impact of Digital Screens on Veterans' Vision 2026-07-13 · PRWeb · Healthcare https://www.prweb.com/releases/pds-optical-launches-national-survey-to-discover-the-impact-of-digital-screens-on-veterans-vision-302822493.html PDS Optical is pioneering a new front in Veteran healthcare with the launch of the Pulse on Digital Strain Survey. This first-of-its-kind initiative is specifically designed to uncover how modern screen time affects the vision health of the Veteran community, a population previously... ———————————————————————————————————————————————————————————— Ideal Option Releases 2025 Patient Outcomes Annual Report, Highlighting Life-Saving Impact Amid Washington State's Ongoing Opioid Crisis 2026-07-13 · PRWeb · Healthcare https://www.prweb.com/releases/ideal-option-releases-2025-patient-outcomes-annual-report-highlighting-life-saving-impact-amid-washington-states-ongoing-opioid-crisis-302820598.html New data show 96% opioid abstinence rates among long-term patients as statewide overdose deaths begin to decline. RENTON, Wash., July 13, 2026 /PRNewswire-PRWeb/ -- Ideal Option, a national leader in outpatient medication-assisted treatment (MAT) for addiction to opioids, stimulants and... ———————————————————————————————————————————————————————————— No Win No Fee Medical Negligence Solicitors 2026-07-13 · GetNews · Healthcare https://www.getnews.info/story/2026/07/13/no-win-no-fee-medical-negligence-solicitors/?source=barchart ———————————————————————————————————————————————————————————— Form 8.3 - Advanced Medical Solutions Group 2026-07-13 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326195/0/en/Form-8-3-Advanced-Medical-Solutions-Group.html 8.3 ———————————————————————————————————————————————————————————— Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development 2026-07-13 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326185/0/en/Cue-Biopharma-Appoints-Dominic-Borie-M-D-Ph-D-as-Chief-Medical-Officer-and-Head-of-Research-Development.html Physician-scientist and immunology leader joins Cue as the company advances key clinical programs in allergic and autoimmune diseases Physician-scientist and immunology leader joins Cue as the company advances key clinical programs in allergic and autoimmune diseases ———————————————————————————————————————————————————————————— Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care 2026-07-13 · GlobeNewswire · Finance, Healthcare, Automotive https://www.globenewswire.com/news-release/2026/07/13/3326176/0/en/Enovis-Companion-Animal-Health-Launches-CT-RevitL-the-Next-Generation-Laser-Therapy-System-for-Veterinary-Care.html DALLAS, TX, July 13, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, today announced the U.S. launch of CT-RevitL™, the next-generation veterinary PBM laser therapy system from its Companion Animal Health business. CT-RevitL delivers enhanced clinical performance, greater mobility and a more intuitive treatment experience for veterinary teams and their patients. ———————————————————————————————————————————————————————————— Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp 2026-07-13 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326189/12101/en/Sol%C3%A9sence-Brings-Patent-Backed-Skin-Health-Innovation-to-Hair-and-Scalp.html New White Label Collection, Powered by WHSPR™ and Kleair™, Debuts with Revitalizing Scalp Serum and Scalp Screen Dry Shampoo SPF 45+ Sunscreen ———————————————————————————————————————————————————————————— Integrity Billing Marks More Than a Decade of Leadership in Behavioral Health Revenue Cycle Management 2026-07-13 · PRWeb · Finance, Healthcare https://www.prweb.com/releases/integrity-billing-marks-more-than-a-decade-of-leadership-in-behavioral-health-revenue-cycle-management-302821600.html Integrity Billing Company, a family-owned behavioral health revenue cycle management firm based in Palm Springs, Florida, is celebrating more than 10 years of serving treatment providers nationwide. The company is recognized for its ethical, U.S.-based billing operations, clinical... ———————————————————————————————————————————————————————————— Glioblastoma Foundation Marks 10 Years with New Push to Accelerate ... 2026-07-13 · PR-Inside · Healthcare https://pr-inside.com/glioblastoma-foundation-marks-10-years-with-new-push-to-accelerate-r5200541.htm (PR-inside.com) As glioblastoma continues to challenge the medical community, the Foundation unveils a new genomic testing lab, an advancing drug pipeline, and a sharper focus on accelerating personalized treatment for patients ahead of Glioblastoma Awareness Day on July 15. DURHAM, NC / ACCESS Newswire / July 13, 2026 / Over the past decade, the Glioblastoma Foundation has worked to advance research, educate patients and caregivers, support the glioblastoma community, and foster collaborations aimed at improving outcomes for individuals facing one of the most aggressive forms of cancer. As it enters its second decade, the Glioblastoma Foundation is expanding its efforts by building the .. ———————————————————————————————————————————————————————————— Hypha Labs (OTCQB:FUNI) Sees State-by-State Psilocybin Reform Creating ... 2026-07-13 · PR-Inside · Healthcare https://pr-inside.com/hypha-labs-otcqb-funi-sees-state-by-state-psilocybin-reform-creating-r5200540.htm (PR-inside.com) Company Believes Industry Is Following the Early Regulatory Path That Fueled the Cannabis Market LAS VEGAS, NV / ACCESS Newswire / July 13, 2026 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company developing advanced mushroom production technologies, believes the rapidly expanding state-by-state adoption of psilocybin programs is creating a significant long-term opportunity for scalable manufacturing infrastructure. With Oregon, Colorado, and New Mexico now operating statewide psilocybin programs and more than two dozen states considering medical, research, or decriminalization legislation, Hypha Labs believes the industry is following a regulatory path similar to the early days of cannabis. "We believe the psychedelic industry is approaching .. ———————————————————————————————————————————————————————————— Glioblastoma Foundation Marks 10 Years with New Push to Accelerate Personalized Treatment 2026-07-13 · Newswire.com · Healthcare https://www.newswire.com/news/glioblastoma-foundation-marks-10-years-with-new-push-to-accelerate-22823333 As glioblastoma continues to challenge the medical community, the Foundation unveils a new genomic testing lab, an advancing drug pipeline, and a sharper focus on accelerating personalized treatment for patients ahead of Glioblastoma Awareness Day on July 15. ———————————————————————————————————————————————————————————— Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant 2026-07-13 · GlobeNewswire · Finance, Healthcare, Real Estate https://www.globenewswire.com/news-release/2026/07/13/3326108/0/en/Autonomix-Medical-Strengthens-Global-Intellectual-Property-Position-with-New-Neural-Sensing-Patent-Grant.html IP portfolio reflects Autonomix’s neural sensing leadership in multi-billion-dollar denervation market ———————————————————————————————————————————————————————————— Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit 2026-07-13 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326105/0/en/Cognition-Therapeutics-Participating-in-Fireside-Chat-at-B-Riley-Securities-Mind-Muscle-Vision-Summit.html PURCHASE, N.Y., July 13, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that the Company’s president and CEO, Lisa Ricciardi , has been invited to participate in a fireside discussion at the B. Riley Mind, Muscle & Vision Summit on July 16, 2026. During the discussion with analyst, William Wood, Ph.D., Ms. Ricciardi will review the status of the Company's ongoing START study as well as the planned initiation of a Phase 3 registrational study of zervimesine (CT1812) in dementia with Lewy bodies (DLB) psychosis. ———————————————————————————————————————————————————————————— Dario Expects Proprietary AI Engine DarioIQ™ to Increase Recurring Revenue from Existing Customers by 10-15% 2026-07-13 · PR Newswire · Finance, AI, Healthcare https://www.prnewswire.com/news-releases/dario-expects-proprietary-ai-engine-darioiq-to-increase-recurring-revenue-from-existing-customers-by-10-15-302823563.html DarioIQ drives higher engagement and retention, better clinical outcomes, higher client ROI and recurring revenue growth for Dario Dario IQ's AI-driven personalization increases member engagement by 40% and improves member retention by 20% by leveraging 13+ billion proprietary real-world... ———————————————————————————————————————————————————————————— Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results 2026-07-13 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/zimmer-biomet-announces-webcast-and-conference-call-of-second-quarter-2026-financial-results-302823400.html WARSAW, Ind., July 13, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its second quarter earnings conference call will be webcast on Wednesday, August 5, 2026 at 8:30 a.m. ET. A news release detailing the... ———————————————————————————————————————————————————————————— Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer’s Disease 2026-07-13 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326085/0/en/Longeveron-Announces-Presentation-of-Clinical-Data-at-the-2026-Alzheimer-s-Association-International-Conference-AAIC-that-Indicate-Its-Cellular-Therapy-Laromestrocel-Reduced-Neuroi.html Longeveron reports new data analysis for its stem cell therapy laromestrocel in mild Alzheimer's disease at AAIC 2026. ———————————————————————————————————————————————————————————— Cynosure Lutronic Brings Next-Generation Monopolar RF to Europe as Patient Demand for Non-Invasive Skin Tightening Reaches New Heights 2026-07-13 · PR Newswire · Healthcare, Retail https://www.prnewswire.com/news-releases/cynosure-lutronic-brings-next-generation-monopolar-rf-to-europe-as-patient-demand-for-non-invasive-skin-tightening-reaches-new-heights-302823763.html XERF, the dual-frequency skin tightening technology that has transformed aesthetics practices in the US and Asia-Pacific, is now available across EMEA. It arrives as new consumer research reveals a spike in demand for non-invasive rejuvenation. XERF arrives in Europe following strong... ———————————————————————————————————————————————————————————— KHAI Ventures Secures Distribution Rights for Wellytics' Health Data and Advanced Software Platform 2026-07-13 · PRWeb · AI, SaaS, Healthcare https://www.prweb.com/releases/khai-ventures-secures-distribution-rights-for-wellytics-health-data-and-advanced-software-platform-302823186.html Healthcare AI, portfolio operations company KHAI Ventures has entered into a strategic distribution agreement with Wellytics Health, a healthcare technology and AI company. Under the agreement, KHAI Ventures secures unrestricted commercial and research rights to utilize, enhance, market,... ———————————————————————————————————————————————————————————— VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline 2026-07-13 · GlobeNewswire · Finance, AI, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326056/0/en/VERAXA-Biotech-to-Launch-AI-enabled-Drug-Discovery-Collaboration-with-Ardigen-to-Support-Growing-BiTAC-Pipeline.html VERAXA Biotech initiates a collaboration with Ardigen SA to optimize cancer target pair selection for growing BiTAC® pipeline. ———————————————————————————————————————————————————————————— Quadruple amputee's 3,000-mile banger rally for Scotland's amputees 2026-07-13 · Pressat · Healthcare https://pressat.co.uk/releases/quadruple-amputees-3000-mile-banger-rally-for-scotlands-amputees-2695a7df6bba992683009800c11720b3/ Monday 13 July, 2026 Cor Hutton has two prosthetic legs, two transplanted hands, one third of a lung and a recent kidney transplant. This August she's driving a clapped-out Audi TT to Nice. She built Scotland's amputee charity because the support she needed didn't exist. Now she's driving to fund it. Sepsis took both of Cor Hutton's hands and both of her feet. Her family never left her side. But when she looked for someone who truly understood what she was living through, she couldn't find them. So, she built Finding Your Feet. Today, Finding Your Feet (FYF) is Scotland's only nationwide charity supporting amputees, those born without limbs, and their families. It offers peer support, counselling, well-being services and inclusive clubs and activities, the kind of community that Cor needed ———————————————————————————————————————————————————————————— ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chronic Non-Infectious Uveitis 2026-07-13 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/13/3326047/0/en/ANI-Pharmaceuticals-Announces-Positive-Six-Month-Topline-Data-from-the-Phase-4-Open-Label-Single-Arm-SYNCHRONICITY-Trial-Evaluating-Fluocinolone-Acetonide-Intravitreal-Implant-in-P.html PRINCETON, N.J., July 13, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced positive topline data from its Phase 4, open-label, single-arm SYNCHRONICITY clinical trial of Fluocinolone Acetonide Intravitreal Implant in patients with chronic non-infectious uveitis affecting the posterior segment of the eye (chronic NIU-PS). ———————————————————————————————————————————————————————————— Karmanos Cancer Institute Rolls Out New Oncology Clinical Trials App Features 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/karmanos-cancer-institute-rolls-out-new-oncology-clinical-trials-app-features-302823127.html New app functions empower patients, caregivers and health care professionals to easily find and access Karmanos' large portfolio of innovative cancer treatment options through actively recruiting clinical trials DETROIT, July 13, 2026 /PRNewswire/ -- The Barbara Ann Karmanos Cancer... ———————————————————————————————————————————————————————————— Bora Biologics Expands U.S. Commercial Manufacturing Platform with ... 2026-07-13 · PR-Inside · SaaS, Healthcare https://pr-inside.com/bora-biologics-expands-u-s-commercial-manufacturing-platform-with-r5200438.htm (PR-inside.com) Expansion Scales U.S. Single-Use Drug Substance Capacity to 20,000 Liters Across Two FDA-Registered Facilities SAN DIEGO, CA / ACCESS Newswire / July 13, 2026 / Bora Biologics, a U.S.-based biologics CDMO engineered for licensed supply, today announced the expansion of its U.S. drug substance manufacturing platform through the addition of the Rockville, Maryland site. The addition strengthens the company's U.S.-anchored BioSecure commercial platform and reinforces its long-term investment in domestic biologics manufacturing. With the addition of Rockville, Bora Biologics scales its total offering of installed U.S. single-use bioreactor capacity to 20,000 liters - scalable to 30,000 liters - across two FDA-registered facilities .. ———————————————————————————————————————————————————————————— Bora Biologics Expands U.S. Commercial Manufacturing Platform with Addition of Rockville Site 2026-07-13 · Newswire.com · SaaS, Healthcare https://www.newswire.com/news/bora-biologics-expands-u-s-commercial-manufacturing-platform-with-addition-of Expansion Scales U.S. Single-Use Drug Substance Capacity to 20,000 Liters Across Two FDA-Registered Facilities ———————————————————————————————————————————————————————————— One Mnet Health Names Matt Ellis Chief Revenue Officer to Lead Next Phase of Growth 2026-07-13 · PRWeb · Finance, Healthcare https://www.prweb.com/releases/one-mnet-health-names-matt-ellis-chief-revenue-officer-to-lead-next-phase-of-growth-302823417.html Experienced revenue cycle executive joins to unify One Mnet Health's software and services under one commercial strategy. ALISO VIEJO, Calif., July 13, 2026 /PRNewswire-PRWeb/ -- One Mnet Health, a leading healthcare technology and patient billing company that serves hospitals, ASCs, and... ———————————————————————————————————————————————————————————— Recent Release, "The Cure: Magic Mushroom Therapy to Heal Mankind Mentally," by Author Michael Davis, Explores Psilocybin's Potential to Transform Mental Health Treatment 2026-07-13 · PR.com · Healthcare https://www.pr.com/press-release/972986 Michael Davis has completed a new book, "The Cure: Magic Mushroom Therapy to Heal Mankind Mentally" — a captivating exploration of the transformative power of psilocybin, the active compound in magic mushrooms. Drawing on his own personal experiences, Davis makes a compelling case for embracing this ancient natural remedy to address the mental health crisis plaguing our nation. Author Michael Davis was [PR.com] ———————————————————————————————————————————————————————————— Advancing Low-Carbon Manufacturing and Global Sustainability Commitments 2026-07-13 · PR Newswire · Healthcare, Energy https://www.prnewswire.com/news-releases/advancing-low-carbon-manufacturing-and-global-sustainability-commitments-302823717.html Report highlights clean energy, innovation and ESG recognition ZIBO, China, July 13, 2026 /PRNewswire/ -- INTCO Medical ("the Company"), a leading global manufacturer of disposable gloves, has released its 2025 Environmental, Social and Governance (ESG) Report, outlining progress in... ———————————————————————————————————————————————————————————— LataMed AI Begins Evaluating Global Healthcare Expansion Opportunities Through Planned Attendance at World Health Expo 2027 2026-07-13 · NewMediaWire · AI, Healthcare, Retail https://www.newmediawire.com/news/latamed-ai-begins-evaluating-global-healthcare-expansion-opportunities-through-planned-attendance-at-world-health-expo-2027-7087662 CARACAS, VENEZUELA - July 13, 2026 ( NEWMEDIAWIRE ) - LataMed AI Corp. (OTC: LMED) (the “Company”), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets, today announced that management has begun planning for the Company's anticipated attendance at the World Health Expo 2027 in Dubai, United Arab Emirates, as part of its broader strategy to evaluate international healthcare expansion opportunities. Management believes attendance at World Health Expo 2027 will provide an important opportunity to engage with healthcare leaders, technology innovators, healthcare providers, government representatives, and potential strategic partners from around the worl ———————————————————————————————————————————————————————————— Red Cross Declares Emergency Blood Shortage after Blood Supply Falls 25% 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/red-cross-declares-emergency-blood-shortage-after-blood-supply-falls-25-302821097.html Donations far lower than needed as hospitals work to protect patient care News Summary: The American Red Cross is declaring an emergency blood shortage after the national blood supply fell about 25% in June. Red Cross blood distributions to hospitals are nearly 3,500 units higher per week... ———————————————————————————————————————————————————————————— Declan Rice Playing While Recovering From a Virus Underscores the UK’s Failure to Warn About Post‑Viral Illness and M.E. 2026-07-13 · Pressat · Healthcare https://pressat.co.uk/releases/declan-rice-playing-while-recovering-from-a-virus-underscores-the-uks-failure-to-warn-about-post-viral-illness-and-me-f006d64d8f99ac354917e017ceb90769/ Monday 13 July, 2026 England midfielder Declan Rice, still recovering from a virus, played 45 minutes in 33+ degree heat during the Quarter Final match against Norway on Saturday night. Fans noted he was clearly struggling and wished him well on social media. His commitment was widely praised, but for people living with post-viral illness and Myalgic Encephalomyelitis (M.E.), the moment was deeply concerning. When a national figure pushes through illness in extreme conditions, it reinforces a powerful cultural message: that exertion during or after viral infection is harmless, even admirable. For many people, it is not. For some, it leads to lifelong disability. This moment exposes a critical failure in UK public health communication, specifically the Chief Medical Officer’s physical activ ———————————————————————————————————————————————————————————— Leads Biolabs Announces Multiple Studies Selected for ESMO 2026, Highlighting the Growing Global Competitiveness of Its Core Pipeline 2026-07-13 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/leads-biolabs-announces-multiple-studies-selected-for-esmo-2026-highlighting-the-growing-global-competitiveness-of-its-core-pipeline-302823685.html NANJING, China, July 13, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that six of its latest research studies have been accepted for presentation at the 2026 European Society for Medical Oncology (ESMO) Annual... ———————————————————————————————————————————————————————————— Tahlia Rahme Brings Warm, Evidence-Based Child Psychology to Melbourne 2026-07-13 · PR.com · Healthcare https://www.pr.com/press-release/972337 As demand for accessible youth mental health services rise across Australia, MLA Psychology strengthens its clinical offering with the appointment of neuroaffirming child and adolescent psychologist Tahlia Rahme. [PR.com] ———————————————————————————————————————————————————————————— Faron Provides Update on Investigator-Initiated Trial Portfolio for ... 2026-07-13 · PR-Inside · Healthcare https://pr-inside.com/faron-provides-update-on-investigator-initiated-trial-portfolio-for-r5200399.htm (PR-inside.com) Investigators update from BLAZE in checkpoint-resistant solid tumors highlights continued progress across Faron's expanding Investigator-Initiated Trial (IIT) portfolio TURKU, FI / ACCESS Newswire / July 13, 2026 / Faron Pharmaceuticals Ltd. (HEL:FARON)(LSE:FARN), a global, clinical-stage biopharmaceutical company focused on creating innovative cancer treatments that leverage the patient's own immune system, today provides an update on its portfolio of Investigator-Initiated Trials (IITs) evaluating bexmarilimab, its wholly owned anti-Clever-1 immunotherapy, in multiple oncology indications. The update covers five IITs in solid tumors and hematological malignancies, reflecting both advances and adjustments across the program. BLAZE: Investigators update combination treatmen ———————————————————————————————————————————————————————————— Genflow Biosciences PLC Announces Mid-Year Operational and Corporate ... 2026-07-13 · PR-Inside · Healthcare https://pr-inside.com/genflow-biosciences-plc-announces-mid-year-operational-and-corporate-r5200397.htm (PR-inside.com) LONDON, UK / ACCESS Newswire / July 13, 2026 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), an emerging leader in the field of longevity research, provides a mid-year operational and corporate summary covering the six-month period to 30 June 2026. No delays in the dog clinical trial: Positive preliminary interim results from the SLAB trial, followed by confirmation of sustained safety and efficacy at the three-month follow-up Expansion of confidentiality agreements with additional Tier-1 animal health companies Strategic technology collaboration with Acuitas Therapeutics ("Acuitas ") for fully funded, non-dilutive LNP delivery development International patent publication extending SIRT6 protection into muscular disease indications New .. ———————————————————————————————————————————————————————————— SCENESSE® approved for EPP in Canada 2026-07-13 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/13/3325896/0/en/SCENESSE-approved-for-EPP-in-Canada.html Health Canada NOC enables treatment for porphyria, metabolic disorder Health Canada NOC enables treatment for porphyria, metabolic disorder ———————————————————————————————————————————————————————————— New clinical data on the Leqembi® subcutaneous autoinjector presented at AAIC® 2026 support similar efficacy and safety to IV formulation in early Alzheimer's disease 2026-07-13 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/new-clinical-data-on-the-leqembi-subcutaneous-autoinjector-presented-at-aaic-2026-support-similar-efficacy-and-safety-to-iv-formulation-in-early-alzheimers-disease-302823525.html STOCKHOLM, July 13, 2026 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today presented new data at the 2026 Alzheimer's Association International Conference (AAIC), held in London, July 12-15, demonstrating that the Leqembi (lecanemab) subcutaneous... ———————————————————————————————————————————————————————————— ALZHEIMER'S ASSOCIATION LAUNCHES "PROTECT-COG" STUDY TO TEST U.S. POINTER LIFESTYLE AND GLP-1 OR SIMILAR DRUG TO CUT RISK OF COGNITIVE DECLINE 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/alzheimers-association-launches-protect-cog-study-to-test-us-pointer-lifestyle-and-glp-1-or-similar-drug-to-cut-risk-of-cognitive-decline-302823408.html LONDON, July 13, 2026 /PRNewswire/ -- The Alzheimer's Association today announced the launch of the PROTECT-Cog Study (Prevention of Risk fOr cogniTive dEcline through Combined Therapy), a first-of-its-kind global clinical trial designed to evaluate whether combining a proven multidomain... ———————————————————————————————————————————————————————————— FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2026 LIFESTYLE PROGRAM IMPROVES BRAIN HEALTH AMONG OLDER ADULTS AT RISK FOR DEMENTIA ACROSS LATIN AMERICA 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/from-the-alzheimers-association-international-conference-2026-lifestyle-program-improves-brain-health-among-older-adults-at-risk-for-dementia-across-latin-america-302823398.html - LatAm-FINGERS Study Findings Confirm and Expand U.S. POINTER Trial Results - - Show Structured Dementia Risk Reduction Strategies Adaptable Across Cultures - Key Takeaways The LatAm-FINGERS study shows lifestyle interventions adapted across Latin American cultures, health systems and... ———————————————————————————————————————————————————————————— Antengene Announces Receipt of USD 60 Million Upfront Payment from UCB 2026-07-13 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/antengene-announces-receipt-of-usd-60-million-upfront-payment-from-ucb-302823509.html SHANGHAI and HONG KONG, July 13, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for... ———————————————————————————————————————————————————————————— Deepening Collaboration in AI-Powered R&D Acceleration: Insilico Medicine and CMS announce additional collaborations in CNS diseases 2026-07-13 · PR Newswire · AI, SaaS, Healthcare https://www.prnewswire.com/news-releases/deepening-collaboration-in-ai-powered-rd-acceleration-insilico-medicine-and-cms-announce-additional-collaborations-in-cns-diseases-302823160.html SHANGHAI, July 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), and China Medical System Holdings Limited ("CMS", 867.HK/8A8.SG), an open-platform innovative company linking... ———————————————————————————————————————————————————————————— Study: "Physical Therapy for the Brain" Delivered by Telephone Shows Outcomes Meeting or Exceeding National In-Person Benchmarks 2026-07-12 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/study-physical-therapy-for-the-brain-delivered-by-telephone-shows-outcomes-meeting-or-exceeding-national-in-person-benchmarks-302823307.html Real-world data from 141 Medicare patients shows significant gains in cognitive function and quality of life through a highly accessible delivery model designed to reach rural neurology deserts LONDON, July 12, 2026 /PRNewswire/ -- Moneta Health, a brain health company delivering... ———————————————————————————————————————————————————————————— Ascelia Pharma Provides Orviglance Update 2026-07-12 · PR-Inside · Healthcare https://pr-inside.com/ascelia-pharma-provides-orviglance-update-r5200292.htm (PR-inside.com) MALMÖ, SE / ACCESS Newswire / July 12, 2026 / Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (STO:ACE), a biopharmaceutical company focused on improving the lives of people living with rare cancer conditions, provides an update following the recent publication of the Complete Response Letter (CRL) by the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Orviglance®. As previously communicated, Ascelia Pharma ("Ascelia") is preparing for a Type A meeting with the FDA to obtain a detailed understanding of the matters outlined in the CRL and to find an expedited path forward for Orviglance. Ascelia views .. ———————————————————————————————————————————————————————————— Cypress Health Partners Physical Therapist Volunteers on Orthopedic Mission Trip in Honduras 2026-07-12 · PRWeb · Healthcare, Automotive https://www.prweb.com/releases/cypress-health-partners-physical-therapist-volunteers-on-orthopedic-mission-trip-in-honduras-302823069.html Five-day medical mission highlights the critical role of physical therapy in restoring patient mobility and improving access to care PORTLAND, Maine, July 12, 2026 /PRNewswire-PRWeb/ -- Earlier this year, physical therapist Andrew Genova, PT, DPT, Managing Partner at MVPT Physical... ———————————————————————————————————————————————————————————— A New Approach to Treating Brain Cancer: HDT Bio Launches Canadian Clinical Program at McGill University 2026-07-12 · PR Newswire · Healthcare, Education https://www.prnewswire.com/news-releases/a-new-approach-to-treating-brain-cancer-hdt-bio-launches-canadian-clinical-program-at-mcgill-university-302822942.html HDT Bio Canada Inc. partners with McGill University and The Neuro to advance HDT-401, an investigational locally administered RNA immune activator, into Phase 1 clinical evaluation for glioblastoma in Canada MONTREAL and SEATTLE, July 12, 2026 /PRNewswire/ -- Among the deadliest of brain... ———————————————————————————————————————————————————————————— LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026 2026-07-12 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/12/3325847/0/en/LEQEMBI-Subcutaneous-Autoinjector-Clinical-Data-Supports-Similar-Efficacy-and-Safety-to-IV-Formulation-in-Early-Alzheimer-s-Disease-Presented-at-the-Alzheimer-s-Association-Interna.html New clinical and real-world data support a subcutaneous treatment pathway from initiation through maintenance treatment, offering dosing convenience for patients and care partners New clinical and real-world data support a subcutaneous treatment pathway from initiation through maintenance treatment, offering dosing convenience for patients and care partners ———————————————————————————————————————————————————————————— LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer's Disease Presented at the Alzheimer's Association International Conference® (AAIC®) 2026 2026-07-12 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/leqembi-subcutaneous-autoinjector-clinical-data-supports-similar-efficacy-and-safety-to-iv-formulation-in-early-alzheimers-disease-presented-at-the-alzheimers-association-international-conference-aaic-2026-302823332.html New clinical and real-world data support a subcutaneous treatment pathway from initiation through maintenance treatment, offering dosing convenience for patients and care partners TOKYO and CAMBRIDGE, Mass., July 12, 2026 /PRNewswire/ -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB)... ———————————————————————————————————————————————————————————— Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz ... 2026-07-12 · PR-Inside · Finance, Healthcare https://pr-inside.com/unicycive-therapeutics-inc-uncy-investigation-bronstein-gewirtz-r5200243.htm (PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 12, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Unicycive Therapeutics, Inc. ("Unicycive" or "the Company") (NASDAQ:UNCY). Investors who purchased Unicycive securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/UNCY. Unicycive Investigation Details On June 30, 2026, Unicycive disclosed that the FDA had issued a second Complete Response Letter ("CRL") regarding the Company's resubmitted New Drug Application for its kidney disease therapy, oxylanthanum, identifying the "same third-party manufacturing deficiencies that were identified in the previous CRL issued in .. ———————————————————————————————————————————————————————————— RE.DOCTOR Launches Mobile-First Home Health Care Agency Software to Streamline Workflows and Introduce Contactless Vital Monitoring 2026-07-12 · PR.com · SaaS, Healthcare https://www.pr.com/press-release/969323 Next-generation cloud platform cuts administrative burdens for mobile clinical workforces while embedding seamless, secure data collection tools at the patient bedside. [PR.com] ———————————————————————————————————————————————————————————— Frequent Heartburn or Reflux Can Be a Sign of Something More Serious, Says Intermountain Health 2026-07-12 · PRUnderground · Healthcare https://www.prunderground.com/frequent-heartburn-or-reflux-can-be-a-sign-of-something-more-serious-says-intermountain-health/00388158/ Dr. Nathan Merriman, Intermountain Health, explains the risk of Gastroesophageal Reflux Disease and how it increases the risk of Esophageal Cancer The post Frequent Heartburn or Reflux Can Be a Sign of Something More Serious, Says Intermountain Health first appeared on ———————————————————————————————————————————————————————————— MMJ The Voice DEA Didn't Want to Hear From During Marijuana Rescheduling ... 2026-07-12 · PR-Inside · Healthcare https://pr-inside.com/mmj-the-voice-dea-didn-t-want-to-hear-from-during-marijuana-rescheduling-r5200181.htm (PR-inside.com) " DEA silenced the only FDA-pathway cannabinoid developer at its ALJ hearing. The courts won't." - Duane Boise, CEO, MMJ International Holdings. WASHINGTON, D.C. / ACCESS Newswire / July 12, 2026 / The most revealing moment of the DEA's marijuana rescheduling process may not have occurred during seven days of testimony in Arlington. It occurred weeks earlier, when the DEA decided who would not be allowed into the hearing room. The agency excluded MMJ International Holdings-the only company developing botanical cannabinoid medicines through the FDA's formal drug approval process-from participating in a hearing whose central question was whether marijuana has a "currently .. ———————————————————————————————————————————————————————————— MMJ The Voice DEA Didn't Want to Hear From During Marijuana Rescheduling Hearings 2026-07-12 · Newswire.com · Healthcare https://www.newswire.com/news/mmj-the-voice-dea-didnt-want-to-hear-from-during-marijuana-rescheduling-hearings " DEA silenced the only FDA-pathway cannabinoid developer at its ALJ hearing. The courts won't." - Duane Boise, CEO, MMJ International Holdings . ———————————————————————————————————————————————————————————— Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1 2026-07-12 · GlobeNewswire · Finance, AI, SaaS, Healthcare https://www.globenewswire.com/news-release/2026/07/12/3325846/0/en/Evaxion-presents-new-preclinical-data-for-cytomegalovirus-vaccine-program-EVX-V1.html COPENHAGEN, Denmark, July 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, presents new data further supporting the multi-component concept of its cytomegalovirus (CMV) vaccine program EVX-V1. ———————————————————————————————————————————————————————————— Bacteria From Gum Disease May Cause Inflammation, Harden Heart Valves 2026-07-12 · NewMediaWire · Retail, Healthcare https://www.newmediawire.com/news/bacteria-from-gum-disease-may-cause-inflammation-harden-heart-valves-7087657 Research Highlights : A lab study investigating mouse and human cardiac tissue found a potential link between gum disease (periodontitis) and a narrowing of the aortic valves (aortic valve stenosis). Currently, there is no medication or treatment available that can prevent or slow the progression of aortic valve stenosis. However, these findings suggest that treating gum disease and associated inflammation of the gums might help prevent the most common form of heart valve disease. Note: The study featured in this news release is a research abstract. Abstracts presented at the American Heart Association’s scientific meetings are not peer-reviewed, and the findings are considered preliminary until published as full manuscripts in a peer-reviewed scientific journal. Embargoed until 8 a.m. CT/ ———————————————————————————————————————————————————————————— EV All Day Launches Instant Battery-Health Check for Used Electric Cars 2026-07-12 · PRWeb · Healthcare, Energy, Automotive https://www.prweb.com/releases/ev-all-day-launches-instant-battery-health-check-for-used-electric-cars-302823331.html A used electric car's most valuable part, its battery, is also the one thing no advert, V5C or history check will show you. EV All Day's new £9.99 check changes that, giving buyers an instant, independent estimate of battery health, real-world range and remaining warranty before they ever... ———————————————————————————————————————————————————————————— Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress 2026-07-12 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/12/3325841/0/en/Hemab-Therapeutics-Presents-New-Clinical-Data-from-HMB-002-in-Von-Willebrand-Disease-and-Introduces-HMB-003-for-Heavy-Menstrual-Bleeding-at-the-ISTH-2026-Congress.html HMB-002 clinical data demonstrate proof of mechanism, with dose-dependent, greater than or equal to 2.4-fold peak increases in Von Willebrand Factor (VWF) and Factor VIII (FVIII), normalization of peak thrombin generation and activated partial thromboplastin time (APTT), and durability supporting potential monthly subcutaneous dosing ———————————————————————————————————————————————————————————— FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2026 2026-07-12 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/from-the-alzheimers-association-international-conference-2026-302823298.html FORMER ELITE SOCCER PLAYERS SHOW EVIDENCE OF BRAIN HEALTH CHANGES IN MID-LIFE Key Takeaways New research provides insights into brain health among former elite professional soccer players during midlife. Former players reported high levels of depression, anxiety, and subjective... ———————————————————————————————————————————————————————————— MNA: Brigham Nurses Prepare for End of Lockout on Monday with Solidarity Walk-In as MGB Home Care Clinicians Demonstrate Power with Ongoing MGB HQ Strike Picketing 2026-07-11 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/mna-brigham-nurses-prepare-for-end-of-lockout-on-monday-with-solidarity-walk-in-as-mgb-home-care-clinicians-demonstrate-power-with-ongoing-mgb-hq-strike-picketing-302823289.html Brigham nurses and MGB Home Care clinicians have told the Governor and MGB they are prepared to negotiate until contract resolutions are reached BOSTON, July 11, 2026 /PRNewswire/ -- Brigham and Women's Hospital nurses, who are locked out by Mass General Brigham billionaires through... ———————————————————————————————————————————————————————————— New to The Street Show #761 to Broadcast Across Bloomberg U.S., Latin ... 2026-07-11 · PR-Inside · Finance, AI, SaaS, Healthcare https://pr-inside.com/new-to-the-street-show-761-to-broadcast-across-bloomberg-u-s-latin-r5200002.htm (PR-inside.com) The show broadcasts at 6:30 PM ET as sponsored programming, with television commercials featuring Big Sky Industrial, Envoy Medical, FreeCast and Datavault AI NEW YORK CITY, NY / ACCESS Newswire / July 11, 2026 / New to The Street announces the upcoming broadcast of Show #761, airing at 6:30 PM ET as sponsored programming across Bloomberg Television in the United States, Latin America and the Middle East and North Africa (MENA). The program features executive interviews and corporate updates from: Sagtec Global Limited (NASDAQ:SAGT) Virtuix Holdings Inc. (NASDAQ:VTIX) Lantern Pharma Inc. (NASDAQ:LTRN) YY Group Holding Limited (NASDAQ:YYGH) Show #761 gives business leaders an international platform to discuss .. ———————————————————————————————————————————————————————————— New to The Street Show #761 to Broadcast Across Bloomberg U.S., Latin America and MENA, Featuring Sagtec Global, Virtuix, Lantern Pharma and YY Group 2026-07-11 · Newswire.com · AI, Healthcare https://www.newswire.com/news/new-to-the-street-show-761-to-broadcast-across-bloomberg-u-s-latin-america-and The show broadcasts at 6:30 PM ET as sponsored programming, with television commercials featuring Big Sky Industrial, Envoy Medical, FreeCast and Datavault AI ———————————————————————————————————————————————————————————— Intermountain Health Data May Help Moms More Safely Deliver Babies and Shorten Labor and Delivery 2026-07-11 · PRUnderground · Healthcare https://www.prunderground.com/intermountain-health-data-may-help-moms-more-safely-deliver-babies-and-shorten-labor-and-delivery/00388150/ Intermountain Health used labor and delivery data to improve the outcomes and experience for pregnant moms and their newborn babies The post Intermountain Health Data May Help Moms More Safely Deliver Babies and Shorten Labor and Delivery first appeared on ———————————————————————————————————————————————————————————— DRAI Health Introduces SpaceXAI-Powered Personalized Voice Interaction in heyDRAI 2026-07-11 · PRWeb · AI, Healthcare https://www.prweb.com/releases/drai-health-introduces-spacexai-powered-personalized-voice-interaction-in-heydrai-302822689.html New capability delivers more natural, adaptive, and human-centered voice-guided healthcare experiences LOS ANGELES, July 11, 2026 /PRNewswire-PRWeb/ -- DRAI Health today announced the launch of a new personalized voice interaction capability within heyDRAI, its AI-powered healthcare... ———————————————————————————————————————————————————————————— Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP 2026-07-11 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/inspire-medical-investigation-continued-kahn-swick--foti-llc-continues-to-investigate-the-officers-and-directors-of-inspire-medical-systems-inc---insp-302823089.html NEW YORK and NEW ORLEANS, July 10, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF continues its investigation into Inspire Medical Systems, Inc. (NYSE: INSP). In August... ———————————————————————————————————————————————————————————— GuideAI Health Announces Marketing and Communications Programs 2026-07-10 · GlobeNewswire · Finance, AI, SaaS, Healthcare https://www.globenewswire.com/news-release/2026/07/10/3325766/0/en/GuideAI-Health-Announces-Marketing-and-Communications-Programs.html BOSTON, July 10, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (Cboe CA: GDAI ) (" GuideAI " or the " Company ") is pleased to announce that it has engaged Upswitch Media Corp. ("Upswitch") and BTV-Business Television ("BTV") — to execute a coordinated marketing, communications and investor-awareness program (the "Program"). The Program is designed to raise awareness of the Company and its artificial intelligence (AI) platform for the detection and characterization of vascular disease among the news, investment and healthcare communities. ———————————————————————————————————————————————————————————— LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) 2026-07-10 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/10/3325759/0/en/LB-Pharmaceuticals-Reports-Inducement-Grant-to-New-Employee-Under-Nasdaq-Listing-Rule-5635-c-4.html NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), today announced that it has granted to Christopher Zergebel, the new Senior Vice President, Clinical Operations of LB Pharmaceuticals, an equity award outside of, but subject to the terms and conditions of, the LB Pharmaceuticals Inc 2025 Equity Incentive Plan. The equity award was granted on July 10, 2026, pursuant to the “inducement grant” exception provided under Nasdaq Listing Rule 5635(c)(4) as an inducement material to Mr. Zergebel entering into employment with LB Pharmaceuticals. ———————————————————————————————————————————————————————————— HealthTree Foundation Announces the Appointment of Lisa Gray to Its Board of Directors 2026-07-10 · PR Newswire · Healthcare, Education https://www.prnewswire.com/news-releases/healthtree-foundation-announces-the-appointment-of-lisa-gray-to-its-board-of-directors-302823076.html SALT LAKE CITY, July 10, 2026 /PRNewswire/ -- The HealthTree Foundation, a nonprofit organization dedicated to advancing cures for multiple myeloma and other blood cancers through patient empowerment, research, and education, today announced the appointment of Lisa Gray, an accomplished... ———————————————————————————————————————————————————————————— Revelation Biosciences Announces Adoption of Stockholder Rights Plan 2026-07-10 · PR-Inside · Finance, Healthcare https://pr-inside.com/revelation-biosciences-announces-adoption-of-stockholder-rights-plan-r5199875.htm (PR-inside.com) SAN DIEGO, CA / ACCESS Newswire / July 10, 2026 /Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, today announced that its Board of Directors (the "Board") has adopted a stockholder rights plan (the "Rights Plan") and declared a dividend distribution of one right (a "Right") for each outstanding share of the Company's common stock. The Rights Plan was adopted pursuant to a Rights Agreement, dated as of July 10, 2026 (the "Rights Agreement"), between the Company and Continental Stock Transfer & Trust Company, as rights agent. .. ———————————————————————————————————————————————————————————— Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 2026-07-10 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/10/3325745/0/en/Context-Therapeutics-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html PHILADELPHIA, July 10, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced that Context has granted a non-qualified stock option award to purchase 146,000 shares of its common stock to a new employee as an inducement material for accepting employment with Context. ———————————————————————————————————————————————————————————— Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026 2026-07-10 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/q32-bio-to-report-36-week-topline-results-from-part-b-of-signal-aa-clinical-trial-of-bempikibart-in-alopecia-areata-on-july-13-2026-302822915.html -- Conference call to be held Monday, July 13th at 8:00 a.m. E.T. -- WALTHAM, Mass., July 10, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and... ———————————————————————————————————————————————————————————— VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Bürgermeister 2026-07-10 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/10/3325749/0/en/VERAXA-Biotech-AG-Appoints-Carl-von-Halem-as-Interim-Chief-Financial-Officer-and-Successor-to-Torsten-B%C3%BCrgermeister.html VERAXA Biotech AG today announced the appointment of Carl von Halem as as Interim Chief Financial Officer. ———————————————————————————————————————————————————————————— BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 2026-07-10 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/10/3325740/0/en/BridgeBio-Pharma-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html PALO ALTO, Calif., July 10, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced that on July 7, 2026, the compensation committee of BridgeBio’s board of directors approved equity grants to 37 new employees in restricted stock units for an aggregate of 83,283 shares of the Company’s common stock. One-fourth of the shares underlying each employee’s restricted stock units will vest on August 16, 2027, with one-twelfth of the remaining shares underlying each such employee’s restricted stock units vesting on a quarterly basis thereafter, in each case, subject to each such employee’s continued employment with the Company or one of its subsidiaries on such ———————————————————————————————————————————————————————————— Gundry MD Celebrates National Day on July 11 with Exclusive Offers and Antioxidant-Rich Health Tips 2026-07-10 · PR Newswire · Healthcare, Education https://www.prnewswire.com/news-releases/gundry-md-celebrates-national--day-on-july-11-with-exclusive-offers-and-antioxidant-rich-health-tips-302823054.html Founded by Dr. Steven Gundry, Gundry MD Marks the Holiday With Savings and Education on Polyphenol-Rich Nutrition LOS ANGELES, July 10, 2026 /PRNewswire/ -- Gundry MD®, the health and wellness brand founded by renowned cardiologist Dr. Steven Gundry, is celebrating National Polyphenol Day... ———————————————————————————————————————————————————————————— Greenland Mines (GRML) Secures Australian Patent for Klotho Gene Therapy Platform 2026-07-10 · NewMediaWire · Finance, SaaS, Healthcare, Real Estate, Retail https://www.newmediawire.com/news/greenland-mines-grml-secures-australian-patent-for-klotho-gene-therapy-platform-7087634 LOS ANGELES, CA - July 10, 2026 ( NEWMEDIAWIRE ) - Greenland Mines (NASDAQ: GRML) announced that IP Australia has granted Australian Patent No. 2023252508 covering gene therapy technology exclusively licensed by the company’s Biotech Division for the treatment of neuromuscular diseases through expression of the human Klotho protein. The patent strengthens the intellectual property supporting Greenland Mines’ Klotho-based therapeutic platform and includes claims covering gene therapy constructs, neuronal and induced pluripotent stem cells, and viral and non-viral delivery systems. The company said the patent further supports development of its KLTO-202 program targeting amyotrophic lateral sclerosis (“ALS”) and other neuromuscular disorders. To view the full press release, visit: https://nn ———————————————————————————————————————————————————————————— BayCare Marks Milestone in Expanding Access to Care in Manatee County 2026-07-10 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/baycare-marks-milestone-in-expanding-access-to-care-in-manatee-county-302823014.html PALMETTO, Fla., July 10, 2026 /PRNewswire/ -- BayCare marked a major milestone today with a topping out ceremony for BayCare Hospital Manatee, placing the final steel beam for the health system's first hospital in Manatee County and advancing its efforts to expand access to care for a... ———————————————————————————————————————————————————————————— Why Quantum BioPharma (QNTM) Is 'One to Watch' 2026-07-10 · NewMediaWire · Finance, SaaS, Healthcare, Retail https://www.newmediawire.com/news/why-quantum-biopharma-qntm-is-one-to-watch-7087631 LOS ANGELES, CA - July 10, 2026 ( NEWMEDIAWIRE ) - Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) is a biopharmaceutical company focused on developing therapies and biotech solutions targeting neurodegenerative, metabolic and alcohol misuse disorders. QNTM was highlighted in a recent article discussing its advancement of a diversified platform spanning clinical-stage therapeutics, consumer-focused wellness products and strategic investments designed to address areas of significant unmet need. The publication reads, “The company’s strategy combines pharmaceutical research and development with commercialization partnerships and licensing structures intended to support multiple potential revenue streams and long-term growth initiatives. Quantum BioPharma is advancing programs across multiple st ———————————————————————————————————————————————————————————— Haoxi Health Technology Ltd Announces $4 Million Registered Direct Offering 2026-07-10 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/10/3325686/0/en/Haoxi-Health-Technology-Ltd-Announces-4-Million-Registered-Direct-Offering.html BEIJING, July 10, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Ltd (NASDAQ: HAO) (“Haoxi” or the “Company”), today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 10,000,000 of the Company’s Class A Ordinary Shares, par value $0.32 per share (the “Shares”) (or pre-funded warrants in lieu thereof) at a purchase price of $0.40 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.33 per share. ———————————————————————————————————————————————————————————— MONPURE LONDON ACCELERATES US RETAIL EXPANSION WITH PARTNER, THE PCA COMPANIES 2026-07-10 · PR Newswire · Healthcare, Retail https://www.prnewswire.com/news-releases/monpure-london-accelerates-us-retail-expansion-with-partner-the-pca-companies-302822935.html NEW YORK, July 10, 2026 /PRNewswire/ -- MONPURE London, the trichologist-backed British hair and scalp health brand adds Ulta Beauty to a growing US retail roster that already includes Nordstrom, Bloomingdale's and Mybeautyspace.com. MONPURE London has launched on Ulta.com, bringing its... ———————————————————————————————————————————————————————————— BigHeart Health Launches My Health. My Power. -- A Free Program Connecting Illinois Medicaid Members to Preventive Care and Social Support 2026-07-10 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/bigheart-health-launches-my-health-my-power--a-free-program-connecting-illinois-medicaid-members-to-preventive-care-and-social-support-302822855.html Virtual care company partners with Walmart to launch statewide grocery store enrollment campaign. CHICAGO, July 10, 2026 /PRNewswire/ -- BigHeart Health (formerly MyOwnDoctor) announces the launch of My Health. My Power., a free program available to Illinois Medicaid members that provides... ———————————————————————————————————————————————————————————— AB Science provides an update on its clinical program, suspending some non-priority clinical trials to focus on two clinical programs 2026-07-10 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/10/3325623/0/en/AB-Science-provides-an-update-on-its-clinical-program-suspending-some-non-priority-clinical-trials-to-focus-on-two-clinical-programs.html PRESS RELEASE ———————————————————————————————————————————————————————————— Fulflex Acquires 300,000-Square-Foot, Fully Automated Medical Products Manufacturing Facility in Texas 2026-07-10 · PR Newswire · Finance, SaaS, Healthcare https://www.prnewswire.com/news-releases/fulflex-acquires-300-000-square-foot-fully-automated-medical-products-manufacturing-facility-in-texas-302822626.html Investment strengthens Fulflex's North American healthcare manufacturing platform, expands capacity, and welcomes more than 250 employees to the global organization. JACKSONVILLE, Texas, July 10, 2026 /PRNewswire/ -- Fulflex today announced the successful completion of its acquisition of... ———————————————————————————————————————————————————————————— Cosmos Health Launches Subscription Model 2026-07-10 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/10/3325604/0/en/Cosmos-Health-Launches-Subscription-Model.html Cosmos Health launches subscription model. ———————————————————————————————————————————————————————————— Vadzo Imaging Introduces Falcon-821CRS: 4K HDR Surgical Camera Module for Orthopedic Imaging and Surgical Visualization 2026-07-10 · Newswire.com · SaaS, Healthcare https://www.newswire.com/news/vadzo-imaging-introduces-falcon-821crs-4k-hdr-surgical-camera-module-22804655 The Falcon-821CRS is an 8MP 4K HDR surgical camera module built on the Onsemi AR0821 HyperLux sensor. Designed for orthopedic imaging, surgical visualization, intraoperative guidance, and operating room integration, this medical-grade USB camera module delivers color-accurate 4K output with on-chip High Dynamic Range, fixed focus optics, and USB 3.0 connectivity. It supports Windows, Linux, and Android in an S-Mount form factor, providing OEM medical device designers and surgical imaging system engineers with a production-ready imaging platform. ———————————————————————————————————————————————————————————— Sanofi's subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector 2026-07-10 · WebWire · Healthcare https://www.webwire.com/ViewPressRel.asp?aId=357483 - - • Sarclisa Escena administered via the CirCLIQ ® on-body injector (OBI) offers a treatment experience designed with patients and HCPs in mind - • The first anticancer treatment to be administered through an OBI, and the first MM treatment available by both SC OBI and manual SC administration in the US - • Efficacy of Sarclisa now available in SC formulation with innovative OBI across approved combinations and lines of therapy The US Food and Drug Administration (FDA) has approved subcut... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357483 ———————————————————————————————————————————————————————————— WHO joins the Open Health Stack Software Foundation to advance open, standards-based digital health for all countries 2026-07-10 · WebWire · Healthcare https://www.webwire.com/ViewPressRel.asp?aId=357482 Digital health systems in many countries have grown in a fragmented way. One programme for immunization, another for HIV, another for maternal health, each built separately, often by different partners, on isolated platforms that cannot easily talk to one another. Health workers re-enter the same information more than once. Ministries struggle to see a complete picture of their own health system and every new investment adds another disconnected piece rather than strengthening the whole in... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357482 ———————————————————————————————————————————————————————————— Fifty 1 Labs Announces Strategic Evolution into Peptide Biotechnology ... 2026-07-10 · PR-Inside · AI, SaaS, Healthcare https://pr-inside.com/fifty-1-labs-announces-strategic-evolution-into-peptide-biotechnology-r5199759.htm (PR-inside.com) Company outlines dual platform spanning peptide R&D, AI-enabled discovery, and planned U.S. telehealth peptide services VANCOUVER, BC / ACCESS Newswire / July 10, 2026 / Fifty 1 Labs, Inc. (OTCID:FITY) (the "Company" or "Fifty 1 Labs") today announced that it is positioning itself as a peptide biotechnology and telehealth company focused on advancing peptide science, musculoskeletal ("MSK") health, recovery, and evidence-driven product innovation. The Company's emerging strategy integrates three complementary areas: peptide research and development, AI-enabled discovery workflows, and a planned U.S.-focused telehealth peptide services platform. Fifty 1 Labs intends to pursue peptide products and programs that may include BPC-157, TB-500, MOTS-c, .. ———————————————————————————————————————————————————————————— CVS Health declares quarterly dividend 2026-07-10 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/cvs-health-declares-quarterly-dividend-302822832.html WOONSOCKET, R.I., July 10, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on August 3, 2026,... ———————————————————————————————————————————————————————————— Anatomage Inc. Announces Recipients of the 2026 Anatomage Teacher Awards 2026-07-10 · PR Newswire · Healthcare, Education https://www.prnewswire.com/news-releases/anatomage-inc-announces-recipients-of-the-2026-anatomage-teacher-awards-302822389.html SANTA CLARA, Calif., July 10, 2026 /PRNewswire/ -- Anatomage Inc., a market leader in medical education technology, is proud to announce the recipients of the Anatomage Teacher Awards, recognizing exceptional educators who have had a positive impact on their students, school, and... ———————————————————————————————————————————————————————————— Expanded Services at Intermountain Bear River Valley Hospital Added to Meet Growing Community Needs 2026-07-10 · PRUnderground · Healthcare https://www.prunderground.com/expanded-services-at-intermountain-bear-river-valley-hospital-added-to-meet-growing-community-needs/00388219/ Intermountain Health Bear River Valley Hospital expands to help northern Utah patients access care available in their community The post Expanded Services at Intermountain Bear River Valley Hospital Added to Meet Growing Community Needs first appeared on ———————————————————————————————————————————————————————————— Growing Demand for Trusted Ibogaine Treatment Information Prompts Launch of New Patient Education Initiative 2026-07-10 · GetNews · Healthcare, Education https://www.getnews.info/story/2026/07/10/growing-demand-for-trusted-ibogaine-treatment-information-prompts-launch-of-new-patient-education-initiative/?source=barchart ———————————————————————————————————————————————————————————— OpenEvidence Launches EvidenceGrade™, Empowering Physicians To See the Strength of Cited Evidence Beneath Each AI Answer 2026-07-10 · PR Newswire · AI, SaaS, Healthcare https://www.prnewswire.com/news-releases/openevidence-launches-evidencegrade-empowering-physicians-to-see-the-strength-of-cited-evidence-beneath-each-ai-answer-302822750.html MIAMI, July 10, 2026 /PRNewswire/ -- OpenEvidence, America's most widely used medical knowledge platform, today announced EvidenceGrade, a new feature that grades and visualizes, in real time, the quality of the published evidence cited in—and used to inform—every answer. A well-known... ———————————————————————————————————————————————————————————— South Beach Detox Meets Rising South Florida Treatment Demand with ... 2026-07-10 · PR-Inside · Healthcare https://pr-inside.com/south-beach-detox-meets-rising-south-florida-treatment-demand-with-r5199743.htm (PR-inside.com) The facility's 36-bed dual-diagnosis program offers a personalized treatment approach in a regional behavioral health system under growing strain MIAMI BEACH, FL / ACCESS Newswire / July 10, 2026 / As demand for mental health and substance use treatment continues to rise in South Florida, South Beach Detox is drawing attention to the growing role that smaller, highly personalized treatment programs play in expanding access to care. With just 36 beds, the facility's modest size is a critical advantage for individuals seeking highly individualized care, and highlights an alternative treatment model that runs counter to the industry trend toward large-scale drug .. ———————————————————————————————————————————————————————————— South Beach Detox Meets Rising South Florida Treatment Demand with Individualized Mental Health and Addiction Care 2026-07-10 · Newswire.com · Healthcare https://www.newswire.com/news/south-beach-detox-meets-rising-south-florida-treatment-demand-with The facility's 36-bed dual-diagnosis program offers a personalized treatment approach in a regional behavioral health system under growing strain ———————————————————————————————————————————————————————————— Jill Bray Begins Second Term as ARCS Foundation National President 2026-07-10 · PRWeb · Healthcare https://www.prweb.com/releases/jill-bray-begins-second-term-as-arcs-foundation-national-president-302820577.html Jill Bray has begun her second term as President of ARCS Foundation National, continuing her leadership of the organization's mission to support outstanding graduate students in STEM and medical research fields. Bray's first term saw the launch of the ARCS Foundation National Scholar... ———————————————————————————————————————————————————————————— Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative 2026-07-10 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/10/3325479/0/en/Clearmind-Medicine-Responds-to-the-U-S-Administration-s-RFI-for-Addiction-Treatment-Innovations-as-Part-of-the-Great-American-Recovery-Initiative.html Vancouver, Canada, July 10, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage a biotech company developing novel, non-hallucinogenic, next-generation, neuroplastogen-derived therapeutics to solve major under-treated mental health problems, with a focus on Alcohol Use Disorder and other addiction related diagnoses, today announced that it has submitted a formal response to the U.S. Department of Health and Human Services (HHS) Request for Information (RFI) about MEAI’s potential as an innovative, empirically-evidenced intervention for the treatment of addiction. ———————————————————————————————————————————————————————————— Form 8.3 Advanced Medical Solutions Group 2026-07-10 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/10/3325477/0/en/Form-8-3-Advanced-Medical-Solutions-Group.html 8.3 ———————————————————————————————————————————————————————————— FSP Group to Showcase Industrial and Networking Power Solutions at TECHNO-FRONTIER 2026 2026-07-10 · PRWeb · Healthcare https://www.prweb.com/releases/fsp-group-to-showcase-industrial-and-networking-power-solutions-at-techno-frontier-2026-302820819.html FSP showcases its latest industrial, networking, and medical power solutions, featuring two new high-performance PSUs at TECHNO-FRONTIER 2026. TAIPEI, July 10, 2026 /PRNewswire-PRWeb/ -- FSP Group will participate in the "TECHNO-FRONTIER 2026" exhibition in Japan. The exhibition will... ———————————————————————————————————————————————————————————— MIRA Pharmaceuticals Reports Successful Formulation Results Supporting ... 2026-07-10 · PR-Inside · Finance, Healthcare https://pr-inside.com/mira-pharmaceuticals-reports-successful-formulation-results-supporting-r5199735.htm (PR-inside.com) Optimized Oral Formulation Demonstrates Favorable Oral Bioavailability Together with Robust Brain and Liver Distribution Following Oral Administration MIAMI, FL / ACCESS Newswire / July 10, 2026 /MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company, today announced positive results from preclinical studies evaluating optimized oral formulations of MIRA-55, the Company's oral drug candidate being developed as a non-opioid therapy for chronic inflammatory pain. Following evaluation of multiple oral formulations, the Company selected a lead formulation demonstrating favorable oral bioavailability together with sustained systemic exposure and reproducible distribution into both brain and liver tissue following oral administ ———————————————————————————————————————————————————————————— Biotech Division of Greenland Mines Announces Australian Patent Grant for Klotho Gene Therapy Technology for Treatment of Neuromuscular Diseases 2026-07-10 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/10/3325439/0/en/Biotech-Division-of-Greenland-Mines-Announces-Australian-Patent-Grant-for-Klotho-Gene-Therapy-Technology-for-Treatment-of-Neuromuscular-Diseases.html NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- via IBN -- Greenland Mines Ltd (Nasdaq: GRML) ("Greenland Mines" or the "Company") today announced that IP Australia has granted Australian Patent No. 2023252508, entitled "Treatment of Neuromuscular Diseases via Gene Therapy that Expresses Klotho Protein," covering technology exclusively licensed by the Company's Biotech Division. The patented technology was invented by researchers at Universitat Autònoma de Barcelona and collaborating institutions. ———————————————————————————————————————————————————————————— Football Fever and the Power of Sport Inspiring Children to Get Active, According to Parents 2026-07-10 · Pressat · Healthcare, Education https://pressat.co.uk/releases/football-fever-and-the-power-of-sport-inspiring-children-to-get-active-according-to-parents-007eab84f0bff3ab0a93c4e830ddb4e8/ Friday 10 July, 2026 Youth Sport Trust survey reveals footballers including England captain Harry Kane dominate the sporting role models parents say inspire children to move more, as Summer of Sport and National School Sports Week show how sport can unite communities. As England’s Men’s Football Team prepare for a World Cup quarter final against Norway with their run capturing the attention of all generations of the nation, new research commissioned by the Youth Sport Trust reveals the British athletes inspiring the nation’s children to be active, according to their parents. The survey, carried out ahead of this year’s National School Sports Week, explored the importance of sporting role models in motivating young people to move more, build healthy habits for life and experience the life-c ———————————————————————————————————————————————————————————— Trulieve Named to TIME's America's Best Companies 2026 List 2026-07-10 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/trulieve-named-to-times-americas-best-companies-2026-list-302822446.html TALLAHASSEE, Fla., July 10, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that it has been named to TIME's list of America's Best Companies 2026. Compiled by TIME... ———————————————————————————————————————————————————————————— BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement 2026-07-10 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/10/3325414/0/en/BMGL-Regains-Compliance-With-Nasdaq-Minimum-Bid-Price-Requirement.html Singapore, July 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today announced that it has received notification from Nasdaq that the Company has regained compliance with the Nasdaq minimum bid price rule. On January 22, 2026, Nasdaq notified the Company that its ordinary shares failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules of The Nasdaq Stock Market. Since then, Nasdaq has determined that for the last 10 consecutive business days, from June 23, 2026 to July 7, 2026, the closing bid price of the Company’s ordinary shares has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2). ———————————————————————————————————————————————————————————— Smartee S22: Incorporating GS MART Technology into Occlusal Reconstructive Therapy in Prosthodontics 2026-07-10 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/smartee-s22-incorporating-gs-mart-technology-into-occlusal-reconstructive-therapy-in-prosthodontics-302822690.html SHENZHEN, China, July 10, 2026 /PRNewswire/ -- Smartee Denti-Technology has announced the launch of S22: GS MART (Mandibular Repositioning Technology) for Occlusal Reconstruction in Prosthodontic Dentistry, expanding the clinical application of its GS MART into prosthodontic dentistry.... ———————————————————————————————————————————————————————————— Tokyo Lifestyle Co., Ltd. Reports Fiscal Year 2026 Financial Results 2026-07-10 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/tokyo-lifestyle-co-ltd-reports-fiscal-year-2026-financial-results-302822525.html TOKYO, July 10, 2026 /PRNewswire/ -- Tokyo Lifestyle Co., Ltd. ("Tokyo Lifestyle" or the "Company") (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, sundry products, luxury products, electronic products, collectible cards, trendy toys as well as other... ———————————————————————————————————————————————————————————— Panchmukhi Air Ambulance in Mumbai Promises to Promote Caution in Transit 2026-07-10 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/10/1761598 Mumbai, India, 2026-07-10 — /EPR Network/ — Medical transport services designed to transport critical patients to distant locations must be equipped with life-support facilities, as [read full press release...] ———————————————————————————————————————————————————————————— Panchmukhi Air Ambulance Service in Raipur Must Be Opted for a Smooth Journey 2026-07-10 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/10/1761567 Raipur, India, 2026-07-10 — /EPR Network/ — Time sensitivity in medical emergencies is a critical factor that makes it necessary to conduct a medical transport [read full press release...] ———————————————————————————————————————————————————————————— Puncture Robotic Showcases AI-Powered Hair Restoration Innovation at WCHR 2026 2026-07-10 · PR Newswire · AI, Healthcare https://www.prnewswire.com/news-releases/puncture-robotic-showcases-ai-powered-hair-restoration-innovation-at-wchr-2026-302822668.html SEOUL, South Korea, July 10, 2026 /PRNewswire/ -- Artificial intelligence is rapidly reshaping medical aesthetics, and hair restoration is undergoing a significant technological transformation. At the 14th World Congress for Hair Research (WCHR 2026), Puncture Robotic attracted... ———————————————————————————————————————————————————————————— MLA Psychology Highlights the Lasting Impact of Birth Trauma During Birth Trauma Awareness Week 2026 2026-07-10 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/10/1761477 Gold Coast, Australia, 2026-07-10 — /EPR Network/ — Birth Trauma Awareness Week, taking place July 13-19, 2026, shines a spotlight on an often-overlooked public health issue [read full press release...] ———————————————————————————————————————————————————————————— Panchmukhi Dead Body Transfer in Delhi is authorized for Corpse Transportation 2026-07-10 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/10/1761474 Delhi, India, 2026-07-10 — /EPR Network/ — The time of death of a loved one can bring about immense grief in the lives of the [read full press release...] ———————————————————————————————————————————————————————————— The Menzies Anxiety Centre Reinforces Commitment to Evidence-Based Anxiety Care Across Sydney 2026-07-10 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/10/1761471 Five Dock, Australia, 2026-07-10 — /EPR Network/ — The Menzies Anxiety Centre is continuing its commitment to delivering high-quality psychological services by combining evidence-based treatment [read full press release...] ———————————————————————————————————————————————————————————— As Stress, Burnout, and Digital Overload Shape Daily Life, "Doing Nothing" Can Help the Body and Mind Recover 2026-07-10 · PR Newswire · Healthcare, Education https://www.prnewswire.com/news-releases/as-stress-burnout-and-digital-overload-shape-daily-life-doing-nothing-can-help-the-body-and-mind-recover-302822463.html WHITTIER, Calif., July 10, 2026 /PRNewswire/ -- A few quiet seconds in line often become a chance to check email. A break between meetings can turn into a quick scroll. Even rest can start to feel like another task. Southern California University of Health Sciences (SCU) is highlighting a... ———————————————————————————————————————————————————————————— Cross-Borough Deliveries Are Where NYC Couriers Fail: Xentra Transport Splits Manhattan, Brooklyn and Queens Into Dedicated Driver Zones 2026-07-10 · PR.com · Healthcare, Automotive https://www.pr.com/press-release/973353 Cross-borough runs are the weak point of same day delivery in New York. A driver finishing in Jamaica gets sent to Tribeca, and the customer eats the delay. Xentra Transport, a NYC-based courier and freight company, has scrapped the citywide driver pool and assigned dedicated drivers to Manhattan, Brooklyn and Queens. The company handles medical, legal, catering, freight and white glove work across the five boroughs and [PR.com] ———————————————————————————————————————————————————————————— Author Sandy Malone Opens Up About Losing Her Mother to Alzheimer's on Top-Ranked Mental Health Podcast 2026-07-10 · PRUnderground · Healthcare, Media https://www.prunderground.com/author-sandy-malone-opens-up-about-losing-her-mother-to-alzheimers-on-top-ranked-mental-health-podcast/00388289/ Malone shares her personal journey of losing her mother to Alzheimer's disease and offers a preview of her forthcoming book during an emotional conversation on one of the world's leading mental health podcasts. The post Author Sandy Malone Opens Up About Losing Her Mother to Alzheimer's on Top-Ranked Mental Health Podcast first appeared on ———————————————————————————————————————————————————————————— CardioCharge Review: Is This Stimulant-Free Heart Support Powder the Smarter Daily Upgrade Buyers Are Rechecking Before Ordering? 2026-07-10 · Newswire.com · Healthcare https://www.newswire.com/news/cardiocharge-review-is-this-stimulant-free-heart-support-powder-the-smarter As interest in stimulant-free heart health support grows, this CardioCharge review examines the brand-stated seven-ingredient electrolyte formula, caffeine-free morning format, current pricing, 365-day guarantee, and the key details buyers are comparing before choosing a daily cardiovascular wellness supplement. ———————————————————————————————————————————————————————————— Cue Biopharma Announces $50.0 Million Private Placement 2026-07-10 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/10/3325290/0/en/Cue-Biopharma-Announces-50-0-Million-Private-Placement.html BOSTON, July 09, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical stage biopharmaceutical company focused on developing transformative therapies targeting functional cures for immunological disorders, today announced that it has entered into a securities purchase agreement with a group of accredited investors for the private placement of (i) 1,418,071 shares of common stock at a purchase price of $33.21 per share and (ii) to certain investors, in lieu of shares of common stock, pre-funded warrants to purchase up to 87,500 shares of common stock at a price per pre-funded warrant of $33.209, for gross proceeds of approximately $50.0 million. ———————————————————————————————————————————————————————————— Gummi World, The Most Certified Gummy Manufacturer, Says Compliance Will Decide the Clinical-Grade Gummy Race 2026-07-10 · PRUnderground · Healthcare https://www.prunderground.com/gummi-world-the-most-certified-gummy-manufacturer-says-compliance-will-decide-the-clinical-grade-gummy-race-2/00388271/ The supplement gummy category is splitting into two tiers, and Gummi World, the industry's most certified gummy manufacturer, says producing products for the premium end of the market requires a level of certification, quality systems and manufacturing infrastructure that not every manufacturer has built. The post Gummi World, The Most Certified Gummy Manufacturer, Says Compliance Will Decide the Clinical-Grade Gummy Race first appeared on ———————————————————————————————————————————————————————————— Stanford-Born Medical Company Advances Next Generation of Cancer Treatment Toward Clinical Deployment 2026-07-10 · PR Newswire · Healthcare, Education https://www.prnewswire.com/news-releases/stanford-born-medical-company-advances-next-generation-of-cancer-treatment-toward-clinical-deployment-302822482.html SILICON VALLEY, Calif., July 9, 2026 /PRNewswire/ -- TibaRay, a Silicon Valley medical technology company founded on Stanford University research, announced today that its first Galactica™ cancer treatment systems have entered manufacturing. The milestone marks a major step for TibaRay as... ———————————————————————————————————————————————————————————— Quantum Insights Launches AURA AI Platform for Clinical Research Labs 2026-07-09 · PressReleaseNews · AI, SaaS, Healthcare https://pressreleasenews.org/pressroom/quantum-insights-launches-aura-ai-platform-for-clinical-research-labs Quantum Insights GmbH announced AURA, an AI-powered analytics platform for clinical research labs that reduces time-to-insight on multi-omics datasets by up to 70% while keeping patient data on-premises. The platform integrates with existing LIMS and ELN systems and is available immediately through a tiered subscription ———————————————————————————————————————————————————————————— Solaris Energy Infrastructure Set to Join S&P SmallCap 600 2026-07-09 · PR Newswire · Finance, Healthcare, Energy https://www.prnewswire.com/news-releases/solaris-energy-infrastructure-set-to-join-sp-smallcap-600-302822362.html NEW YORK, July 9, 2026 /PRNewswire/ -- Solaris Energy Infrastructure Inc. (NYSE: SEI) will replace Catalyst Pharmaceuticals Inc. (NASD: CPRX) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 15. Angelini Pharma S.p.A. is acquiring Catalyst... ———————————————————————————————————————————————————————————— HCC Healthcare Signs Business Combination Agreement with RF Acquisition Corp III to Pursue Nasdaq Listing 2026-07-09 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/09/3325251/0/en/HCC-Healthcare-Signs-Business-Combination-Agreement-with-RF-Acquisition-Corp-III-to-Pursue-Nasdaq-Listing.html Transaction expected to provide HCC Healthcare with access to public capital markets to accelerate growth in integrated medical and long-term care services across Asia Transaction expected to provide HCC Healthcare with access to public capital markets to accelerate growth in integrated medical and long-term care services across Asia ———————————————————————————————————————————————————————————— Day 7 ALJ Hearing: Prominent Pain Physician Calls State Medical Marijuana ... 2026-07-09 · PR-Inside · Healthcare https://pr-inside.com/day-7-alj-hearing-prominent-pain-physician-calls-state-medical-marijuana-r5199567.htm (PR-inside.com) "Dr. Kenneth Finn, former President of the American Board of Pain Medicine, testified that today's state 'medical marijuana' system is a 'ruse'-one where the clinical evidence is lacking and standards are missing, as he reminisced of the old pill mills" stated Duane Boise CEO MMJ International Holdings. WASHINGTON, D.C. / ACCESS Newswire / July 9, 2026 / Day seven of the Drug Enforcement Administration's marijuana rescheduling hearing produced some of the most pointed testimony yet against the government's effort to move marijuana to Schedule III - and it came from a board certified pain physician the court accepted as an expert. Kenneth .. ———————————————————————————————————————————————————————————— Day 7 ALJ Hearing: Prominent Pain Physician Calls State Medical Marijuana System a Ruse 2026-07-09 · Newswire.com · Healthcare https://www.newswire.com/news/day-7-alj-hearing-prominent-pain-physician-calls-state-medical-marijuana-system "Dr. Kenneth Finn, former President of the American Board of Pain Medicine, testified that today's state 'medical marijuana' system is a 'ruse'-one where the clinical evidence is lacking and standards are missing, as he r eminisced of the old pill mills " stated Duane Boise CEO MMJ International Holdings. ———————————————————————————————————————————————————————————— Gerresheimer Publishes Its First Voluntary Sustainability Report Aligned With the CSRD 2026-07-09 · NewMediaWire · Healthcare, Energy https://www.newmediawire.com/news/gerresheimer-publishes-its-first-voluntary-sustainability-report-aligned-with-the-csrd-7087611 2025 Results: -31% CO2e, 54% electricity from renewable sources, -63% lost time incident rate Ambitious CO2e reduction target of -52% by 2030 DUSSELDORF, GERMANY - July 9, 2026 ( NEWMEDIAWIRE ) - Gerresheimer, an innovative systems and solutions provider and global partner to the pharma, biotech, and cosmetics industries, has published its first voluntary separate Non-financial Report for the 2025 financial year, aligned with the Corporate Sustainability Reporting Directive (CSRD). The audited report transparently details the Group’s sustainability performance in financial year 2025. Gerresheimer was able to reduce its scope 1 and scope 2 CO2e emissions by 31% compared to the base year 2019 and increase the share of electricity from renewable sources in its total electricity consumption to ———————————————————————————————————————————————————————————— Encompass Health announces date of 2026 second quarter earnings call 2026-07-09 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/encompass-health-announces-date-of-2026-second-quarter-earnings-call-302822276.html BIRMINGHAM, Ala., July 9, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its second quarter ended June 30, 2026, after the market closes on Wednesday, Aug. 5, 2026. The Company will host an investor conference call at 10 a.m. ET on... ———————————————————————————————————————————————————————————— Inventiva Announces Completion of the EIB Warrant Restructuring with the Issuance of New EIB Warrants 2026-07-09 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/09/3325223/0/en/Inventiva-Announces-Completion-of-the-EIB-Warrant-Restructuring-with-the-Issuance-of-New-EIB-Warrants.html Daix (France), New York City (New York, United States), July 9, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of metabolic dysfunction-associated steatohepatitis (“ MASH ”), is pleased to announce the completion of the final step of the transactions previously announced on June 2, 2026 (the “ Combined Transaction ”) through the issuance of approximately 15.7 million new warrants ( bons de souscription d’actions ) (the " New EIB Warrants ") to the European Investment Bank (the " EIB ") and the surrender and cancellation of all remaining warrants originally issued to the EIB in January 2024 (the “ Legacy EIB Tranche B Warrants ”) that were not rep ———————————————————————————————————————————————————————————— Sheila Busheri Scholarship for Medical Students Opens 2027 Application Cycle for Future Healthcare Leaders 2026-07-09 · GetNews · Healthcare https://www.getnews.info/story/2026/07/09/sheila-busheri-scholarship-for-medical-students-opens-2027-application-cycle-for-future-healthcare-leaders/?source=barchart ———————————————————————————————————————————————————————————— Michael Rasekhi Scholarship for Medical Students Announces National Call for Applications 2026-07-09 · GetNews · Healthcare https://www.getnews.info/story/2026/07/09/michael-rasekhi-scholarship-for-medical-students-announces-national-call-for-applications/?source=barchart ———————————————————————————————————————————————————————————— Dr. Eric Haeger Scholarship for Future Doctors Announces 2026 Application Cycle for Undergraduate Pre-Medical Students Nationwide 2026-07-09 · GetNews · Healthcare https://www.getnews.info/story/2026/07/09/dr-eric-haeger-scholarship-for-future-doctors-announces-2026-application-cycle-for-undergraduate-premedical-students-nationwide/?source=barchart ———————————————————————————————————————————————————————————— Dr. Ranjan Rajbanshi Scholarship for Medical Students Opens 2026 Application Cycle for Aspiring Healthcare Professionals Nationwide 2026-07-09 · GetNews · Healthcare https://www.getnews.info/story/2026/07/09/dr-ranjan-rajbanshi-scholarship-for-medical-students-opens-2026-application-cycle-for-aspiring-healthcare-professionals-nationwide/?source=barchart ———————————————————————————————————————————————————————————— Dr. Timothy Francis Scholarship for Medical Students Announces National Application Cycle for Future Healthcare Leaders 2026-07-09 · GetNews · Healthcare https://www.getnews.info/story/2026/07/09/dr-timothy-francis-scholarship-for-medical-students-announces-national-application-cycle-for-future-healthcare-leaders/?source=barchart ———————————————————————————————————————————————————————————— Dr. Steven Muscoreil Scholarship for Future Doctors Announces 2026 Application Cycle for Pre-Medical Students Nationwide 2026-07-09 · GetNews · Healthcare https://www.getnews.info/story/2026/07/09/dr-steven-muscoreil-scholarship-for-future-doctors-announces-2026-application-cycle-for-premedical-students-nationwide/?source=barchart ———————————————————————————————————————————————————————————— Allegheny Health Network Names Allan Klapper, MD, President of AHN Grove City Hospital 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/allegheny-health-network-names-allan-klapper-md-president-of-ahn-grove-city-hospital-302822214.html GROVE CITY, Pa., July 9, 2026 /PRNewswire/ -- Allegheny Health Network (AHN) today announced that Allan Klapper, MD, has been named the president of AHN Grove City Hospital. Dr. Klapper will maintain his responsibility as president of AHN Wexford Hospital. At Grove City Hospital, he... ———————————————————————————————————————————————————————————— Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases 2026-07-09 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/09/3325172/0/en/Cosmos-Health-Expands-Share-Buyback-to-4-14-Million-Shares-Continues-Open-Market-Repurchases.html Cosmos Health has now repurchased a total of 4,140,000 shares for approximately $831,000. ———————————————————————————————————————————————————————————— Fogg Law Group Secures $2 Million Medical Malpractice Jury Verdict in Lee County Stillbirth Case 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/fogg-law-group-secures-2-million-medical-malpractice-jury-verdict-in-lee-county-stillbirth-case-302822030.html PALM BEACH GARDENS, Fla., July 9, 2026 /PRNewswire/ -- Florida-based Fogg Law Group recently obtained a $2,000,000 jury verdict on behalf of parents who filed a medical malpractice lawsuit following the stillbirth of their daughter. After a week-long trial in Lee County, Florida, jurors... ———————————————————————————————————————————————————————————— Pulmonary Fibrosis Foundation Elects Dr. Bradford Bemiss and Dr. Krishna Thavarajah to Board of Directors 2026-07-09 · PRWeb · Healthcare https://www.prweb.com/releases/pulmonary-fibrosis-foundation-elects-dr-bradford-bemiss-and-dr-krishna-thavarajah-to-board-of-directors-302822203.html The Pulmonary Fibrosis Foundation is strengthening its Board with two leading PF and ILD experts whose clinical, research and patient care experience will help guide the organization's next chapter. CHICAGO, July 9, 2026 /PRNewswire-PRWeb/ -- The Pulmonary Fibrosis Foundation (PFF) today... ———————————————————————————————————————————————————————————— VERAXA Biotech (VRXA) Advances Lead BiTAC® T-Cell Engager Program With Cell Line Development Partnership 2026-07-09 · NewMediaWire · Finance, Healthcare, Retail https://www.newmediawire.com/news/veraxa-biotech-vrxa-advances-lead-bitac-r-t-cell-engager-program-with-cell-line-development-partnership-7087607 LOS ANGELES, CA - July 9, 2026 ( NEWMEDIAWIRE ) - VERAXA Biotech (NASDAQ: VRXA) , an emerging leader in designing novel cancer therapies, has begun cell line development for its lead BiTAC(R) T-cell engager (“BiTAC(R)-TCE”) program, marking another step in preparing the company’s most advanced oncology candidate for future clinical development. The company has initiated cell line development for its lead BiTAC(R) T-cell engager program, selecting ATUM to support manufacturing development as the candidate advances toward IND/CTA-enabling studies. ATUM will apply its Leap-In Transposase(R) technology to generate stable clonal cell lines for VERAXA’s lead therapeutic candidate. The collaboration represents an important development milestone, supporting manufacturing, analytical development an ———————————————————————————————————————————————————————————— SS Innovations International (SSII) Is 'One to Watch' 2026-07-09 · NewMediaWire · Finance, Healthcare, Retail https://www.newmediawire.com/news/ss-innovations-international-ssii-is-one-to-watch-7087605 LOS ANGELES, CA - July 9, 2026 ( NEWMEDIAWIRE ) - SS Innovations International (NASDAQ: SSII) develops differentiated surgical robotic technologies, highlighted by its advanced, cost-efficient SSi Mantra surgical robotic system. Spearheaded by a team of visionary engineers and Dr. Sudhir Srivastava, an acclaimed robotic cardiac surgeon and the company’s founder, Chairman and Chief Executive Officer, the SSi Mantra features differentiated capabilities in areas such as telesurgery, cardiac surgery and pediatric procedures. The SSi Mantra’s broad-based surgical robotic applications, modularity, user friendliness, training capabilities, clinical track record and relative cost advantages have contributed to its early commercial success. Clinically validated, advanced surgical robotics technolog ———————————————————————————————————————————————————————————— Vadzo Introduces Falcon-821CRS Telehealth Camera Module with 4K HDR for Remote Clinical Examinations Under Mixed Lighting 2026-07-09 · Newswire.com · SaaS, Healthcare, Automotive https://www.newswire.com/news/vadzo-introduces-falcon-821crs-telehealth-camera-module-with-4k-hdr-22807777 The Falcon-821CRS is an 8MP color rolling shutter USB camera built on the Onsemi AR0821 HyperLux sensor and introduced as a telehealth camera module for remote clinical examinations conducted under mixed lighting conditions. The camera delivers 4K LI-HDR output, on-chip auto exposure, and full UVC compliance with no driver installation required on Windows, Linux, or Android. It supports teleconsultation, virtual care, remote patient examination, telemedicine cart deployments, and OEM medical device integration through a single USB 3.2 connection. ———————————————————————————————————————————————————————————— AZ Blue Health Choice Expands Access to Care with In-Home, Whole-Family Care Model Through Nest Health Partnership 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/az-blue-health-choice-expands-access-to-care-with-in-home-whole-family-care-model-through-nest-health-partnership-302822167.html Program delivers measurable results for Medicaid members, closing care gaps and reducing avoidable ER visits in Mohave and Maricopa Counties PHOENIX, July 9, 2026 /PRNewswire/ -- One year after launching its partnership with Nest Health, Blue Cross Blue Shield of Arizona Health Choice (AZ... ———————————————————————————————————————————————————————————— OrangeBag Now Serves All of Houston and Surrounding Areas with Commercial Laundry and Linen Service 2026-07-09 · PR.com · Healthcare https://www.pr.com/press-release/972953 OrangeBag has expanded its commercial laundry and linen service to cover all of Greater Houston. Businesses from Downtown and the Galleria to Sugar Land, The Woodlands, Katy, and Pearland can now schedule pickup and delivery for hotels, gyms, spas, medical offices, and short-term rentals. The program offers guaranteed counts, documented pricing, and contract terms under three years. [PR.com] ———————————————————————————————————————————————————————————— In HelloNation, Pediatric Expert Dr. James Wapshare Explains What Parents Should Expect at a Newborn's First Pediatric Visit 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/in-hellonation-pediatric-expert-dr-james-wapshare-explains-what-parents-should-expect-at-a-newborns-first-pediatric-visit-302822157.html The article reviews key steps, guidance, and early care topics covered during a newborn's first medical appointment. GOSHEN, N.Y., July 9, 2026 /PRNewswire/ -- What should parents expect during a newborn's first pediatric visit? HelloNation has published an article that answers this... ———————————————————————————————————————————————————————————— SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/suewallst-reminds-shareholders-of-a-lead-plaintiff-deadline-of-august-31-2026-in-insulet-corporation-lawsuit---podd-302822151.html Notice to Pension Funds, Asset Managers, and Fiduciaries Holding PODD: Institutional Portfolios Face Significant Exposure Following Two Omnipod Medical Device Corrections and Over $90 Per Share Decline from Pre-Disclosure Levels NEW YORK, July 9, 2026 /PRNewswire/ -- Institutional... ———————————————————————————————————————————————————————————— Using Brain Implants, Intermountain Health Performs 100th Procedure to Reduce Epilepsy Seizures 2026-07-09 · PRUnderground · Healthcare https://www.prunderground.com/using-brain-implants-intermountain-health-performs-100th-procedure-to-reduce-epilepsy-seizures/00388234/ Intermountain Health Doctors Perform 100th Surgical Procedure to Improve Lives of Epilepsy Patients Using High-Tech Brain Implants to Reduce Seizures The post Using Brain Implants, Intermountain Health Performs 100th Procedure to Reduce Epilepsy Seizures first appeared on ———————————————————————————————————————————————————————————— ACHP Forms Patient Advisory Council to Elevate Patient Voices in Chronic Disease Research 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/achp-forms-patient-advisory-council-to-elevate-patient-voices-in-chronic-disease-research-302822133.html WASHINGTON, July 9, 2026 /PRNewswire/ -- The Alliance of Community Health Plans (ACHP) is amplifying patients' voices on chronic disease research via its newly launched Patient Advisory Council. The council's purpose is to ensure patient perspectives remain at the center of ACHP's... ———————————————————————————————————————————————————————————— Renew Biotechnologies Unifies Wasatch BioLabs and Resonant Under One Brand to Advance Sequencing-Based Diagnostics 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/renew-biotechnologies-unifies-wasatch-biolabs-and-resonant-under-one-brand-to-advance-sequencing-based-diagnostics-302821155.html Brand consolidation strengthens Renew's ability to move advanced molecular technologies from discovery to clinical implementation. PLEASANT GROVE, Utah, July 9, 2026 /PRNewswire/ -- Renew Biotechnologies today announced the consolidation of Wasatch BioLabs and Resonant under the Renew... ———————————————————————————————————————————————————————————— DIA AND MHRA LAUNCH NEW GLOBAL REGULATORY SCIENCE SUMMIT IN LONDON TO ADVANCE SAFER AND SMARTER HEALTH INNOVATION 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/dia-and-mhra-launch-new-global-regulatory-science-summit-in-london-to-advance-safer-and-smarter-health-innovation-302822113.html The DIA-MHRA Global Summit Unites Two World-Leading Organizations Around Regulatory Science, Scientific Innovation, Health Access, Patient Safety, and Cross-Sector Collaboration LONDON, July 9, 2026 /PRNewswire/ -- The Drug Information Association (DIA) and the Medicines and Healthcare... ———————————————————————————————————————————————————————————— Hydrogels for Medical Application Market to Reach USD 2.93 Billion by 2033, Expanding at 9.2% CAGR Driven by Advanced Wound Care Demand, Controlled Drug Delivery Innovation, and Tissue Engineering Breakthroughs - Verified Market Research 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/hydrogels-for-medical-application-market-to-reach-usd-2-93-billion-by-2033--expanding-at-9-2-cagr-driven-by-advanced-wound-care-demand-controlled-drug-delivery-innovation-and-tissue-engineering-breakthroughs--verified-market-r-302821850.html The global Hydrogels for Medical Application Market, valued at USD 1.50 billion in 2025, is entering a sustained scaling phase as clinical adoption of hydrogel-based platforms accelerates across hospitals, specialty clinics, and research institutions worldwide. Rising healthcare demand... ———————————————————————————————————————————————————————————— Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease 2026-07-09 · GlobeNewswire · Finance, SaaS, Healthcare https://www.globenewswire.com/news-release/2026/07/09/3325085/0/en/Serina-Therapeutics-Announces-Completion-of-Sentinel-Dosing-in-Cohort-1-of-Phase-1b-Registrational-Trial-of-SER-252-for-Advanced-Parkinson-s-Disease.html HUNTSVILLE, Ala., July 09, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology, today announced the completion of sentinel dosing in Cohort 1 of its ongoing Phase 1b registrational clinical trial evaluating SER-252 in patients with advanced Parkinson’s disease. ———————————————————————————————————————————————————————————— Wiley Launches Advanced Immunology to Deepen Understanding of the Immune System in Health and Disease 2026-07-09 · WebWire · Finance, Healthcare, Media https://www.webwire.com/ViewPressRel.asp?aId=357434 Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today announced the launch of Advanced Immunology, a new open access journal designed to connect basic science and clinical discovery across the immune system. - - This new title, now open for submissions, is part of the ongoing expansion of Wiley's Advanced Portfolio, reflecting Wiley's commitment to accelerating science that addresses humanity's most pressing challenges across a wide range of disciplin... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357434 ———————————————————————————————————————————————————————————— Air Canada Foundation’s 14th Annual Golf Tournament Raises Record Breaking $1.5 Million, Celebrates Lifetime Impact Surpassing $20 Million 2026-07-09 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/09/3325062/0/en/Air-Canada-Foundation-s-14th-Annual-Golf-Tournament-Raises-Record-Breaking-1-5-Million-Celebrates-Lifetime-Impact-Surpassing-20-Million.html MONTRÉAL, July 09, 2026 (GLOBE NEWSWIRE) -- The Air Canada Foundation hosted its 14 th annual Golf Tournament on Tuesday at Club de golf Le Mirage in Terrebonne, Québec. The event raised a record breaking $1.5 million to support the health and well-being of children and youth across Canada. ———————————————————————————————————————————————————————————— Willkins Expands Its Premium Supplement Range to Support Everyday Health and Peak Performance 2026-07-09 · PRUnderground · Healthcare https://www.prunderground.com/willkins-expands-its-premium-supplement-range-to-support-everyday-health-and-peak-performance/00388197/ Willkins, a trusted health and wellness brand, continues to strengthen its position in the nutritional supplement market by offering premium-quality vitamins, minerals, and wellness supplements. The post Willkins Expands Its Premium Supplement Range to Support Everyday Health and Peak Performance first appeared on ———————————————————————————————————————————————————————————— Piedmont Urgent Care Retires Billing Voicemail With an AI Agent Built by Hello Patient 2026-07-09 · PR Newswire · AI, Healthcare https://www.prnewswire.com/news-releases/piedmont-urgent-care-retires-billing-voicemail-with-an-ai-agent-built-by-hello-patient-302822079.html At WellStreet's Georgia network, Piedmont Urgent Care, more than 20,000 patient billing calls a month are now answered with no hold time, freeing close to 1,000 staff hours a month. AUSTIN, Texas, July 9, 2026 /PRNewswire/ -- Piedmont Urgent Care, the largest network of urgent cares in... ———————————————————————————————————————————————————————————— The Protocase Companies Mark Major U.S. Manufacturing Milestone With Launch of Laser Cutting Operations in Wilmington 2026-07-09 · NewMediaWire · Energy, Automotive, Healthcare https://www.newmediawire.com/news/the-protocase-companies-mark-major-u-s-manufacturing-milestone-with-launch-of-laser-cutting-operations-in-wilmington-7087600 Latest Investment Expands Production Capacity and Strengthens the Company's Growing U.S. Manufacturing Footprint WILMINGTON, NC - July 9, 2026 ( NEWMEDIAWIRE ) - The Protocase Companies today announced the launch of laser cutting operations at its Wilmington, North Carolina manufacturing facility, marking a major milestone in the company's continued expansion of its U.S. manufacturing footprint. The first production parts were successfully cut on July 7, bringing one of Protocase's foundational manufacturing capabilities to its rapidly growing U.S. operation. Laser cutting is one of the core technologies behind Protocase's proprietary High Velocity Mass Customization (HVMC) manufacturing model. Bringing the capability to Wilmington establishes end-to-end precision sheet metal fabrication w ———————————————————————————————————————————————————————————— Geon Performance Solutions Appoints Cathy Dodd as Chief Commercial ... 2026-07-09 · PR-Inside · Healthcare https://pr-inside.com/geon-performance-solutions-appoints-cathy-dodd-as-chief-commercial-r5199495.htm (PR-inside.com) WESTLAKE, OH / ACCESS Newswire / July 9, 2026 / Geon® Performance Solutions, a global leader in the formulation, development and manufacture of performance polymer solutions, today announced the appointment of Cathy Dodd as chief commercial officer (CCO). In this role, Dodd will oversee the company's sales, marketing and business development strategies to expand Geon's global reach. She will assume the role July 13th, 2026. As CCO, Dodd will lead Geon's efforts to collaborate with customers on solving complex challenges and developing innovative, sustainable solutions across the markets the company serves, including medical, building and infrastructure, power and communications, transportation, industrial .. ———————————————————————————————————————————————————————————— TailorMed and Tennr Announce Collaboration to Streamline Patient Medication ... 2026-07-09 · PR-Inside · SaaS, Healthcare https://pr-inside.com/tailormed-and-tennr-announce-collaboration-to-streamline-patient-medication-r5199491.htm (PR-inside.com) Collaboration connects referral automation and medication journey support for infusion centers, specialty pharmacies, and the patients they serve NEW YORK, NY / ACCESS Newswire / July 9, 2026 / TailorMed, a leading medication success platform, and Tennr, the patient orchestration platform that moves patients from script to seat, today announced a collaboration designed to help infusion centers and specialty pharmacies streamline patient access, affordability, and adherence workflows. The collaboration brings together two advanced technology platforms focused on reducing burden for care teams and their patients. Tennr helps providers automate referral intake, documentation review, and access-related workflows, while TailorMed helps organizations identify, .. ———————————————————————————————————————————————————————————— MyOutdoorJoy Celebrates the Launch of the New One Million Kids Outdoors Initiative 2026-07-09 · PR.com · Healthcare https://www.pr.com/press-release/973054 MyOutdoorJoy is excited to be an official partner of the One Million Kids Outdoors (1MKO) initiative. In partnership with the Outdoors Alliance for Kids, the One Million Kids Outdoors (1MKO) Initiative is a national movement that aims to get one million kids outdoors over the next year to transform their health and well-being. [PR.com] ———————————————————————————————————————————————————————————— Liberty HealthShare CEO Featured on Becker's Healthcare Podcast 2026-07-09 · PR Newswire · Healthcare, Retail, Media https://www.prnewswire.com/news-releases/liberty-healthshare-ceo-featured-on-beckers-healthcare-podcast-302821982.html Dorsey Morrow Discusses Affordability, Transparency, and Consumer Choice Ministry Reports 20 Consecutive Months of Enrollment Growth as Americans Explore Alternatives to Health Insurance CANTON, Ohio, July 9, 2026 /PRNewswire/ -- Liberty HealthShare® Chief Executive Officer Dorsey Morrow... ———————————————————————————————————————————————————————————— Endoscopy Procedure Estimates Market Hospital Procedure Trends 2026-07-09 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/09/1762207 The global Endoscopy Procedures Estimate Market size was estimated at 193.87 million procedures in 2025 and is projected to reach 217.10 million procedures by 2033, registering a [read full press release...] ———————————————————————————————————————————————————————————— Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/systemic-lupus-erythematosus-market-at-a-turning-point-as-6-late-stage-emerging-therapies-set-to-redefine-treatment-landscape--delveinsight-302821555.html Companies like Biogen and Royalty Pharma (Litifilimab), Biogen and UCB (Dapirolizumab pegol), Idorsia Pharmaceuticals and Viatris (Cenerimod), Novartis (Ianalumab, YTB3231), Kyowa Kirin (KK-4277), and others are advancing late, mid, and early-stage drugs, showing promise in the systemic... ———————————————————————————————————————————————————————————— SunBooster Launches in the US, Bringing the Sun's Wellness Benefits to Modern Indoor Lifestyles 2026-07-09 · PRWeb · Healthcare, Energy https://www.prweb.com/releases/sunbooster-launches-in-the-us-bringing-the-suns-wellness-benefits-to-modern-indoor-lifestyles-302821995.html Designed for today's indoor lifestyles, SunBooster by SunLED Life Science restores beneficial near-infrared light during screen time, supporting energy, mood and overall wellbeing NEW YORK and AMSTERDAM, July 9, 2026 /PRNewswire-PRWeb/ -- SunLED Life Science, a health-centered technology... ———————————————————————————————————————————————————————————— Stanford Surgeon Performs North America's First PITAC Procedure for ... 2026-07-09 · PR-Inside · Healthcare, Education https://pr-inside.com/stanford-surgeon-performs-north-america-s-first-pitac-procedure-for-r5199430.htm (PR-inside.com) Dr. Leah Backhus discusses how the minimally invasive chemotherapy technique offers a new option for pleural mesothelioma patients who aren't candidates for more extensive surgery. CHESTNUT HILL, MA / ACCESS Newswire / July 9, 2026 / Mesothelioma Hope , a leading online resource providing education, patient advocacy, and support for those diagnosed with mesothelioma, has published a new interview with Dr. Leah Backhus, the Stanford Medicine thoracic surgeon who performed North America's first PITAC (pressurized intrathoracic aerosol chemotherapy) procedure forpleural mesotheliomain 2025. The full interview is available atMesotheliomaHope.com . PITAC is a minimally invasive procedure that delivers aerosolized chemotherapy directly into the chest .. ———————————————————————————————————————————————————————————— New Survey From The Longevity Centers of America Finds Working-Age ... 2026-07-09 · PR-Inside · Healthcare https://pr-inside.com/new-survey-from-the-longevity-centers-of-america-finds-working-age-r5199421.htm (PR-inside.com) A national survey of 1,750 U.S. adults finds that frustration with the healthcare system runs deepest in midlife, not old age. WEST PALM BEACH, FL / ACCESS Newswire / July 9, 2026 / Adults aged 30 to 44 were more than twice as likely as those over 60 to say a doctor had dismissed a health concern in the past two years (38% vs. 17%), according to a national survey released by The Longevity Centers of America (LCOA). The finding runs counter to a common assumption that older adults, who use the healthcare system most, are its most frustrated users. It surfaced .. ———————————————————————————————————————————————————————————— Ocumetics Announces Corporate and Operational Update as Positive Six-Month Clinical Results Advance Next Phase of First-in-Human Study 2026-07-09 · NewMediaWire · Healthcare https://www.newmediawire.com/news/ocumetics-announces-corporate-and-operational-update-as-positive-six-month-clinical-results-advance-next-phase-of-first-in-human-study-7087593 CALGARY, ALBERTA - July 9, 2026 ( NEWMEDIAWIRE ) - Ocumetics Technology Corp. ("Ocumetics" or the "Company") (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a developer of advanced vision restoration technologies, is pleased to provide shareholders with a corporate and operational update highlighting continued progress across its clinical development program, manufacturing activities, regulatory initiatives, financing strategy and commercialization efforts. Key Highlights - Positive six-month results from the Company's First-in-Human ("FIH") study support advancement to Group Two clinical surgeries . - Financing initiative launched to fund completion of the FIH study and accelerate commercialization activities. - Next-generation accommodating intraocular lens (“ Ocumetics Lens ”) with a breakthrou ———————————————————————————————————————————————————————————— Health Insurance Comparison for International Students Entering U.S. Universities in Fall 2026 2026-07-09 · PressReleaseNews · Healthcare, Education https://pressreleasenews.org/pressroom/health-insurance-comparison-for-international-students-entering-u-s-universities-in-fall-2026 California, United States, June 18, 2026 -- A side-by-side evaluation of five health insurance providers for F-1, J-1, and OPT students enrolling at U.S. universities in Fall 2026, assessed by PPO network quality, university waiver acceptance, coverage depth, and annual cost. ———————————————————————————————————————————————————————————— FDA Approves RHB-204 for Crohn’s Disease: Market Impact Analysis by DelveInsight | AstraZeneca, Immunic, Suzhou Connect Biopharma, Pfizer, Bristol-Myers Squibb 2026-07-09 · GetNews · Healthcare https://www.getnews.info/story/2026/07/09/fda-approves-rhb204-for-crohns-disease-market-impact-analysis-by-delveinsight-astrazeneca-immunic-suzhou-connect-biopharma-pfizer-bristolmyers-squibb/?source=barchart ———————————————————————————————————————————————————————————— Clinical Trial Supplies Market Industry Statistics and Growth 2026-07-09 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/09/1762194 The global Clinical Trial Supplies Market size was valued at USD 5.7 billion in 2025 and is projected to grow from USD 6.1 billion in 2026 to [read full press release...] ———————————————————————————————————————————————————————————— ENvue Medical Unveils Its First Robotic-Assisted, Artificial Intelligence, Feeding Tube Automation Tool 2026-07-09 · GlobeNewswire · Finance, AI, Healthcare https://www.globenewswire.com/news-release/2026/07/09/3324896/0/en/ENvue-Medical-Unveils-Its-First-Robotic-Assisted-Artificial-Intelligence-Feeding-Tube-Automation-Tool.html ENvue Targeting Combined $10 Billion+ Enteral Feeding and Vascular Access Market Opportunity* ———————————————————————————————————————————————————————————— Medical Care Technologies Showcases Strength of Operating Subsidiaries ... 2026-07-09 · PR-Inside · Finance, AI, SaaS, Healthcare, Gaming https://pr-inside.com/medical-care-technologies-showcases-strength-of-operating-subsidiaries-r5199411.htm (PR-inside.com) Infinite Auctions and Real Game News Deliver Tangible Results and Non-Dilutive Funding for Core Technology Initiatives MESA, AZ / ACCESS Newswire / July 9, 2026 /Medical Care Technologies Inc. (OTC PINK:MDCE) announced today that its two wholly-owned subsidiaries are delivering robust operational performance, generating revenue and technological innovation that support the parent company's healthcare technology development. Infinite Auctions has launched a new website powered by a fully in-house developed auction software platform. A significant portion of the iconic memorabilia featured will contribute proceeds to company operations and the advancement of AI vision-based technologies. Complementing this, subsidiary Real Game Used has rolled out a .. ———————————————————————————————————————————————————————————— Medical Care Technologies Showcases Strength of Operating Subsidiaries with New Websites, Automated Systems, and Star-Powered Auction Momentum 2026-07-09 · Newswire.com · Finance, Healthcare, Gaming https://www.newswire.com/news/medical-care-technologies-showcases-strength-of-operating-subsidiaries-with-new Infinite Auctions and Real Game News Deliver Tangible Results and Non-Dilutive Funding for Core Technology Initiatives ———————————————————————————————————————————————————————————— IGC Pharma to Showcase AI Portfolio at AAIC 2026, Including AHA Platform ... 2026-07-09 · PR-Inside · Finance, AI, SaaS, Healthcare https://pr-inside.com/igc-pharma-to-showcase-ai-portfolio-at-aaic-2026-including-aha-platform-r5199409.htm (PR-inside.com) Seven presentations highlight patent-pending agentic automation, speech-based cognitive models, EHR mining, and predictive analytics designed to support Alzheimer's discovery and clinical development POTOMAC, MD / ACCESS Newswire / July 9, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company developing therapeutics for Alzheimer's disease, today announced it will showcase its artificial intelligence portfolio across seven scientific presentations at the Alzheimer's Association International Conference (AAIC) 2026, taking place July 12-15 in London. IGC Pharma is building computational infrastructure designed to accelerate data integration, patient stratification, and clinical development workflows in Alzheimer's diseas ———————————————————————————————————————————————————————————— SimiTree Expands CLARITY Into a Full RCM Platform, Now Available as ... 2026-07-09 · PR-Inside · Finance, SaaS, Healthcare https://pr-inside.com/simitree-expands-clarity-into-a-full-rcm-platform-now-available-as-r5199402.htm (PR-inside.com) EMR-agnostic RCM platform gives post-acute and behavioral health organizations greater control over their revenue cycle. HAMDEN, CT / ACCESS Newswire / July 9, 2026 / SimiTree, a leading services and software company focused on behavioral health, home health, and hospice providers, today announced the evolution of CLARITY into the CLARITY RCM Platform, a comprehensive, standalone revenue cycle management technology platform available to any post-acute or behavioral health organization. Since its launch, CLARITY has earned a reputation for bringing unprecedented transparency to revenue cycle performance. What began as a powerful analytics dashboard has grown into a full-featured RCM platform, one that organizations can .. ———————————————————————————————————————————————————————————— Dr. Ran Rubinstein Discusses FDA-Approved SKINVIVE by JUVÉDERM for ... 2026-07-09 · PR-Inside · Healthcare https://pr-inside.com/dr-ran-rubinstein-discusses-fda-approved-skinvive-by-juv-derm-for-r5199400.htm (PR-inside.com) Double board-certified facial plastic surgeon Dr. Ran Rubinstein discusses the newest FDA-approved indication for SKINVIVE by JUVÉDERM and what it means for patients interested in non-surgical neck rejuvenation in Newburgh, NY and Montvale, NJ. NEWBURGH, NY AND MONTVALE, NJ / ACCESS Newswire / July 9, 2026 / Dr. Ran Rubinstein, a double board-certified facial plastic surgeon serving patients throughLaser & Cosmetic Surgery Specialists, PCin Newburgh, NY andRubinstein Plastic Surgery Centerin Montvale, NJ, is highlighting the newest FDA approval of SKINVIVE by JUVÉDERM for reducing visible neck lines in adults over the age of 21. The new indication gives patients another non-surgical .. ———————————————————————————————————————————————————————————— Dr. Ran Rubinstein Discusses FDA-Approved SKINVIVE by JUVÉDERM for Neck Lines in Newburgh, NY and Montvale, NJ 2026-07-09 · Newswire.com · Healthcare https://www.newswire.com/news/dr-ran-rubinstein-discusses-fda-approved-skinvive-by-juv-derm-for-neck-22821733 Double board-certified facial plastic surgeon Dr. Ran Rubinstein discusses the newest FDA-approved indication for SKINVIVE by JUVÉDERM and what it means for patients interested in non-surgical neck rejuvenation in Newburgh, NY and Montvale, NJ. ———————————————————————————————————————————————————————————— IGC Pharma to Showcase AI Portfolio at AAIC 2026, Including AHA Platform That Reduced Alzheimer's Data Harmonization Time by 90% in Representative Workflow 2026-07-09 · Newswire.com · AI, SaaS, Healthcare https://www.newswire.com/news/igc-pharma-to-showcase-ai-portfolio-at-aaic-2026-including-aha-platform-that Seven presentations highlight patent-pending agentic automation, speech-based cognitive models, EHR mining, and predictive analytics designed to support Alzheimer's discovery and clinical development ———————————————————————————————————————————————————————————— Retia Medical Appoints Christopher Benassi to Strategic Advisory Board 2026-07-09 · PR Newswire · SaaS, Healthcare https://www.prnewswire.com/news-releases/retia-medical-appoints-christopher-benassi-to-strategic-advisory-board-302821463.html Veteran Baxter Connected Care Executive Christopher Benassi Joins Advisory Board as Company Advances FDA-Cleared Cardiovascular Intelligence Platform WHITE PLAINS, N.Y., July 9, 2026 /PRNewswire/ -- Retia Medical, the developer of cardiovascular intelligence software that transforms... ———————————————————————————————————————————————————————————— Withings Launches Withings Medical, Bringing Clinical Care to Medicare-Eligible Patients Under CMS's New ACCESS Model 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/withings-launches-withings-medical-bringing-clinical-care-to-medicare-eligible-patients-under-cmss-new-access-model-302821919.html A new clinical care service, launching first in the U.S., built on nearly two decades of health monitoring. BOSTON, July 9, 2026 /PRNewswire/ -- Withings, a leader in connected health and at-home monitoring, today announced Withings Medical, a new clinical care service marking the... ———————————————————————————————————————————————————————————— VSee Health CEO Issues Shareholder Update as Company Focuses on iDoc ... 2026-07-09 · PR-Inside · Finance, Healthcare https://pr-inside.com/vsee-health-ceo-issues-shareholder-update-as-company-focuses-on-idoc-r5199397.htm (PR-inside.com) HOUSTON, TX / ACCESS Newswire / July 9, 2026 /VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today issued the following letter from Chairman and Chief Executive Officer Dr. Imoigele Aisiku providing shareholders with an update on the Company's strategic transformation and outlook. Dear Fellow Shareholders, Over the past two years, VSee Health has undergone a significant transformation. Our objective has been straightforward: simplify the Company, strengthen our operating business, improve our financial profile and position VSee for long-term growth. Today, I would like to update you on several important milestones that we .. ———————————————————————————————————————————————————————————— VSee Health CEO Issues Shareholder Update as Company Focuses on iDoc TeleHealth Solutions for Revenue Growth and Profitability 2026-07-09 · Newswire.com · Finance, Healthcare https://www.newswire.com/news/vsee-health-ceo-issues-shareholder-update-as-company-focuses-on-idoc-telehealth ———————————————————————————————————————————————————————————— LataMed AI Chief Executive Officer Dr. Kevin Rodan to Be Recognized by Ministry of Health for Healthcare Innovation 2026-07-09 · NewMediaWire · AI, Healthcare, Retail https://www.newmediawire.com/news/latamed-ai-chief-executive-officer-dr-kevin-rodan-to-be-recognized-by-ministry-of-health-for-healthcare-innovation-7087591 CARACAS, VENEZUELA - July 9, 2026 ( NEWMEDIAWIRE ) - LataMed AI Corp. (OTC: LMED) (the “Company”), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets, today announced that Dr. Kevin Rodan, Chief Executive Officer of LataMed AI Corp., is expected to receive a Certificate of Excellence from the Ministry of Health in recognition of his contributions to healthcare innovation, technological development, clinical practice, and healthcare advancement. According to information provided to the Company, the recognition is expected to be presented on July 10, 2026 as part of Ministry of Health initiatives focused on acknowledging healthcare professionals whos ———————————————————————————————————————————————————————————— Emergency Care Partners Announces Strategic Partnership with Empower ... 2026-07-09 · PR-Inside · Healthcare https://pr-inside.com/emergency-care-partners-announces-strategic-partnership-with-empower-r5199396.htm (PR-inside.com) PHOENIX, AZ / ACCESS Newswire / July 9, 2026 / Emergency Care Partners (ECP), the nation's largest single specialty provider of emergency medicine physician services, today announced a new strategic partnership with Empower Emergency Physicians, a premier independent emergency medicine group based in the Phoenix Metropolitan area. Founded in 2003, Empower Emergency Physicians serves as the exclusive emergency medicine services provider for Dignity Health CommonSpirit's St. Joseph's Hospitals, including: St. Joseph's Hospital and Medical Center, St. Joseph's Westgate Medical Center, and freestanding emergency rooms: St. Joseph's Glendale Medical Center, and St. Joseph's Litchfield Park Medical Center. Collectively, the group's clinicians treat .. ———————————————————————————————————————————————————————————— As Supplement Enforcement Tightens, One Platform is Betting Every Brand ... 2026-07-09 · PR-Inside · SaaS, Healthcare https://pr-inside.com/as-supplement-enforcement-tightens-one-platform-is-betting-every-brand-r5199395.htm (PR-inside.com) Federal regulators increased scrutiny of dietary supplements throughout 2025. NutraVeri gives founders a 60-second readiness score before they invest in formulas that regulators - or the market - may reject. MIAMI, FL / ACCESS Newswire / July 9, 2026 /Nitches Inc. (OTCID:NICH) - The dietary supplement industry is entering one of the most closely scrutinized periods in its history, and NutraVeri believes every founder will soon need something the industry has never had: an objective readiness check before manufacturing begins. Regulatory scrutiny intensified throughout 2025 as the U.S. Food and Drug Administration (FDA), the Federal Trade Commission (FTC), and the National Advertising .. ———————————————————————————————————————————————————————————— Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate 2026-07-09 · GlobeNewswire · Finance, Healthcare, Automotive https://www.globenewswire.com/news-release/2026/07/09/3324792/24675/en/Fate-Therapeutics-Receives-FDA-Clearance-of-Investigational-New-Drug-Application-for-FT839-Product-Candidate.html First-of-Kind, Dual-CAR T cell Targeting CD19 and CD38 for Comprehensive Elimination of Complex, Multi-System Autoimmune Disorders Advances into Phase 1/2 Clinical Development ———————————————————————————————————————————————————————————— Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome 2026-07-09 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/09/3324798/0/en/Quoin-Pharmaceuticals-Receives-FDA-IND-Clearance-to-Initiate-Phase-2-Study-of-QRX003-in-Peeling-Skin-Syndrome.html Quoin Pharmaceuticals (NASDAQ: QNRX) receives FDA IND clearance for a Phase 2 study of QRX003 in Peeling Skin Syndrome, with initiation expected in 2H 2026 ———————————————————————————————————————————————————————————— Smiles on the Upper Westside Welcomes Dr. Nwadiuto Ekeh to New York City Dental Practice 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/smiles-on-the-upper-westside-welcomes-dr-nwadiuto-ekeh-to-new-york-city-dental-practice-302820027.html NEW YORK, July 13, 2026 /PRNewswire/ -- Smiles on the Upper Westside is pleased to announce that Dr. Nwadiuto Ekeh, DDS, has joined the practice's dental team. Dr. Ekeh brings a dedication to gentle, patient-centered care and specialized training in preventive, restorative, and aesthetic... ———————————————————————————————————————————————————————————— Mall of Hope Calls on The Community to Help Families Living with Alzheimer’s and Dementia 2026-07-09 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/09/1762147 USA, 2026-07-09 — /EPR Network/ — Mall of Hope is inviting individuals, businesses, and community partners to join its mission of supporting families affected by Alzheimer’s [read full press release...] ———————————————————————————————————————————————————————————— CervoMed Announces Completion of Enrollment in Phase 2 Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia, a Type of Frontotemporal Dementia 2026-07-09 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/09/3324708/0/en/CervoMed-Announces-Completion-of-Enrollment-in-Phase-2-Study-of-Neflamapimod-for-Nonfluent-Variant-Primary-Progressive-Aphasia-a-Type-of-Frontotemporal-Dementia.html Interim biomarker data accepted for presentation at the 19 th Clinical Trials on Alzheimer's Disease (CTAD) conference ———————————————————————————————————————————————————————————— Award-Winning Collective Counseling Solutions and The Second Act Launch Joint Venture to Reimagine Behavioral Health Navigation 2026-07-09 · PRWeb · AI, SaaS, Healthcare https://www.prweb.com/releases/award-winning-collective-counseling-solutions-and-the-second-act-launch-joint-venture-to-reimagine-behavioral-health-navigation-302820391.html Award-winning, Denver-based behavioral health innovator Collective Counseling Solutions and The Second Act, creator of the AI-powered matching platform trysam.ai, today announced a joint venture to launch a purpose-built platform that simplifies how individuals find the right therapist.... ———————————————————————————————————————————————————————————— Maternity Products Market to Reach USD 102.49 Billion by 2036 Driven by Rising Maternal Health Awareness, Growing Demand for Pregnancy Wellness Solutions 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/maternity-products-market-to-reach-usd-102-49-billion-by-2036-driven-by-rising-maternal-health-awareness-growing-demand-for-pregnancy-wellness-solutions-302821818.html NEWARK, Del., July 9, 2026 /PRNewswire/ -- According to Future Market Insights (FMI), the global maternity products market is entering a robust growth phase as expectant and new mothers increasingly prioritize comfort, wellness, and specialized pregnancy care solutions. The market was... ———————————————————————————————————————————————————————————— Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2026 on August 11 2026-07-09 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/cardinal-health-to-announce-fourth-quarter-and-year-end-results-for-fiscal-year-2026-on-august-11-302819942.html DUBLIN, Ohio, July 9, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2026 on August 11, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these... ———————————————————————————————————————————————————————————— RYBODYN AWARDED $1.3M DOW GRANT TO ADVANCE NOVEL ANTIBODY THERAPIES FOR LUNG CANCER 2026-07-09 · PR Newswire · AI, SaaS, Healthcare https://www.prnewswire.com/news-releases/rybodyn-awarded-1-3m-dow-grant-to-advance-novel-antibody-therapies-for-lung-cancer-302821583.html Competitive CDMRP award funds preclinical programs against two cryptic cell-surface targets discovered directly in patient tumors using the company's AI-powered RyboCypher™ platform and CypherAtlas™ knowledgebase SAN DIEGO, July 9, 2026 /PRNewswire/ -- RyboDyn, Inc., a biotechnology... ———————————————————————————————————————————————————————————— Blue Earth Therapeutics announces first participant dosed in Phase 1 clinical trial investigating Actinium (²²⁵Ac) rhPSMA-10.1 Injection in metastatic castration-resistant prostate cancer 2026-07-09 · PR Newswire · SaaS, Healthcare, Education https://www.prnewswire.com/news-releases/blue-earth-therapeutics-announces-first-participant-dosed-in-phase-1-clinical-trial-investigating-actinium-ac-rhpsma-10-1-injection-in-metastatic-castration-resistant-prostate-cancer-302820625.html The University College London (UCL) sponsored study evaluates safety, tolerability and radiation dosimetry of an investigational alpha‑emitting PSMA‑targeted radiopharmaceutical therapy, building on Blue Earth Therapeutics' radiohybrid platform. For Media and Investors only OXFORD,... ———————————————————————————————————————————————————————————— Acumen Pharmaceuticals and Unlearn Collaborate to Explore Analyses ... 2026-07-09 · PR-Inside · AI, Healthcare https://pr-inside.com/acumen-pharmaceuticals-and-unlearn-collaborate-to-explore-analyses-r5199290.htm (PR-inside.com) SAN FRANCISCO, CA AND NEWTON, MA / ACCESS Newswire / July 9, 2026 / Unlearn, a pioneer of AI-powered solutions for clinical development, today announced a collaboration with Acumen Pharmaceuticals (Acumen), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer's disease (AD). The collaboration will utilize Unlearn's AI-generated digital twins of trial participants in two of Acumen's AD clinical trials testing their AβO-specific antibody sabirnetug. Digital twins are comprehensive forecasts of an individual trial participant's clinical outcomes at all future timepoints across a given study, used to augment insights .. ———————————————————————————————————————————————————————————— Acumen Pharmaceuticals and Unlearn Collaborate to Explore Analyses of Alzheimer's Disease Clinical Programs 2026-07-09 · Newswire.com · Healthcare https://www.newswire.com/news/acumen-pharmaceuticals-and-unlearn-collaborate-to-explore-analyses-of ———————————————————————————————————————————————————————————— Greenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01 2026-07-09 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/09/3324636/0/en/Greenwich-LifeSciences-Announces-European-Approval-for-Use-of-Commercially-Manufactured-GP2-in-FLAMINGO-01.html STAFFORD, Texas, July 09, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided the following update on the use of commercially manufactured GP2 in FLAMINGO-01 in Europe. ———————————————————————————————————————————————————————————— InxMed Announces Publication in The Lancet Respiratory Medicine Featuring Promising Anticancer Activity of Ifebemtinib in combination with Garsorasib in First-Line non-small cell lung cancer (NSCLC) Harboring KRAS G12C Mutation 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/inxmed-announces-publication-in-the-lancet-respiratory-medicine-featuring-promising-anticancer-activity-of-ifebemtinib-in-combination-with-garsorasib-in-first-line-non-small-cell-lung-cancer-nsclc-harboring-kras-g12c-mutation-302821769.html NANJING, China, July 9, 2026 /PRNewswire/ -- InxMed Co., Ltd ("InxMed"), a clinical-stage biotechnology company dedicated to developing innovative therapies targeting cancer treatment resistance and metastasis, today announced that the clinical results of ifebemtinib (IN10018), a highly... ———————————————————————————————————————————————————————————— Willis: Food industry faces mounting risks and falling confidence in risk management in 2026 2026-07-09 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/09/3324583/0/en/Willis-Food-industry-faces-mounting-risks-and-falling-confidence-in-risk-management-in-2026.html LONDON, July 09, 2026 (GLOBE NEWSWIRE) -- Fears over food safety and health have risen sharply, with almost half of companies (45%) naming this among their biggest risks, up from 29% in 2024, amid growing concern over ultra-processed foods and rising litigation exposure. That’s according to the Global Food, Beverage and Agriculture Risk Report 2026 , published today by Willis, a WTW business (NASDAQ: WTW). ———————————————————————————————————————————————————————————— WuXi Biologics' MFG8 Drug Substance Facility Secures FDA PLI Approval, Advancing Commercial Supply of a Potential Blockbuster Autoimmune Therapy 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/wuxi-biologics-mfg8-drug-substance-facility-secures-fda-pli-approval-advancing-commercial-supply-of-a-potential-blockbuster-autoimmune-therapy-302821695.html SHIJIAZHUANG, China, July 9, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its MFG8 drug substance manufacturing facility located in Hebei has successfully passed the Pre-License... ———————————————————————————————————————————————————————————— Rong Diao Honored as a Professional of the Year for 2026 in Food/Biotech by Strathmore's Who's Who Worldwide Publication 2026-07-09 · PR.com · Healthcare https://www.pr.com/press-release/973257 Rong Diao of Morris Plains, New Jersey, has been named a Professional of the Year for 2026 in food/biotech by Strathmore's Who's Who Worldwide for her outstanding contributions and achievements in food, biotech, manufacturing, and research and development. About Rong Diao Rong Diao is an owner of Omni BioFood and a respected leader in the food and biotechnology industries. Omni BioFood specializes in research and [PR.com] ———————————————————————————————————————————————————————————— Dayton Children's Hospital goes live with Sectra's ophthalmology solution to unify imaging across specialties 2026-07-09 · PR Newswire · SaaS, Healthcare https://www.prnewswire.com/news-releases/dayton-childrens-hospital-goes-live-with-sectras-ophthalmology-solution-to-unify-imaging-across-specialties-302821675.html LINKÖPING, Sweden, July 9, 2026 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) announces that Dayton Children's Hospital is now live with Sectra's ophthalmology solution, extending the hospital's enterprise imaging platform beyond radiology.... ———————————————————————————————————————————————————————————— New German expert consensus highlights role for NPWT in mitigating the economic impact of postoperative wound complications 2026-07-09 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/09/3324546/0/en/New-German-expert-consensus-highlights-role-for-NPWT-in-mitigating-the-economic-impact-of-postoperative-wound-complications.html Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces the publication by expert clinicians of new consensus-based guidance - developed by them for the use of single-use negative pressure wound therapy (sNPWT) in closed surgical incisions. The guidance is supported by practical clinical practice recommendations for Germany and has been published in the internationally recognised journal of surgery Die Chirurgie. The new German consensus was supported by Smith+Nephew, a pioneer in sNPWT and manufacturer of the PICO™7 sNPWT system. ———————————————————————————————————————————————————————————— New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions 2026-07-09 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/09/3324547/0/en/New-German-expert-consensus-provides-first-risk-based-recommendations-for-sNPWT-use-in-closed-surgical-incisions.html Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces the publication of new consensus-based guidance - developed independently by expert clinicians for the use of single-use negative pressure wound therapy (sNPWT) in closed surgical incisions. The guidance is supported by practical clinical practice recommendations for Germany. Published in internationally recognised journal of surgery Die Chirurgie, the new German consensus was supported by Smith+Nephew, a pioneer in sNPWT and manufacturer of the PICO ™ 7 sNPWT system. ———————————————————————————————————————————————————————————— Roche receives CE Mark for blood test to identify tuberculosis infection 2026-07-09 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/09/3324540/0/en/Roche-receives-CE-Mark-for-blood-test-to-identify-tuberculosis-infection.html Basel, 9 July 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that its Elecsys IGRA TB test has received the CE Mark, introducing a new blood testing solution for identifying tuberculosis infection (TBI, also known as latent TB) in routine laboratory settings. The new solution enables fast, simple, and efficient diagnosis, and can provide results in under 24 hours. The Interferon Gamma Release Assay (IGRA) itself takes just 19 minutes per patient to process, which is approximately half the time of currently used methods. Laboratories now have an option for IGRA testing, with faster turnaround and scalable throughput on Roche’s systems. ———————————————————————————————————————————————————————————— DEA's Own Pharmacologist Undercuts Marijuana Rescheduling Order 2026-07-09 · PR-Inside · Healthcare https://pr-inside.com/dea-s-own-pharmacologist-undercuts-marijuana-rescheduling-order-r5199261.htm (PR-inside.com) "Government's Own Scientific Expert Testified Marijuana Failed DEA's Traditional Medical Use Standard, Lacked Reproducible Chemistry, and That HHS Omitted Critical Public Health Findings" stated Duane Boise CEO MMJ International Holdings. WASHINGTON, DC / ACCESS Newswire / July 8, 2026 / One witness may ultimately define the entire DEA marijuana rescheduling proceeding-not because she opposed marijuana legalization, but because she authored the Drug Enforcement Administration's own scientific review. Dr. Luli Akinfiresoye, a pharmacologist in DEA's Drug and Chemical Evaluation Section and author of the agency's 2024 Scientific Data Review, testified under subpoena during the marijuana rescheduling hearing. Her testimony revealed a striking scientific .. ———————————————————————————————————————————————————————————— HanchorBio Tests Broader Ambitions for HCB101 Through InxMed Partnership 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/hanchorbio-tests-broader-ambitions-for-hcb101-through-inxmed-partnership-302821384.html Taiwan-listed biotech looks to expand the value of its lead oncology asset through combination research with late-stage cancer drug resistance specialist InxMed. TAIPEI and SHANGHAI and SAN FRANCISCO, July 8, 2026 /PRNewswire/ -- HanchorBio, Inc. (TWSE: 7827) is taking another step to... ———————————————————————————————————————————————————————————— Insilico Medicine Releases Positive Profit Alert for the First Half of 2026 2026-07-09 · PR Newswire · AI, Healthcare https://www.prnewswire.com/news-releases/insilico-medicine-releases-positive-profit-alert-for-the-first-half-of-2026-302821358.html CAMBRIDGE, Mass., July 8, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico" or the "Company", HKEX: 3696), a generative artificial intelligence (AI)-driven clinical-stage biotech company, today delivered a positive profit alert for the six months ended June 30, 2026 ("First Half of... ———————————————————————————————————————————————————————————— Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo 2026-07-09 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announces-first-patient-dosed-in-phase-ii-clinical-trial-of-lnk01004-ointment-for-vitiligo-302820857.html HANGZHOU, China, SHANGHAI and BOSTON, July 8, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that the first patient was successfully dosed on... ———————————————————————————————————————————————————————————— Inspirational Memoir “The Miracle of Eve: Saved by Grace!” Shares a Powerful Story of Faith, Survival, Family, and Hope Through Cancer 2026-07-08 · WebWire · Healthcare https://www.webwire.com/ViewPressRel.asp?aId=357370 In her moving and faith-filled memoir, “The Miracle of Eve: Saved by Grace!,” author Yvonne D. Baku opens her heart to readers with a story that is as vulnerable as it is victorious. What began as a season of unexplained pain, exhaustion, uncertainty, and medical appointments soon became a life-altering journey through a diagnosis of stage IV large B-cell non-Hodgkin's lymphoma — a journey that tested her body, her marriage, her family, her faith, and her understanding of purpose. - - At... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357370 ———————————————————————————————————————————————————————————— LumaCare Lasers Partners with Flex to Unlock HSA and FSA Funds for Cold Laser Therapy 2026-07-08 · PRUnderground · Healthcare https://www.prunderground.com/lumacare-lasers-partners-with-flex-to-unlock-hsa-and-fsa-funds-for-cold-laser-therapy/00388137/ Cold laser therapy device manufacturer announces its dual-head LumaCare Duo device is now eligible for purchase using HSA and FSA funds through a new partnership with Flex. The post LumaCare Lasers Partners with Flex to Unlock HSA and FSA Funds for Cold Laser Therapy first appeared on ———————————————————————————————————————————————————————————— RipeGlobal and Subscribili Partner to Drive Case Acceptance and Practice Growth Across Dental Organizations 2026-07-08 · PR Newswire · AI, SaaS, Healthcare, Education https://www.prnewswire.com/news-releases/ripeglobal-and-subscribili-partner-to-drive-case-acceptance-and-practice-growth-across-dental-organizations-302820356.html Integration combines clinical education, AI-driven scheduling, and in-office membership infrastructure to close the care gap for uninsured patients, accelerate case acceptance, and unlock chair time for DSOs nationwide AUSTIN, Texas, July 8, 2026 /PRNewswire-PRWeb/ -- RipeGlobal, the... ———————————————————————————————————————————————————————————— Gout Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight 2026-07-08 · GetNews · Healthcare https://www.getnews.info/story/2026/07/08/gout-pipeline-accelerates-as-25-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight/?source=barchart ———————————————————————————————————————————————————————————— ESCLC Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight 2026-07-08 · GetNews · Healthcare https://www.getnews.info/story/2026/07/08/esclc-pipeline-accelerates-as-25-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight/?source=barchart ———————————————————————————————————————————————————————————— Eczema Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight 2026-07-08 · GetNews · Healthcare https://www.getnews.info/story/2026/07/08/eczema-pipeline-accelerates-as-100-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight/?source=barchart ———————————————————————————————————————————————————————————— RNA Therapies Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight 2026-07-08 · GetNews · Healthcare https://www.getnews.info/story/2026/07/08/rna-therapies-pipeline-accelerates-as-20-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight/?source=barchart ———————————————————————————————————————————————————————————— Glioblastoma Pipeline Accelerates as 200+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight 2026-07-08 · GetNews · Healthcare https://www.getnews.info/story/2026/07/08/glioblastoma-pipeline-accelerates-as-200-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight/?source=barchart ———————————————————————————————————————————————————————————— JAK Inhibitor Pipeline Accelerates as 50+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight 2026-07-08 · GetNews · Healthcare https://www.getnews.info/story/2026/07/08/jak-inhibitor-pipeline-accelerates-as-50-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight/?source=barchart ———————————————————————————————————————————————————————————— Levi & Korsinsky Reminds Insulet Corporation Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 31, 2026 - PODD 2026-07-08 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/levi--korsinsky-reminds-insulet-corporation-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-august-31-2026---podd-302821158.html Insulet's SEC Filings Touted Quality Assurance Inspections "At Various Steps in the Manufacturing Cycle" While Manufacturing Issues at Its Acton Facility Allegedly Led to Medical Device Corrections Affecting Millions of Pods NEW YORK, July 8, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP... ———————————————————————————————————————————————————————————— AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC. 2026-07-08 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/08/3324473/0/en/AIMEI-HEALTH-TECHNOLOGY-CO-LTD-ANNOUNCES-TERMINATION-OF-BUSINESS-COMBINATION-AGREEMENT-WITH-UNITED-HYDROGEN-GROUP-INC.html Aimei Health Technology Co., Ltd. Announces Termination of Business Combination Agreement ———————————————————————————————————————————————————————————— Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026 2026-07-08 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/evolent-to-release-second-quarter-2026-financial-results-on-thursday-august-6-2026-302820804.html WASHINGTON, July 8, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its second quarter 2026 financial results on Thursday, August 6, 2026, before market open,... ———————————————————————————————————————————————————————————— Hair Restoration Institute of Minnesota Reports Strong Early Patient Response to Dutasteride Mesotherapy 2026-07-08 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/hair-restoration-institute-of-minnesota-reports-strong-early-patient-response-to-dutasteride-mesotherapy-302821207.html Bloomington clinic sees rising demand for targeted scalp injection treatment weeks after becoming the first provider in Minnesota to offer it BLOOMINGTON, Minn., July 8, 2026 /PRNewswire/ -- Hair Restoration Institute of Minnesota (HRIMN), the first hair restoration provider in Minnesota... ———————————————————————————————————————————————————————————— More Correctional Facilities Are Choosing Armor Health for Innovative, Patient-Centered Healthcare Services 2026-07-08 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/more-correctional-facilities-are-choosing-armor-health-for-innovative-patient-centered-healthcare-services-302821196.html MIAMI, July 8, 2026 /PRNewswire/ -- As correctional healthcare continues to evolve, more jails and correctional facilities are placing their trust in Armor Health to deliver high-quality, compassionate, and innovative contract healthcare services. Built on a foundation of clinical... ———————————————————————————————————————————————————————————— Cosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market Repurchases 2026-07-08 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/08/3324405/0/en/Cosmos-Health-Share-Buyback-Surpasses-4-Million-Shares-Continues-Open-Market-Repurchases.html Cosmos Health has now repurchased a total of 4,060,000 shares for approximately $811,000. ———————————————————————————————————————————————————————————— Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of DCVax®-L For Glioblastoma Using Individual Patient Level Data in Multiple Independent Analyses 2026-07-08 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/northwest-biotherapeutics-presents-updated-survival-data-from-phase-iii-trial-of-dcvax-l-for-glioblastoma-using-individual-patient-level-data-in-multiple-independent-analyses-302821136.html Scientific Presentation at British Neuro-Oncology Annual Meeting Shows Original Analysis of Survival Extension Was Likely Underestimated BETHESDA, Md., July 8, 2026 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax®... ———————————————————————————————————————————————————————————— RateQuote and Benepicks Announce Strategic Partnership for End-to-End ICHRA Enrollment 2026-07-08 · PR Newswire · SaaS, Healthcare https://www.prnewswire.com/news-releases/ratequote-and-benepicks-announce-strategic-partnership-for-end-to-end-ichra-enrollment-302820277.html Combining licensed agent expertise and ICHRA technology to deliver complete enrollment for carriers, brokers, and employers. CHARLESTON, S.C., July 8, 2026 /PRNewswire-PRWeb/ -- RateQuote, a national health insurance brokerage, and Benepicks, a purpose-built ICHRA technology platform,... ———————————————————————————————————————————————————————————— /U P D A T E -- Pearl Health/ 2026-07-08 · PR Newswire · AI, SaaS, Healthcare https://www.prnewswire.com/news-releases/pearl-health-raises-110-million-to-expand-its-ai-platform-helping-providers-deliver-better-outcomes-at-lower-cost-for-medicare-patients-302820795.html In the news release, Pearl Health Raises $110 Million to Expand Its AI Platform Helping Providers Deliver Better Outcomes at Lower Cost for Medicare Patients, issued 08-Jul-2026 by Pearl Health over PR Newswire, we are advised by the company that changes have been made. The complete,... ———————————————————————————————————————————————————————————— PIH Health First in Los Angeles County and Orange County to Transition to SCOUT MD™ Localization Technology 2026-07-08 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/pih-health-first-in-los-angeles-county-and-orange-county-to-transition-to-scout-md-localization-technology-302821083.html Advanced wire-free radar technology supports surgical precision and enhances patient care WHITTIER, Calif., July 8, 2026 /PRNewswire/ -- PIH Health Whittier Hospital has become the first hospital in Los Angeles County and Orange County to transition to SCOUT MD™ localization technology,... ———————————————————————————————————————————————————————————— AAPC Launches CPC-M Credential, the Highest Standard of Mastery in Medical Coding 2026-07-08 · PRWeb · Finance, Healthcare https://www.prweb.com/releases/aapc-launches-cpc-m-credential-the-highest-standard-of-mastery-in-medical-coding-302820247.html New certification recognizes experienced medical coding professionals whose expertise drives compliance, revenue integrity, and organizational leadership SALT LAKE CITY, July 8, 2026 /PRNewswire-PRWeb/ -- AAPC, the nation's leading organization for healthcare business professionals, today... ———————————————————————————————————————————————————————————— Nuritas and Professor Graeme Close Launch Clinical Study Evaluating Bioactive Peptides in Longevity and Healthy Aging 2026-07-08 · PRWeb · Healthcare, Education https://www.prweb.com/releases/nuritas-and-professor-graeme-close-launch-clinical-study-evaluating-bioactive-peptides-in-longevity-and-healthy-aging-302820234.html New landmark research collaboration between Liverpool John Moores University and Nuritas investigates the role of PeptiStrong® in supporting functional strength, muscle health and longevity in adults aged 60-85 DUBLIN, July 8, 2026 /PRNewswire-PRWeb/ -- Nuritas, a biotechnology... ———————————————————————————————————————————————————————————— Weight Loss Rankings Launches Free, Independent Scores for GLP-1 Telehealth Providers 2026-07-08 · PressReleaseNews · Healthcare, Retail https://pressreleasenews.org/pressroom/weight-loss-rankings-launches-free-independent-scores-for-glp-1-telehealth-providers Weight Loss Rankings launches as a free, independent, bilingual directory that scores GLP-1 telehealth providers on price, clinical oversight, and safety. It pairs independent 0-10 provider scores with an evidence-based, PMID-cited research library and free consumer tools. ———————————————————————————————————————————————————————————— All Kinds of Therapy Expands Directory Ecosystem with Wave of Innovative 2026 Partners 2026-07-08 · PRWeb · Healthcare https://www.prweb.com/releases/all-kinds-of-therapy-expands-directory-ecosystem-with-wave-of-innovative-2026-partners-302820202.html The leading independent directory for behavioral health and transitional care announces meaningful growth, broadening its coverage of local, remote, and specialized options for adolescents, young adults, and family systems. SOUTH PORTLAND, Maine, July 8, 2026 /PRNewswire-PRWeb/ -- All... ———————————————————————————————————————————————————————————— BioVigil Adds Hospital Executive Patti DePompei to Board of Directors 2026-07-08 · PRWeb · Healthcare, Education https://www.prweb.com/releases/biovigil-adds-hospital-executive-patti-depompei-to-board-of-directors-302820211.html BioVigil hand hygiene and infection prevention has added former University Hospitals Rainbow Babies & Children's Hospital and MacDonald Women's Hospital President Patti DePompei to its Board of Directors. ANN ARBOR, Mich., July 8, 2026 /PRNewswire-PRWeb/ -- BioVigil, the leader in... ———————————————————————————————————————————————————————————— New Waterjet Therapy at Intermountain Lutheran and Saint Joseph Hospitals Targets Prostate Condition 2026-07-08 · PRUnderground · Healthcare https://www.prunderground.com/new-waterjet-therapy-at-intermountain-lutheran-and-saint-joseph-hospitals-targets-prostate-condition/00388096/ Men with Benign Prostatic Hyperplasia (BPH), or an enlarged prostate can now be treated via Aquablation Therapy at Intermountain Health Lutheran Hospital The post New Waterjet Therapy at Intermountain Lutheran and Saint Joseph Hospitals Targets Prostate Condition first appeared on ———————————————————————————————————————————————————————————— MTM Health Names Chris Echols Regional Vice President of Operations 2026-07-08 · PR-Inside · Healthcare https://pr-inside.com/mtm-health-names-chris-echols-regional-vice-president-of-operations-r5199049.htm (PR-inside.com) LAKE SAINT LOUIS, MO / ACCESS Newswire / July 8, 2026 / MTM Health, a leading provider of non-emergency medical transportation (NEMT) and healthcare logistics solutions, is pleased to announce the appointment of Chris Echols as Regional Vice President of Operations, effective July 6, 2026. In this role, Echols will oversee client relationships and overall NEMT operations across the eastern region of the United States. Echols brings more than two decades of senior leadership experience in healthcare services, with a strong focus on NEMT operations, strategic planning, financial analysis, contracting, and operational excellence. Most relevantly, he served as Senior Vice President .. ———————————————————————————————————————————————————————————— WorldWide HealthStaff Solutions connects health systems with experienced perioperative nurses to support surgical care 2026-07-08 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/worldwide-healthstaff-solutions-connects-health-systems-with-experienced-perioperative-nurses-to-support-surgical-care-302820907.html CHARLOTTE, N.C., July 8, 2026 /PRNewswire/ -- As hospitals and surgical care providers in the U.S. continue to face nursing shortages, WorldWide HealthStaff Solutions (WWHS), a Medical Solutions company, is helping organizations fill critical staffing gaps and support patient care with... ———————————————————————————————————————————————————————————— Vitamin brands boost ad spend by 27% as 11.8 million Australians turn to supplements 2026-07-08 · WebWire · Healthcare, Retail https://www.webwire.com/ViewPressRel.asp?aId=357334 Australia's vitamins and supplements market is heating up, with brands increasing advertising investment as millions of Australians continue to make supplements part of their everyday health routines. - - New Nielsen Ad Intel data shows advertising spend in the vitamins and supplements sector reached $75.1 million in the 12 months from 1 June 2025 to 31 May 2026, up 26.5% year-on-year. - - The lift in spend comes as Nielsen Consumer & Media View (CMV) data shows the category has become f... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357334 ———————————————————————————————————————————————————————————— Global Medical Device Reprocessing Market to Register Sustainable Growth at a CAGR of ~8% by 2034 | DelveInsight 2026-07-08 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/global-medical-device-reprocessing-market-to-register-sustainable-growth-at-a-cagr-of-8-by-2034--delveinsight-302820495.html The medical device reprocessing market is witnessing steady growth, driven by the increasing demand for cost-effective healthcare solutions and the rising emphasis on reducing medical waste. Hospitals and healthcare providers are increasingly adopting reprocessed SUDs to lower procurement... ———————————————————————————————————————————————————————————— Medical Radiation Detection, Monitoring & Safety Market worth $2.22 billion by 2031 | MarketsandMarkets™ 2026-07-08 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/medical-radiation-detection-monitoring--safety-market-worth-2-22-billion-by-2031--marketsandmarkets-302820471.html DELRAY BEACH, Fla., July 8, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Medical Radiation Detection, Monitoring & Safety Market is projected to grow from about USD 1.47 billion in 2026 to USD 2.22 billion by 2031, at a CAGR of 8.6%. Browse 500 market data Tables and 50... ———————————————————————————————————————————————————————————— Newest Issue of Chairside(R) Magazine Explores the Innovations Reshaping ... 2026-07-08 · PR-Inside · Healthcare https://pr-inside.com/newest-issue-of-chairside-r-magazine-explores-the-innovations-reshaping-r5199020.htm (PR-inside.com) Volume 21, Issue 2 highlights the technologies, workflows and clinical insights helping dentists improve efficiency, predictability and patient care. IRVINE, CA / ACCESS Newswire / July 8, 2026 / Volume 21, Issue 2 of Chairside®magazine is now available in print and online at chairsidemagazine.com. This special innovations issue features two free CEUs and examines the breakthroughs driving progress in modern dentistry. "Innovation only matters if it solves real problems for practicing dentists," said Jim Glidewell, CDT, founder and president of Glidewell. "This new issue of Chairside magazine highlights the people, research and technologies shaping today's advancements, with a focus on how they .. ———————————————————————————————————————————————————————————— EduMed.org launches interactive school matching tool for nursing and allied health students 2026-07-08 · PRWeb · Healthcare, Education https://www.prweb.com/releases/edumedorg-launches-interactive-school-matching-tool-for-nursing-and-allied-health-students-302820180.html New quizzes, school comparisons and expert guidance help students identify degree programs that fit their learning style, budget and career goals. RENO, Nev., July 8, 2026 /PRNewswire-PRWeb/ -- EduMed.org -- a leader in higher education information for nursing and allied health -- today... ———————————————————————————————————————————————————————————— Newest Issue of Chairside(R) Magazine Explores the Innovations Reshaping Modern Dentistry 2026-07-08 · Newswire.com · Healthcare https://www.newswire.com/news/newest-issue-of-chairside-r-magazine-explores-the-innovations-22815991 Volume 21, Issue 2 highlights the technologies, workflows and clinical insights helping dentists improve efficiency, predictability and patient care. ———————————————————————————————————————————————————————————— Vadzo Announces Processed Bayer Output from Falcon-2020BRS with Support for On-Board IQ Processing such as Color Correction, Auto Exposure and Denoising 2026-07-08 · Newswire.com · Healthcare https://www.newswire.com/news/vadzo-announces-processed-bayer-output-from-falcon-2020brs-with-22814273 The Falcon-2020BRS is a 20MP color USB camera built on the onsemi HyperLux LP AR2020 sensor. It delivers processed Bayer output through an onboard ISP supporting color correction, auto exposure and denoising over USB 3.2 Gen 1. The camera is designed for aerial survey, document scanning, precision metrology, semiconductor inspection, high-resolution medical imaging and industrial inspection applications requiring 5120 x 3840 pixel resolution with per-frame IQ consistency on Windows, Linux and Android. ———————————————————————————————————————————————————————————— Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance 2026-07-08 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/porton-advanceds-uc-mscs-cell-bank-for-exosome-manufacturing-receives-us-fda-drug-master-file-dmf-acceptance-302820818.html CRANBURY, N.J. and SUZHOU, China, July 8, 2026 /PRNewswire/ -- Recently, Porton Advanced proudly announced that its Umbilical Cord-Derived Mesenchymal Stem Cell (UC-MSCs) Cell Bank for exosome manufacturing has been accepted for filing by the FDA's Center for Biologics Evaluation and... ———————————————————————————————————————————————————————————— Osteoarthritis Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Merck, Peptinov, LG Chem, Akan Bioscience, BioTissue, Eupraxia Pharma, OliPass 2026-07-08 · GetNews · Healthcare https://www.getnews.info/story/2026/07/08/osteoarthritis-pipeline-2026-fda-updates-therapy-innovations-and-clinical-trial-landscape-analysis-by-delveinsight-merck-peptinov-lg-chem-akan-bioscience-biotissue-eupraxia-pharma-olipass/?source=barchart ———————————————————————————————————————————————————————————— NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board 2026-07-08 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/08/3324174/0/en/NewcelX-Appoints-World-Renowned-Diabetes-Cure-Focused-Pioneer-Dr-Camillo-Ricordi-to-Scientific-Advisory-Board.html The appointment follows New c elX's recently announced successful FDA Type B Pre-IND meeting for NCEL-101 , providing a clear regulatory pathway toward clinical trials ———————————————————————————————————————————————————————————— Medical Care Technologies Subsidiary Infinite Auctions Surges Past ... 2026-07-08 · PR-Inside · Healthcare, Gaming https://pr-inside.com/medical-care-technologies-subsidiary-infinite-auctions-surges-past-r5199016.htm (PR-inside.com) Iconic LeBron, Kobe, and Iverson Game Worn Items Headline Event Generating Non-Dilutive Capital for Operations and Technology Development MESA, AZ / ACCESS Newswire / July 8, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today highlighted powerful momentum at its wholly-owned subsidiary Infinite Auctions, where the ongoing summer memorabilia auction has already reached $158,478.02 in total value with over 82,500 views and more than two weeks remaining until the July 25 close. The auction features standout iconic items, including a LeBron James record milestone jersey with a current bid of $42,500, a pair of Kobe Bryant 2001 NBA Finals game-worn sneakers at .. ———————————————————————————————————————————————————————————— Medical Care Technologies Subsidiary Infinite Auctions Surges Past $158,000 in High-Profile Memorabilia Auction with Explosive Viewer Engagement 2026-07-08 · Newswire.com · Healthcare, Gaming https://www.newswire.com/news/medical-care-technologies-subsidiary-infinite-auctions-surges-past-158-000-in Iconic LeBron, Kobe, and Iverson Game Worn Items Headline Event Generating Non-Dilutive Capital for Operations and Technology Development ———————————————————————————————————————————————————————————— Ultragenyx Releases 2025 Impact Report Emphasizing Commitment to Rare Disease Patients, Innovation, and Global Impact 2026-07-08 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/08/3324167/20739/en/Ultragenyx-Releases-2025-Impact-Report-Emphasizing-Commitment-to-Rare-Disease-Patients-Innovation-and-Global-Impact.html NOVATO, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) released its 2025 Impact Report , detailing the company's work on behalf of patients and families living with rare and ultra-rare diseases. In 2025, Ultragenyx advanced five investigational therapies in pivotal clinical programs with the potential to reach tens of thousands of patients around the world — while continuing to build on years of work to support patients who cannot yet access approved treatments, which have now reached individuals in 50 countries. ———————————————————————————————————————————————————————————— The BioMechanics Method Names 2026 Corrective Exercise Specialist of the Year 2026-07-08 · PRWeb · Healthcare https://www.prweb.com/releases/the-biomechanics-method-names-2026-corrective-exercise-specialist-of-the-year-302820162.html Dr. Amanda Olsson, a former researcher and policy advisor to the Australian government and founder of Silverback Strength in Brisbane, Australia, wins the health and fitness industry's prestigious specialty award for her exceptional work in corrective exercise, movement health, and... ———————————————————————————————————————————————————————————— 1upHealth Announces 1up Gateway to Simplify CMS-0057-F Compliance for ... 2026-07-08 · PR-Inside · Healthcare https://pr-inside.com/uphealth-announces-1up-gateway-to-simplify-cms-0057-f-compliance-for-r5199013.htm (PR-inside.com) New model enables organizations with existing data infrastructure to better meet interoperability requirements BOSTON, MA / ACCESS Newswire / July 8, 2026 /1upHealth, a leader in health data interoperability, today announced the 1up Gateway, a new model to support compliance with the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) among health plans with existing FHIR infrastructure. With this new release, 1upHealth is ensuring the broader payer ecosystem is prepared for interoperability regulations ahead of the final January 1, 2027 deadline. As plans adapt to CMS-0057-F mandates spanning Patient Access, Provider Access, Payer-to-Payer Data Exchange, and Electronic Prior Authorization APIs, they must .. ———————————————————————————————————————————————————————————— Futbol Fans Practice More Than 800,000 CPR Training Compressions at FIFA Fan Experiences 2026-07-08 · NewMediaWire · Retail, Education, Healthcare https://www.newmediawire.com/news/futbol-fans-practice-more-than-800-000-cpr-training-compressions-at-fifa-fan-experiences-7087562 DALLAS - July 8, 2026 ( NEWMEDIAWIRE ) - At the 2026 FIFA World Cup Fan events across four U.S. host cities, the American Heart Association is bringing Hands-Only CPR training directly to fans, who have already completed more than 800,000 training chest compressions - marking one of the largest public CPR education efforts in the organization’s history. More than 350,000 cardiac arrests occur outside of hospitals in the United States each year, and while immediate CPR can double or even triple a person’s chance of survival , many bystanders still hesitate to act, often because they lack training. Across Dallas, Atlanta, Philadelphia and New York, more than 8,000 attendees have participated in hands-on training at the American Heart Association’s Mobile CPR Unit. Participants learn to recog ———————————————————————————————————————————————————————————— Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI 2026-07-08 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/quest-diagnostics-now-the-largest-clinical-reference-lab-to-extend-oncology-test-access-through-oncoemr-mpi-302819760.html American Oncology Network (AON) and other community oncology providers launching now as part of a pilot program that provides access to Haystack MRD SECAUCUS, N.J., July 8, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today... ———————————————————————————————————————————————————————————— Doceree Closes the Measurement Loop Across Every HCP Channel 2026-07-08 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/doceree-closes-the-measurement-loop-across-every-hcp-channel-302820771.html A unified Closed Loop Measurement framework now connects Investment, Reach, Performance, and Outcome across nine HCP channels: Point of Care, Programmatic, Account-Based Marketing, Copay, CTV, DOOH, Social, Email, and Text. The framework is powered by Clinical Intent Signals,... ———————————————————————————————————————————————————————————— CeraVe Champions Skin Health for All: Free Dermatologist Care for World Skin Health Day 2026 2026-07-08 · PR Newswire · Healthcare, Education https://www.prnewswire.com/news-releases/cerave-champions-skin-health-for-all-free-dermatologist-care-for-world-skin-health-day-2026-302820315.html CeraVe, an official corporate sponsor of World Skin Health Day, is partnering with volunteer dermatologists to deliver free clinical consultations and vital education to underserved communities. CeraVe is again supporting World Skin Health Day 2026 for the third consecutive year as an... ———————————————————————————————————————————————————————————— The Professionals Arrived First - Now Their Institutions are Following: ... 2026-07-08 · PR-Inside · Healthcare https://pr-inside.com/the-professionals-arrived-first-now-their-institutions-are-following-r5199002.htm (PR-inside.com) MIAMI, FL / ACCESS Newswire / July 8, 2026 /Aimwell Partners Inc. (OTCID:AIMN) - Technology adoption rarely begins with procurement. It begins with the professionals doing the work. Analysts, regulatory affairs specialists, clinical researchers, and scientific leaders discover tools that improve their decisions long before their organizations adopt them at scale. Institutions tend to follow the people they trust. Aimwell Partners Inc. (OTCID:AIMN), the parent company of AimwellBio, announced today that it is engaged in active enterprise-level discussions with multiple organizations that the company is not yet able to identify publicly. While those discussions remain confidential, the company believes the path that .. ———————————————————————————————————————————————————————————— Research Analyst Report on NanoViricides Rates Company "Outperform"; ... 2026-07-08 · PR-Inside · Finance, Healthcare https://pr-inside.com/research-analyst-report-on-nanoviricides-rates-company-outperform-r5199000.htm (PR-inside.com) SHELTON, CT / ACCESS Newswire / July 8, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, reports that a Coverage Initiating Research Report on the Company by an Independent Analyst has been published, dated as of July 6, 2026. The report rates the Company with a rating of "Outperform" and has assigned a target price of $6.00, based on the analyst's estimates. This research report provides a summary of the Company's current programs, as well as additional longer term programs. The report was written by Mr. Robert LeBoyer, Senior Vice .. ———————————————————————————————————————————————————————————— Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Potential by 2036 – DelveInsight | Teva Pharma, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharma, Reviva Pharma 2026-07-08 · GetNews · Healthcare https://www.getnews.info/story/2026/07/08/schizophrenia-market-gains-momentum-with-expanding-pipeline-and-investment-potential-by-2036-delveinsight-teva-pharma-royalty-pharma-medincell-sumitomo-pharma-otsuka-pharma-reviva-pharma/?source=barchart ———————————————————————————————————————————————————————————— Acelpa Health Expands Data Analytics Capabilities to Deliver Deeper Market Access Insights for Pharmaceutical Manufacturers 2026-07-08 · PRWeb · Healthcare https://www.prweb.com/releases/acelpa-health-expands-data-analytics-capabilities-to-deliver-deeper-market-access-insights-for-pharmaceutical-manufacturers-302820149.html New collaboration with MedEdge Solutions enhances visibility across patient access, reimbursement, adherence, and specialty pharmacy workflows WHITTIER, Calif., July 8, 2026 /PRNewswire-PRWeb/ -- Acelpa Health, a national network of specialty pharmacy and infusion services providers,... ———————————————————————————————————————————————————————————— Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer’s Association International Conference in London on July 13, 2026 2026-07-08 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/08/3324070/34858/en/Vaccinex-to-Report-New-Biomarker-Data-and-Plans-for-Phase-2B-Clinical-Trial-of-Pepinemab-in-AD-at-the-Alzheimer-s-Association-International-Conference-in-London-on-July-13-2026.html Vaccinex reports new biomarker research and plans for Phase 2 randomized clinical trial of pepinemab in Alzheimer's Disease at the AAIC in July ———————————————————————————————————————————————————————————— Planet DDS and Truro Bring Predictive Intelligence to the Denticon Ecosystem: Transforming Patient-Facing Dental Operations for Capacity and Revenue Optimization 2026-07-08 · PRWeb · Finance, AI, SaaS, Healthcare, Education https://www.prweb.com/releases/planet-dds-and-truro-bring-predictive-intelligence-to-the-denticon-ecosystem-transforming-patient-facing-dental-operations-for-capacity-and-revenue-optimization-302820294.html This new native integration leverages advanced machine learning to optimize schedule management, strengthen patient relationships, reduce staff overload, and maximize practice productivity, for single location practices and multi-location networks. PLYMOUTH, Minn., July 8, 2026... ———————————————————————————————————————————————————————————— Conavi Medical Announces JSCAI Publication Demonstrating the Clinical Utility of Hybrid IVUS OCT Imaging 2026-07-08 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/08/3323985/0/en/Conavi-Medical-Announces-JSCAI-Publication-Demonstrating-the-Clinical-Utility-of-Hybrid-IVUS-OCT-Imaging.html Publication demonstrates how complementary IVUS and OCT information supports lesion assessment, treatment planning, and stent optimization while helping manage contrast use Publication demonstrates how complementary IVUS and OCT information supports lesion assessment, treatment planning, and stent optimization while helping manage contrast use ———————————————————————————————————————————————————————————— Odysight.ai Receives Purchase Order from Elbit Systems on Behalf of the Israeli Ministry of Defense for Deployment of Its Vision-Based Prognostics and Health Management System 2026-07-08 · GlobeNewswire · Finance, AI, Healthcare https://www.globenewswire.com/news-release/2026/07/08/3323972/0/en/Odysight-ai-Receives-Purchase-Order-from-Elbit-Systems-on-Behalf-of-the-Israeli-Ministry-of-Defense-for-Deployment-of-Its-Vision-Based-Prognostics-and-Health-Management-System.html The purchase order, valued at approximately $0.3 million (NIS 1.0 million), expands Odysight.ai’s operational portfolio and may lead to wide deployment across the Israeli Defense Forces upon successful completion ———————————————————————————————————————————————————————————— LataMed AI Provides Shareholder Update Regarding Upcoming 5-for-1 Forward Stock Split and Mandatory Share Exchange Process 2026-07-08 · NewMediaWire · Finance, AI, Retail, Healthcare https://www.newmediawire.com/news/latamed-ai-provides-shareholder-update-regarding-upcoming-5-for-1-forward-stock-split-and-mandatory-share-exchange-process-7087556 CARACAS, VENEZUELA - July 8, 2026 ( NEWMEDIAWIRE ) - LataMed AI Corp. (OTC: LMED) (the “Company”) today provided shareholders with an update regarding the implementation of its previously announced 5-for-1 forward stock split and the related mandatory share exchange process. As of July 7, 2026, the Company has provided FINRA with all requested information and documentation relating to the forward stock split and mandatory share exchange process. Based on the current status of the filing, management presently anticipates that the corporate action may become effective within approximately the next week, subject to FINRA's review and final processing. The Company will provide shareholders with a further update as soon as FINRA establishes the official effective date. The forward stock split w ———————————————————————————————————————————————————————————— Satellos Reports Six-Month Interim TRAILHEAD Data Showing Reduced Muscle Fat Fraction, Increased Effort, Stable Strength, Lower CK and Favorable Safety Profile in DMD Adults Treated with SAT-3247 2026-07-08 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/08/3323924/0/en/Satellos-Reports-Six-Month-Interim-TRAILHEAD-Data-Showing-Reduced-Muscle-Fat-Fraction-Increased-Effort-Stable-Strength-Lower-CK-and-Favorable-Safety-Profile-in-DMD-Adults-Treated-w.html TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat degenerative muscle diseases, today announced six-month interim data from TRAILHEAD evaluating its investigational drug candidate SAT-3247 in adults living with Duchenne muscular dystrophy ("Duchenne" or "DMD"). ———————————————————————————————————————————————————————————— SPAR Austria's Biodiversity Summit highlights the importance of crop diversity 2026-07-08 · WebWire · Healthcare, Education https://www.webwire.com/ViewPressRel.asp?aId=357324 The Biodiversity Summit, organised by SPAR Austria in cooperation with ARCHE NOAH, an Austrian association dedicated to preserving crop diversity, brought together Markus Kaser, Deputy Chairman of the Board of SPAR Austria; Volker Plass, Managing Director of ARCHE NOAH; Michelin-starred chef Paul Ivić; and environmental physician Prof. Dr Daniela Haluza from the Medical University of Vienna in Schiltern, Lower Austria, to discuss how crop diversity can be preserved. Climate change, g... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357324 ———————————————————————————————————————————————————————————— Pacific Mind Health Releases Free Guide to Help People Overcome Self-Consciousness in Everyday Moments 2026-07-08 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/pacific-mind-health-releases-free-guide-to-help-people-overcome-self-consciousness-in-everyday-moments-302820033.html LOS ANGELES, July 8, 2026 /PRNewswire/ -- Pacific Mind Health has released a FREE downloadable guide, How to Get Out of Your Own Spotlight. It's designed to help people recognize and interrupt the spotlight effect, the tendency to overestimate how much others notice, remember, and judge... ———————————————————————————————————————————————————————————— Seattle's Best Plastic Surgeon Featured in Seattle Magazine and Seattle ... 2026-07-08 · PR-Inside · Healthcare https://pr-inside.com/seattle-s-best-plastic-surgeon-featured-in-seattle-magazine-and-seattle-r5198869.htm (PR-inside.com) Dr. Javad Sajan Featured in Seattle Magazine and Seattle Met SEATTLE, WA / ACCESS Newswire / July 8, 2026 / As patients increasingly rely on independent media, physician credentials, and published expertise when researching plastic surgery, regional publications are playing a larger role in highlighting surgeons whose work extends beyond the operating room. Recent articles published bySeattle MagazineandSeattle Metfeature Dr. Javad Sajan, emphasizing not only his surgical experience but also his innovative techniques and patient-first philosophy. It is these factors that led both publications to recognize him as one of Seattle's best plastic surgeons, based on his combination of clinical expertise, advanced .. ———————————————————————————————————————————————————————————— “The Art of Undieting” by Monica Woolridge — Amazon's Best-Selling Book Available for Free Download – Ending Soon (07/10/2026) 2026-07-08 · WebWire · Healthcare, Retail https://www.webwire.com/ViewPressRel.asp?aId=357039 Best Seller Publishing is proud to announce the release of “The Art of Undieting: A Soul-led, Science-Backed Guide to Redefining Health on Your Body's Terms” by wellness advocate and transformational health coach Monica Woolridge—available for free download on Amazon for two more days—now through July 10, 2026. - - For decades, millions have been trapped in exhausting cycles of dieting, calorie counting, restriction, and frustration, chasing weight loss while feeling increasingly discon... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357039 ———————————————————————————————————————————————————————————— Advanced Acupuncture Brings Personalized Acupuncture Care to Hallandale Beach FL 2026-07-08 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/08/1762021 Hallandale Beach, USA, 2026-07-08 — /EPR Network/ — Advanced Acupuncture is proud to provide personalized acupuncture in Hallandale Beach FL, helping individuals achieve better health [read full press release...] ———————————————————————————————————————————————————————————— Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy 2026-07-08 · Pressat · Healthcare https://pressat.co.uk/releases/grnenthal-receives-fda-orphan-drug-and-rare-pediatric-disease-designations-for-tegacorat-for-the-treatment-of-duchenne-muscular-dystrophy-4caf76f5ba7381565e5c56a515645618/ Wednesday 8 July, 2026 Aachen, 08 July 2026 – Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD). Tegacorat, a non-steroidal Selective Glucocorticoid Receptor Agonist and Modulator (SEGRAM), is an orally available investigational compound being developed to provide an alternative to glucocorticoid-based treatments such as prednisone, the current standard of care in DMD. Conventional glucocorticoids bind to the glucocorticoid receptor and influence gene expression. Among other mechanisms, this triggers two patterns of activity: transrepression, mainly linked to anti-inflammatory effects, and transactiv ———————————————————————————————————————————————————————————— July 8 Strike of 4,500 MNA Nurses & Clinicians Begins Wednesday Morning After MGB Billionaires Refuse to Negotiate Fair Contracts for Safe Patient Care 2026-07-08 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/july-8-strike-of-4-500-mna-nurses--clinicians-begins-wednesday-morning-after-mgb-billionaires-refuse-to-negotiate-fair-contracts-for-safe-patient-care-302820584.html Brigham nurses and MGB Home Care clinicians begin one-day, and seven-day strikes after MGB refused to negotiate to avert the strikes BOSTON, July 8, 2026 The largest strike of nurses and healthcare professionals in state history begins Wednesday, July 8 after the billionaires and... ———————————————————————————————————————————————————————————— Sectra publishes Annual Report and Sustainability Report for 2025/2026 2026-07-08 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/sectra-publishes-annual-report-and-sustainability-report-for-20252026-302820567.html LINKÖPING, Sweden, July 8, 2026 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT-B) is publishing its Annual Report and Sustainability Report for the 2025/2026 fiscal year today. This report also includes the Corporate Governance Report for the... ———————————————————————————————————————————————————————————— Do Breast Cancer and Irregular Heartbeat Have Common Risk Factors and Rates? 2026-07-08 · NewMediaWire · Retail, Healthcare https://www.newmediawire.com/news/do-breast-cancer-and-irregular-heartbeat-have-common-risk-factors-and-rates-7087554 Research Highlights: A new, global analysis finds atrial fibrillation/flutter and breast cancer rates may follow similar risk factors and patterns across regions, particularly among women ages 55 and older. In about 40% of the 204 countries and regions evaluated, the rates of both breast cancer and atrial fibrillation/flutter were similar in older women, with the highest-risk zones in Western nations. Researchers identified modifiable risk factors, particularly alcohol use and smoking, which could substantially reduce the impact of both conditions. DALLAS - July 8, 2026 ( NEWMEDIAWIRE ) - Alcohol use and smoking were linked to breast cancer and atrial fibrillation/flutter in women ages 55 years and older in multiple regions of the world, according to new, independent research published tod ———————————————————————————————————————————————————————————— Der Geschäftsbericht von Piramal Pharma für das Geschäftsjahr 2026 unterstreicht die globale Reichweite, das innovationsgetriebene Wachstum und die Meilensteine im Bereich Nachhaltigkeit 2026-07-08 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/der-geschaftsbericht-von-piramal-pharma-fur-das-geschaftsjahr-2026-unterstreicht-die-globale-reichweite-das-innovationsgetriebene-wachstum-und-die-meilensteine-im-bereich-nachhaltigkeit-302820470.html MUMBAI, Indien, 8. Juli 2026 /PRNewswire/ -- Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), ein weltweit führendes Pharma-, Gesundheits- und Wellnessunternehmen, hat seinen Geschäftsbericht für das Geschäftsjahr 2026 veröffentlicht. Dieser hebt ein Jahr hervor, das durch die... ———————————————————————————————————————————————————————————— Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors 2026-07-08 · GlobeNewswire · SaaS, Healthcare https://www.globenewswire.com/news-release/2026/07/08/3323819/0/en/Avacta-Appoints-Healthcare-Executive-Patrick-Vink-as-Deputy-Chairman-of-the-Board-of-Directors.html LONDON and PHILADELPHIA, July 08, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION ® , a tumor-activated oncology delivery platform, is pleased to announce the appointment of Dr. Patrick Vink, a seasoned healthcare executive, to its Board of Directors as Non-Executive Deputy Chairman and Senior Independent Director. ———————————————————————————————————————————————————————————— Le rapport annuel de Piramal Pharma pour l'exercice 2026 souligne l'envergure mondiale de la société, sa croissance axée sur l'innovation et ses avancées majeures en matière de développement durable 2026-07-08 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/le-rapport-annuel-de-piramal-pharma-pour-lexercice-2026-souligne-lenvergure-mondiale-de-la-societe-sa-croissance-axee-sur-linnovation-et-ses-avancees-majeures-en-matiere-de-developpement-durable-302820309.html MUMBAI, Inde, 8 juillet 2026 /PRNewswire/ -- Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), l'un des leaders mondiaux du secteur pharmaceutique, de la santé et du bien-être, a publié son rapport annuel pour l'exercice 2026, qui met en lumière une année marquée par le... ———————————————————————————————————————————————————————————— /C O R R E C T I O N -- Oak Essentials/ 2026-07-08 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/oak-essentials-launches-the-oak-advisory-council-in-honor-of-womens-health-month-302819908.html In the news release, Oak Essentials Launches the Oak Advisory Council in Honor of Women's Health Month, issued 07-Jul-2026 by Oak Essentials over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows: OAK ESSENTIALS LAUNCHES THE... ———————————————————————————————————————————————————————————— Movemedical Launches Ask Move AI, the First AI Assistant Purpose-Built for Med Device Field Operations 2026-07-08 · PR Newswire · AI, SaaS, Healthcare https://www.prnewswire.com/news-releases/movemedical-launches-ask-move-ai-the-first-ai-assistant-purpose-built-for-med-device-field-operations-302817222.html Mobile-first AI assistant built on 15+ years of surgical case data gives field reps a conversational interface for every step of their case workflow. SAN DIEGO, July 7, 2026 /PRNewswire/ -- Movemedical, the leading field inventory management platform for the medical device industry, today... ———————————————————————————————————————————————————————————— OTR Therapeutics Enters Strategic Collaboration with LG Chem to Accelerate Development of Novel Oncology Therapies 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/otr-therapeutics-enters-strategic-collaboration-with-lg-chem-to-accelerate-development-of-novel-oncology-therapies-302820060.html SHANGHAI, July 7, 2026 /PRNewswire/ -- OTR Therapeutics, a clinical-stage biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies, today announced that it has entered into a strategic collaboration agreement with LG Chem, a leading global... ———————————————————————————————————————————————————————————— SAC Health Acquires Former Rite-Aid Building to Expand Care to the High Desert 2026-07-07 · PRWeb · Healthcare https://www.prweb.com/releases/sac-health-acquires-former-rite-aid-building-to-expand-care-to-the-high-desert-302819264.html SAC Health finalized the purchase of former Rite Aid building in Victorville, California, for a future medical clinic location. SAN BERNARDINO, Calif., July 7, 2026 /PRNewswire-PRWeb/ -- Moving forward with its mission to provide accessible, high-quality healthcare to underserved... ———————————————————————————————————————————————————————————— Epidermolysis Bullosa Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | RegeneRx Biopharma, BridgeBio Pharma, Berg Pharma, Holostem Terapie 2026-07-07 · GetNews · Healthcare https://www.getnews.info/story/2026/07/07/epidermolysis-bullosa-pipeline-2026-moa-and-roa-insights-clinical-trials-status-and-key-companies-involved-by-delveinsight-regenerx-biopharma-bridgebio-pharma-berg-pharma-holostem-terapie/?source=barchart ———————————————————————————————————————————————————————————— Migraine Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | GlaxoSmithKline, Merck, Pfizer, Bausch Health, Amgen, Abbvie, AstraZeneca, Eli Lilly 2026-07-07 · GetNews · Healthcare https://www.getnews.info/story/2026/07/07/migraine-pipeline-2026-fda-updates-therapy-innovations-and-clinical-trial-landscape-analysis-by-delveinsight-glaxosmithkline-merck-pfizer-bausch-health-amgen-abbvie-astrazeneca-eli-lilly/?source=barchart ———————————————————————————————————————————————————————————— Multiple Myeloma Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Bluebird bio, Cellectis SA, Caribou Biosciences, Luminary Therapeutics, Poseida Therapeutics 2026-07-07 · GetNews · Healthcare https://www.getnews.info/story/2026/07/07/multiple-myeloma-pipeline-2026-therapies-moa-insights-and-key-clinical-trial-updates-by-delveinsight-bluebird-bio-cellectis-sa-caribou-biosciences-luminary-therapeutics-poseida-therapeutics/?source=barchart ———————————————————————————————————————————————————————————— Graft vs Host Disease Pipeline 2026: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight | Cellestia Biotech, Pfizer, Chia Tai Tianqing Pharma, Regimmune Corp 2026-07-07 · GetNews · Healthcare https://www.getnews.info/story/2026/07/07/graft-vs-host-disease-pipeline-2026-indepth-clinical-trials-analysis-and-emerging-therapies-report-by-delveinsight-cellestia-biotech-pfizer-chia-tai-tianqing-pharma-regimmune-corp/?source=barchart ———————————————————————————————————————————————————————————— Vitiligo Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Dermira, Amgen, Pfizer, Dermavant Sciences, Incyte, TWi Biotechnology, Aclaris 2026-07-07 · GetNews · Healthcare https://www.getnews.info/story/2026/07/07/vitiligo-pipeline-2026-therapies-under-investigation-clinical-trials-milestones-and-fda-approvals-by-delveinsight-dermira-amgen-pfizer-dermavant-sciences-incyte-twi-biotechnology-aclaris/?source=barchart ———————————————————————————————————————————————————————————— New Data From AI Ebook Generator Automateed: 77,000+ Books Created Across 216 Countries 2026-07-07 · PRWeb · AI, SaaS, Healthcare https://www.prweb.com/releases/new-data-from-ai-ebook-generator-automateed-77-000-books-created-across-216-countries-302818065.html Automateed, an AI ebook generator, analyzed more than 77,000 books created on its platform. Self-help, health, and business titles dominate, with the US, India, and Brazil leading — and emerging markets close behind. LEWES, Del., July 7, 2026 /PRNewswire-PRWeb/ -- Automateed, an AI ebook... ———————————————————————————————————————————————————————————— Black Book Poll Finds AI Has Entered the EHR, but Governed Scale Remains ... 2026-07-07 · PR-Inside · AI, Healthcare https://pr-inside.com/black-book-poll-finds-ai-has-entered-the-ehr-but-governed-scale-remains-r5198758.htm (PR-inside.com) Q2-Q3 2026 poll of 507 healthcare leaders shows ambient AI is advancing fastest, while governance, clinician trust, workforce readiness and post-go-live monitoring remain barriers to enterprise-scale adoption. CHICAGO, IL / ACCESS Newswire / July 7, 2026 / Black Book Research today released findings from its AI in the EHR Adoption Readiness Poll, a 507-respondent assessment of healthcare executives, informatics leaders and clinical operations respondents fielded in Q2-Q3 2026. The poll finds that AI has moved from strategic conversation into active EHR workflows, but most healthcare organizations have not yet built the operating model required to scale it safely, consistently and measurably. The .. ———————————————————————————————————————————————————————————— Lifshitz Law PLLC Announces Investigations of Corcept Therapeutics, ... 2026-07-07 · PR-Inside · Finance, Healthcare https://pr-inside.com/lifshitz-law-pllc-announces-investigations-of-corcept-therapeutics-r5198756.htm (PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 7, 2026 / Lifshitz Law Firm Corcept Therapeutics, Inc. (NASDAQ:CORT) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the Company overstated the strength of the clinical trials supporting relacorilant by representing them as "powerful support" for Corcept's New Drug Application ("NDA") to the U.S. Food and Drug Administration ("FDA"); (ii) the Company falsely conveyed confidence in relacorilant's regulatory prospects by claiming they had communicated with the FDA, .. ———————————————————————————————————————————————————————————— New Clinic for Young Children with Autism Opening its Doors in Lake Zurich 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/new-clinic-for-young-children-with-autism-opening-its-doors-in-lake-zurich-302819964.html LAKE ZURICH, Ill., July 7, 2026 /PRNewswire/ -- Caravel Autism Health, a leader in the diagnosis and treatment of young children on the autism spectrum, is hosting a ribbon-cutting on Wednesday, July 8 to celebrate the grand opening of a new, state-of-the-art autism therapy clinic. The... ———————————————————————————————————————————————————————————— Vanda Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Investigational Therapy for Charcot-Marie-Tooth Disease Type 2S 2026-07-07 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-fda-rare-pediatric-disease-designation-for-investigational-therapy-for-charcot-marie-tooth-disease-type-2s-302819555.html WASHINGTON, July 7, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation to VCA-894A, Vanda's investigational antisense oligonucleotide therapy for the... ———————————————————————————————————————————————————————————— LM PAY S.A. Reports Solid FY 2025 Performance and Positive Q1 2026 Business Momentum - Preliminary Results 2026-07-07 · NewMediaWire · Healthcare, Retail https://www.newmediawire.com/news/lm-pay-s-a-reports-solid-fy-2025-performance-and-positive-q1-2026-business-momentum-preliminary-results-7087551 WARSAW, POLAND - July 7, 2026 ( NEWMEDIAWIRE ) - LM PAY is a fast-growing fintech provider of embedded finance solutions specifically designed for the healthcare and insurance sectors. With 15 years of operating experience in Poland, the Company has established a trusted network of over 13,000 medical clinics and service providers , as well as insurance brokers, offering instant point-of-sale consumer financing for medical, dental, aesthetic, and insurance services. Sitting at the intersection of service access and financial inclusion, LM PAY is on a mission to make essential treatments more affordable through responsible, transparent, and sustainable financing. 2025 FY Operational Highlights (preliminary results): Outperforming Market Expectations LM PAY’s commercial success was driven by ———————————————————————————————————————————————————————————— Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation 2026-07-07 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/07/3323631/0/en/Wave-Life-Sciences-Announces-Singapore-Court-Hearing-to-be-held-on-July-14-2026-to-Approve-Scheme-of-Arrangement-for-Redomiciliation.html CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- As previously announced, Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“ Wave ” or “ Wave Life Sciences ”), has obtained the requisite shareholder approval required in connection with its proposed redomiciliation (“ Redomiciliation ”) to the United States by way of the implementation of a statutory procedure known as a scheme of arrangement under Section 210 of the Companies Act 1967 of Singapore (the “ Scheme of Arrangement ”). The Scheme of Arrangement remains subject to approval by the High Court of the Republic of Singapore (the “ Singapore Court ”). ———————————————————————————————————————————————————————————— Oak Essentials Launches the Oak Advisory Council in Honor of Women's Health Month 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/oak-essentials-launches-the-oak-advisory-council-in-honor-of-womens-health-month-302819908.html Six leading experts in dermatology, women's health, esthetics, pelvic health, mental health, and nutrition join the brand to advance its commitment to aging beautifully. LOS ANGELES, July 7, 2026 /PRNewswire/ -- Oak Essentials, the clean skincare brand founded by Jenni Kayne, is... ———————————————————————————————————————————————————————————— VERAXA Biotech (VRXA) Shareholders Should Watch Novartis Latest $1.5B ADC Acquisition 2026-07-07 · NewMediaWire · Finance, SaaS, Healthcare, Retail https://www.newmediawire.com/news/veraxa-biotech-vrxa-shareholders-should-watch-novartis-latest-1-5b-adc-acquisition-7087549 LOS ANGELES, CA - July 7, 2026 ( NEWMEDIAWIRE ) - VERAXA Biotech (NASDAQ: VRXA) operates in one of biotechnology’s most active partnering environments , with pharmaceutical companies continuing to commit billions of dollars to differentiated antibody therapeutics. The latest example came this week as Novartis agreed to acquire Myricx Bio for $1.1 billion upfront, plus up to $400 million in milestone payments, to gain access to the company’s novel N-myristoyltransferase inhibitor (“NMTi”) payload platform and two lead ADC programs. The acquisition reflects continued industry demand for innovative antibody technologies capable of addressing limitations of existing cancer therapies. Novartis has agreed to acquire Myricx Bio for $1.1 billion upfront, with up to $400 million in milestone paymen ———————————————————————————————————————————————————————————— Project Biohacking Launches Free Peptide Dosage Calculator for Dogs and Cats Supporting BPC-157, TB-500 and GHK-Cu 2026-07-07 · PRUnderground · Healthcare, Education https://www.prunderground.com/project-biohacking-launches-free-peptide-dosage-calculator-for-dogs-and-cats-supporting-bpc-157-tb-500-and-ghk-cu/00388076/ The free, browser-based Peptide Calculator for Pets converts a vet-provided dose into an exact syringe draw for dogs and cats, with supply tracking and dosing schedules The post Project Biohacking Launches Free Peptide Dosage Calculator for Dogs and Cats Supporting BPC-157, TB-500 and GHK-Cu first appeared on ———————————————————————————————————————————————————————————— Vadzo Imaging Launches Falcon-544CRS: 5MP Onsemi AR0544 HyperLux LP Wearable Medical Camera Engineered for Body-Worn Imaging 2026-07-07 · Newswire.com · SaaS, Healthcare https://www.newswire.com/news/vadzo-imaging-launches-falcon-544crs-5mp-onsemi-ar0544-hyperlux-lp-22804077 Vadzo Imaging's Falcon-544CRS is a 5MP wearable medical camera built on the Onsemi AR0544 HyperLux LP sensor delivering USB 3.2 connectivity, a 1/4.2-inch BSI architecture with 1.4 µm pixel pitch, rolling shutter imaging and embedded HDR in a compact form factor for body-worn clinical systems. As an AR0544 low power USB camera in Vadzo's Falcon USB camera series the Falcon-544CRS brings 2592×1944 resolution and UVC plug-and-play integration to body worn camera module designs for ambulatory monitoring, wound care documentation, telemedicine endpoints and surgical vision platforms where conventional USB camera products are too heavy or too power-hungry for patient-worn deployment. ———————————————————————————————————————————————————————————— The Inner Circle acknowledges Nicole L. Dyer MD honored as a Pinnacle Lifetime Member 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/the-inner-circle-acknowledges-nicole-l-dyer-md-honored-as-a-pinnacle-lifetime-member-302819717.html EVANSTON, Wyo., July 7, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Nicole L. Dyer MD is honored as a Pinnacle Lifetime Member for her contributions to Innovation and Compassion in Health Care. Dr. Nicole L. Dyer is a respected internist whose career is defined by... ———————————————————————————————————————————————————————————— Wearable Medical Devices Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight 2026-07-07 · GetNews · Healthcare https://www.getnews.info/story/2026/07/07/wearable-medical-devices-market-statistics-expected-to-experience-major-growth-by-2032-according-to-delveinsight/?source=barchart ———————————————————————————————————————————————————————————— Smart Medical Devices Market to Reach USD 131.33 Billion by 2032 at 12.20% CAGR 2026-07-07 · GetNews · Healthcare https://www.getnews.info/story/2026/07/07/smart-medical-devices-market-to-reach-usd-13133-billion-by-2032-at-1220-cagr/?source=barchart ———————————————————————————————————————————————————————————— Can $2,500 and a Smartphone App Double the Success of Sight-Restoring Surgery? New Orbis International Study Says Yes 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/can-2-500-and-a-smartphone-app-double-the-success-of-sight-restoring-surgery-new-orbis-international-study-says-yes-838579145.html NEW YORK, July 7, 2026 /PRNewswire/ -- A new study from global eye care nonprofit Orbis International, published today in the Bulletin of the World Health Organization, reveals a surprisingly simple solution to a major global health challenge. By combining a free smartphone app, focused... ———————————————————————————————————————————————————————————— Cosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market Repurchases 2026-07-07 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/07/3323580/0/en/Cosmos-Health-Share-Buyback-Expands-to-3-87-Million-Shares-Continues-Open-Market-Repurchases.html Cosmos Health has now repurchased a total of 3,870,000 shares for approximately $758,000. ———————————————————————————————————————————————————————————— NASA’s New Horizons Spacecraft Wakes from Hibernation in Good Health 2026-07-07 · NASA · Healthcare https://science.nasa.gov/missions/new-horizons/nasas-new-horizons-spacecraft-wakes-from-hibernation-in-good-health/ Following its longest hibernation period ever of nearly a year, NASA’s New Horizons spacecraft has emerged in good health and is ready to begin transmitting science data gathered in the distant Kuiper Belt far beyond Pluto. On June 23, flight controllers at the Johns Hopkins Applied Physics Laboratory (APL) in Laurel, Maryland, confirmed New Horizons, […] ———————————————————————————————————————————————————————————— Purpose Healing Center Announces Grand Opening of New Tucson Rehab Facility Accepting AHCCCS 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/purpose-healing-center-announces-grand-opening-of-new-tucson-rehab-facility-accepting-ahcccs-302819480.html New Silverbell Road treatment center expands access to accredited inpatient and outpatient addiction and mental health programs for Tucson residents covered by AHCCCS and many other insurance plans. TUCSON, Ariz., July 7, 2026 /PRNewswire/ -- Amid a rising addiction and mental health... ———————————————————————————————————————————————————————————— Mantra Health Expands Policy Efforts with Newly Appointed Head of Government Relationships Maria Jose (MJ) Norero 2026-07-07 · PR Newswire · Healthcare, Education https://www.prnewswire.com/news-releases/mantra-health-expands-policy-efforts-with-newly-appointed-head-of-government-relationships-maria-jose-mj-norero-302819794.html NEW YORK, July 7, 2026 /PRNewswire/ -- Mantra Health, the digital mental health provider built exclusively to support student well-being and success across higher education, today announced the appointment of Maria Jose (MJ) Norero as Head of Government Relations. This newly developed... ———————————————————————————————————————————————————————————— SS Innovations International (SSII) Wins Outstanding Company at 2026 Surgical Robotics Industry Awards 2026-07-07 · NewMediaWire · Finance, Healthcare, Retail https://www.newmediawire.com/news/ss-innovations-international-ssii-wins-outstanding-company-at-2026-surgical-robotics-industry-awards-7087545 LOS ANGELES, CA - July 7, 2026 ( NEWMEDIAWIRE ) - SS Innovations International Inc. (NASDAQ: SSII) , a developer of innovative surgical robotic technologies, has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards (“SRIA”), receiving recognition from the industry organization for its work in developing and commercializing robotic surgery technology ( https://ibn.fm/lDfv9 ). The company was selected over nine other finalists, including several established medical technology companies active in robotic surgery. The award comes as adoption of the SSi Mantra surgical robotic system continues to expand, with more than 11,700 procedures completed globally. SSi Mantra has received regulatory approvals in 14 countries, supporting the company’s in ———————————————————————————————————————————————————————————— WAVES Opens in East Bay, Restoring Emergency and Specialty Veterinary Care Following Closure of Longstanding BAVS Hospital 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/waves-opens-in-east-bay-restoring-emergency-and-specialty-veterinary-care-following-closure-of-longstanding-bavs-hospital-302819783.html SAN LEANDRO, Calif., July 7, 2026 /PRNewswire/ -- Washington Avenue Veterinary Emergency & Specialty Hospital (WAVES) is a new, locally owned, veterinarian-led emergency and specialty hospital serving the San Francisco East Bay area. Located at the former Bay Area Veterinary Specialists... ———————————————————————————————————————————————————————————— Pegasus One Health's SONG Framework Helps Healthcare Organizations Predict Whether Their AI Agents Will Scale or Stall 2026-07-07 · PRWeb · AI, Healthcare https://www.prweb.com/releases/pegasus-one-healths-song-framework-helps-healthcare-organizations-predict-whether-their-ai-agents-will-scale-or-stall-302817193.html Healthcare AI pilots die in the gap between a working model and a production-ready environment, with an estimated 80% never making it to production. Pegasus One's SONG framework gives healthcare leaders a diagnostic to predict, before they invest, whether an AI agent will scale or quietly... ———————————————————————————————————————————————————————————— High Rise Financial LLC Expands Into Nevada, Bringing Pre-Settlement ... 2026-07-07 · PR-Inside · Finance, Healthcare https://pr-inside.com/high-rise-financial-llc-expands-into-nevada-bringing-pre-settlement-r5198703.htm (PR-inside.com) National lawsuit funding company expands services to help Nevada plaintiffs access financial support while awaiting settlements LAS VEGAS, NV / ACCESS Newswire / July 7, 2026 / High Rise Financial LLC, a premier provider of pre-settlement funding solutions, is proud to announce the expansion of its services into Nevada. The move enables plaintiffs throughout the state to access financial assistance while pursuingpersonal injury ,wrongful death ,medical malpractice , and other civil litigation claims. The expansion reflects High Rise Financial LLC's continued commitment to helping individuals navigate the financial challenges that often accompany lengthy legal proceedings. Plaintiffs frequently face mounting medical expenses, lost .. ———————————————————————————————————————————————————————————— DIAGNOS to Extend the Exercise Period of Stock Warrants 2026-07-07 · GlobeNewswire · Finance, AI, Healthcare https://www.globenewswire.com/news-release/2026/07/07/3323533/0/en/DIAGNOS-to-Extend-the-Exercise-Period-of-Stock-Warrants.html BROSSARD, Quebec, July 07, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical health issues using advanced Artificial Intelligence ( AI ) techniques, announces that it intends to amend the expiry date of 6,715,369 stock warrants (each a “Warrant”) from August 5, 2026 to June 5, 2027 (the “Amendment”). The Warrants were issued as part of a non-brokered private placement of units initially announced on February 5, 2025 and on February 14, 2025. ———————————————————————————————————————————————————————————— Mölnlycke Health Care accelerates U.S. growth journey with three wound care product launches 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/molnlycke-health-care-accelerates-us-growth-journey-with-three-wound-care-product-launches-302819750.html PEACHTREE CORNERS, Ga., July 7, 2026 /PRNewswire/ -- Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, has launched three product innovations in the U.S. since the start of 2026. Designed to expand access to advanced wound care solutions and strengthen the company's U.S.... ———————————————————————————————————————————————————————————— Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy 2026-07-07 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/07/3323532/0/en/Vera-Therapeutics-Receives-FDA-Accelerated-Approval-for-TRUTAKNA-for-Adult-Patients-with-Primary-IgA-Nephropathy.html Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy ———————————————————————————————————————————————————————————— EDETEK to Support the FDA's Real-Time Clinical Trials Initiative with Its R&D Cloud and Sponsor Partnership Program 2026-07-07 · PR Newswire · AI, SaaS, Healthcare https://www.prnewswire.com/news-releases/edetek-to-support-the-fdas-real-time-clinical-trials-initiative-with-its-rd-cloud-and-sponsor-partnership-program-302819697.html Offering a Near-Real-Time, AI-Enabled R&D Cloud and End-to-End Sponsor Partnerships to Help Advance Continuous, Data-Driven Regulatory Oversight in Early-Phase Clinical Development PRINCETON, N.J., July 7, 2026 /PRNewswire/ -- EDETEK today announced the launch of a sponsor partnership... ———————————————————————————————————————————————————————————— Seven-In-10 Voters Say Banning or Heavily Restricting Youth Access to Technology Could Have Unintended Consequences 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/seven-in-10-voters-say-banning-or-heavily-restricting-youth-access-to-technology-could-have-unintended-consequences-302818705.html New Survey and Focus Groups Find Broad Support for Comprehensive Youth Mental Health Solutions and Digital Literacy Initiatives WASHINGTON, July 7, 2026 /PRNewswire/ -- The Coalition to Empower our Future today released new research finding that voters and parents across the country... ———————————————————————————————————————————————————————————— Alfie Hammersham Launches Data-Driven 'One Year Fast' Protocol 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/alfie-hammersham-launches-data-driven-one-year-fast-protocol-302819705.html VENICE, Fla., July 7, 2026 /PRNewswire/ -- Alfie Hammersham has initiated the "One Year Fast," an ambitious, highly structured 52-week health project and digital documentary. The launch marks the beginning of a year-long cycle dedicated to discipline, metabolic reset, and holistic health... ———————————————————————————————————————————————————————————— Eagle Telemedicine Expands Executive Leadership, Names Madeline Wills Executive Vice President and General Counsel 2026-07-07 · PRWeb · Healthcare https://www.prweb.com/releases/eagle-telemedicine-expands-executive-leadership-names-madeline-wills-executive-vice-president-and-general-counsel-302818839.html Healthcare legal executive to lead legal strategy, governance, and risk as Eagle scales its national specialty care network ATLANTA, July 7, 2026 /PRNewswire-PRWeb/ -- Eagle Telemedicine, the leading specialty virtual care partner for hospitals and health systems navigating workforce... ———————————————————————————————————————————————————————————— United Health Products Establishes Collaboration to Conduct Clinical Study 2026-07-07 · NewMediaWire · Healthcare https://www.newmediawire.com/news/united-health-products-establishes-collaboration-to-conduct-clinical-study-7087542 DARIEN, CT - July 7, 2026 ( NEWMEDIAWIRE ) - United Health Products, Inc. (OTCQB: UEEC) today announced an agreement with NAMSA, a global leader in MedTech contract research, whereby NAMSA will serve as Sponsor of a new clinical study of UHP’s CelluSTAT Hemostatic Gauze. Consistent with the company’s recent proposal to the FDA to have a non-affiliated party oversee a new clinical study, which the FDA approved in March of this year, NAMSA will initially seek an Investigational Device Exemption (IDE) to organize and conduct a study of UHP’s neutralized cellulose hemostat technology. Upon completion of the study, UHP will hold an exclusive right of reference to all data from the study to use in a revised Premarket Approval (PMA) application. This plan will allow a study to proceed (subject to ———————————————————————————————————————————————————————————— Vadzo Imaging Validates Bolt-2020MRS 20MP Monochrome MIPI Camera Across Single, Dual, and Quad Camera Configurations on NVIDIA Jetson Orin NX 2026-07-07 · Newswire.com · Healthcare, Automotive https://www.newswire.com/news/vadzo-imaging-validates-bolt-2020mrs-20mp-monochrome-mipi-camera-across-single Vadzo Imaging confirms validated NVIDIA Jetson Orin NX support for the Bolt-2020MRS, a 20MP Onsemi AR2020 Monochrome MIPI Camera, across single camera, dual camera, and quad camera MIPI CSI-2 configurations, with module-level V4L2 Camera Driver support and confirmed ISP pipeline compatibility for fleet management, drone/UAV, medical device, and AGV/AMR deployments requiring high-resolution monochrome imaging at the edge. ———————————————————————————————————————————————————————————— America's #1 Health Talk Radio Show Rebrands as Health Talk America (HTA) 2026-07-07 · NewMediaWire · Healthcare, Retail, Media, Education https://www.newmediawire.com/news/america-s-1-health-talk-radio-show-rebrands-as-health-talk-america-hta-7087538 The Dr. Bob Martin Show Enters a New Era While Honoring a 30-Year Legacy. The HTA ReBrand and Host Dr. Adam Brockman are Represented by Agent Alan Morell of Creative Management Partners LLC (CMP) BEVERLY HILLS, CA - July 7, 2026 ( NEWMEDIAWIRE ) - Announcing today, after more than 30 years as a nationally syndicated powerhouse, ‘The Dr. Bob Martin Show’ has officially rebranded as ‘Health Talk America,’ ushering in a new era for the nation’s largest and most trusted health talk radio program while honoring the legacy of its legendary founder, Dr. Bob Martin. Broadcasting on 500+ stations and platforms nationally and worldwide and reaching an audience of 1.5-2 million weekly action-takers, ‘Health Talk America’ continues its mission to challenge the health status quo, uncover root causes of ———————————————————————————————————————————————————————————— Retina Consultants, P.C. Selects AllyGPO and BioCareSD as Primary Specialty GPO and Drug Distribution Partners 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/retina-consultants-pc-selects-allygpo-and-biocaresd-as-primary-specialty-gpo-and-drug-distribution-partners-302818869.html Connecticut's largest vitreoretinal practice joins the growing AllyGPO and BioCareSD retina network, bringing significant scale, clinical depth, and an enduring commitment to physician-led, independent care FRISCO, Texas, and TEMPE, Ariz., July 7, 2026 /PRNewswire/ -- AllyGPO®, a leading... ———————————————————————————————————————————————————————————— Healthy by Nature® Launches ZeoForce™, a New AI-Informed Detox Formula Developed Using Functional Medicine, Clinical Research, and Proprietary Artificial Intelligence 2026-07-07 · PRWeb · AI, Healthcare https://www.prweb.com/releases/healthy-by-nature-launches-zeoforce-a-new-ai-informed-detox-formula-developed-using-functional-medicine-clinical-research-and-proprietary-artificial-intelligence-302818118.html New 16-in-1 supplement is the first product developed using the company's AI-assisted formulation methodology, designed to reduce ingredient redundancy, optimize dosing, and improve ingredient synergy. ASHEVILLE, N.C., July 7, 2026 /PRNewswire-PRWeb/ -- Healthy by Nature® today announced... ———————————————————————————————————————————————————————————— In an Industry-First, Revvo Introduces MCP-Powered Tire Intelligence 2026-07-07 · PRWeb · AI, Healthcare https://www.prweb.com/releases/in-an-industry-first-revvo-introduces-mcp-powered-tire-intelligence-302817339.html Fleet operators can now ask AI about tire health, maintenance, and roadside risk using natural language across their existing fleet systems. SAN MATEO, Calif., July 7, 2026 /PRNewswire-PRWeb/ -- Revvo.ai, the leader in AI-powered tire intelligence, today announced support for the Model... ———————————————————————————————————————————————————————————— A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill It 2026-07-07 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/a-190-billion-weight-loss-boom-exposed-a-tissue-restoration-gap-and-one-nasdaq-company-is-moving-to-fill-it-302819380.html Issued on behalf of Conexeu Sciences Inc. Conexeu Sciences Inc. (NASDAQ: CNXU) completed the P.R.O.O.F phase of its CXU preclinical program, the evidence base behind a focused first move into a roughly $11 billion medical aesthetics injectable market, an opening the company argues today's... ———————————————————————————————————————————————————————————— Insilico Initiates Phase III Clinical Trial for Rentosertib, Its AI-Empowered TNIK Inhibitor for Idiopathic Pulmonary Fibrosis 2026-07-07 · PR Newswire · AI, Healthcare https://www.prnewswire.com/news-releases/insilico-initiates-phase-iii-clinical-trial-for-rentosertib-its-ai-empowered-tnik-inhibitor-for-idiopathic-pulmonary-fibrosis-302819553.html Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital peer-reviewed papers: the discovery-to-clinic journey in Nature Biotechnology, and positive Phase IIa clinical results in Nature Medicine Rentosertib represents a novel... ———————————————————————————————————————————————————————————— MacKenzie Scott's $20 Million Gift Accelerates Active Minds' National Leadership in Youth Mental Health 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/mackenzie-scotts-20-million-gift-accelerates-active-minds-national-leadership-in-youth-mental-health-302819549.html WASHINGTON, July 7, 2026 /PRNewswire/ -- Active Minds, the nation's leading nonprofit mobilizing youth and young adults to change the culture around mental health so that it is prioritized in society, today announced a $20 million unrestricted gift from philanthropist MacKenzie Scott —... ———————————————————————————————————————————————————————————— Discover Your Ability 2026: They Were Told They Couldn't. They Proved They Could. 2026-07-07 · Pressat · Finance, Healthcare https://pressat.co.uk/releases/discover-your-ability-2026-they-were-told-they-couldnt-they-proved-they-could-64ce70f8fdada307263c6b8722152a4d/ Tuesday 7 July, 2026 More than 250 participants from across the UK and Europe - came together in Norwich for Able2B's flagship “Discover Your Ability” event, helping raise more than £20,000 so far while proving that disability does not define potential. From children taking their first independent steps to adults overcoming life-changing injuries and diagnoses, Discover Your Ability 2026 wasn't about competition - it was about changing perceptions, celebrating potential and demonstrating what can be achieved when we focus on ability rather than disability. Children, young people and adults living with a wide range of disabilities, neurological conditions and long-term health conditions came together to tackle a series of physical challenges, not against one another, but alongside one anoth ———————————————————————————————————————————————————————————— Oncotelic Successfully Completes Initial Safety Cohort of Phase 1b SP-03-B101 Trial; Independent Safety Review Committee Recommends Dose Escalation and European Expansion Underway 2026-07-07 · GlobeNewswire · SaaS, Healthcare https://www.globenewswire.com/news-release/2026/07/07/3323328/0/en/Oncotelic-Successfully-Completes-Initial-Safety-Cohort-of-Phase-1b-SP-03-B101-Trial-Independent-Safety-Review-Committee-Recommends-Dose-Escalation-and-European-Expansion-Underway.html Clinical Program Advances Following Favorable Safety Review; Peer-Reviewed Publication Further Validates Deciparticle ™ Platform ———————————————————————————————————————————————————————————— Pennington Biomedical Releases RURAL Health Study's Key Drivers of Chronic Disease in Franklin Parish, Louisiana 2026-07-07 · PR.com · Healthcare https://www.pr.com/press-release/973013 Franklin Parish data now available to go along with Assumption Parish data revealed earlier this year from Pennington Biomedical. [PR.com] ———————————————————————————————————————————————————————————— Medical Care Technologies, Inc. (OTC Pink:MDCE) Details Six-Phase Internal ... 2026-07-07 · PR-Inside · AI, SaaS, Healthcare https://pr-inside.com/medical-care-technologies-inc-otc-pink-mdce-details-six-phase-internal-r5198596.htm (PR-inside.com) Medical Care Technologies, Inc. (OTC PINK:MDCE) Details Six-Phase Internal Testing Protocol Driving Melanoma Scan Beta Progress MESA, AZ / ACCESS Newswire / July 7, 2026 / Medical Care Technologies, Inc. (OTC PINK:MDCE) today elaborated on the rigorous six-phase internal testing framework that has powered the encouraging results announced on June 26, 2026. Following the initial structured testing announcement on June 12, 2026, the Company has implemented a comprehensive, multi-stage internal evaluation process focused on training and optimizing its proprietary AI vision models for the MDCE Melanoma Scan Beta platform. The six-phase internal testing protocol includes: Dataset Ingestion & Preprocessing - Systematic curation and augmentation .. ———————————————————————————————————————————————————————————— Medical Care Technologies, Inc. (OTC Pink:MDCE) Details Six-Phase Internal Testing Protocol Driving Melanoma Scan Beta Progress 2026-07-07 · Newswire.com · Healthcare https://www.newswire.com/news/medical-care-technologies-inc-otc-pink-mdce-details-six-phase-internal-testing Medical Care Technologies, Inc. (OTC PINK:MDCE) Details Six-Phase Internal Testing Protocol Driving Melanoma Scan Beta Progress ———————————————————————————————————————————————————————————— Siloam International Hospitals Receives Magnet with Distinction(TM), Highest Global Standard 2026-07-07 · PR-Inside · Healthcare https://www.pr-inside.com/siloam-international-hospitals-receives-magnet-with-distinction-tm-highest-global-standard-r5198594.htm (PR-inside.com) Southeast Asia's Only Hospital Network with Two Hospitals Receiving Distinction JAKARTA, July 4, 2026 - (ACN Newswire) - Siloam International Hospitals has again been recognised at the highest level with two of its hospitals receiving Magnet® with Distinction Recognition. Siloam Hospitals Kebon Jeruk became the first hospital in Indonesia to receive the recognition on 23 June 2026, followed by Siloam Hospitals Lippo Village on 26 June 2026. With this achievement, Siloam has become the only hospital network in Southeast Asia with more than one hospital recognised as Magnet® with Distinction. To date, only 95 healthcare organisations worldwide have achieved Magnet® with .. ———————————————————————————————————————————————————————————— IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 ... 2026-07-07 · PR-Inside · Finance, Healthcare https://pr-inside.com/igc-pharma-ceo-and-principal-financial-officer-purchase-more-than-r5198589.htm (PR-inside.com) Senior management elects restricted common stock at $0.27 per share in lieu of repayment of amounts owed, including more than $552,362 of personal cash previously advanced to IGC POTOMAC, MD / ACCESS Newswire / July 7, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company developing therapeutics for Alzheimer's disease, today announced that Chief Executive Officer Ram Mukunda and Principal Financial Officer Claudia Grimaldi have purchased an aggregate of 4,274,853 shares of IGC common stock directly from the Company at $0.27 per share. The shares were purchased through the cancellation of approximately $1.15 million of outstanding .. ———————————————————————————————————————————————————————————— CluePoints and Tufts CSDD Publish Peer-Reviewed Evidence Quantifying the Financial Value of RBQM 2026-07-07 · PRWeb · Healthcare https://www.prweb.com/releases/cluepoints-and-tufts-csdd-publish-peer-reviewed-evidence-quantifying-the-financial-value-of-rbqm-302819388.html New research demonstrates RBQM-enabled trials achieve up to 23x ROI and 19% shorter phase durations, providing the industry's first quantitative business case for risk-based oversight in clinical development WAYNE, Pa., July 7, 2026 /PRNewswire/ -- CluePoints, provider of leading... ———————————————————————————————————————————————————————————— IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company 2026-07-07 · Newswire.com · Finance, Healthcare https://www.newswire.com/news/igc-pharma-ceo-and-principal-financial-officer-purchase-more-than-1-15-million Senior management elects restricted common stock at $0.27 per share in lieu of repayment of amounts owed, including more than $552,362 of personal cash previously advanced to IGC ———————————————————————————————————————————————————————————— Thailand Health Excellence 2026 Partners with ArokaGO to Connect More Than 285 Thai Healthcare Providers with the Global Medical Tourism Market supported by TAT 2026-07-07 · PRWeb · Healthcare https://www.prweb.com/releases/thailand-health-excellence-2026-partners-with-arokago-to-connect-more-than-285-thai-healthcare-providers-with-the-global-medical-tourism-market-supported-by-tat-302818114.html Expanding Thailand's Health & Healing Ecosystem Through Digital Innovation Thailand Health Excellence 2026: The Next Chapter of Global Healing, supported by the Tourism Authority of Thailand (TAT), has announced a strategic partnership with ArokaGO, a leading global Medical Tourism... ———————————————————————————————————————————————————————————— Widespread Hospital Discharge Delays Due to Lack of Adequate Home Oxygen Access 2026-07-07 · PRWeb · Healthcare https://www.prweb.com/releases/widespread-hospital-discharge-delays-due-to-lack-of-adequate-home-oxygen-access-302817383.html A national survey found that limited access to high-flow home oxygen is delaying hospital discharges and increasing risks and costs for patients and the healthcare system. WASHINGTON, July 7, 2026 /PRNewswire-PRWeb/ -- Across the country, people ready to be discharged from the hospital... ———————————————————————————————————————————————————————————— Trucordia Welcomes Steve Roberts as Executive Vice President, Health Benefits & Financial Services 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/trucordia-welcomes-steve-roberts-as-executive-vice-president-health-benefits--financial-services-302816071.html LINDON, Utah, July 7, 2026 /PRNewswire/ -- Trucordia, a top 20 U.S. insurance brokerage, announced today that Steve Roberts has joined the company as Executive Vice President, Health Benefits & Financial Services. Roberts excels in bringing teams together to deliver scalable,... ———————————————————————————————————————————————————————————— Akari Therapeutics Appoints Former AACR President and Renowned Oncology Drug Development Leader, Patricia LoRusso, D.O., to Scientific Advisory Board 2026-07-07 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/07/3323219/0/en/Akari-Therapeutics-Appoints-Former-AACR-President-and-Renowned-Oncology-Drug-Development-Leader-Patricia-LoRusso-D-O-to-Scientific-Advisory-Board.html Globally recognized leader in early-phase oncology clinical development and experimental therapeutics ———————————————————————————————————————————————————————————— Syra Health Appoints Dr. Cori McMahon as Chief Medical Officer to Support its Growth Strategy 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/syra-health-appoints-dr-cori-mcmahon-as-chief-medical-officer-to-support-its-growth-strategy-302818873.html CARMEL, Ind., July 7, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today the appointment of Dr.... ———————————————————————————————————————————————————————————— Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones 2026-07-07 · PRWeb · SaaS, Healthcare https://www.prweb.com/releases/piramal-pharmas-fy2026-annual-report-showcases-global-scale-innovation-led-growth-and-sustainability-milestones-302819498.html MUMBAI, India, July 7, 2026 /PRNewswire/ -- Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a year of strengthening its global platform, investing in... ———————————————————————————————————————————————————————————— Nuzlo Launches Pet Health App, Announces Upcoming Veterinary Practice Management System 2026-07-07 · PR.com · AI, SaaS, Healthcare https://www.pr.com/press-release/972918 Nuzlo LLC has launched the Nuzlo app, a pet health and wellness platform available on iOS and Android that helps pet owners track medications, vaccines, and symptoms with AI-powered guidance. The Mobile, Alabama-based startup is also preparing to launch Clinic Connect, a cloud-based veterinary Practice Information Management System (PIMS) designed to modernize how veterinary practices manage patient records, scheduling, [PR.com] ———————————————————————————————————————————————————————————— Most 'AI-Powered' Tools Ask Users to Trust the Black Box - NutraVeri ... 2026-07-07 · PR-Inside · AI, SaaS, Healthcare https://pr-inside.com/most-ai-powered-tools-ask-users-to-trust-the-black-box-nutraveri-r5198577.htm (PR-inside.com) The Platform's Deterministic Supplement Readiness Score Delivers the Same Result for the Same Formula Every Time, Traces Every Score to Public FDA and FTC Sources, and Now Offers a Partner Program for Operators Serving Supplement Founders MIAMI, FL / ACCESS Newswire / July 7, 2026 /Nitches Inc. (OTCID:NICH) - Most AI-powered platforms ask users to trust the answer without ever showing how it was reached. The model is a black box. The output can change between runs, and the reasoning often cannot be verified. NutraVeri, operated by Nitches Inc. (OTCID:NICH), was built on the opposite philosophy. Its proprietary Supplement Readiness Score is deterministic. .. ———————————————————————————————————————————————————————————— LSU's Pennington Biomedical Researchers Identify Key Factors That Build Resilience and Support Mental Health in Female Athletes 2026-07-07 · PR.com · Healthcare https://www.pr.com/press-release/971565 This longitudinal study highlights modifiable factors that may help reduce depression, anxiety, PTSD and stress [PR.com] ———————————————————————————————————————————————————————————— Most 'AI-Powered' Tools Ask Users to Trust the Black Box - NutraVeri Built One They Can Audit 2026-07-07 · Newswire.com · AI, SaaS, Healthcare https://www.newswire.com/news/most-ai-powered-tools-ask-users-to-trust-the-black-box-nutraveri-built-one-they The Platform's Deterministic Supplement Readiness Score Delivers the Same Result for the Same Formula Every Time, Traces Every Score to Public FDA and FTC Sources, and Now Offers a Partner Program for Operators Serving Supplement Founders ———————————————————————————————————————————————————————————— Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up 2026-07-07 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/07/3323178/0/en/Clinical-Excellence-in-Continuity-of-Care-Counterpart-Assistant-CA-Use-Associated-With-Stronger-Performance-Across-Transitions-of-Care-Measures-and-Post-Hospitalization-Follow-Up.html Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up ———————————————————————————————————————————————————————————— HomeTrust Bank Adds Specialized Healthcare Banking Division 2026-07-07 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/07/3323177/21341/en/HomeTrust-Bank-Adds-Specialized-Healthcare-Banking-Division.html ASHEVILLE, N.C., July 07, 2026 (GLOBE NEWSWIRE) -- HomeTrust Bancshares, Inc. (NYSE: HTB), the holding company of HomeTrust Bank (“HomeTrust” or the “Bank”), today announced the addition of its new Healthcare Banking Division, a specialized line of business designed to serve the distinct financial needs of healthcare practices and professionals. The new division will provide customized financial solutions and relationship-driven support for medical, dental, and veterinary practices throughout each stage of the business lifecycle, from acquisition and ownership transition to expansion and long-term operations. ———————————————————————————————————————————————————————————— Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day 2026-07-07 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/07/3323171/11676/en/Veru-to-Present-at-2026-Obesity-Weight-Loss-Drug-Development-Summit-and-Pre-Conference-Workshop-Day.html MIAMI, FL, July 07, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will present at the 2026 4 th Annual Obesity & Weight Loss Drug Development Summit, and the Pre-Conference Workshop Day taking place on July 14-16, 2026, in Boston, Massachusetts. ———————————————————————————————————————————————————————————— enVVeno Medical Secures Transformational U.S. Patent for enVVe System, ... 2026-07-07 · PR-Inside · Finance, Healthcare, Real Estate https://pr-inside.com/envveno-medical-secures-transformational-u-s-patent-for-envve-system-r5198568.htm (PR-inside.com) New Patent Broadly Protects Core Technology Behind Potential First Non-Surgical Replacement Venous Valve Builds on First-Ever FDA IDE Approval for Pivotal Study of enVVe System Targeting Multi-Billion-Dollar Market Opportunity enVVe Pivotal Study on Track for Enrollment to Commence and First Patients Data Release Expected by the End of Q4 2026 IRVINE, CA / ACCESS Newswire / July 7, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company") today announced the issuance of U.S. Patent No. 12,575,932, further expanding its intellectual property portfolio supporting its enVVe® transcatheter replacement venous valve system for the treatment of venous disease. The issued patent covers key components .. ———————————————————————————————————————————————————————————— Correction: Biovica appoints Maria Ekdahl as new Chief Financial Officer ... 2026-07-07 · PR-Inside · Finance, Healthcare, Education https://pr-inside.com/correction-biovica-appoints-maria-ekdahl-as-new-chief-financial-officer-r5198566.htm (PR-inside.com) UPPSALA, SE / ACCESS Newswire / July 7, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica International AB today announced the appointment of Maria Ekdahl as Chief Financial Officer (CFO). Ekdahl brings more than 20 years of senior finance leadership experience, including her current role as CFO of Nasdaq Stockholm-listed pharmaceutical company, Infant Bacterial Therapeutics AB (IBT), and will join Biovica on October 14, 2026. Ekdahl has broad experience across financial management, capital markets, investor relations and business operations, gained from senior finance roles at listed companies and large organizations including Infant Bacterial Therapeutics, Svenska Filminstitutet, Karolinska University Hospital and Telenor Sverige. .. ———————————————————————————————————————————————————————————— Absentia Labs' Digital Liver Model Becomes First AI Drug Development ... 2026-07-07 · PR-Inside · AI, Healthcare https://pr-inside.com/absentia-labs-digital-liver-model-becomes-first-ai-drug-development-r5198565.htm (PR-inside.com) Founded by MIT-Trained Scientists, Biotech Startup Advances Predictive AI to Improve Human Safety Assessment, Reduce Costly Drug Attrition and Accelerate Drug Development BOSTON, MA / ACCESS Newswire / July 7, 2026 / Absentia Labs , a biotech startup building comprehensive AI models of human biology, announces the acceptance of its Digital Liver Model for predicting Drug-Induced Liver Injury (DILI) into the U.S.Food and Drug Administration's(FDA) Drug Development Tool Qualification Program. "Much of the conversation around AI in pharmaceuticals has focused on drug discovery and finding promising new molecules faster," said Farhan Khodaee, PhD, CEO and co-founder of Absentia Labs. "We're focused on .. ———————————————————————————————————————————————————————————— KIFFIK Biomedical Appoints Dr. Mark Vreeke as Chief Technology Officer ... 2026-07-07 · PR-Inside · Healthcare https://pr-inside.com/kiffik-biomedical-appoints-dr-mark-vreeke-as-chief-technology-officer-r5198561.htm (PR-inside.com) Veteran biosensor innovator and technology leader brings decades of experience developing and scaling breakthrough healthcare technologies MIAMI, FL / ACCESS Newswire / July 7, 2026 / KIFFIK Biomedical Inc. ("KIFFIK"), a biotechnology company advancing access to interstitial fluid (ISF) to create new visibility into human biology, today announced that Mark Vreeke, Ph.D., has joined the company as Chief Technology Officer (CTO). Dr. Vreeke brings more than three decades of experience developing and scaling biosensor and medical device technologies. He is an inventor with more than one hundred issued U.S. patents and an author whose scientific work has been cited more than 50,000 .. ———————————————————————————————————————————————————————————— AM Technical Solutions Acquires Sequence, Inc., Expanding Life Sciences Engineering and Commissioning, Qualification, and Validation (CQV) Capabilities 2026-07-07 · Newswire.com · Healthcare https://www.newswire.com/news/am-technical-solutions-acquires-sequence-inc-expanding-life-sciences-22812459 We acquired Sequence to expand life sciences engineering and CQV services. Learn how we can help pharma and biopharma manufacturers. ———————————————————————————————————————————————————————————— Kythera Labs Expands Partnership with Databricks Launching the Clinical Semantic Bridge MCP on Databricks Marketplace 2026-07-07 · PR Newswire · SaaS, Healthcare https://www.prnewswire.com/news-releases/kythera-labs-expands-partnership-with-databricks-launching-the-clinical-semantic-bridge-mcp-on-databricks-marketplace-302817357.html New MCP integration bridges diseases, medications, procedures, laboratory tests, outcomes, and eligibility criteria in plain language to automatically translate them into retrieval-ready code sets across clinical vocabularies directly into Databricks Marketplace FRANKLIN, Tenn., July 7,... ———————————————————————————————————————————————————————————— Air Voel Strengthens Online Access to CPAP Machines for Canadians Managing Sleep Apnea 2026-07-07 · PressReleaseNews · Healthcare https://pressreleasenews.org/pressroom/air-voel-strengthens-online-access-to-cpap-machines-for-canadians-managing-sleep-apnea Air Voel, a Canadian online retailer specializing in sleep therapy equipment, is expanding its online selection of CPAP machines to help customers compare home, travel, auto-adjusting, and bi-level therapy options. ———————————————————————————————————————————————————————————— Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI 2026-07-07 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/07/3323070/0/en/Clearmind-Reports-Successful-Formulation-Feasibility-Study-Supporting-Potential-New-Additional-Route-of-Administration-Development-for-MEAI.html Vancouver, Canada, July 07, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, such as addictions and weight-loss, announced continued progress in evaluating intranasal delivery of its proprietary MEAI (5-Methoxy-2-aminoindane) as a potential additional route of administration, initially for the treatment of alcohol use disorder (AUD). ———————————————————————————————————————————————————————————— Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management 2026-07-07 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/07/3323068/0/en/Vivani-Medical-Enters-into-Agreement-with-Novo-Nordisk-to-Evaluate-NPM-139-a-Miniature-Ultra-Long-Acting-Semaglutide-Implant-for-Chronic-Weight-Management.html Vivani Medical entered into agreement with Novo Nordisk to evaluate its miniature subdermal semaglutide (GLP-1) implant for weight management ———————————————————————————————————————————————————————————— Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026 2026-07-07 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/07/3323065/0/en/Acumen-Pharmaceuticals-to-Present-Data-on-Enhanced-Brain-Delivery-EBD-Technology-and-Early-Alzheimer-s-Disease-Insights-at-the-Alzheimer-s-Association-International-Conference-AAIC.html NEWTON, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen), a clinical-stage biopharmaceutical company developing novel therapeutics that target soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), will present three key studies at the upcoming Alzheimer's Association International Conference (AAIC ® ) 2026 in London. Shared in one oral and two poster presentations, the data highlight Acumen’s progress with JCR Pharmaceuticals (JCR), in developing next generation therapeutics through Enhanced Brain Delivery (EBD) technology and expanding the field’s understanding of early symptomatic AD through the patient lens. The conference will be held July 12-15, 2026, both in-person and online. ———————————————————————————————————————————————————————————— BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™ 2026-07-07 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/07/3323056/0/en/BriaCell-Engages-Consulting-and-Branding-Firms-to-Support-Commercial-and-Market-Access-Evaluation-of-Bria-IMT.html PHILADELPHIA and VANCOUVER, British Columbia, July 07, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced that it has engaged Charles River Associates (CRA) (Nasdaq: CRAI) and Kaleio, Inc. to support commercial strategy, market access evaluation and brand planning for Bria-IMT. ———————————————————————————————————————————————————————————— MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec) 2026-07-07 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/07/3323060/0/en/MeiraGTx-Announces-400-million-Strategic-Investment-by-Oberland-Capital-to-Support-Development-and-Commercialization-of-AAV2-hAQP1-and-Botaretigene-Sparoparvovec-bota-vec.html LONDON and NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced that it has entered into an agreement with Oberland Capital Management LLC (Oberland Capital) for an investment of up to $400 million in the Company, including up to $375 million in non-dilutive capital for capped royalty payments on certain products and up to $25 million in equity. ———————————————————————————————————————————————————————————— Biovica Appoints Maria Ekdahl as New Chief Financial Officer 2026-07-07 · PR-Inside · Finance, Healthcare, Education https://pr-inside.com/biovica-appoints-maria-ekdahl-as-new-chief-financial-officer-r5198529.htm (PR-inside.com) UPPSALA, SE / ACCESS Newswire / July 7, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica International AB today announced the appointment of Maria Ekdahl as Chief Financial Officer (CFO). Ekdahl brings more than 20 years of senior finance leadership experience, including her current role as CFO of Nasdaq Stockholm-listed pharmaceutical company, Infant Bacterial Therapeutics AB (IBT), and will join Biovica on October 14, 2026. Ekdahl has broad experience across financial management, capital markets, investor relations and business operations, gained from senior finance roles at listed companies and large organizations including Infant Bacterial Therapeutics, Svenska Filminstitutet, Karolinska University Hospital and Telenor Sverige. .. ———————————————————————————————————————————————————————————— Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy 2026-07-07 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/07/3323052/0/en/Alterity-Therapeutics-Receives-FDA-End-of-Phase-2-Meeting-Minutes-Confirming-Registrational-Pathway-for-ATH434-in-Multiple-System-Atrophy.html – Official FDA minutes confirm the previously announced End-of-Phase 2 meeting outcomes and provide additional detail on the planned Phase 3 protocol — ———————————————————————————————————————————————————————————— Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP 2026-07-07 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/07/3322987/0/en/Semnur-Pharmaceuticals-Inc-Semnur-a-Majority-Owned-Subsidiary-of-Scilex-Holding-Company-Nasdaq-SCLX-Scilex-Announces-Signing-of-Binding-Term-Sheet-for-Proposed-100-Million-Strategi.html PALO ALTO, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR) , a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies, today announced the signing of a binding term sheet with iHolding Group LLP (“iHolding”), a private investment group headquartered in Almaty, Republic of Kazakhstan. The term sheet contemplates that iHolding will purchase $100,000,000 of newly issued shares of Semnur common stock. The purchase price for such shares is expected to be $10.00 per share, which would represent approximately 10,000,000 shares. ———————————————————————————————————————————————————————————— American Parkinson Disease Association Announces New Training Course for Mental Health Practitioners 2026-07-07 · PR Newswire · Healthcare, Education https://www.prnewswire.com/news-releases/american-parkinson-disease-association-announces-new-training-course-for-mental-health-practitioners-302817236.html Free five-part course will provide valuable insights into the mental and emotional experiences of people with Parkinson's and offers a CE credit for each session. NEW YORK, July 7, 2026 /PRNewswire/ -- The American Parkinson Disease Association (APDA) will soon launch a free five-part... ———————————————————————————————————————————————————————————— Obesity Rates in the U.S. Climbed to About 40% of Adults and 20% of Youth in 2023 2026-07-07 · NewMediaWire · Healthcare, Education https://www.newmediawire.com/news/obesity-rates-in-the-u-s-climbed-to-about-40-of-adults-and-20-of-youth-in-2023-7087532 Research Highlights: Researchers analyzed U.S. health information from 1999 to 2023 and found that the prevalence of obesity increased from 30% to 41%, respectively. Severe obesity among U.S. adults rose from 5% to 10%, and abdominal obesity (the accumulation of fatty tissue in the abdominal area) increased from 48% to 61%, respectively, during the 24-year study period. Researchers recommended ongoing monitoring of body mass index (BMI) and waist circumference to help guide individual and population-wide prevention efforts targeting obesity as a major modifiable risk factor. DALLAS - July 7, 2026 ( NEWMEDIAWIRE ) - Obesity rates among U.S. adults and children rose sharply in recent years and by 2023, 40% of adults and 20% of youth met the criteria for obesity, according to new, independent ———————————————————————————————————————————————————————————— Andreas Mattsson appointed as new Chief Legal Officer 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/andreas-mattsson-appointed-as-new-chief-legal-officer-302819245.html STOCKHOLM, July 7, 2026 /PRNewswire/ -- Hygiene and health company Essity has appointed Andreas Mattsson as the new Chief Legal Officer and member of the company's Executive Management Team. He succeeds Mikael Schmidt who has decided to retire as of December 31, 2026. Andreas Mattsson... ———————————————————————————————————————————————————————————— Biovica Expands Master Services Agreement with a Current Customer, ... 2026-07-07 · PR-Inside · Healthcare https://pr-inside.com/biovica-expands-master-services-agreement-with-a-current-customer-r5198460.htm (PR-inside.com) UPPSALA, SE / ACCESS Newswire / July 7, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a company specializing in blood-based cancer monitoring, today announces an expanded Master Services Agreement with a current customer, one of the world's leading pharmaceutical companies, which has a broad and active oncology pipeline. Under the agreement, Biovica will provide DiviTum® TKa testing services for oncology development programs. The agreement establishes an expanded framework for laboratory testing services to support preclinical and clinical development activities across oncology, including areas such as next-generation cell-cycle therapies and immuno-oncology. Through Biovica's established laboratory services infrastructure and DiviTum TKa, Bi ———————————————————————————————————————————————————————————— Almost 1 in 2 people living with incontinence experience skin irritation, Ontex research shows 2026-07-07 · GlobeNewswire · Healthcare, Retail https://www.globenewswire.com/news-release/2026/07/07/3322886/0/en/Almost-1-in-2-people-living-with-incontinence-experience-skin-irritation-Ontex-research-shows.html At the occasion of World Skin Health Day (July 8 ) , Ontex highlights growing clinical and consumer focus on skin protection ———————————————————————————————————————————————————————————— Bijna 1 op de 2 mensen met incontinentie ervaart huidirritatie, blijkt uit onderzoek van Ontex 2026-07-07 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/07/3322886/0/nl/Bijna-1-op-de-2-mensen-met-incontinentie-ervaart-huidirritatie-blijkt-uit-onderzoek-van-Ontex.html Naar aanleiding van World Skin Health Day (8 juli) benadrukt Ontex de groeiende klinische en consumentenfocus op huidbescherming ———————————————————————————————————————————————————————————— Beckman Coulter Diagnostics Expands Alzheimer's Portfolio with CE-Marked p-Tau217 Blood Test and New High-Specificity Research Assay 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/beckman-coulter-diagnostics-expands-alzheimers-portfolio-with-ce-marked-p-tau217-blood-test-and-new-high-specificity-research-assay-302818858.html CE-marked Access p-Tau217 blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of cognitive decline across Europe Brain Derived pTau217 RUO assay selectively detects brain-derived pTau217 unlocking new neurodegenerative insights... ———————————————————————————————————————————————————————————— EQT to acquire the TachoSil® biosurgery business from Corza Medical 2026-07-07 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/eqt-to-acquire-the-tachosil-biosurgery-business-from-corza-medical-302819146.html EQT to acquire Corza Biosurgery, a premier biosurgery business built around TachoSil, a leading hemostat and sealant patch used across a wide range of surgical specialties TachoSil supports improved surgical outcomes through rapid bleeding control and tissue sealing, and is backed by... ———————————————————————————————————————————————————————————— Vicore Pharma to Participate in the Leerink Therapeutics Forum 2026-07-07 · PR-Inside · Finance, Healthcare https://pr-inside.com/vicore-pharma-to-participate-in-the-leerink-therapeutics-forum-r5198452.htm (PR-inside.com) STOCKHOLM, SE / ACCESS Newswire / July 7, 2026 / Vicore Pharma Holding AB (NASDAQ Stockholm:VICO)(NASDAQ:VCRE), a clinical-stage biopharmaceutical company unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today announced that the company will participate in the Leerink Therapeutics Forum. Location: Boston Harbor Hotel, Boston, Mass. Format: 1×1 meetings Date: Tuesday, July 14, 2026 Participant: Ahmed Mousa, CEO For more information, please contact: Megan Richards, VP of IR and Comms, +1 978 269-4372, megan.richards@vicorepharma.com Hans Jeppsson, CFO, +46 70 553 14 65, hans.jeppsson@vicorepharma.com About Vicore Pharma Vicore Pharma is a clinical-stage biopharmaceutical company unlocking the .. ———————————————————————————————————————————————————————————— Noah Noor Health Services Supports Independent Living Through Companion Care Services 2026-07-07 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/07/1761834 Noah Noor Health Services proudly supports independent living through companion care services. These services help people stay active, safe, and socially connected at home. Many [read full press release...] ———————————————————————————————————————————————————————————— Bayer Foundation Women Entrepreneurs Award: From AI Diagnostics to Circular Food Tech, 15 Women Are Transforming Health and Food Systems Worldwide 2026-07-07 · PR Newswire · AI, Healthcare https://www.prnewswire.com/news-releases/bayer-foundation-women-entrepreneurs-award-from-ai-diagnostics-to-circular-food-tech-15-women-are-transforming-health-and-food-systems-worldwide-302818328.html LEVERKUSEN, Germany and VIENNA, July 7, 2026 /PRNewswire/ -- The Bayer Foundation Women Entrepreneurs Award, powered by the Impact Hub Network, honours 15 women from Latin America, Africa, and Asia addressing critical challenges in global healthcare and food security. Selected from 1,172... ———————————————————————————————————————————————————————————— Untethered Airway Health Center Brings In-House Feeding Therapy to Brookfield – Closing a Critical Gap for SE Wisconsin Families 2026-07-07 · PRUnderground · Healthcare https://www.prunderground.com/untethered-airway-health-center-brings-in-house-feeding-therapy-to-brookfield-closing-a-critical-gap-for-se-wisconsin-families/00388012/ With the addition of Speech-Language Pathologist and Lactation Consultant Caryn Singh, families in the greater Milwaukee area can now access tongue-tie treatment and specialized feeding therapy under one roof - no referrals, no runaround. The post Untethered Airway Health Center Brings In-House Feeding Therapy to Brookfield - Closing a Critical Gap for SE Wisconsin Families first appeared on ———————————————————————————————————————————————————————————— Coastal Chiropractic Welcomes Sports Medicine Specialist Dr Heather Champion 2026-07-07 · PRUnderground · Healthcare https://www.prunderground.com/coastal-chiropractic-welcomes-sports-medicine-specialist-dr-heather-champion/00387994/ Local chiropractic clinic adds a Certified Chiropractic Sports Physician to help active St Pete residents recover and perform better. The post Coastal Chiropractic Welcomes Sports Medicine Specialist Dr Heather Champion first appeared on ———————————————————————————————————————————————————————————— Le tout premier patient international commence un traitement par lymphocytes T porteurs de récepteurs antigéniques chimériques (cellules CAR-T) récemment approuvé contre les tumeurs solides au Centre international de cancérologie Jiahui 2026-07-07 · PR Newswire · Healthcare, Automotive https://www.prnewswire.com/news-releases/le-tout-premier-patient-international-commence-un-traitement-par-lymphocytes-t-porteurs-de-recepteurs-antigeniques-chimeriques-cellules-car-t-recemment-approuve-contre-les-tumeurs-solides-au-centre-international-de-cancerologie--302818863.html SHANGHAI, 7 juillet 2026 /PRNewswire/ -- Le Centre international de cancérologie Jiahui a accueilli le tout premier patient international à entamer un traitement par Satri-cel, la première thérapie par cellules CAR-T au monde approuvée pour le traitement de tumeurs solides, marquant ainsi... ———————————————————————————————————————————————————————————— Diabetic Kidney Disease Market Emerging as a High-Growth Healthcare Investment Space Through 2034 – DelveInsight | Curacle, Boehringer Ingelheim, Bayer, Pfizer, Mitsubishi Tanabe Pharma, PhytoHealth 2026-07-07 · GetNews · Healthcare https://www.getnews.info/story/2026/07/06/diabetic-kidney-disease-market-emerging-as-a-highgrowth-healthcare-investment-space-through-2034-delveinsight-curacle-boehringer-ingelheim-bayer-pfizer-mitsubishi-tanabe-pharma-phytohealth/?source=barchart ———————————————————————————————————————————————————————————— Amyotrophic Lateral Sclerosis Market Trends, Innovation, and Future Growth Outlook to 2036 – DelveInsight | Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK, Biogen, Ionis Pharma 2026-07-07 · GetNews · Healthcare https://www.getnews.info/story/2026/07/06/amyotrophic-lateral-sclerosis-market-trends-innovation-and-future-growth-outlook-to-2036-delveinsight-helixmith-sanofi-denali-therapeutics-transposon-therapeutics-gsk-biogen-ionis-pharma/?source=barchart ———————————————————————————————————————————————————————————— Sensorineural Hearing Loss Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Sensorion, Fennec Pharma, Sound Pharma, Decibel Therapeutics 2026-07-07 · GetNews · Healthcare https://www.getnews.info/story/2026/07/06/sensorineural-hearing-loss-pipeline-2026-fda-approvals-and-clinical-trials-landscape-with-moa-and-roa-highlights-by-delveinsight-sensorion-fennec-pharma-sound-pharma-decibel-therapeutics/?source=barchart ———————————————————————————————————————————————————————————— Sleep Apnea Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Apnimed, Eli Lilly, Incannex Healthcare, Axsome Therapeutics, Jazz Pharma, Bioprojet 2026-07-07 · GetNews · Healthcare https://www.getnews.info/story/2026/07/06/sleep-apnea-pipeline-2026-therapies-moa-insights-and-key-clinical-trial-updates-by-delveinsight-apnimed-eli-lilly-incannex-healthcare-axsome-therapeutics-jazz-pharma-bioprojet/?source=barchart ———————————————————————————————————————————————————————————— Weltweit erster internationaler Patient beginnt im Jiahui International Cancer Center die Behandlung mit einer neu zugelassenen CAR-T-Zelltherapie gegen solide Tumoren 2026-07-07 · PR Newswire · Healthcare, Automotive https://www.prnewswire.com/news-releases/weltweit-erster-internationaler-patient-beginnt-im-jiahui-international-cancer-center-die-behandlung-mit-einer-neu-zugelassenen-car-t-zelltherapie-gegen-solide-tumoren-302818852.html SHANGHAI, 7. Juli 2026 /PRNewswire/ -- Das Jiahui International Cancer Center (JICC) hat den weltweit ersten internationalen Patienten für den Beginn einer Behandlung mit Satri-cel – der weltweit ersten zugelassenen CAR-T-Therapie gegen einen soliden Tumor – empfangen; dies markiert einen... ———————————————————————————————————————————————————————————— Emergency List Helps Summer Travelers Prioritize First Aid Essentials 2026-07-06 · PRUnderground · Healthcare https://www.prunderground.com/emergency-list-helps-summer-travelers-prioritize-first-aid-essentials/00387012/ Emergency List encourages people to prepare for unexpected medical needs as summer travel and adventure season begins. The post Emergency List Helps Summer Travelers Prioritize First Aid Essentials first appeared on ———————————————————————————————————————————————————————————— ESHRE 42nd Annual Meeting: Halving fertility treatment costs could more than double births, major global study shows 2026-07-06 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/eshre-42nd-annual-meeting-halving-fertility-treatment-costs-could-more-than-double-births-major-global-study-shows-302813542.html A landmark international study has found that halving patient out-of-pocket costs was associated with a 2.67-fold increase in births achieved through assisted reproductive technology (ART). LONDON, July 6, 2026 /PRNewswire/ -- Presented at the 42nd Annual Meeting of the European Society... ———————————————————————————————————————————————————————————— Electronic Caregiver Expands Access to Intelligent Care Across New ... 2026-07-06 · PR-Inside · SaaS, Healthcare https://pr-inside.com/electronic-caregiver-expands-access-to-intelligent-care-across-new-r5198340.htm (PR-inside.com) LAS CRUCES, NM / ACCESS Newswire / July 6, 2026 /Electronic Caregiver, Inc., New Mexico's pioneering healthcare technology company, today announced a series of milestones that significantly expand access to intelligent care throughout the state while reinforcing New Mexico's emergence as a national center for healthcare innovation. The company has achieved New Mexico Medicaid in-network provider status, received approval under the state's Developmental Disabilities (DD) Waiver Program , and recently launched its next-generationAdvanced Primary Care Management platform featuring new integrations with state and federal Health Information Exchanges to support more connected, informed, and longitudinal care. Together, these advancements enable Electronic Caregiver to .. ———————————————————————————————————————————————————————————— Electronic Caregiver Expands Access to Intelligent Care Across New Mexico While Advancing the Rio Grande Health Technology and Services Corridor 2026-07-06 · Newswire.com · Healthcare https://www.newswire.com/news/electronic-caregiver-expands-access-to-intelligent-care-across-new-22820796 ———————————————————————————————————————————————————————————— Biohacking Pioneer and Coffee Mogul Dave Asprey Honored with 2026 Mindshare ... 2026-07-06 · PR-Inside · Healthcare, Media https://pr-inside.com/biohacking-pioneer-and-coffee-mogul-dave-asprey-honored-with-2026-mindshare-r5198334.htm (PR-inside.com) Celebrating two decades of leadership in biohacking, human optimization, and health innovation CORONADO, CA / ACCESS Newswire / July 6, 2026 / Dave Asprey, four-time New York Times bestselling author and widely recognized as the Father of Biohacking, has been named a recipient of the 2026 Pinnacle Award. Presented annually, the Pinnacle Award recognizes a leader whose work creates a lasting and positive impact on global health and wellness. Asprey is the CEO of Upgrade Labs and host of the Webby Award-winning podcast, The Human Upgrade, with over 1,000 episodes. Over more than two decades, Dave Asprey has fundamentally changed the way .. ———————————————————————————————————————————————————————————— Biohacking Pioneer and Coffee Mogul Dave Asprey Honored with 2026 Mindshare Summit Pinnacle Award 2026-07-06 · Newswire.com · Healthcare https://www.newswire.com/news/biohacking-pioneer-and-coffee-mogul-dave-asprey-honored-with-2026-22820755 Celebrating two decades of leadership in biohacking, human optimization, and health innovation ———————————————————————————————————————————————————————————— Active Motif Announces Exclusive Global Distribution Agreement with Arima Genomics for Advanced 3D Genomics Solutions 2026-07-06 · PR Newswire · SaaS, Healthcare https://www.prnewswire.com/news-releases/active-motif-announces-exclusive-global-distribution-agreement-with-arima-genomics-for-advanced-3d-genomics-solutions-302818771.html Agreement expands Active Motif's research genomics portfolio while supporting Arima's strategic focus on its clinical diagnostics platform CARLSBAD, Calif., July 6, 2026 /PRNewswire/ -- Active Motif, a leading provider of epigenetics and multiomic solutions to mechanistic, translational,... ———————————————————————————————————————————————————————————— AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulatory Agency and Health Canada 2026-07-06 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/amo-pharma-announces-update-on-scientific-advice-for-registrational-clinical-study-of-amo-02-in-congenital-myotonic-dystrophy-type-1-following-meetings-with-the-us-food-and-drug-administration-the-uk-medicines-and-healthcare--302818767.html Based on regulatory agency feedback, the Company plans a registrational study that will evaluate hospitalization as the primary outcome measure, supported by multiple functional assessments as secondary outcome measures. LONDON, July 6, 2026 /PRNewswire/ -- AMO Pharma Limited ("AMO... ———————————————————————————————————————————————————————————— HelloNation Explains Personal Injury Evidence and Comparative Negligence Featuring Family Law Attorney Mark E. Zimmer 2026-07-06 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/hellonation-explains-personal-injury-evidence-and-comparative-negligence-featuring-family-law-attorney-mark-e-zimmer-302778036.html The article outlines how evidence, medical records, and Pennsylvania fault laws affect personal injury claims after an accident. READING, Penn., July 6, 2026 /PRNewswire/ -- What steps should someone take after an accident to help protect their legal rights? Mark E. Zimmer, Family Law... ———————————————————————————————————————————————————————————— Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2026-07-06 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/06/3322763/0/en/Xilio-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html WALTHAM, Mass., July 06, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced that, effective July 1, 2026, the company granted non-qualified stock options to purchase 107,060 shares of its common stock to three new employees under Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan. ———————————————————————————————————————————————————————————— Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs 2026-07-06 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/06/3322753/0/en/Alcon-and-RxSight-Announce-Collaboration-to-Develop-Adjustable-PCIOLs.html ALISO VIEJO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting intraocular lenses (PCIOLs). ———————————————————————————————————————————————————————————— Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes 2026-07-06 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/06/3322747/0/en/Context-Therapeutics-Added-to-Russell-2000-and-Russell-3000-Indexes.html PHILADELPHIA, July 06, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors, today announced that the Company was added to the small-cap Russell 2000 ® and the broad-market Russell 3000 ® Indexes, effective at the close of U.S. equity markets on June 26, 2026. ———————————————————————————————————————————————————————————— MedStar Health Offers New Thumb Joint Replacement for Thumb Arthritis 2026-07-06 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/medstar-health-offers-new-thumb-joint-replacement-for-thumb-arthritis-302818683.html D.C. and Baltimore firsts bring "mini hip replacement" innovation to thumb arthritis care. COLUMBIA, Md., July 6, 2026 /PRNewswire/ -- MedStar Health hand surgeons in both D.C. and Baltimore became the first in their respective regions to perform a break-through treatment for patients... ———————————————————————————————————————————————————————————— Update DEA Hearing July 6: Harvard Expert Testifies State Dispensary ... 2026-07-06 · PR-Inside · Healthcare https://pr-inside.com/update-dea-hearing-july-6-harvard-expert-testifies-state-dispensary-r5198262.htm (PR-inside.com) DOJ Says the Controlled Substances Act Protects Legitimate Scientific Research. MMJ Says the Government Should Start Treating It That Way. "The government cannot tell companies to spend years following the FDA's scientific pathway, then dismiss those same efforts as a 'pocketbook interest' when they seek equal treatment under the law. We didn't build a market-we built a medicine." stated Duane Boise, President & CEO, MMJ International Holdings WASHINGTON, DC / ACCESS Newswire / July 6, 2026 /MMJ International Holdings, Inc. (MMJIH), together with MMJ BioPharma Cultivation, Inc. and MMJ BioPharma Labs, Inc., today responded to the Department of Justice's recent filing before .. ———————————————————————————————————————————————————————————— Update DEA Hearing July 6: Harvard Expert Testifies State Dispensary Cannabis Does Not Meet Pharmaceutical Standards 2026-07-06 · Newswire.com · Healthcare https://www.newswire.com/news/update-dea-hearing-july-6-harvard-expert-testifies-state-dispensary-cannabis DOJ Says the Controlled Substances Act Protects Legitimate Scientific Research. MMJ Says the Government Should Start Treating It That Way. "The government cannot tell companies to spend years following the FDA's scientific pathway, then dismiss those same efforts as a 'pocketbook interest' when they seek equal treatment under the law. We didn't build a market-we built a medicine." stated Duane Boise, President & CEO, MMJ International Holdings ———————————————————————————————————————————————————————————— VERAXA Biotech (VRXA) Highlights BiTAC Pipeline Progress, Advances Partnering Strategy 2026-07-06 · NewMediaWire · Finance, SaaS, Healthcare, Retail https://www.newmediawire.com/news/veraxa-biotech-vrxa-highlights-bitac-pipeline-progress-advances-partnering-strategy-7087527 LOS ANGELES, CA - July 6, 2026 ( NEWMEDIAWIRE ) - VERAXA Biotech (NASDAQ: VRXA) provided a corporate and pipeline update highlighting progress during the first half of 2026, including continued advancement of its proprietary BiTAC(R) platform and growing interest from potential pharmaceutical partners. The company said its pipeline now includes four BiTAC-based T-cell engager programs targeting solid tumors, two bispecific antibody-drug conjugate (“ADC”) programs and two non-BiTAC assets available for partnering. VERAXA said it plans to prioritize investment in its BiTAC portfolio while seeking to monetize selected non-BiTAC programs to help finance future development, with the goal of advancing lead BiTAC-TCE candidate VXA-102 to IND/CTA readiness by early 2028. Company executives also ci ———————————————————————————————————————————————————————————— What's Lurking in Common Dust Found in Homes, Businesses, and Schools in Puerto Rico? 2026-07-06 · WebWire · Healthcare https://www.webwire.com/ViewPressRel.asp?aId=357231 House dust is a part of everyday life, yet few people fully understand what it contains or how it can impact human health. Far from being simple dirt, house dust is a complex mixture of materials originating from both indoor and outdoor environments. These may include soil particles, human skin cells, pet dander, textile fibers, pollen, mold spores, and microscopic organisms such as dust mites and their waste byproducts. - - For many individuals, exposure to house dust can trigger allergic... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357231 ———————————————————————————————————————————————————————————— Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases 2026-07-06 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/06/3322689/0/en/Cosmos-Health-Share-Buyback-Increases-to-3-64-Million-Shares-Continues-Open-Market-Purchases.html Cosmos Health has now repurchased a total of 3,640,000 shares for approximately $700,000 ———————————————————————————————————————————————————————————— National Recognition for Kentown Support’s Collaborative Approach to Children’s Palliative Care 2026-07-06 · Pressat · Healthcare https://pressat.co.uk/releases/national-recognition-for-kentown-supports-collaborative-approach-to-childrens-palliative-care-ab050262a6affd9584fb4cf90d744238/ Monday 6 July, 2026 Kentown Support is delighted to announce that it has won the Partnership Working Across Health and Social Care Award at the 2026 Palliative and End of Life Care Awards. This national recognition celebrates the collaborative approach at the heart of the Kentown programme model and acknowledges the impact of partnership working in delivering coordinated, family-centred care for seriously ill children and young people. The category recognises teams that demonstrate exceptional multi-level collaboration across the health and social care sectors, creating lasting and sustainable impact beyond individual organisations. While the judges recognised the Kentown programme model overall, they paid tribute to its Greater Manchester programme, commenting that it: “Delivers an except ———————————————————————————————————————————————————————————— Medical Equipment Maintenance Market Demand Across Hospitals, Clinics, and Diagnostic Centers 2026-07-06 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/06/1761816 The global Medical Equipment Maintenance Market size was valued at USD 41.9 billion in 2023 and is projected to grow from USD 55.4 billion in 2026 to [read full press release...] ———————————————————————————————————————————————————————————— Leader in Pulmonary Vascular Research Named New Editor-in-Chief of Circulation Journal 2026-07-06 · NewMediaWire · Healthcare, Retail https://www.newmediawire.com/news/leader-in-pulmonary-vascular-research-named-new-editor-in-chief-of-circulation-journal-7087523 DALLAS - July 6, 2026 ( NEWMEDIAWIRE ) - The American Heart Association announced that effective with today’s issue, Bradley A. Maron, M.D., FAHA, is the new editor-in-chief of Circulation , the Association’s flagship peer-reviewed journal and one of the world’s leading scientific publications in cardiovascular medicine. In the role, Maron will help shape the journal’s editorial direction and continue its commitment to publishing rigorous, practice-changing science for clinicians, researchers and healthcare professionals worldwide. Maron is a board-certified clinical cardiologist and distinguished researcher across the basic, translational, clinical and population health spectrum. He is recognized globally for mechanistic and clinical advances in pulmonary hypertension, right heart failure ———————————————————————————————————————————————————————————— Vadzo Imaging Positions Falcon-521CRS and Falcon-521MRS as a Color and Monochrome USB Camera Pair for Multi-Spectral Industrial Vision Systems 2026-07-06 · Newswire.com · Healthcare https://www.newswire.com/news/vadzo-imaging-positions-falcon-521crs-and-falcon-521mrs-as-a-color-and-22799583 "Vadzo's Falcon-521CRS color USB camera and Falcon-521MRS monochrome USB camera from Vadzo Imaging deliver a matched 5MP color and monochrome USB camera pair built on the Onsemi AR0521 2.2 um BSI CMOS sensor for multi-spectral industrial vision systems, simultaneous visible and NIR spectral analysis, multi-spectral medical imaging and pathology, factory automation and industrial inspection, semiconductor and PCB surface analysis, and digital microscopy and life sciences spectral sample analysis across production-grade industrial deployments." ———————————————————————————————————————————————————————————— Marchman Act Attorney Mark G. Astor to Present at 2026 Florida Society of Addiction Medicine Conference 2026-07-06 · PressReleaseNews · Healthcare https://pressreleasenews.org/pressroom/marchman-act-attorney-mark-g-astor-to-present-at-2026-florida-society-of-addiction-medicine-conference Mark G. Astor, founder of Astor Simovitch Law Firm, will present on Florida's Marchman Act at the 2026 FSAM Annual Conference in Tampa, offering legal guidance to addiction medicine professionals on court-ordered treatment options for families. ———————————————————————————————————————————————————————————— F9 Marketing adds digital PR distribution service for healthcare clinics 2026-07-06 · PressReleaseNews · Healthcare https://pressreleasenews.org/pressroom/f9-marketing-adds-digital-pr-distribution-service-for-healthcare-clinics F9 Marketing has added a digital PR distribution service for healthcare clinics. It reports publisher authority and search rankings. ———————————————————————————————————————————————————————————— CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicine 2026-07-06 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/curifylabs-raises-14m-series-a-to-power-the-future-of-personalized-medicine-302818576.html Investment from Sandwater, HealthCap, and Tesi will enhance supply chain, customer support, and R&D HELSINKI and JACKSONVILLE, Fla., July 6, 2026 /PRNewswire/ -- CurifyLabs, a health technology company transforming how personalized medicines are made, today announced the closing of a $14... ———————————————————————————————————————————————————————————— The New Rules of Biotech Now Available in Hardcover and Audiobook 2026-07-06 · NewMediaWire · Healthcare, Retail https://www.newmediawire.com/news/the-new-rules-of-biotech-now-available-in-hardcover-and-audiobook-7087522 RENO, NEVADA - July 6, 2026 ( NEWMEDIAWIRE ) - The New Rules of Biotech: A Founder’s Guide to Building Great Companies, by biotechnology founder and longtime industry operator David Craig, is now available in a hardcover edition ($29.99) and as an audiobook on Google Play. These join the paperback ($21.99) and Kindle ($11.99) editions already on sale through Amazon. Founders, investors, board members, and operators can now choose the format that fits how they read, work, and listen. The book opens from a clear premise: the biotech playbook written for 2021 no longer works. Capital is more expensive, the Food and Drug Administration (FDA) bar has moved, and the Inflation Reduction Act has rewritten the economics of a drug before it is ever approved. Investors who once funded a slide deck an ———————————————————————————————————————————————————————————— Marquis Who's Who Honors Kareem Collins for Excellence in Cancer Exercise, ... 2026-07-06 · PR-Inside · Healthcare https://pr-inside.com/marquis-who-s-who-honors-kareem-collins-for-excellence-in-cancer-exercise-r5198231.htm (PR-inside.com) BROOKLYN, NY / ACCESS Newswire / July 6, 2026 / Marquis Who's Who is proud to honor Kareem Collins for his distinguished contributions to healthcare, fitness, cancer exercise, Parkinson's disease programming and inclusive wellness. Mr. Collins' recognition reflects more than two decades of dedication to exercise science, patient-centered coaching and adaptive movement for individuals navigating complex health challenges. His leadership continues to help clients move forward, one step at a time. Mr. Collins is a self-employed entrepreneur and cancer exercise specialist affiliated with Memorial Sloan Kettering Cancer Center. Since 2020, he has built a specialized practice focused on post-cancer exercise, helping .. ———————————————————————————————————————————————————————————— Brook.ai and SRHO - The National Association Partner to Bring AI-Enabled Continuous Care Infrastructure to more than 275 Hospitals Nationwide 2026-07-06 · PR Newswire · AI, SaaS, Healthcare https://www.prnewswire.com/news-releases/brookai-and-srho--the-national-association-partner-to-bring-ai-enabled-continuous-care-infrastructure-to-more-than-275-hospitals-nationwide-302818538.html Partnership Accelerates Remote Care Adoption Across SRHO Member Health Systems, Extending Brook's Agentic AI Platform to Communities Nationwide SEATTLE, July 6, 2026 /PRNewswire/ -- Brook.ai, the remote care company, a pioneer of AI-enabled continuous care infrastructure, and SRHO – The... ———————————————————————————————————————————————————————————— A Shared Vision for Infusion Care: Right Way Medical Joins WeInfuse's Distributor Connect Program as a Key Medical Supplier to Simplify the Provider Experience 2026-07-06 · PR Newswire · SaaS, Healthcare https://www.prnewswire.com/news-releases/a-shared-vision-for-infusion-care-right-way-medical-joins-weinfuses-distributor-connect-program-as-a-key-medical-supplier-to-simplify-the-provider-experience-302818527.html DALLAS, July 6, 2026 /PRNewswire/ -- WeInfuse, the premier software platform for infusion providers and specialty pharmacies, welcomes Right Way Medical, a trusted medical device distributor delivering infusion products, asset tracking, and expert biomedical services, to its Distributor... ———————————————————————————————————————————————————————————— Vadzo Imaging Introduces Falcon-544MRH: 5MP Monochrome Autofocus USB Camera Based on Onsemi HyperLux LP AR0544 2026-07-06 · Newswire.com · Healthcare https://www.newswire.com/news/vadzo-imaging-introduces-falcon-544mrh-5mp-monochrome-autofocus-usb-22800961 The Falcon-544MRH is a 5MP Monochrome Autofocus USB 3.2 Gen1 Camera built on the Onsemi HyperLux LP AR0544 sensor. It is designed for document scanning, OCR imaging, barcode and QR code scanning, biometrics, access control, medical imaging, laboratory and microscopy imaging, and quality inspection and defect detection in robotics and industrial vision systems. It delivers a 5MP monochrome Autofocus USB camera with VCM autofocus, rolling shutter, and HyperLux LP low-power architecture with plug-and-play UVC support for Windows, Linux, and Android in a compact M12 form factor. ———————————————————————————————————————————————————————————— Dr. Augusta Uwah to Speak at Telehealth USA 2026 in Anaheim 2026-07-06 · PRUnderground · Finance, AI, Healthcare https://www.prunderground.com/dr-augusta-uwah-to-speak-at-telehealth-usa-2026-in-anaheim/00387753/ "ClinEfficiency Pro founder and physician executive to address the healthcare AI adoption gap at Telehealth USA 2026, July 8-9 in Anaheim, CA" The post Dr. Augusta Uwah to Speak at Telehealth USA 2026 in Anaheim first appeared on ———————————————————————————————————————————————————————————— Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California 2026-07-06 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/securing-new-1-6-plus-million-square-feet-of-new-space-after-fire-medline-leases-two-large-distribution-centers-in-northern-california-302818441.html Massive new medical supplies distribution space represents 45% expansion of Medline's customer-facing NorCal footprint NORTHFIELD, Ill., July 6, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) has announced a lease agreement for an existing 925,000-square-foot warehouse in Tracy, Calif., for... ———————————————————————————————————————————————————————————— Fuchs Endothelial Corneal Dystrophy Market Forecast Highlights Significant Growth During the Forecast Period (2026-2036), Owing to the Expanding Treatment Landscape and Increasing Patient Pool | DelveInsight 2026-07-06 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/fuchs-endothelial-corneal-dystrophy-market-forecast-highlights-significant-growth-during-the-forecast-period-20262036-owing-to-the-expanding-treatment-landscape-and-increasing-patient-pool--delveinsight-302818131.html The Fuchs endothelial corneal dystrophy market is expected to witness steady growth over the coming years, driven by the rising prevalence of the disease, an aging global population, and increasing awareness of corneal disorders. Additionally, the expected launch of emerging therapies... ———————————————————————————————————————————————————————————— In HelloNation, Dental Expert Anthony Pasquale Explains the Differences Between Dental Implants and Traditional Bridges 2026-07-06 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/in-hellonation-dental-expert-anthony-pasquale-explains-the-differences-between-dental-implants-and-traditional-bridges-302818429.html The article compares two common tooth replacement options to help patients understand which solution may best fit their oral health needs. NORTHWOOD, N.H., July 6, 2026 /PRNewswire/ -- What's the best way to replace a missing tooth: dental implants or a traditional dental bridge? A new... ———————————————————————————————————————————————————————————— Smarter, Lighter, & Construction-Free: Egg Medical Debuts EggNest® Complete 2.0 for Interventional Labs 2026-07-06 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/smarter-lighter--construction-free-egg-medical-debuts-eggnest-complete-2-0-for-interventional-labs-302817274.html MINNEAPOLIS, July 6, 2026 /PRNewswire/ -- Egg Medical, a leader in Enhanced Radiation Protection Devices (ERPDs) for interventional procedures, today announced the official launch of EggNest Complete 2.0, the latest evolution of the advanced EggNest ERPD system. Designed to reduce scatter... ———————————————————————————————————————————————————————————— Correction: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026 2026-07-06 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/06/3322485/0/en/Correction-Inspire-Medical-Systems-Inc-to-Report-Second-Quarter-2026-Financial-Results-on-August-3-2026.html MINNEAPOLIS, July 06, 2026 (GLOBE NEWSWIRE) -- This press release corrects the earnings release date included in the earlier version issued on July 6, 2026. No other information has changed. ———————————————————————————————————————————————————————————— Lexaria Updates Business Development 2026-07-06 · NewMediaWire · Finance, Healthcare https://www.newmediawire.com/news/lexaria-updates-business-development-7087518 KELOWNA, BRITISH COLUMBIA - July 6, 2026 ( NEWMEDIAWIRE ) - Lexaria Bioscience Corp. (Nasdaq: LEXX) (the “ Company ” or “ Lexaria ”), a global innovator in drug delivery platforms, is pleased to have experienced many positive meetings with potential pharmaceutical partners and collaborators at the 2026 BIO International Convention (“BIO”) in San Diego, CA. “Lexaria had a full schedule at BIO, meeting with a diverse group of companies ranging from innovative smaller tech-focused firms to multi-billion-dollar global pharmaceutical companies,” said Richard Christopher, CEO of Lexaria Bioscience Corp. “We are balancing new exploratory corporate opportunities with existing corporate relationships, with the intent of entering into partnership arrangements. Not a week goes by without discussion w ———————————————————————————————————————————————————————————— LataMed AI Begins Planned Expansion Into Colombia Through Initial Due Diligence and Strategic Planning 2026-07-06 · NewMediaWire · AI, SaaS, Healthcare, Retail https://www.newmediawire.com/news/latamed-ai-begins-planned-expansion-into-colombia-through-initial-due-diligence-and-strategic-planning-7087517 CARACAS, VENEZUELA - July 6, 2026 ( NEWMEDIAWIRE ) - LataMed AI Corp. (OTC: LMED) (the “Company”), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets, today announced that management has commenced the preliminary due diligence and strategic planning process relating to the Company’s planned expansion into Colombia. The Company stated that the initial phase of the expansion initiative includes evaluating the corporate, regulatory, legal, operational, and commercial requirements associated with establishing a Colombian operating subsidiary and supporting the future deployment of the Company’s digital healthcare platform within the Colombian market. M ———————————————————————————————————————————————————————————— MIRA Pharmaceuticals Reports Successful Formulation Results for SKNY-1, ... 2026-07-06 · PR-Inside · Finance, Healthcare https://pr-inside.com/mira-pharmaceuticals-reports-successful-formulation-results-for-skny-r5198155.htm (PR-inside.com) New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with Once-Daily Dosing Potential MIAMI, FL / ACCESS Newswire / July 6, 2026 /MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company, today announced positive results from preclinical studies evaluating the optimized oral formulation of SKNY-1, the Company's oral drug candidate being developed for obesity and addiction-related disorders. The studies demonstrated favorable oral bioavailability together with reproducible systemic exposure and robust brain penetration, and substantial liver exposure following oral administration. Peak plasma concentrations were observed approximately six to twelve hours after dosing, s ———————————————————————————————————————————————————————————— NEBOSH Course in Bangalore 2026-07-06 · PressReleaseNews · Healthcare, Education https://pressreleasenews.org/pressroom/nebosh-course-in-bangalore The NEBOSH Course in Bangalore is a globally recognized health and safety qualification designed for individuals who want to build a successful career in occupational health, safety, and environmental management. This course provides comprehensive kn ———————————————————————————————————————————————————————————— NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS" 2026-07-06 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/neurosense-to-participate-in-roth-hosted-kol-webinar-on-the-future-of-als-treatment-a-quest-to-outrun-als-302818300.html Featuring renowned ALS expert Prof. Jeremy Shefner, the discussion will address key unmet needs in ALS, trial endpoint design, and PrimeC's path forward CAMBRIDGE, Mass., July 6, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical... ———————————————————————————————————————————————————————————— Moleculin CEO, Walter Klemp, Highlights Positive Preliminary MIRACLE Trial Results in Virtual Investor "What This Means" Segment 2026-07-06 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/06/3322423/0/en/Moleculin-CEO-Walter-Klemp-Highlights-Positive-Preliminary-MIRACLE-Trial-Results-in-Virtual-Investor-What-This-Means-Segment.html HOUSTON, July 06, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that Walter Klemp, Chairman and Chief Executive Officer of Moleculin, participated in a Virtual Investor “What This Means” segment . ———————————————————————————————————————————————————————————— As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase ... 2026-07-06 · PR-Inside · Finance, Healthcare, Education https://pr-inside.com/as-the-ebola-epidemic-spreads-nanoviricides-advances-towards-a-phase-r5198149.htm (PR-inside.com) SHELTON, CT / ACCESS Newswire / July 6, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, updates that it has continued to advance its broad-spectrum antiviral drug NV-387 towards a Phase II Clinical Trial of the NV-387 Oral Gummies formulation as a Treatment for the Current Bundibugyo Ebolavirus in the Democratic Republic of Congo (DRC). NanoViricides has already put together a team with a renowned Principal Investigator and with support from a well known University in the Ebola-affected region for the execution of this clinical trial after regulatory approvals. NanoViricides' proposal .. ———————————————————————————————————————————————————————————— Every AI Intelligence Platform Asks the Market to Trust Its Numbers. ... 2026-07-06 · PR-Inside · AI, SaaS, Healthcare https://pr-inside.com/every-ai-intelligence-platform-asks-the-market-to-trust-its-numbers-r5198148.htm (PR-inside.com) 419 regulatory, clinical, and research signals are now publicly available at aimwellbio.com/signals-no login, no sales call, and no requirement to take the company's word for anything. MIAMI, FL / ACCESS Newswire / July 6, 2026 /Aimwell Partners Inc. (OTC PINK:AIMN) - There is a test that very few AI intelligence companies can pass: show the data before the demo. Most cannot. The claims live in pitch decks. The metrics live in case studies that cannot be independently verified. The product sits behind an intake form, a sales sequence, or a non-disclosure agreement. The market is asked to trust first and verify later. Aimwell Partners .. ———————————————————————————————————————————————————————————— As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo 2026-07-06 · Newswire.com · Healthcare https://www.newswire.com/news/as-the-ebola-epidemic-spreads-nanoviricides-advances-towards-a-phase-ii ———————————————————————————————————————————————————————————— Every AI Intelligence Platform Asks the Market to Trust Its Numbers. Aimwell Partners Inc. (OTC:AIMN) Just Opened the Data 2026-07-06 · Newswire.com · AI, SaaS, Healthcare https://www.newswire.com/news/every-ai-intelligence-platform-asks-the-market-to-trust-its-numbers-aimwell 419 regulatory, clinical, and research signals are now publicly available at aimwellbio.com/signals-no login, no sales call, and no requirement to take the company's word for anything. ———————————————————————————————————————————————————————————— Fate Therapeutics to Present Preliminary Clinical Data of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Sclerosis at the ISSCR 2026 Annual Meeting 2026-07-06 · GlobeNewswire · Finance, Healthcare, Automotive https://www.globenewswire.com/news-release/2026/07/06/3322405/24675/en/Fate-Therapeutics-to-Present-Preliminary-Clinical-Data-of-FT819-Off-the-Shelf-CAR-T-Cell-Product-Candidate-for-Systemic-Sclerosis-at-the-ISSCR-2026-Annual-Meeting.html SAN DIEGO, July 06, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies broadly to patients with cancer and autoimmune disease, today announced that preliminary clinical data from the Company’s off-the-shelf CAR T-cell product candidate, FT819, will be presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting, being held at the Palais des congrès de Montréal in Montréal, Canada on July 8 - 11, 2026. ———————————————————————————————————————————————————————————— Wellness MD Group Redefines the MSO Model: A Compliance-First, Full-Stack Partner for the Modern Wellness Clinic 2026-07-06 · PRWeb · Healthcare https://www.prweb.com/releases/wellness-md-group-redefines-the-mso-model-a-compliance-first-full-stack-partner-for-the-modern-wellness-clinic-302817417.html Wellness MD Group, a leading Management Services Organization for wellness clinics, announced a strategic partnership with Healthcare Compliance Pros (HCP) as part of its evolution into a full-stack, compliance-first partner offering medical director placement, multi-state telehealth... ———————————————————————————————————————————————————————————— Celltrion USA and Prometheus Laboratories Inc. Announce Sponsored Testing ... 2026-07-06 · PR-Inside · Healthcare https://pr-inside.com/celltrion-usa-and-prometheus-laboratories-inc-announce-sponsored-testing-r5198141.htm (PR-inside.com) Celltrion Testing Access Program Expands Availability of Therapeutic Drug Monitoring to Support Patient Transition to Subcutaneous Infliximab JERSEY CITY, NJ AND SAN DIEGO, CA / ACCESS Newswire / July 6, 2026 / Celltrion USA ("Celltrion") and Prometheus Laboratories Inc. ("Prometheus") today announced a sponsored collaboration to provide access to Anser® IFX therapeutic drug monitoring (TDM) services for patients eligible to receive ZYMFENTRA® (infliximab-dyyb), the first and only FDA-approved subcutaneous infliximab for the maintenance treatment in adults with moderately to severely active ulcerative colitis and moderately to severely active Crohn's disease following intravenous (IV) infliximab. Through the Celltrion Testing Access Program, eligible patients .. ———————————————————————————————————————————————————————————— CERTIFY Health Names Nimi Kuruvilla Vice President of Customer Success to Scale Enterprise Customer Operations 2026-07-06 · PR Newswire · SaaS, Healthcare https://www.prnewswire.com/news-releases/certify-health-names-nimi-kuruvilla-vice-president-of-customer-success-to-scale-enterprise-customer-operations-302817999.html Nimi will lead customer onboarding, implementation, and long-term account operations as CERTIFY Health grows across DSOs, enterprise ambulatory groups, and multi-site provider organizations. ROCKVILLE, Md., July 6, 2026 /PRNewswire/ -- CERTIFY Health, a unified healthcare platform for... ———————————————————————————————————————————————————————————— Dario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership 2026-07-06 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/dario-signs-new-agreement-with-a-major-health-insurer-in-arizona-representing-hundreds-of-thousands-of-lives-through-amwell-partnership-302818159.html Agreement representative of Dario's channel-led growth strategy to bring cardiometabolic digital health solution at scale to self-insured employers seeking measurable reductions in cardiometabolic risk and total cost of care via payer relationships NEW YORK, July 6, 2026 /PRNewswire/ --... ———————————————————————————————————————————————————————————— Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA 2026-07-06 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/06/3322321/0/en/Invivyd-Announces-Receipt-of-Twelve-Months-Advanced-Notice-of-Emergency-Use-Authorization-EUA-Termination-for-PEMGARDA-and-Provides-an-Update-on-Next-Steps-with-the-U-S-FDA.html NEW HAVEN, Conn., July 06, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has sent Invivyd a Notice of Termination for the PEMGARDA ® (pemivibart) Emergency Use Authorization (EUA), following the U.S. Department of Health and Human Services’ (HHS) announcement of advanced Notice of Termination of the COVID-19 EUA declaration on June 30, 2026 ( link ), with an effective date of June 29, 2027. Consequently, the EUA for PEMGARDA is set to terminate on June 29, 2027. PEMGARDA (pemivibart) is Invivyd’s investigational monoclonal antibody authorized by the FDA under an EUA since March 2024 for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents who have moderate-to-severe immune compromise ———————————————————————————————————————————————————————————— Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks 2026-07-06 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/06/3322293/0/en/Pharvaris-Announces-FDA-Acceptance-of-New-Drug-Application-for-Deucrictibant-IR-for-On-Demand-Treatment-of-Hereditary-Angioedema-Attacks.html ZUG, Switzerland, July 06, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for deucrictibant immediate-release (IR) capsule (20 mg) for the on-demand treatment (ODT) of Hereditary Angioedema (HAE) attacks. The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of April 23, 2027. ———————————————————————————————————————————————————————————— Animal Feed Probiotic Market to Reach 8,384.4 Million by 2036 as Livestock Health Optimization and Antibiotic-Free Feed Strategies Accelerate Global Demand 2026-07-06 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/animal-feed-probiotic-market-to-reach-8-384-4-million-by-2036-as-livestock-health-optimization-and-antibiotic-free-feed-strategies-accelerate-global-demand-302818281.html NEWARK, Del, July 6, 2026 /PRNewswire/ -- According to the latest analysis by Future Market Insights (FMI), the global animal feed probiotic market is poised for significant expansion as livestock producers increasingly adopt microbial feed solutions to improve animal health, feed... ———————————————————————————————————————————————————————————— What is the Best Social Media Platform for Plastic Surgeons? 2026-07-06 · PR-Inside · SaaS, Healthcare, Media, Education https://pr-inside.com/what-is-the-best-social-media-platform-for-plastic-surgeons-r5198038.htm (PR-inside.com) The Best Social Media Platform for Plastic Surgeons is JAASPIRE SEATTLE, WA / ACCESS Newswire / July 6, 2026 / Social media has become one of the primary ways prospective patients evaluate plastic surgeons before scheduling consultations. Many patients now review educational content, before-and-after photographs, and a surgeon's online presence alongside credentials when researching cosmetic procedures. At the same time, many medical practices are searching for alternatives to traditional social media platforms that rely heavily on algorithms to determine which content users see. Those changes have contributed to growing interest in creator-focused platforms. As plastic surgeons seek platforms that support patient education, .. ———————————————————————————————————————————————————————————— “The Art of Undieting” by Monica Woolridge — Free on Amazon for a Limited Time (Until 07/10/2026) 2026-07-06 · WebWire · Healthcare, Retail https://www.webwire.com/ViewPressRel.asp?aId=357038 Best Seller Publishing is proud to announce the release of “The Art of Undieting: A Soul-led, Science-Backed Guide to Redefining Health on Your Body's Terms” by wellness advocate and transformational health coach Monica Woolridge—available for free download on Amazon for a limited time—now through July 10, 2026. - - For decades, millions have been trapped in exhausting cycles of dieting, calorie counting, restriction, and frustration, chasing weight loss while feeling increasingly dis... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357038 ———————————————————————————————————————————————————————————— AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder 2026-07-06 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/06/3322260/0/en/AtaiBeckley-Doses-Last-Patient-in-VLS-01-Phase-2b-TRD-Study-Plans-Phase-3-in-Major-Depressive-Disorder.html 156 patients randomized in multi-center, double-blind, placebo-controlled Phase 2b Elumina trial; topline data anticipated in Q4 2026 ———————————————————————————————————————————————————————————— Vanta to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22, 2026, at 10:00 a.m. ET 2026-07-06 · Newswire.com · SaaS, Healthcare, Retail https://www.newswire.com/news/vanta-to-participate-in-the-health-wellness-longevity-virtual-conference News Release Highlights: Vanta has been invited to present at Maxim Group's "Health, Wellness & Longevity" Virtual Conference on July 22, 2026, providing the Company with an opportunity to engage institutional investors and showcase its long-term strategy for building an integrated U.S.-focused consumer health sciences and longevity platform spanning peptide therapies, nutraceuticals and premium functional hydration products. The Company believes participation in the conference supports its broader U.S. corporate growth and capital markets strategy by expanding visibility among institutional investors, family offices, investment advisors and other capital markets participants as it advances the development and commercialization of its integrated consumer health sciences and longevity e ———————————————————————————————————————————————————————————— Panchmukhi Air Ambulance in Patna is in Demand for its ICU Facilities 2026-07-06 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/06/1761411 Patna, India, 2026-07-06 — /EPR Network/ — An ICU-facilitated medical transport would be highly beneficial for transporting sick patients to their chosen healthcare facility without [read full press release...] ———————————————————————————————————————————————————————————— Restore Wellness Center Expands Advanced Stem Cell Therapy for Neuropathy and Regenerative Medicine Services Across Arizona 2026-07-06 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/06/1761399 Scottsdale, AZ, 2026-07-06 — /EPR Network/ — Through their innovations in non-surgical solutions for people suffering from chronic pain, peripheral neuropathy, circulatory problems, and movement difficulties, [read full press release...] ———————————————————————————————————————————————————————————— World's First International Patient Begins Treatment with Newly Approved Solid Tumor CAR-T Therapy at Jiahui International Cancer Center 2026-07-06 · PR Newswire · Healthcare, Automotive https://www.prnewswire.com/news-releases/worlds-first-international-patient-begins-treatment-with-newly-approved-solid-tumor-car-t-therapy-at-jiahui-international-cancer-center-302818233.html SHANGHAI, July 6, 2026 /PRNewswire/ -- Jiahui International Cancer Center (JICC) has welcomed the world's first international patient to begin treatment with Satri-cel, the world's first approved CAR-T therapy for a solid tumor, marking a historic milestone in expanding global access to... ———————————————————————————————————————————————————————————— Find Luxury Rehab Launches Online Directory to Help Families Discover Trusted Luxury Addiction and Mental Health Treatment Centers 2026-07-06 · PR.com · Healthcare https://www.pr.com/press-release/970611 Find Luxury Rehab announces the availability of its online directory, providing individuals and families with a centralized resource to research addiction treatment and mental health rehabilitation centers across the United States and internationally. [PR.com] ———————————————————————————————————————————————————————————— BioNxt Advances GLP-1 Sublingual Semaglutide ODF Program with Next ... 2026-07-06 · PR-Inside · SaaS, Healthcare https://pr-inside.com/bionxt-advances-glp-1-sublingual-semaglutide-odf-program-with-next-r5198033.htm (PR-inside.com) VANCOUVER, BC / ACCESS Newswire / July 6, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce continued progress in its sublingual Semaglutide oral dissolvable film ("ODF") program, marking the next stage of development for the Company's GLP-1 delivery platform. Expanding BioNxt's Thin-Film Platform into GLP-1 Therapeutics BioNxt's Semaglutide ODF program is designed to evaluate a needle-free, patient-friendly thin-film delivery format for GLP-1 receptor agonists, a class of therapeutics widely used in the treatment of type 2 diabetes, obesity, weight management, and related metabolic disorders. The program builds .. ———————————————————————————————————————————————————————————— MRX1 Successfully Delivered to Clinical Trial Site 2026-07-06 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/mrx1-successfully-delivered-to-clinical-trial-site-302817806.html LONDON, July 6, 2026 /PRNewswire/ -- Ananda Pharma Limited is a UK based bio pharmaceutical company developing regulatory approved cannabidiol medicines to treat complex, chronic conditions. The directors announce the MRX1 investigational product manufactured in 2025 has been delivered to... ———————————————————————————————————————————————————————————— Vicore Pharma Appoints Rob Slack as Chief Scientific Officer 2026-07-06 · PR-Inside · Finance, Healthcare https://pr-inside.com/vicore-pharma-appoints-rob-slack-as-chief-scientific-officer-r5198029.htm (PR-inside.com) STOCKHOLM, SE / ACCESS Newswire / July 6, 2026 / Vicore Pharma Holding (STO:VICO) - Dr. Slack brings over 20 years' experience in fibrosis and respiratory translational science and joins from GSK, where he served as Vice President and Head of Respiratory Biology Stockholm, Sweden & Cambridge, Mass., July 6, 2026 - Vicore Pharma Holding AB (Nasdaq Stockholm: VICO, Nasdaq US: VCRE), a clinical-stage biopharmaceutical company unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists, today announced the appointment of Rob Slack, PhD, FRSB, as Chief Scientific Officer. Dr. Slack succeeds Johan Raud, MD, PhD, .. ———————————————————————————————————————————————————————————— Molecular Partners Updates on Clinical Progress Across Expanding Pipeline of DARPin Radiotherapeutics 2026-07-06 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/06/3322137/0/en/Molecular-Partners-Updates-on-Clinical-Progress-Across-Expanding-Pipeline-of-DARPin-Radiotherapeutics.html ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., July 06, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today provided an update across its pipeline of targeted alpha Radio-DARPin therapeutics (RDTs). ———————————————————————————————————————————————————————————— Ascletis Submits Two IND Applications to the U.S. FDA for the Treatment of Obesity: ASC36 Once-Monthly Injection, a Peptide Amylin Receptor Agonist, and ASC36_35 FDC Once-Monthly Injection, a Co-Formulation of ASC36 Plus Peptide GLP-1R/GIPR Agonist ASC35 2026-07-06 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/ascletis-submits-two-ind-applications-to-the-us-fda-for-the-treatment-of-obesity-asc36-once-monthly-injection-a-peptide-amylin-receptor-agonist-and-asc3635-fdc-once-monthly-injection-a-co-formulation-of-asc36-plus-peptide-g-302818044.html ASC36_35 FDC, a once-monthly subcutaneous (SQ) injection co-formulation of ASC36 and ASC35, is a potentially first-in-class drug candidate targeting three validated targets of amylin receptor, GLP-1R and GIPR. ASC36_35 FDC demonstrated approximately 51% greater relative body weight... ———————————————————————————————————————————————————————————— InnoCare Announces First Patient Dosed in Clinical Trial of Novel CDH17 targeted ADC ICP-B208 in China 2026-07-06 · GlobeNewswire · SaaS, Healthcare https://www.globenewswire.com/news-release/2026/07/06/3322119/0/en/InnoCare-Announces-First-Patient-Dosed-in-Clinical-Trial-of-Novel-CDH17-targeted-ADC-ICP-B208-in-China.html ICP-B208 is InnoCare's second ADC from its in-house platform to enter clinical development. There are no approved CDH17 targeted ADCs globally. ———————————————————————————————————————————————————————————— Startup Island TAIWAN Bridges Tech Hubs, Launching East Coast Biotech Initiative in Boston 2026-07-06 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/startup-island-taiwan-bridges-tech-hubs-launching-east-coast-biotech-initiative-in-boston-302818034.html BOSTON, July 5, 2026 /PRNewswire/ -- Following its success building a solid foundation on the U.S. West Coast, Startup Island TAIWAN, a national brand backed by the National Development Council (NDC), is expanding its reach to Boston, cementing the region's commitment to fostering... ———————————————————————————————————————————————————————————— Scientific Interest Grows in Liver Health Herbal Supplements Featuring Milk Thistle, Turmeric and Dandelion Root, Highlights PureHealth Research 2026-07-05 · PR Newswire · Healthcare, Retail https://www.prnewswire.com/news-releases/scientific-interest-grows-in-liver-health-herbal-supplements-featuring-milk-thistle-turmeric-and-dandelion-root-highlights-purehealth-research-302817733.html MANASSAS, Va., July 5, 2026 /PRNewswire/ -- PureHealth Research is drawing attention to growing consumer and industry interest in herbal approaches to liver wellness and the role of targeted botanical ingredients in maintaining healthy liver function. Liver health herbal supplements... ———————————————————————————————————————————————————————————— Santin Chiropractic Grows Team and Community Roots in Thunder Bay 2026-07-05 · PRUnderground · Healthcare https://www.prunderground.com/santin-chiropractic-grows-team-and-community-roots-in-thunder-bay/00387685/ Santin Chiropractic welcomes physiotherapist resident Gautam KC and joined Thunder Bay's business community at the 1st Annual Linkwell Golf Social. The post Santin Chiropractic Grows Team and Community Roots in Thunder Bay first appeared on ———————————————————————————————————————————————————————————— Transport BPO Extends Dispatch and Back Office Support to Transportation ... 2026-07-04 · PR-Inside · Healthcare, Automotive https://pr-inside.com/transport-bpo-extends-dispatch-and-back-office-support-to-transportation-r5197642.htm (PR-inside.com) TransportBPO has extended its transport dispatch and back office services to trucking companies and owner operators across the US, Canada, UK and Australia, covering load booking, driver check calls, invoicing and compliance paperwork. VANCOUVER, WA / ACCESS Newswire / July 4, 2026 /TransportBPO (https://transportbpo.com), the specialist call center and business process outsourcing provider for the ground transportation industry, has extended its dispatch and back office services to trucking companies, owner operators and small freight fleets across the United States, Canada, the United Kingdom and Australia. The move brings trucking into a service lineup already covering taxi, cab, private hire, non-emergency medical transportation, .. ———————————————————————————————————————————————————————————— New to The Street Show #760 Airs Tonight on Bloomberg Television Across ... 2026-07-04 · PR-Inside · AI, Healthcare https://pr-inside.com/new-to-the-street-show-760-airs-tonight-on-bloomberg-television-across-r5197641.htm (PR-inside.com) Honoring Economic Freedom and American Capitalism Through Television That Connects Markets, Entrepreneurs, and Investors National Sponsored Broadcast Includes Executive Interviews and Television Commercial Campaigns from Lantern Pharma, Medicus Pharma, Datavault AI and Big Sky Industrial NEW YORK CITY, NY / ACCESS Newswire / July 4, 2026 /New to The Street, one of America's longest-running business television brands, today announced that Show #760 will air tonight, Saturday, July 4, 2026, at 6:30 p.m. ET as sponsored programming on Bloomberg Television, delivering executive interviews, market commentary, and corporate updates to national and international audiences on Independence Day. The broadcast features leaders across legal advisory, biotechnology, .. ———————————————————————————————————————————————————————————— New to The Street Show #760 Airs Tonight on Bloomberg Television Across the U.S. on Independence Day Featuring Sullivan & Cromwell’s Frank Aquila, Medicus Pharma, PetVivo, FreeCast and YY Group 2026-07-04 · Newswire.com · AI, Healthcare https://www.newswire.com/news/new-to-the-street-show-760-airs-tonight-on-bloomberg-television-across-the-u-s Honoring Economic Freedom and American Capitalism Through Television That Connects Markets, Entrepreneurs, and Investors National Sponsored Broadcast Includes Executive Interviews and Television Commercial Campaigns from Lantern Pharma, Medicus Pharma, Datavault AI and Big Sky Industrial ———————————————————————————————————————————————————————————— Strategic Collaboration | Sanyou Bio and Baiyunshan Xihe Join Forces to Advance Innovative Radiopharmaceuticals and Radiodiagnostics 2026-07-04 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/strategic-collaboration--sanyou-bio-and-baiyunshan-xihe-join-forces-to-advance-innovative-radiopharmaceuticals-and-radiodiagnostics-302817920.html SHANGHAI and GUANGZHOU, China, July 4, 2026 /PRNewswire/ -- Sanyou Biopharmaceutical Co., Ltd. ("Sanyou Bio") and Guangzhou Baiyunshan Xihe Health Pharmaceutical Co., Ltd. ("Baiyunshan Xihe") jointly announced the official signing of a strategic cooperation agreement. This partnership... ———————————————————————————————————————————————————————————— Nation Health MD Explains How Lymph System Supplements Can Support Healthy Lymphatic Drainage and Natural Detox Processes 2026-07-04 · PR Newswire · Healthcare, Retail https://www.prnewswire.com/news-releases/nation-health-md-explains-how-lymph-system-supplements-can-support-healthy-lymphatic-drainage-and-natural-detox-processes-302817717.html MANASSAS, Va., July 4, 2026 /PRNewswire/ -- Nation Health MD is drawing attention to growing consumer interest in lymphatic wellness and the role of targeted nutritional support in maintaining healthy lymphatic drainage, fluid balance and overall vitality. Lymph system supplements... ———————————————————————————————————————————————————————————— Why Circulation Health Supplements Are Gaining Attention for Supporting Healthy Vascular Function and Everyday Wellness, According to PureHealth Research 2026-07-04 · PR Newswire · Healthcare, Retail https://www.prnewswire.com/news-releases/why-circulation-health-supplements-are-gaining-attention-for-supporting-healthy-vascular-function-and-everyday-wellness-according-to-purehealth-research-302817734.html MANASSAS, Va., July 4, 2026 /PRNewswire/ -- PureHealth Research is highlighting growing consumer interest in circulation wellness and the role of targeted nutritional supplementation in maintaining healthy blood flow, vascular function, and overall cardiovascular wellness. Circulation... ———————————————————————————————————————————————————————————— How to Negotiate Your Medical Bills to Save Money 2026-07-04 · Newswire.com · Healthcare https://www.newswire.com/news/how-to-negotiate-your-medical-bills-to-save-money ———————————————————————————————————————————————————————————— New York Cancer & Blood Specialists Welcomes Medical Oncologist-Hematologist Dr. Sobha Atluri 2026-07-04 · PR.com · Healthcare https://www.pr.com/press-release/972846 New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, proudly announces the addition of Dr. Sobha Atluri, a hematologist-oncologist dedicated to providing evidence-based, comprehensive cancer care. Beginning July 1, 2026, Dr. Atluri will be practicing at NYCBS’s office located at 1050 Clove Road, Staten Island, NY 10301 and 2801 Richmond Avenue, Staten Island, NY [PR.com] ———————————————————————————————————————————————————————————— New York Cancer & Blood Specialists Welcomes Medical Oncologist-Hematologist, Dr. Neel Patel 2026-07-04 · PR.com · Healthcare https://www.pr.com/press-release/972844 New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, proudly announces the addition of Dr. Neel Patel, a hematologist-oncologist dedicated to providing evidence-based, compassionate cancer care. Beginning July 1, 2026, Dr. Patel will be practicing at NYCBS’s offices located at 1050 Clove Road, Staten Island, NY 10301, and 2801 Richmond Avenue, Staten Island, NY [PR.com] ———————————————————————————————————————————————————————————— New York Health Welcomes Board-Certified Primary Care Physician, Dr. Deepa Malineni 2026-07-04 · PR.com · Healthcare https://www.pr.com/press-release/972851 New York Health (NY Health) is proud to announce the addition of Dr. Deepa Malineni, a board-certified internal medicine physician with over 15 years of experience providing comprehensive, evidence-based care. Dr. Malineni will be practicing at NY Health’s office located at 1061 N Broadway, North Massapequa, NY 11758. “We are thrilled to welcome Dr. Malineni to our practice,” said Dr. Rohit [PR.com] ———————————————————————————————————————————————————————————— Levels Family Chiropractic Launches $25 New-Patient Special for July 2026-07-04 · PRUnderground · Healthcare https://www.prunderground.com/levels-family-chiropractic-launches-25-new-patient-special-for-july/00387615/ Urbandale clinic offers full consultation, neurological exam, and digital X-rays for residents dealing with back pain, sciatica, scoliosis, neck pain, and headaches The post Levels Family Chiropractic Launches $25 New-Patient Special for July first appeared on ———————————————————————————————————————————————————————————— Marginal Zone Lymphoma Pipeline Accelerates as 50+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/03/marginal-zone-lymphoma-pipeline-accelerates-as-50-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight/?source=barchart ———————————————————————————————————————————————————————————— HER2 Positive Breast Cancer Pipeline Accelerates as 50+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/03/her2-positive-breast-cancer-pipeline-accelerates-as-50-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight/?source=barchart ———————————————————————————————————————————————————————————— Neuroblastoma Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/03/neuroblastoma-pipeline-accelerates-as-20-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight/?source=barchart ———————————————————————————————————————————————————————————— Sjögren’s Disease Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/03/sjgrens-disease-pipeline-accelerates-as-20-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight/?source=barchart ———————————————————————————————————————————————————————————— Non-Alcoholic Fatty Liver Disease Pipeline Accelerates as 90+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/03/nonalcoholic-fatty-liver-disease-pipeline-accelerates-as-90-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight/?source=barchart ———————————————————————————————————————————————————————————— Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program 2026-07-03 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/03/3321992/0/en/Appili-Therapeutics-Announces-Receipt-from-NIAID-of-a-Notice-of-Termination-for-Convenience-on-the-Contract-for-the-VXV-01-Program.html HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases today announced that it has received a Notice of Termination for Convenience from the National Institute of Allergy and Infectious Diseases (“NIAID”), part of the National Institutes of Health (“NIH”), in connection with the Company’s contract supporting development of the VXV-01 fungal vaccine candidate. ———————————————————————————————————————————————————————————— Court Approval of a Restructuring Transaction Allowing Continuation of Uninterrupted Operations 2026-07-03 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/03/3321988/0/en/Court-Approval-of-a-Restructuring-Transaction-Allowing-Continuation-of-Uninterrupted-Operations.html MONTREAL, July 03, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“ Premier Health” or the “Company” ) announces that, in connection with the proceedings initiated on June 23, 2026 by the Royal Bank of Canada (the “ Applicant ”) in its capacity as a secured creditor (the “ CCAA Proceedings ”), the Québec Superior Court (Commercial Division) (the “ Court ”) has issued today an order approving the acquisition of all of the equity interests in three affiliates of the Company, namely Solutions Staffing Inc. (“ SSI ”), Canadian Health Care Agency Ltd. (“ CHCA ”) and Premier Soin Nordik Inc. / Premier Health Nordik Inc. (“ Nordik Québec ”), by way of reverse vesting orders (the “ Transaction ” and the “ Approval and Reverse Vesting Orders ”). ———————————————————————————————————————————————————————————— Average Whiplash Settlement After a Car Accident in South Carolina: What Injury Victims Should Know 2026-07-03 · PRWeb · Healthcare, Automotive https://www.prweb.com/releases/average-whiplash-settlement-after-a-car-accident-in-south-carolina-what-injury-victims-should-know-302816581.html Learn what affects the average whiplash settlement after a South Carolina car accident, including injury severity, medical costs, lost wages, and the legal options available to injured victims. CHARLESTON, S.C., July 3, 2026 /PRNewswire-PRWeb/ -- Individuals who suffer whiplash injuries... ———————————————————————————————————————————————————————————— Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 2026-07-03 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/03/3321980/0/en/Teladoc-Health-Announces-Employee-Inducement-Award-under-NYSE-Rule-303A-08.html NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. ———————————————————————————————————————————————————————————— Quankang launches UES140 Series 140W GaN power adapters for medical and ITE applications 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/03/quankang-launches-ues140-series-140w-gan-power-adapters-for-medical-and-ite-applications/?source=barchart ———————————————————————————————————————————————————————————— easyJet launches onboard summer collection to support UNICEF's Children's Emergency Fund 2026-07-03 · WebWire · Finance, Healthcare https://www.webwire.com/ViewPressRel.asp?aId=357171 - - • easyJet customer donations will help UNICEF respond to emergencies in countries around the world, such as those impacted by ongoing conflict, natural disasters and public health crises - • One such example of where funding will be diverted is in the Democratic Republic of the Congo (DRC), which is currently battling against a recent Ebola outbreak affecting children and vulnerable communities - • CEF funding will also be used to support communities impacted by recent earthqua... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357171 ———————————————————————————————————————————————————————————— Le DoH et le MIT - Koch Institute entrent en partenariat pour faire progresser la recherche sur le cancer assistée par l'IA 2026-07-03 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/le-doh-et-le-mit--koch-institute-entrent-en-partenariat-pour-faire-progresser-la-recherche-sur-le-cancer-assistee-par-lia-302817786.html ABOU DABI, Émirats arabes unis, 3 juillet 2026 /PRNewswire/ -- Le Department of Health – Abu Dhabi (DoH), l'autorité de régulation du secteur de la santé dans l'émirat, et le MIT – Koch Institute for Integrative Cancer Research ont annoncé une collaboration stratégique visant à faire... ———————————————————————————————————————————————————————————— Soil Health Management Market worth $25.92 billion by 2031, at a CAGR of 8.6% 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/03/soil-health-management-market-worth-2592-billion-by-2031-at-a-cagr-of-86/?source=barchart ———————————————————————————————————————————————————————————— Floridians on Track to Set New Record for Annual Drownings 2026-07-03 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/floridians-on-track-to-set-new-record-for-annual-drownings-302817775.html Nicklaus Children's Hospital, YMCA of South Florida and Florida Panthers Sound Alarm Just in Time for Hot Holiday Weekend Media kit available for download MIAMI, July 3, 2026 /PRNewswire/ -- More than 62 lives have been claimed in drownings across the State of Florida so far this year. At... ———————————————————————————————————————————————————————————— Xtalks Announces its Life Science Webinar Calendar for July 2026 2026-07-03 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/xtalks-announces-its-life-science-webinar-calendar-for-july-2026-302817703.html Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, clinical trials, commercialization and HEOR, emerging market, food ingredients and innovations, laboratory technology, medical device safety and regulation, patient recruitment and retention, pharma... ———————————————————————————————————————————————————————————— MOTS-c is having its biggest month yet: California Trim Clinic breaks down the new human trial and FDA review putting the mitochondrial peptide in the spotlight 2026-07-03 · PRUnderground · Healthcare https://www.prunderground.com/mots-c-is-having-its-biggest-month-yet-california-trim-clinic-breaks-down-the-new-human-trial-and-fda-review-putting-the-mitochondrial-peptide-in-the-spotlight/00387583/ MOTS-c has spent years circulating through longevity circles, metabolic-health communities, and peptide discussions. July 2026 marks a turning point as the mitochondrial-derived peptide enters a Phase 2a human metabolic trial and heads toward an FDA advisory committee review focused on compounded access. California Trim Clinic offers physician-guided, patient-specific compounded MOTS-c through licensed pharmacy partners for qualifying patients when prescribed and legally permitted. Patients interested in exploring the treatment can complete California Trim Clinic's confidential MOTS-c assessment to request a licensed-provider evaluation. The new attention does not mean every scientific question has been answered. It does mean MOTS-c has crossed into a larger conversation involving insulin ———————————————————————————————————————————————————————————— Department of Health und MIT - Koch Institute arbeiten zusammen, um die KI-gestützte Krebsforschung voranzutreiben 2026-07-03 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/department-of-health-und-mit--koch-institute-arbeiten-zusammen-um-die-ki-gestutzte-krebsforschung-voranzutreiben-302817763.html ABU DHABI, VAE, 3. Juli 2026 /PRNewswire/ -- Das Gesundheitsministerium von Abu Dhabi (Department of Health – Abu Dhabi, DoH), die Aufsichtsbehörde für den Gesundheitssektor im Emirat, und das MIT – Koch Institute for Integrative Cancer Research haben eine strategische Zusammenarbeit... ———————————————————————————————————————————————————————————— Forlong Medical Highlights Premium ISO & CE Certified Cotton Wool Roll 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/03/forlong-medical-highlights-premium-iso-ce-certified-cotton-wool-roll/?source=barchart ———————————————————————————————————————————————————————————— UEFA launches medical handover protocol to strengthen player care 2026-07-03 · WebWire · SaaS, Healthcare, Education https://www.webwire.com/ViewPressRel.asp?aId=357153 This pilot initiative precedes the future introduction of an integrated medical platform for European football, representing the long-term goal of effective medical data-sharing across European football. - - The new protocol, developed in collaboration with European Football Clubs (EFC), is designed to help medical staff share key information securely when players move between club and national team environments. It will serve as an initial step and learning phase, helping to inform and ref... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357153 ———————————————————————————————————————————————————————————— AMA modernizes maternity care coding to reflect today's obstetric care 2026-07-03 · WebWire · Healthcare https://www.webwire.com/ViewPressRel.asp?aId=357148 The American Medical Association (AMA) is making the most significant update to maternity care coding in decades to reflect how pregnancy care is delivered and improve the data needed to advance maternal health. - - The revised Current Procedural Terminology (CPT®) codes replace the decades-old global maternity care bundle with a reporting framework that captures four distinct phases of care—antepartum care, labor management, delivery, and postpartum care. The changes will provide welcome... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357148 ———————————————————————————————————————————————————————————— Mesothelioma Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | GSK, Merck, Bristol-Myers Squibb, AstraZeneca, Roche, Novartis, Pfizer Inc 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/03/mesothelioma-pipeline-2026-moa-roa-fdaapproved-drugs-and-clinical-trial-progress-assessment-by-delveinsight-gsk-merck-bristolmyers-squibb-astrazeneca-roche-novartis-pfizer-inc/?source=barchart ———————————————————————————————————————————————————————————— Idiopathic Pulmonary Fibrosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/03/idiopathic-pulmonary-fibrosis-pipeline-2026-therapies-under-investigation-clinical-trials-milestones-and-fda-approvals-by-delveinsight-boehringer-ingelheim-puretech-guangzhou-joyo-pharma/?source=barchart ———————————————————————————————————————————————————————————— Medical Care Technologies Inc. (OTC Pink:MDCE) Subsidiary Infinite ... 2026-07-03 · PR-Inside · Healthcare, Gaming https://pr-inside.com/medical-care-technologies-inc-otc-pink-mdce-subsidiary-infinite-r5197402.htm (PR-inside.com) Rare Dual-Signed, Photo-Matched "The Kobe 1" Sneakers from Series-Clinching 01' NBA Finals Game 5 Now Available Alongside 2009 Playoff Sneakers at $40,000 Buy It Now in Live Summer 2026 Flash Auction. MESA, AZ / ACCESS Newswire / July 3, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that two of the most significant Kobe Bryant game-worn sneaker lots in recent years are now available in its Infinite Auctions Summer 2026 Game Used Flash Auction at https://infiniteauctions.com/auctions, currently live and running through Saturday, July 18, 2026 at 9:00 PM EST. Both lots feature exceptional provenance, dual signatures, and ironclad photo-match authentication .. ———————————————————————————————————————————————————————————— Medical Care Technologies Inc. (OTC Pink:MDCE) Subsidiary Infinite Auctions Presents Kobe Bryant 2001 NBA Finals Championship Sneakers with $200,000 Buy It Now Option 2026-07-03 · Newswire.com · Healthcare, Gaming https://www.newswire.com/news/medical-care-technologies-inc-otc-pink-mdce-subsidiary-infinite-4462392 Rare Dual-Signed, Photo-Matched "The Kobe 1" Sneakers from Series-Clinching 01' NBA Finals Game 5 Now Available Alongside 2009 Playoff Sneakers at $40,000 Buy It Now in Live Summer 2026 Flash Auction. ———————————————————————————————————————————————————————————— To Celebrate America’s 250th Birthday, Utah Intermountain Health Babies Receive Special Onesie 2026-07-03 · PRUnderground · Healthcare https://www.prunderground.com/to-celebrate-americas-250th-birthday-utah-intermountain-health-babies-receive-special-onesie/00387542/ Babies born at Intermountain Health hospitals across Utah to receive special commemorative onesie to celebrate America's 250th birthday The post To Celebrate America's 250th Birthday, Utah Intermountain Health Babies Receive Special Onesie first appeared on ———————————————————————————————————————————————————————————— Spasticity Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Huons, Supernus Pharma, Sun Pharma, Acorda Therapeutics, Merz Pharmaceuticals GmbH 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/03/spasticity-pipeline-2026-moa-and-roa-insights-clinical-trials-status-and-key-companies-involved-by-delveinsight-huons-supernus-pharma-sun-pharma-acorda-therapeutics-merz-pharmaceuticals-gmbh/?source=barchart ———————————————————————————————————————————————————————————— Scleroderma Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Bayer, Novartis, GSK, Boehringer Ingelheim, Celgene Corp., Johnson & Johnson 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/03/scleroderma-pipeline-2026-fda-updates-therapy-innovations-and-clinical-trial-landscape-analysis-by-delveinsight-bayer-novartis-gsk-boehringer-ingelheim-celgene-corp-johnson-johnson/?source=barchart ———————————————————————————————————————————————————————————— In HelloNation, Education Expert Chelsea Gianni Details the Path to Becoming a Registered Nurse 2026-07-03 · PR Newswire · Healthcare, Education https://www.prnewswire.com/news-releases/in-hellonation-education-expert-chelsea-gianni-details-the-path-to-becoming-a-registered-nurse-302817269.html The article highlights how program length, clinical training, and online coursework shape nursing education in West Virginia. WHEELING, W.Va., July 3, 2026 /PRNewswire/ -- How long does it take to become a registered nurse in West Virginia? HelloNation has published the answer in an... ———————————————————————————————————————————————————————————— In HelloNation, Personal Injury Attorney Steve Caya Shares How Car Accident Settlement Values Are Determined 2026-07-03 · PR Newswire · Healthcare, Automotive https://www.prnewswire.com/news-releases/in-hellonation-personal-injury-attorney-steve-caya-shares-how-car-accident-settlement-values-are-determined-302817248.html The article outlines how medical documentation, lost income, long-term injuries, and comparative negligence affect settlement amounts. MADISON, Wis., July 3, 2026 /PRNewswire/ -- How much is a car accident settlement worth in Madison? HelloNation has published the answer in an article... ———————————————————————————————————————————————————————————— 1800Wheelchair reports handicap scooter use climbing as cities upgrade sidewalks 2026-07-03 · PressReleaseNews · Healthcare https://pressreleasenews.org/pressroom/1800wheelchair-reports-handicap-scooter-use-climbing-as-cities-upgrade-sidewalks 1800Wheelchair notes rising handicap scooter adoption nationwide as municipalities expand curb ramps, wider sidewalks and other accessible infrastructure improvements. ———————————————————————————————————————————————————————————— Ascelia Pharma Provides Update on the Orviglance NDA 2026-07-03 · PR-Inside · Healthcare https://pr-inside.com/ascelia-pharma-provides-update-on-the-orviglance-nda-r5197381.htm (PR-inside.com) MALMÖ, SE / ACCESS Newswire / July 3, 2026 / Ascelia Pharma AB (publ) (STO:ACE), a biotechnology company focused on improving the lives of people living with rare cancer conditions, today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Company's New Drug Application (NDA) for Orviglance®. Ascelia will engage with the FDA to find an expedited path forward. The FDA has informed the Company that it is currently unable to approve the NDA for Orviglance in its present form and has requested additional clinical data and product documentation. We seek .. ———————————————————————————————————————————————————————————— TransportBPO Rolls Out Medicaid-Trained NEMT Dispatch Teams as Medical Transportation Providers Face Nationwide Dispatcher Shortage 2026-07-03 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/transportbpo-rolls-out-medicaid-trained-nemt-dispatch-teams-as-medical-transportation-providers-face-nationwide-dispatcher-shortage-302817239.html Outsourced NEMT dispatch and call center service handles trip scheduling, broker coordination and patient calls for non-emergency medical transportation companies across the United States VANCOUVER, Wash., July 3, 2026 /PRNewswire/ -- TransportBPO (TransportBPO.com), the... ———————————————————————————————————————————————————————————— Overactive Bladder Pipeline 2026: Detailed Clinical Trials and FDA-Approved Therapies Review by DelveInsight | Astellas Pharma, Laborie, Hisamitsu Pharma, Medtronic, Pfizer, Teva Pharma 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/03/overactive-bladder-pipeline-2026-detailed-clinical-trials-and-fdaapproved-therapies-review-by-delveinsight-astellas-pharma-laborie-hisamitsu-pharma-medtronic-pfizer-teva-pharma/?source=barchart ———————————————————————————————————————————————————————————— Blood-Based Biomarker for Alzheimer’s Disease Diagnostics Market Growth Across Clinical Research 2026-07-03 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/03/1761573 The global Blood-Based Biomarker For Alzheimer’s Disease Diagnostics Market was valued at USD 169.2 million in 2025 and is projected to grow from USD 194.8 million in [read full press release...] ———————————————————————————————————————————————————————————— DoH and MIT- Koch Institute Partner to Advance AI-Driven Cancer Research 2026-07-03 · PR Newswire · AI, Healthcare https://www.prnewswire.com/news-releases/doh-and-mit-koch-institute-partner-to-advance-ai-driven-cancer-research-302817575.html ABU DHABI, UAE, July 3, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, and the MIT – Koch Institute for Integrative Cancer Research have announced a strategic collaboration to advance AI-enabled oncology research,... ———————————————————————————————————————————————————————————— New Release Author William Nelson's New Book, "God's Medical Plan Yesterday and Today," Explores Divine Healing Through Scripture, Faith, and Modern Medicine 2026-07-03 · PR.com · Healthcare https://www.pr.com/press-release/972236 William Nelson has completed a new book, "God's Medical Plan Yesterday and Today," which presents a transformative perspective on God's eternal blueprint for healing. Drawing from the miraculous acts of Jesus and the promises woven throughout Scripture, Nelson invites readers to journey beyond conventional views of medicine and discover how faith and healthcare can work together in harmony. This compelling [PR.com] ———————————————————————————————————————————————————————————— Recent Release, "Juicing for Life," from Christian Faith Publishing Authors Dr. Barbara Desautels and Richard Desautels, Offers a Comprehensive Juicing Guide 2026-07-03 · PR.com · Healthcare https://www.pr.com/press-release/972227 Dr. Barbara Desautels and Richard Desautels, RN BSN have completed a new book, "Juicing for Life" that draws on their decades-long experience with the transformative benefits of juicing. The authors share their personal journey, from incorporating juicing as a family activity to relying on it to regain their own health. With a focus on using fresh, natural ingredients to address a wide range of ailments, this [PR.com] ———————————————————————————————————————————————————————————— ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT Q2 2026 2026-07-03 · PRWeb · Finance, Healthcare https://www.prweb.com/releases/zinzino-ab-publ-preliminary-sales-report-q2-2026-302817562.html Zinzino group revenue increased 17% in Q2, compared with the previous year. GOTHENBURG, Sweden, July 3, 2026 /PRNewswire/ -- The revenue in June for Zinzino's sales markets increased by 14% and amounted to SEK 296.8 (259.3.9) million. Faun Pharma's external sales increased and amounted to... ———————————————————————————————————————————————————————————— TotalBond Veterinary Hospital at Paw Creek Strengthens Commitment to Lifelong Pet Health in Charlotte 2026-07-03 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/03/1761298 Charlotte, NC, 2026-07-03 — /EPR Network/ — TotalBond Veterinary Hospital at Paw Creek continues to reinforce its commitment to providing exceptional veterinary care for pets and [read full press release...] ———————————————————————————————————————————————————————————— Rapid Care PLLC Offers Trusted Urgent Care in Sanford, NC and Fayetteville, NC 2026-07-03 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/03/1761279 SANFORD, NC, 2026-07-03 — /EPR Network/ — Rapid Care PLLC is pleased to announce the continued expansion of its patient-centered urgent care services, making it easier [read full press release...] ———————————————————————————————————————————————————————————— Delray Orthodontics Highlights Customized Orthodontic Treatment Plans Featuring Braces 2026-07-03 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/03/1761246 Delray Beach, FL, 2026-07-03 — /EPR Network/ — No two smiles are the same, and neither should any two treatment plans be. A leading South [read full press release...] ———————————————————————————————————————————————————————————— Delray Orthodontics Announces New Patient Openings for Families Relocating to Delray Beach, Florida Seeking Immediate Dental Care Treatment 2026-07-03 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/03/1761236 Delray Beach, FL, 2026-07-03 — /EPR Network/ — Relocating to a new city brings plenty of challenges. Finding trusted healthcare right away is often one [read full press release...] ———————————————————————————————————————————————————————————— How Post-Surgery Rehab Centers in India Help Patients Regain Independence 2026-07-03 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/03/1761250 Hyderabad, India, 2026-07-03 — /EPR Network/ — Recovering from surgery is a gradual process that extends far beyond the operating room. Whether the procedure involves [read full press release...] ———————————————————————————————————————————————————————————— Delray Orthodontics Showcases Modern Orthodontic Care Through Invisalign Treatment in Delray Beach, FL 2026-07-03 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/03/1761238 Delray Beach, FL, 2026-07-03 — /EPR Network/ — The way orthodontic care is delivered has changed dramatically over the past decade. What once required years [read full press release...] ———————————————————————————————————————————————————————————— Coldwater Animal Hospital Delivers Comprehensive Pet Care to Rochester, NY 2026-07-03 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/03/1761222 New York, USA, 2026-07-03 — /EPR Network/ — Coldwater Animal Hospital, a trusted name in Rochester’s veterinary community for more than three decades, continues to [read full press release...] ———————————————————————————————————————————————————————————— Animal Medical Clinic of Gulf Gate Delivers Comprehensive Veterinary Care in Sarasota, FL 2026-07-03 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/03/1761215 Sarasota, FL, 2026-07-03 — /EPR Network/ — Animal Medical Clinic of Gulf Gate has built a reputation as one of Sarasota’s most trusted veterinary practices, [read full press release...] ———————————————————————————————————————————————————————————— Sky Labs présente « CART BP pro » comme une solution prometteuse pour les essais cliniques mondiaux 2026-07-03 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/sky-labs-presente--cart-bp-pro--comme-une-solution-prometteuse-pour-les-essais-cliniques-mondiaux-302817532.html BÂLE, Suisse et SÉOUL, Corée du Sud, 3 juillet 2026 /PRNewswire/ -- Sky Labs (CEO Jack Byunghwan Lee) a annoncé le 2 juillet avoir présenté ses solutions de plateforme de données lors du 9th Digital Biomarkers in Clinical Trials Summit à Bâle, en Suisse. À cette occasion, l'entreprise a... ———————————————————————————————————————————————————————————— Sky Labs präsentiert „CART BP pro" als potenzielle Lösung für den Einsatz in globalen klinischen Studien 2026-07-03 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/sky-labs-prasentiert-cart-bp-pro-als-potenzielle-losung-fur-den-einsatz-in-globalen-klinischen-studien-302817531.html BASEL, Schweiz und SEOUL, Südkorea, 3. Juli 2026 /PRNewswire/ -- Sky Labs (CEO Jack Byunghwan Lee) gab am 2. [Monat hinzufügen]* bekannt, dass das Unternehmen auf dem 9. Digital Biomarkers in Clinical Trials Summit in Basel (Schweiz) sein Datenplattform-Geschäft vorgestellt hat. Dabei hob... ———————————————————————————————————————————————————————————— Sky Labs presenta «CART BP pro» como una solución clave para ensayos clínicos farmacéuticos a escala mundial 2026-07-03 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/sky-labs-presenta-cart-bp-pro-como-una-solucion-clave-para-ensayos-clinicos-farmaceuticos-a-escala-mundial-302817530.html BASILEA, Suiza, y SEÚL, Corea del Sur, 3 de julio de 2026 /PRNewswire/ -- Sky Labs (CEO: Jack Byunghwan Lee) anunció el día 2 que presentó su plataforma de datos en la 9th Digital Biomarkers in Clinical Trials Summit, celebrada en Basilea (Suiza). Durante el evento, la compañía destacó el... ———————————————————————————————————————————————————————————— Sky Labs Showcases 'CART BP pro' for Potential Use in Drug Clinical Trials on Global Stage 2026-07-03 · PR Newswire · SaaS, Healthcare https://www.prnewswire.com/news-releases/sky-labs-showcases-cart-bp-pro-for-potential-use-in-drug-clinical-trials-on-global-stage-302817529.html BASEL, Switzerland and SEOUL, South Korea, July 3, 2026 /PRNewswire/ -- Sky Labs (CEO Jack Byunghwan Lee) announced on the 2nd that it introduced its data platform business at the 9th Digital Biomarkers in Clinical Trials Summit in Basel, Switzerland, highlighting the potential of its... ———————————————————————————————————————————————————————————— Startup Island TAIWAN-Led Delegation Secures More Than 100 Business Meetings at BIO 2026, Expanding Global Opportunities for Taiwanese Biotech Startups 2026-07-03 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/startup-island-taiwan-led-delegation-secures-more-than-100-business-meetings-at-bio-2026-expanding-global-opportunities-for-taiwanese-biotech-startups-302817522.html TAIPEI, July 3, 2026 /PRNewswire/ -- Six Taiwanese biomedical startups held more than 100 one-on-one business meetings with global pharmaceutical companies, investors, industry partners and research organizations at the BIO International Convention 2026, held from June 22 to 25 in San... ———————————————————————————————————————————————————————————— DOJ's Marijuana Rescheduling Court Filing Sends a Dangerous Message 2026-07-03 · PR-Inside · Healthcare https://pr-inside.com/doj-s-marijuana-rescheduling-court-filing-sends-a-dangerous-message-r5197271.htm (PR-inside.com) "This case has become much larger than marijuana," Duane Boise CEO of MMJ International Holdings stated. “The government is effectively telling the Court that protecting patients through the FDA approval process and protecting the public through workplace drug testing are not interests the Controlled Substances Act was designed to protect. We respectfully disagree. Congress enacted the CSA to protect public health, scientific integrity, and public safety-not to reward those who bypassed the federal system while penalizing those who followed it.” WASHINGTON, D.C. / ACCESS Newswire / July 3, 2026 /MMJ International Holdings, Inc. (MMJIH), together with its subsidiaries MMJ BioPharma Cultivation, .. ———————————————————————————————————————————————————————————— Myasthenia Gravis Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Alpine Immune Science, Toleranzia, Cabaletta Bio, Rallybio, Alexion Pharma, Takeda 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/02/myasthenia-gravis-pipeline-2026-key-companies-moa-roa-and-clinical-trials-evaluation-by-delveinsight-alpine-immune-science-toleranzia-cabaletta-bio-rallybio-alexion-pharma-takeda/?source=barchart ———————————————————————————————————————————————————————————— Insulin Resistance Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Exscien Crp, Glycomantra, Hanmi Pharma, NorthSea Therapeutics, Amolyt Pharma 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/02/insulin-resistance-pipeline-2026-fda-approvals-and-clinical-trials-landscape-with-moa-and-roa-highlights-by-delveinsight-exscien-crp-glycomantra-hanmi-pharma-northsea-therapeutics-amolyt-pharma/?source=barchart ———————————————————————————————————————————————————————————— Chronic Lower Back Pain Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Collegium Pharma, Eli Lilly and Company, Camurus, Braeburn, Scilex Holding, Mesoblast 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/02/chronic-lower-back-pain-pipeline-2026-therapies-moa-insights-and-key-clinical-trial-updates-by-delveinsight-collegium-pharma-eli-lilly-and-company-camurus-braeburn-scilex-holding-mesoblast/?source=barchart ———————————————————————————————————————————————————————————— Autistic Disorder Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Jazz Pharma, Axial Therapeutics, Eli Lilly, Scioto Biosciences, Roche 2026-07-03 · GetNews · Healthcare https://www.getnews.info/story/2026/07/02/autistic-disorder-pipeline-2026-fda-updates-therapy-innovations-and-clinical-trial-landscape-analysis-by-delveinsight-jazz-pharma-axial-therapeutics-eli-lilly-scioto-biosciences-roche/?source=barchart ———————————————————————————————————————————————————————————— ERAS Stockholders Have Rights - If you Lost Money Investing in Erasca, Inc. Contact Robbins LLP for Information About Recovering Your Losses 2026-07-02 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/eras-stockholders-have-rights--if-you-lost-money-investing-in-erasca-inc-contact-robbins-llp-for-information-about-recovering-your-losses-302817179.html SAN DIEGO, July 2, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Erasca, Inc. (NASDAQ: ERAS) securities between January 14, 2025 and April 26, 2026. Erasca, Inc., a clinical-stage... ———————————————————————————————————————————————————————————— Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 2026-07-02 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/02/3321604/0/en/Vor-Bio-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on July 1, 2026, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 71,200 shares of Vor Bio’s common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 15,150 shares of Vor Bio’s common stock to 7 newly hired employees. The foregoing stock options and RSUs were granted as material inducements to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”). ———————————————————————————————————————————————————————————— GuideAI Health Corp. Engages Market Maker 2026-07-02 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/02/3321592/0/en/GuideAI-Health-Corp-Engages-Market-Maker.html BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- GuideAI Health Corp. (Cboe CA: GDAI) (the “ Company ” or “ GuideAI ”) announces that it has engaged DS Market Solutions Inc. (Address: 1160 Walden Circle, Unit 6, Mississauga, ON, Canada; Contact: David Sears) (“DSM”) as a market maker for its common shares traded on Cboe Canada Inc. (“Cboe Canada”). ———————————————————————————————————————————————————————————— Beverly Hills' Century Psychology Group Expands Specialized Services for Anxiety Treatment, Autism Evaluations, and Couples Therapy 2026-07-02 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/beverly-hills-century-psychology-group-expands-specialized-services-for-anxiety-treatment-autism-evaluations-and-couples-therapy-302817170.html Century Psychology Group, a Beverly Hills mental health practice led by Dr. Shannon N. Daneshrad, Psy.D., has expanded its specialized clinical services for anxiety treatment, Autism Spectrum Disorder evaluations, and couples therapy. The expansion broadens access to evidence-based... ———————————————————————————————————————————————————————————— Mobia Medical Announces Vivistim® Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule 2026-07-02 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/02/3321580/0/en/Mobia-Medical-Announces-Vivistim-Procedure-Remains-Assigned-to-New-Technology-APC-1580-under-CMS-Proposed-2027-Hospital-Outpatient-Prospective-Payment-System-Rule.html AUSTIN, Texas, July 02, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that the Centers for Medicare and Medicaid Services (CMS) has proposed to maintain CPT® Code 64568, the procedure code used for the Vivistim® procedure, under the New Technology Ambulatory Payment Classification (APC) 1580 for calendar year (CY) 2027, with an associated hospital outpatient payment rate of approximately $45,000, unchanged from the CY 2026 rate. CMS is expected to publish the final Hospital Outpatient Prospective Payment System (OPPS) rule in November of this year, with any changes taking effect January 1, 2027. ———————————————————————————————————————————————————————————— ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 2026-07-02 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/02/3321570/0/en/ORIC-Pharmaceuticals-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html SOUTH SAN FRANCISCO and SAN DIEGO, July 02, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on July 1, 2026 (the “Grant Date”), ORIC granted a total of 44,400 non-qualified stock options and 7,200 restricted stock units to three new non-executive employees who began their employment with ORIC in June 2026. ———————————————————————————————————————————————————————————— Air Voel Strengthens Sleep Therapy Support with Reliable ResMed AirSense 11 Repair and CPAP Machine Repair Toronto Services 2026-07-02 · PressReleaseNews · Healthcare https://pressreleasenews.org/pressroom/air-voel-strengthens-sleep-therapy-support-with-reliable-resmed-airsense-11-repair-and-cpap-machine-repair-toronto-services Air Voel continues to enhance sleep therapy for Canadians by expanding dependable equipment support through professional ResMed AirSense 11 repair and CPAP machine repair Toronto services. ———————————————————————————————————————————————————————————— Konstantin Vision & Eyewear Center debuts one-visit glasses NYC service in Manhattan 2026-07-02 · PressReleaseNews · Healthcare https://pressreleasenews.org/pressroom/konstantin-vision-eyewear-center-debuts-one-visit-glasses-nyc-service-in-manhattan Konstantin Vision & Eyewear Center has introduced an executive eye exam and premium eyewear styling program in Manhattan for glasses NYC shoppers seeking coordinated care and frame selection. ———————————————————————————————————————————————————————————— Air Voel Expands Comprehensive Sleep Therapy Support with Reliable ResMed BiPAP Repair and AirSense 11 Repair Services 2026-07-02 · PressReleaseNews · Healthcare https://pressreleasenews.org/pressroom/air-voel-expands-comprehensive-sleep-therapy-support-with-reliable-resmed-bipap-repair-and-airsense-11-repair-services Air Voel continues to strengthen its commitment to improving sleep health for Canadians by providing dependable ResMed BiPAP repair and AirSense 11 repair services. ———————————————————————————————————————————————————————————— Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 2026-07-02 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/02/3321549/0/en/Outset-Medical-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html Outset announces inducement grant. ———————————————————————————————————————————————————————————— VERAXA Biotech (VRXA) Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program 2026-07-02 · NewMediaWire · Finance, SaaS, Healthcare, Retail https://www.newmediawire.com/news/veraxa-biotech-vrxa-initiates-cell-line-development-for-lead-bitac-cancer-therapy-program-7087478 LOS ANGELES, CA - July 2, 2026 ( NEWMEDIAWIRE ) - VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager (“BiTAC-TCE”) program through a collaboration with ATUM, which will apply its Leap-In Transposase(R) technology to generate stable clonal cell lines supporting IND/CTA-enabling activities and future clinical development. The collaboration follows encouraging preclinical data presented at the 2026 American Association for Cancer Research (“AACR”) Annual Meeting and is intended to support CMC development, including early process, analytical and formulation development, as well as the production of material for nonclinical studies. VERAXA said its BiTAC-TCE platform is designed to improve tumor selectivity by splitting the T-cel ———————————————————————————————————————————————————————————— Veterinary Vaccines Market to Reach $18.46 Billion by 2031, Driven by Rising Pet Ownership and Increasing Focus on Animal Health 2026-07-02 · GetNews · Healthcare https://www.getnews.info/story/2026/07/02/veterinary-vaccines-market-to-reach-1846-billion-by-2031-driven-by-rising-pet-ownership-and-increasing-focus-on-animal-health/?source=barchart ———————————————————————————————————————————————————————————— Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases 2026-07-02 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/02/3321515/0/en/Cosmos-Health-Expands-Buyback-to-3-42-Million-Shares-With-Additional-770-000-Share-Repurchase-Continues-Open-Market-Purchases.html Cosmos Health expands buyback to 3.42 million shares with additional share repurchase. ———————————————————————————————————————————————————————————— How Workers' Compensation in Georgia Works Explained in HelloNation Featuring Workers' Compensation Attorney Barton Solomon 2026-07-02 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/how-workers-compensation-in-georgia-works-explained-in-hellonation-featuring-workers-compensation-attorney-barton-solomon-302817107.html The article outlines the no-fault system, medical care requirements, and how benefits are calculated. CHATSWORTH, Ga., July 2, 2026 /PRNewswire/ -- How does workers' compensation work in Georgia? HelloNation has published a HelloNation article that provides the answer, explaining the... ———————————————————————————————————————————————————————————— In HelloNation, Dental Expert Dustin Plunkett Explains Why Routine Dental Checkups Matter for Families 2026-07-02 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/in-hellonation-dental-expert-dustin-plunkett-explains-why-routine-dental-checkups-matter-for-families-302817095.html Consistent Dental Visits Help Families Catch Problems Early and Build Habits That Support Long-Term Oral Health. JOHNS ISLAND, S.C., July 2, 2026 /PRNewswire/ -- How often should families in Johns Island schedule dental checkups, and what does each appointment actually include? A... ———————————————————————————————————————————————————————————— Personal Injury Documentation Beyond Medical Records Explained in HelloNation Featuring Personal Injury Attorney D. Seth Holliday 2026-07-02 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/personal-injury-documentation-beyond-medical-records-explained-in-hellonation-featuring-personal-injury-attorney-d-seth-holliday-302817083.html The article examines why medical records alone may not fully show pain, limitations, and emotional stress after an injury. RINGGOLD, Ga., July 2, 2026 /PRNewswire/ -- Are medical records alone enough to prove the full impact of a personal injury in Georgia? HelloNation has published a... ———————————————————————————————————————————————————————————— Cloud of Goods Calls for Destination Readiness Ahead of ADA Anniversary, Helping Travelers Plan Mobility, Accessibility, and Medical Gear Before Arrival 2026-07-02 · PR Newswire · SaaS, Healthcare, Automotive https://www.prnewswire.com/news-releases/cloud-of-goods-calls-for-destination-readiness-ahead-of-ada-anniversary-helping-travelers-plan-mobility-accessibility-and-medical-gear-before-arrival-302817072.html As the July 26 ADA anniversary approaches, Cloud of Goods urges destinations, hotels, travel advisors, and travelers to think beyond accessible venues and plan the gear support travelers need once they arrive. COCONUT CREEK, Fla., July 2, 2026 /PRNewswire/ -- Ahead of the July 26... ———————————————————————————————————————————————————————————— Your Teen Asked the Internet How to Lose Weight. California Trim Clinic Gives Them Access to a Real Doctor Instead 2026-07-02 · PRUnderground · Healthcare, Energy, Education https://www.prunderground.com/your-teen-asked-the-internet-how-to-lose-weight-california-trim-clinic-gives-them-access-to-a-real-doctor-instead/00387497/ Teenagers can ask a chatbot for a weight-loss plan in seconds. A 2026 nutrition study found that meal plans generated for adolescents missed their estimated daily energy needs by an average of 695 calories, with major inconsistencies across calories, carbohydrates, fats, and micronutrients. At the same time, Florida Atlantic University reports that 22.2% of U.S. high school students are living with obesity. Families are now navigating a collision of rising medical need, algorithm-generated diets, viral body trends, and injectable products sold through social media. California Trim Clinic gives families a direct path into medical care. A private virtual consultation with Dr. Lynda A. Szczech costs $99, and families who enroll receive weekly check-ins from the California Trim Clinic care tea ———————————————————————————————————————————————————————————— After Durnell: Why the Fight Against Pesticides and their Health Harms Is Entering a New Chapter 2026-07-02 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/after-durnell-why-the-fight-against-pesticides-and-their-health-harms-is-entering-a-new-chapter-302817105.html An analysis from Center for Food Safety WASHINGTON, July 2, 2026 /PRNewswire/ -- More than 200,000 Americans have sued Monsanto, arguing that their Roundup pesticide gave them cancer. They are farmers, groundskeepers, landscapers, and regular folks tending to their own yards. People that... ———————————————————————————————————————————————————————————— CORRECTION FROM SOURCE: Emerging Growth Research Issues Flash Report ... 2026-07-02 · PR-Inside · Finance, Healthcare https://pr-inside.com/correction-from-source-emerging-growth-research-issues-flash-report-r5197144.htm (PR-inside.com) The tiered reward structure only has to be at or above the specified price level on the 3, 6, 9, or 12 month observation date. It was previously mentioned that the pricing needed to be sustained over that time period. NEW YORK CITY, NY / ACCESS Newswire / July 2, 2026 / Emerging Growth Research today issued a flash report on OSR Health, Inc. (Nasdaq:OSRH), formerly OSR Holdings, reaffirming its Buy-Emerging rating and 12-month price target of $10.00. The flash report highlights OSRH's newly announced Shareholder Loyalty Program, a novel plan to reward long-term shareholders with Contingent Value Rights ("CVR") rather than .. ———————————————————————————————————————————————————————————— CORRECTION FROM SOURCE: Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target 2026-07-02 · Newswire.com · Healthcare https://www.newswire.com/news/correction-from-source-emerging-growth-research-issues-flash-report-on-osr The tiered reward structure only has to be at or above the specified price level on the 3, 6, 9, or 12 month observation date.  It was previously mentioned that the pricing needed to be sustained over that time period.   ———————————————————————————————————————————————————————————— ZetrOZ Systems Delivers the Future of Sports Medicine Soft Tissue Injury ... 2026-07-02 · PR-Inside · Healthcare https://pr-inside.com/zetroz-systems-delivers-the-future-of-sports-medicine-soft-tissue-injury-r5197141.htm (PR-inside.com) At the National Athletic Trainers Association meeting, the inventors of sam® showcase the clinically validated, FDA-cleared device that revolutionizes recovery from soft-tissue injuries for athletes and active people, with endorsements from physicians, professional athletes, and military veterans. PHILADELPHIA, PA / ACCESS Newswire / July 2, 2026 /ZetrOZ Systems unveiled sam® 3.0, the new evolution of its award-winning Sustained Acoustic Medicine wearable ultrasound technology, at the annual meeting of the National Athletic Trainers Association (NATA) on June 29-July 2. The sam® device has been clinically validated in 40 studies to accelerate healing and reduce pain in soft-tissue injuries common to amateur and professional .. ———————————————————————————————————————————————————————————— ZetrOZ Systems Delivers the Future of Sports Medicine Soft Tissue Injury Treatment with National Launch of sam 3.0 at NATA in Philadelphia USA to Celebrate 250 Years of American Innovation 2026-07-02 · Newswire.com · Healthcare https://www.newswire.com/news/zetroz-systems-delivers-the-future-of-sports-medicine-soft-tissue-22816626 At the National Athletic Trainers Association meeting, the inventors of sam® showcase the clinically validated, FDA-cleared device that revolutionizes recovery from soft-tissue injuries for athletes and active people, with endorsements from physicians, professional athletes, and military veterans. ———————————————————————————————————————————————————————————— MNA: MGB Billionaires Refuse to Negotiate with Brigham and Women's Hospital Nurses, Forcing Nurses to Strike July 8 for Patient Safety 2026-07-02 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/mna-mgb-billionaires-refuse-to-negotiate-with-brigham-and-womens-hospital-nurses-forcing-nurses-to-strike-july-8-for-patient-safety-302817068.html On July 2, the billionaires and corporate executives who run Mass General Brigham refused to compromise with Brigham nurses, forcing nurses to strike July 8 BOSTON, July 2, 2026 /PRNewswire/ -- The billionaires and corporate executives on the Mass General Brigham Board of Directors have... ———————————————————————————————————————————————————————————— Intermountain Health Experts Remind People the Importance of Staying Hydrated This Summer 2026-07-02 · PRUnderground · Healthcare https://www.prunderground.com/intermountain-health-experts-remind-people-the-importance-of-staying-hydrated-this-summer/00387481/ It's not just what you drink - it's also what you eat! Intermountain Health reminds people to stay hydrated and eat right during heat of summer The post Intermountain Health Experts Remind People the Importance of Staying Hydrated This Summer first appeared on ———————————————————————————————————————————————————————————— 2026 Provider EHR IT Consulting Benchmark as Health Systems Shift from ... 2026-07-02 · PR-Inside · Healthcare https://pr-inside.com/provider-ehr-it-consulting-benchmark-as-health-systems-shift-from-r5197106.htm (PR-inside.com) 620 qualified executives across 145 provider organizations evaluated 20 EHR optimization, workflow redesign and selective implementation consulting firms under Black Book's Research project-verified Q1-Q18 framework TAMPA, FL / ACCESS Newswire / July 2, 2026 / Black Book Research today announced the Q3 2026 release of Healthcare IT Consulting & Advisory Services: USA Provider Organizations, Hospitals, Health Systems & Clinical Enterprises - EHR Optimization, Workflow Redesign & Selective Implementation, a 52-page market benchmark evaluating provider EHR consulting performance, buyer priorities and the 2027-2028 outlook for optimization, stabilization and selective implementation. The study reflects input from 620 qualified executives representing 145 provider organizations ———————————————————————————————————————————————————————————— 2026 Provider EHR IT Consulting Benchmark as Health Systems Shift from Replacement-Led Projects to Optimization, Workflow Redesign and Measurable Installed-Base Value 2026-07-02 · Newswire.com · Healthcare https://www.newswire.com/news/2026-provider-ehr-it-consulting-benchmark-as-health-systems-shift-from-22815298 620 qualified executives across 145 provider organizations evaluated 20 EHR optimization, workflow redesign and selective implementation consulting firms under Black Book's Research project-verified Q1-Q18 framework ———————————————————————————————————————————————————————————— We re in the Game: Bear Bryant Award Returns to EA SPORTS College Football 27 2026-07-02 · NewMediaWire · Healthcare, Retail, Gaming, Media https://www.newmediawire.com/news/we-re-in-the-game-bear-bryant-award-returns-to-ea-sports-college-football-27-7087471 HOUSTON - July 2, 2026 ( NEWMEDIAWIRE ) - The name of the legendary Paul “Bear” Bryant is synonymous with excellence in the game of college football, and once again, fans playing EA SPORTS College Football 27’s Dynasty Mode will have the chance to win the American Heart Association’s Paul “Bear” Bryant Award as the game’s National Coach of the Year. Last year’s video game release saw the Bryant Award join the Heisman Trophy, Lou Groza Award, Lombardi Award, Unitas Golden Arm Award and Broyles Award as featured awards in the game. The continued inclusion of the Paul “Bear” Bryant Coach of the Year Award in one of the most celebrated video game franchises in history is another step in the efforts by the American Heart Association, a relentless force changing the future of health for everyone ———————————————————————————————————————————————————————————— Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio 2026-07-02 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/radnostix-acquires-lucerno-dynamics-assets-expanding-radiopharma-medical-device-portfolio-302816984.html IDAHO FALLS, Idaho, July 2, 2026 /PRNewswire/ -- Radnostix, Inc. (OTCQB: INIS) ("Radnostix" or the "Company"), a leader in radioisotope production and nuclear medicine solutions, today announced the successful closing of its acquisition of key assets from Lucerno Dynamics, LLC, including... ———————————————————————————————————————————————————————————— ConocoPhillips Contributes $1 Million for Earthquake Relief in Venezuela 2026-07-02 · WebWire · Healthcare https://www.webwire.com/ViewPressRel.asp?aId=357092 ConocoPhillips announced today a $1 million contribution to support humanitarian relief efforts for communities affected by the earthquakes that struck Venezuela on June 24. The company will also double match eligible employee donations toward the response. - - The contribution will help local relief organizations provide food, water, shelter, medical care and other essential assistance to those impacted by the earthquakes. ConocoPhillips is proud of its history of operations in Venezuela f... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357092 ———————————————————————————————————————————————————————————— Hospital Procurement Expectations Outpace AI Regulation for Medical Device Manufacturers 2026-07-02 · PR Newswire · AI, Healthcare https://www.prnewswire.com/news-releases/hospital-procurement-expectations-outpace-ai-regulation-for-medical-device-manufacturers-302816974.html As AI becomes embedded in medical technologies, manufacturers should prepare to demonstrate AI governance alongside cybersecurity SCHAUMBURG, Ill., July 2, 2026 /PRNewswire/ -- Medical device manufacturers are entering a new procurement landscape where demonstrating cybersecurity and... ———————————————————————————————————————————————————————————— TomTom and Transit Technologies partner to deliver enhanced fleet and logistics operations 2026-07-02 · WebWire · Healthcare, Automotive https://www.webwire.com/ViewPressRel.asp?aId=357090 TomTom ( TOM2 ), the specialist in mapping and location technology, and Transit Technologies, a leading provider of software solutions powering mobility systems, today announced a strategic partnership integrating TomTom Orbis Maps and Live Traffic into Transit Technologies' fleet and logistics solutions, bringing real-time routing intelligence to transit, paratransit, and non-emergent medical transportation (NEMT) networks across the United States and Central America. - - Transit Techn... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357090 ———————————————————————————————————————————————————————————— Greenlight Guru achieves ISO 42001 certification for AI governance across medtech quality and clinical solutions 2026-07-02 · PR Newswire · AI, Healthcare https://www.prnewswire.com/news-releases/greenlight-guru-achieves-iso-42001-certification-for-ai-governance-across-medtech-quality-and-clinical-solutions-302816764.html The certification covers AI governance across the company's eQMS and EDC products, giving medical device companies independently verified evidence for audits and vendor qualification INDIANAPOLIS, July 2, 2026 /PRNewswire/ -- Greenlight Guru, which builds quality management, product... ———————————————————————————————————————————————————————————— 45Drives Announces First Wave of Featured Speakers for Fourth Annual Creator Summit 2026-07-02 · NewMediaWire · AI, Energy, Retail, Education, Healthcare https://www.newmediawire.com/news/45drives-announces-first-wave-of-featured-speakers-for-fourth-annual-creator-summit-7087467 Leaders From Unraid, JR Automation, and Some of the Technology Community's Most Influential Creators Revealed as 45Drives Prepares for Its Largest Creator Summit Yet WILMINGTON, NC - July 2, 2026 ( NEWMEDIAWIRE ) - As organizations race to build private AI infrastructure and creators increasingly embrace self-hosting, open-source software, and locally owned technology, the leaders driving those movements will come together this October at the Fourth Annual Creator Summit. Today, 45Drives announced the first wave of featured speakers for the event, taking place October 20-22 at the Skyline Center in Wilmington, North Carolina. Designed to bring together enterprise technology leaders, infrastructure architects, creators, engineers, and the open-source community, Creator Summit has become one ———————————————————————————————————————————————————————————— Cornerstone Physiotherapy Marks 18 Years With Milestone Opening of ... 2026-07-02 · PR-Inside · Healthcare https://pr-inside.com/cornerstone-physiotherapy-marks-18-years-with-milestone-opening-of-r5197035.htm (PR-inside.com) TORONTO, ON / ACCESS Newswire / July 2, 2026 /Cornerstone Physiotherapy, a multidisciplinary clinical group founded in 2008 by physiotherapists Adam Brown and Joon Nah, has officially opened its tenth facility in the Greater Toronto Area. Located at 5086 Hurontario Street, just north of the Square One shopping district, the new site marks the company's second clinical location within the city of Mississauga. The expansion represents a major 18-year milestone for the clinician-founded company, which began as a single local practice and has systematically scaled to meet the growing demand for evidence-based rehabilitation across Ontario. The new Mississauga Square One facility .. ———————————————————————————————————————————————————————————— Thailand Launches "Thailand Health Excellence 2026" The Next Chapter of Global Healing Advancing Thailand as a Global Health & Healing Destination supported by TAT 2026-07-02 · PRWeb · Healthcare https://www.prweb.com/releases/thailand-launches-thailand-health-excellence-2026-the-next-chapter-of-global-healing-advancing-thailand-as-a-global-health--healing-destination-supported-by-tat-302816516.html The world is entering a new era in which health has become one of the defining priorities shaping how people live and travel. Increasingly, people are seeking journeys that not only offer leisure and relaxation, but also promote disease prevention, recovery, longevity, emotional... ———————————————————————————————————————————————————————————— Danone USA's Economic Impact: Putting Health Through Food in Action for America 2026-07-02 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/danone-usas-economic-impact-putting-health-through-food-in-action-for-america-302816924.html Study Reports Danone's Business Had a $9.6 Billion Impact to the U.S. Economy in 2025 Key Points Danone sources ~90% of its ingredients domestically and, in 2025, purchased approximately 200 million gallons of milk from U.S. farms across several states. Danone's U.S. footprint helps... ———————————————————————————————————————————————————————————— MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals 2026-07-02 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/02/3321364/0/en/MacroGenics-Completes-Sale-of-GMP-Manufacturing-Operations-to-Bora-Pharmaceuticals.html ROCKVILLE, MD, July 02, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, and Bora Pharmaceuticals Co., Ltd. (TWSE: 6472; OTCQX: BORAY), a global leader in pharmaceutical manufacturing, today announced completion of the sale of MacroGenics’ good manufacturing practice (GMP) drug substance manufacturing operations to Bora. ———————————————————————————————————————————————————————————— Medical Care Technologies Inc. (OTC Pink:MDCE) Advances Beyond Original ... 2026-07-02 · PR-Inside · AI, Healthcare https://pr-inside.com/medical-care-technologies-inc-otc-pink-mdce-advances-beyond-original-r5197033.htm (PR-inside.com) Rapid Internal Innovation Renders U.S. Provisional Patent Application No. 63/854,935 Obsolete, Highlighting Exceptional Velocity in AI Development MESA, AZ / ACCESS Newswire / July 2, 2026 /Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that it has elected not to proceed with its U.S. Provisional Patent Application No. 63/854,935, originally filed in July 2025 for its AI Vision Technology. This decision reflects the Company's accelerated pace of innovation, as its current proprietary AI vision systems and software have advanced significantly beyond the original application. Since filing the provisional patent in July 2025, MDCE's engineering teams have achieved substantial breakthroughs in computer vision .. ———————————————————————————————————————————————————————————— Medical Care Technologies Inc. (OTC Pink:MDCE) Advances Beyond Original AI Vision Patent - Technology Has Evolved Faster Than Expected 2026-07-02 · Newswire.com · AI, Healthcare https://www.newswire.com/news/medical-care-technologies-inc-otc-pink-mdce-advances-beyond-original-ai-vision Rapid Internal Innovation Renders U.S. Provisional Patent Application No. 63/854,935 Obsolete, Highlighting Exceptional Velocity in AI Development ———————————————————————————————————————————————————————————— New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad’s Prolaris® Biopsy Test in Localized Prostate Cancer 2026-07-02 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/02/3321352/15459/en/New-Large-Scale-Meta-Analysis-Demonstrates-Strong-Prognostic-Performance-of-Myriad-s-Prolaris-Biopsy-Test-in-Localized-Prostate-Cancer.html New published data shows Prolaris Biopsy Test adds significant prognostic information beyond conventional clinical risk categories for prostate cancer. ———————————————————————————————————————————————————————————— Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms ... 2026-07-02 · PR-Inside · Finance, Healthcare https://pr-inside.com/emerging-growth-research-issues-flash-report-on-osr-health-inc-reaffirms-r5197025.htm (PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 2, 2026 / Emerging Growth Research today issued a flash report on OSR Health, Inc. (NASDAQ:OSRH), formerly OSR Holdings, reaffirming its Buy-Emerging rating and 12-month price target of $10.00. The flash report highlights OSRH's newly announced Shareholder Loyalty Program, a novel plan to reward long-term shareholders with Contingent Value Rights ("CVR") rather than pursuing a reverse stock split. The Company's Board has approved the plan, which remains subject to legal counsel's opinion, with a record date targeted for July 31, 2026. Key Highlights From the Flash Report: Shareholder Loyalty Program via Contingent Value Rights: OSRH .. ———————————————————————————————————————————————————————————— Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target 2026-07-02 · Newswire.com · Healthcare https://www.newswire.com/news/emerging-growth-research-issues-flash-report-on-osr-health-inc-reaffirms-buy ———————————————————————————————————————————————————————————— Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, File Suit Against Enki Health Services, Inc., for Alleged Failure to Provide Required Meal Periods and Rest Periods 2026-07-02 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/employment-law-attorneys-at-blumenthal-nordrehaug-bhowmik-de-blouw-llp-file-suit-against-enki-health-services-inc-for-alleged-failure-to-provide-required-meal-periods-and-rest-periods-302816416.html Enki Health Services, Inc., allegedly failed to provide employees with accurate wages due to missed meals and break breaks. This allegedly resulted in violations of various California Labor Codes. **THIS IS AN ATTORNEY ADVERTISEMENT** LOS ANGELES, July 2, 2026 /PRNewswire/ -- The Los... ———————————————————————————————————————————————————————————— Most AI Tools Ask You to Trust the Black Box; NutraVeri Built One You ... 2026-07-02 · PR-Inside · AI, SaaS, Healthcare https://pr-inside.com/most-ai-tools-ask-you-to-trust-the-black-box-nutraveri-built-one-you-r5197014.htm (PR-inside.com) The platform's readiness score is deterministic: the same supplement formula always produces the same result, every number traces to a public FDA or FTC source, and founders can change one input and watch exactly which risk moves. The first score is free. MIAMI, FL / ACCESS Newswire / July 2, 2026 /Nitches Inc. (OTCID:NICH) - Ask most "AI-powered" tools how they reached a conclusion and the honest answer is that no one can fully say. The model is a black box. The output changes between runs. There is no way to inspect the work. NutraVeri, operated by Nitches Inc. (OTCID:NICH), took the .. ———————————————————————————————————————————————————————————— Most AI Tools Ask You to Trust the Black Box; NutraVeri Built One You Can Audit 2026-07-02 · Newswire.com · AI, SaaS, Healthcare https://www.newswire.com/news/most-ai-tools-ask-you-to-trust-the-black-box-nutraveri-built-one-you-can-audit The platform's readiness score is deterministic: the same supplement formula always produces the same result, every number traces to a public FDA or FTC source, and founders can change one input and watch exactly which risk moves. The first score is free. ———————————————————————————————————————————————————————————— Tenon Medical(R) Announces FDA 510(k) Clearance for Catamaran(R) SI ... 2026-07-02 · PR-Inside · Finance, Healthcare https://pr-inside.com/tenon-medical-r-announces-fda-510-k-clearance-for-catamaran-r-si-r5197006.htm (PR-inside.com) ~ Updated clearance incorporates various instrument upgrades, as well as per-procedure costs, improving unit economics driven by the reclassification of certain instruments from disposable to reusable status ~ ~ Clearance reflects Tenon's commitment to continuous innovation and operational efficiency, with reusable instrumentation expected to drive lower capex and logistical spend, contributing positively to gross margins and cash flow ~ LOS GATOS, CA / ACCESS Newswire / July 2, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance .. ———————————————————————————————————————————————————————————— New Cadence Healthcare Welcomes Dr. Karen Rasmussen as Third Physician, Reuniting Three Doctors from the Same Long Beach Residency Program 2026-07-02 · Send2Press · Healthcare https://www.send2press.com/wire/new-cadence-healthcare-welcomes-dr-karen-rasmussen-as-third-physician-reuniting-three-doctors-from-the-same-long-beach-residency-program/ LONG BEACH, Calif., July 2, 2026 (SEND2PRESS NEWSWIRE) -- New Cadence Healthcare, a membership-based primary care practice in Long Beach, today announced that Dr. Karen Rasmussen will join the practice as its third physician beginning August 2026. Dr. Rasmussen is a board-certified family physician who has cared for patients in Southern California for more than a decade. ———————————————————————————————————————————————————————————— The Healthcare Technology Report Announces The Top Healthcare Technology Companies of 2026: Volume I 2026-07-02 · PRWeb · Healthcare https://www.prweb.com/releases/the-healthcare-technology-report-announces-the-top-healthcare-technology-companies-of-2026-volume-i-302816458.html The Healthcare Technology Report is pleased to announce The Top Healthcare Technology Companies of 2026: Volume I NEW YORK, July 2, 2026 /PRNewswire-PRWeb/ -- Medical science has advanced to a point previously thought unimaginable, with breakthrough therapies, complex genomic mapping, and... ———————————————————————————————————————————————————————————— Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial 2026-07-02 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/02/3321253/0/en/Polyrizon-Announces-Successful-Results-for-NASARIX-Biocompatibility-Program-Supporting-Advancement-Towards-First-in-Human-Clinical-Trial.html Raanana, Israel, July 02, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced successful results from its biocompatibility evaluation program for its proprietary NASARIX TM Allergy Blocker nasal spray, with all required biological safety tests meeting their predetermined acceptance criteria. ———————————————————————————————————————————————————————————— IVI RMA Global and Conceivable Life Sciences Announce Partnership to Deploy the First Automated IVF Lab in the US 2026-07-02 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/ivi-rma-global-and-conceivable-life-sciences-announce-partnership-to-deploy-the-first-automated-ivf-lab-in-the-us-302816394.html IVI RMA Global continues to improve patient outcomes by combining cutting-edge technology with world-class clinical expertise MADRID and NEW YORK, July 2, 2026 /PRNewswire/ -- IVI RMA Global, the world's leading fertility care organization, and Conceivable Life Sciences today announced a... ———————————————————————————————————————————————————————————— Top National Health Plan Extends Agreement for Mental Health and Expands Dario Partnership into Cardiometabolic Care, Demonstrating Successful Multi-Condition Growth Strategy 2026-07-02 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/top-national-health-plan-extends-agreement-for-mental-health-and-expands-dario-partnership-into-cardiometabolic-care-demonstrating-successful-multi-condition-growth-strategy-302816343.html Third health plan customer to expand beyond initial deployment, reinforcing Dario's land-and-expand strategy and creating significant opportunity to grow revenue within existing customer base NEW YORK, July 2, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company",... ———————————————————————————————————————————————————————————— Kane Biotech Announces Results of Annual and Special Meeting of Shareholders 2026-07-02 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/02/3321244/0/en/Kane-Biotech-Announces-Results-of-Annual-and-Special-Meeting-of-Shareholders.html WINNIPEG, Manitoba, July 02, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) the voting results from its annual and special meeting of shareholders (the “Meeting”) on June 24, 2026. ———————————————————————————————————————————————————————————— Cartesian Therapeutics Announces New Employment Inducement Grants 2026-07-02 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/02/3321228/0/en/Cartesian-Therapeutics-Announces-New-Employment-Inducement-Grants.html FREDERICK, Md., July 02, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the granting of inducement awards to eight new employees. On July 1, 2026, the Company issued to these employees options to purchase an aggregate of 238,700 shares of the Company’s common stock with an exercise price of $10.18, the closing trading price of the Company’s common stock on the Nasdaq Global Market on the date of grant. The options were granted pursuant to the Company’s Amended and Restated 2018 Employment Inducement Incentive Award Plan and were approved by the Company’s board of directors. The options vest as to 25% on July 1, 2027, and then in thirty-six subs ———————————————————————————————————————————————————————————— British Wheel of Yoga Announces Free Ayurveda for Sleep Masterclass 2026-07-02 · Pressat · Healthcare https://pressat.co.uk/releases/british-wheel-of-yoga-announces-free-ayurveda-for-sleep-masterclass-22bb2b8a6f806fedcdc4190d00af96a4/ Thursday 2 July, 2026 The British Wheel of Yoga (BWY) is inviting everyone to a completely free online masterclass, Ayurveda for Sleep, led by Ayurvedic expert and BWY Teacher Trainer Tarik Dervish. The session, which takes place on Wednesday 8 July from 5-6.15pm, will explore why so many people struggle to wake feeling rested, and how Ayurveda can offer practical ways to support better sleep. Recent UK research shows that poor sleep quality and short sleep are common, with many adults sleeping less than seven hours a night and reporting sleep disorders or unrefreshing sleep. “In Ayurveda, sleep is not treated in isolation,” says Tarik Dervish. “It is understood as part of a larger picture: one that includes daily rhythm, diet, environment, stress and our relationship with nature.” Ayurved ———————————————————————————————————————————————————————————— Partner Therapeutics Announces Publication of Results From the eNRGy Trial of Zenocutuzumab in Patients with NRG1+ Cholangiocarcinoma in Journal of Clinical Oncology (JCO) 2026-07-02 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/partner-therapeutics-announces-publication-of-results-from-the-enrgy-trial-of-zenocutuzumab-in-patients-with-nrg1-cholangiocarcinoma-in-journal-of-clinical-oncology-jco-302816350.html Zenocutuzumab offers meaningful and durable antitumor activity, substantially reduced toxicity and no treatment‑limiting safety concerns, distinguishing it favorably from existing standards of care LEXINGTON, Mass., July 2, 2026 /PRNewswire/ -- Partner Therapeutics, Inc. (PTx), a private,... ———————————————————————————————————————————————————————————— SOCO® Launches Small-Pack Solidification Solutions for Healthcare and Emergency Sanitation Applications 2026-07-02 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/soco-launches-small-pack-solidification-solutions-for-healthcare-and-emergency-sanitation-applications-302816822.html LOS ANGELES, July 2, 2026 /PRNewswire/ -- As healthcare facilities, portable sanitation providers and emergency response organizations seek safer methods for liquid waste management, SOCO® announced the launch of its small-pack solidification solutions designed for medical liquid waste... ———————————————————————————————————————————————————————————— Discover Health Welcomes Two Board-Certified Pediatricians to Its San Francisco Practice 2026-07-02 · PRWeb · Healthcare https://www.prweb.com/releases/discover-health-welcomes-two-board-certified-pediatricians-to-its-san-francisco-practice-302816390.html Dr. Nicole Glynn and Dr. Sophia Hurd join Discover Health's concierge pediatric team, expanding access to relationship-driven care for Bay Area families. SAN FRANCISCO, July 2, 2026 /PRNewswire-PRWeb/ -- Discover Health, a concierge medical practice dedicated to personalized,... ———————————————————————————————————————————————————————————— TherapyHive Launches On-Demand Hourly Therapy Offices in New York City, Empowering Flexible, Hybrid Practices 2026-07-02 · Newswire.com · Healthcare https://www.newswire.com/news/therapyhive-launches-on-demand-hourly-therapy-offices-in-new-york-city-22808061 Designed to Meet the Evolving Needs of Today's Mental Health Professionals, TherapyHive's Hourly Offices Eliminate the Burden of Long-Term Leases While Maintaining a Premium, Compliant and Client-Ready Environment ———————————————————————————————————————————————————————————— Alligator Announces First Patient Dosed in Investigator-Initiated Study ... 2026-07-02 · PR-Inside · Finance, Healthcare, Education https://pr-inside.com/alligator-announces-first-patient-dosed-in-investigator-initiated-study-r5196925.htm (PR-inside.com) LUND, SE / ACCESS Newswire / July 2, 2026 / Alligator Bioscience (STO:ATORX) First patient dosed in an investigator-initiated trial evaluating intratumoral mitazalimab, with or without intratumoral nivolumab Study evaluates how local CD40 activation affects the tumor microenvironment ahead of surgery to inform future clinical development Trial conducted at an Ivy League university in the United States Lund, Sweden - 2 July 2026 - Alligator Bioscience (Nasdaq Stockholm: ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, today announces that the first patient has been dosed in an investigator-initiated trial (IIT, NCT07319195) evaluating intratumoral administration of mitazalimab, Alligator's lead CD40 agonist, in patients ———————————————————————————————————————————————————————————— 14th Enterprise Awards Recognises the Visionaries Shaping the Future of UK Tech 2026-07-02 · Pressat · Finance, Healthcare, Retail https://pressat.co.uk/releases/14th-enterprise-awards-recognises-the-visionaries-shaping-the-future-of-uk-tech-d0577ab9c4d3212e381abe43f564c4c8/ Thursday 2 July, 2026 Entrepreneurs and Founder Friendly Funds recognised for driving the next generation of UK innovation London, 2 July 2026 – Some of the UK's most outstanding entrepreneurs were recognised last night (1 July) at the glittering Enterprise Awards, held at Drapers' Hall in the City of London. Now in its 14th year, the Enterprise Awards celebrates entrepreneurship, innovation and business leadership, recognising founders and business leaders at every stage of growth. Since the awards were launched, nearly 120 entrepreneurs have been recognised, whose businesses now generate over $3.1 billion in annual revenue and employ around 18,000 people worldwide. Welcomed by John O’Connell, founder of the Awards and Executive Chair of ScaleUp Group and led by Tola Sargeant, Chair of th ———————————————————————————————————————————————————————————— Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference 2026-07-02 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/02/3321125/0/en/Oculis-to-Participate-at-the-Piper-Sandler-Virtual-Ophthalmology-Conference.html ZUG, Switzerland, July 2, 2026 – Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic and ophthalmic diseases with significant unmet medical needs, announced today that Oculis’ management will participate in a fireside chat at the Piper Sandler Virtual Ophthalmology Conference. ———————————————————————————————————————————————————————————— Pharmaceutical CRO Market Opportunities in Clinical Trial Management 2026-07-02 · Express Press Release · Healthcare https://express-press-release.net/news/2026/07/02/1761369 The global Pharmaceutical CRO Market size was valued at USD 45.3 billion in 2025 and is projected to grow from USD 48.5 billion in 2026 to USD [read full press release...] ———————————————————————————————————————————————————————————— Black Book Italy Provider Pulse Finds FSE 2.0 Faces Regional Interoperability, ... 2026-07-02 · PR-Inside · Healthcare https://pr-inside.com/black-book-italy-provider-pulse-finds-fse-2-0-faces-regional-interoperability-r5196922.htm (PR-inside.com) Survey of Italian healthcare IT users finds regional fragmentation, diagnostic-data usability and PNRR deadline pressure are redefining Italy's EHR/HIT competitive landscape LONDON, UK / ACCESS Newswire / July 2, 2026 / Black Book Research today released findings from its Italy State of Acute Care EHR, FSE 2.0 and Digital Health 2026 report, identifying Italy as one of Europe's most important tests of whether a regionally decentralized healthcare system can deliver national clinical-data utility before PNRR and European Health Data Space expectations converge. The 2026 Italy report follows Black Book's Norway and Germany provider pulse research and extends the firm's Q2 European interoperability .. ———————————————————————————————————————————————————————————— Final Outcome of AlzeCure's Rights Issue 2026-07-02 · PR-Inside · Healthcare https://pr-inside.com/final-outcome-of-alzecure-s-rights-issue-r5196921.htm (PR-inside.com) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO RUSSIA, BELARUS, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION IS IN WHOLE OR IN PART SUBJECT TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO ACQUIRE SECURITIES IN ALZECURE PHARMA AB. SEE ALSO THE SECTION "IMPORTANT INFORMATION" BELOW. STOCKHOLM, SE / ACCESS Newswire / July 2, 2026 / AlzeCure Pharma AB ("AlzeCure" or "the Company")(STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops a broad portfolio of small molecule product candidates for diseases affecting the .. ———————————————————————————————————————————————————————————— Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712 2026-07-02 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/02/3321081/0/en/Molecular-Partners-and-Orano-Med-Announce-First-Patients-Dosed-in-Phase-1-2a-Trial-of-DLL3-Radio-DARPin-MP0712.html ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass. and VILLEJUIF, France, July 02, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners”), and Orano Med, a clinical-stage radiopharmaceutical company and a pioneer in the development of lead-212 ( 212 Pb) based targeted alpha therapies (TAT), today announced that the first patients were dosed in the ongoing US multicenter Phase 1/2a study of drug candidate MP0712. ———————————————————————————————————————————————————————————— Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering 2026-07-02 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/02/3321078/0/en/Elicio-Therapeutics-Announces-Pricing-of-15-Million-Registered-Direct-Offering.html BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that it has entered into a definitive securities purchase agreement led by two new fundamental institutional investors with participation from a large existing shareholder for the purchase of an aggregate of 4,380,313 shares of its common stock pursuant to a registered direct offering (the “Offering”). The Offering is expected to result in gross proceeds of approximately $15 million, before deducting placement agents’ fees and other Offering expenses. The closing of the Offering is expected to occur on or about July 6, 2026, subject to the satisfaction of cus ———————————————————————————————————————————————————————————— Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery 2026-07-02 · PR Newswire · AI, SaaS, Healthcare https://www.prnewswire.com/news-releases/insilico-medicine-announces-collaboration-with-takeda-to-advance-strategic-ai-drug-discovery-302816559.html Partnership to leverage Pharma.AI platform for novel drug candidates across Takeda's therapeutic areas CAMBRIDGE, Mass., July 1, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico" HKEX:3696), a leader in clinical-stage generative AI for drug discovery, today announced a strategic... ———————————————————————————————————————————————————————————— FDA Alignment to Advance ProstACT Global Phase 3 Trial 2026-07-02 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/02/3321065/0/en/FDA-Alignment-to-Advance-ProstACT-Global-Phase-3-Trial.html MELBOURNE, Australia and INDIANAPOLIS, July 02, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals (ASX: TLX, NASDAQ: TLX, “Telix”) today announced the successful outcome of a Type B meeting with the United States (U.S.) Food and Drug Administration (FDA) to review the Part 1 safety and dosimetry data and Part 2 protocol design of the ProstACT Global Phase 3 trial of its therapeutic candidate TLX591-Tx (lutetium-177 ( 177 Lu) rosopatamab tetraxetan) in metastatic castration resistant prostate cancer. ———————————————————————————————————————————————————————————— Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC 2026-07-02 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/abbisko-therapeutics-and-astrazeneca-enter-a-strategic-collaboration-to-conduct-the-clinical-trial-of-lumipodlin-absk043-a-first-in-class-oral-pd-l1-inhibitor-in-combination-with-tagrisso-for-nsclc-302816115.html SHANGHAI, July 1, 2026 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) today announced that it has entered into a strategic collaboration agreement with AstraZeneca (LSE/STO/NYSE: AZN) to jointly advance the clinical development of a... ———————————————————————————————————————————————————————————— Renal Cancer Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Domain | DelveInsight 2026-07-02 · GetNews · Healthcare https://www.getnews.info/story/2026/07/01/renal-cancer-pipeline-appears-robust-with-75-key-pharma-companies-actively-working-in-the-domain-delveinsight/?source=barchart ———————————————————————————————————————————————————————————— Human Papillomavirus-positive Oropharyngeal Cancer Pipeline Appears Robust With 5+ Key Pharma Companies Actively Working in the Domain | DelveInsight 2026-07-02 · GetNews · Healthcare https://www.getnews.info/story/2026/07/01/human-papillomaviruspositive-oropharyngeal-cancer-pipeline-appears-robust-with-5-key-pharma-companies-actively-working-in-the-domain-delveinsight/?source=barchart ———————————————————————————————————————————————————————————— Grant Helps More Arizona Moms Access Postpartum Support 2026-07-02 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/grant-helps-more-arizona-moms-access-postpartum-support-302816467.html An AZ Blue Foundation Momentum Maker Grant is helping 4ᵗʰ Trimester Arizona expand maternal mental health and postpartum support statewide PHOENIX, July 1, 2026 /PRNewswire/ -- For many Arizona families, support after birth can be hard to find. Across the state, moms continue to face gaps... ———————————————————————————————————————————————————————————— Gold Coast Health Plan Celebrates 15 Years of Growth and Impact in Serving Ventura County's Medi-Cal Members 2026-07-01 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/gold-coast-health-plan-celebrates-15-years-of-growth-and-impact-in-serving-ventura-countys-medi-cal-members-302816457.html Local Medi-Cal plan marks 15 years of connecting Ventura County's most vulnerable residents with high-quality care and services CAMARILLO, Calif., July 1, 2026 /PRNewswire/ -- Gold Coast Health Plan (GCHP) is celebrating 15 years of providing coordinated care for Ventura County's Medi-Cal... ———————————————————————————————————————————————————————————— Physician's Choice Founder Logan Chierotti Named EY Entrepreneur Of The Year® 2026 Mountain West Award Winner 2026-07-01 · PR Newswire · Finance, Healthcare, Retail https://www.prnewswire.com/news-releases/physicians-choice-founder-logan-chierotti-named-ey-entrepreneur-of-the-year-2026-mountain-west-award-winner-302816380.html The founder behind America's #1 probiotic brand is recognized for building one of the most disruptive forces in consumer health DENVER, July 1, 2026 /PRNewswire/ -- Physician's Choice, the #1 probiotic brand in America with $300M+ in projected annual revenue and a presence in over 80,000... ———————————————————————————————————————————————————————————— Infinx Named Top-Scoring Vendor in KLAS Revenue Cycle Prior Authorization ... 2026-07-01 · PR-Inside · Finance, AI, Healthcare https://pr-inside.com/infinx-named-top-scoring-vendor-in-klas-revenue-cycle-prior-authorization-r5196780.htm (PR-inside.com) KLAS customer feedback highlights Infinx's strength in prior authorization automation, partnership, support, and long-term customer value CUPERTINO, CA / ACCESS Newswire / July 1, 2026 / Infinx Healthcare, a provider of AI-enabled patient access and revenue cycle solutions, today announced it received the highest overall score in the KLAS Research Revenue Cycle Prior Authorization segment, earning an Overall Score of 90.1 on KLAS' 100-point scale. The score places Infinx at the top of the segment and ahead of the segment average (85.8) and the broader software average (83.1), as reported in KLAS' April 2026 report card. KLAS performance insights reflect feedback gathered .. ———————————————————————————————————————————————————————————— PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry 2026-07-01 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/01/3321029/0/en/PDS-Health-Surpasses-Five-Million-CEREC-Chairside-Restorations-with-Dentsply-Sirona-Marking-a-Major-Milestone-in-Scaled-Digital-Dentistry.html This milestone reflects PDS Health’s continued investment in digital technologies that help practices operate more efficiently, expand access to same-day restorative care and deliver a more consistent experience for patients. This milestone reflects PDS Health’s continued investment in digital technologies that help practices operate more efficiently, expand access to same-day restorative care and deliver a more consistent experience for patients. ———————————————————————————————————————————————————————————— Online Auction of Advanced CNC Machining Assets from RX Industries, Manufacturer of High-Precision Components for the Aerospace, Defense, Space and Medical Industries 2026-07-01 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/online-auction-of-advanced-cnc-machining-assets-from-rx-industries-manufacturer-of-high-precision-components-for-the-aerospace-defense-space-and-medical-industries-302816302.html HILTON HEAD ISLAND, S.C., July 1, 2026 /PRNewswire/ -- Integra Asset Solutions, in partnership with Machinery Resources International (MRI), is pleased to announce an upcoming online auction featuring the assets of RX Industries in Hilton Head Island, SC, a manufacturer specializing in... ———————————————————————————————————————————————————————————— Why VERAXA Biotech (VRXA) Shareholders Should Pay Serious Attention to Antibody Therapeutics Sector Deals 2026-07-01 · NewMediaWire · Healthcare, Retail https://www.newmediawire.com/news/why-veraxa-biotech-vrxa-shareholders-should-pay-serious-attention-to-antibody-therapeutics-sector-deals-7087461 LOS ANGELES, CA - July 1, 2026 ( NEWMEDIAWIRE ) - Biotechnology investors often focus on clinical milestones, regulatory approvals, and commercial launches. Yet in antibody therapeutics, some of the largest value-creating events occur much earlier. Strategic licensing agreements, research collaborations, and acquisitions, have become important catalysts for companies developing differentiated technology platforms, and have resulted in significant market value shifts. That trend has been particularly evident in antibody-drug conjugates (ADCs) and T-cell engager (TCE) therapeutics. Pharmaceutical companies continue to pursue external innovation as they seek new approaches for treating difficult cancers, creating an environment in which promising technology platforms can attract significant c ———————————————————————————————————————————————————————————— SE INAUGURA UN HOSPITAL MÓVIL DE EMERGENCIAS DE SAMARITAN'S PURSE EN VENEZUELA, PARA ATENDER A VÍCTIMAS DE TERREMOTOS 2026-07-01 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/se-inaugura-un-hospital-movil-de-emergencias-de-samaritan-s-purse-en-venezuela-para-atender-a-victimas-de-terremotos-842224890.html Boone, N.C., 1 de julio de 2026 /PRNewswire-HISPANIC PR WIRE/ -- Ayer, la organización internacional cristiana de ayuda humanitaria Samaritan's Purse recibió a sus primeros pacientes en el Hospital Móvil de Emergencias en La Guaira, Venezuela. Dos terremotos consecutivos sacudieron la... ———————————————————————————————————————————————————————————— Major Biopharmaceutical Company Files First-in-Human Trial Supported by PAK BioSolutions GMP Purification System 2026-07-01 · PRWeb · SaaS, Healthcare https://www.prweb.com/releases/major-biopharmaceutical-company-files-first-in-human-trial-supported-by-pak-biosolutions-gmp-purification-system-302816092.html A major biopharmaceutical company has filed a First-in-Human (FIH) clinical trial application with drug product manufactured using the PAK BioSolutions system. The milestone demonstrates the platform's performance in GMP clinical manufacturing environments. Drug product manufactured using... ———————————————————————————————————————————————————————————— AOB Pharma and Biorasi to Partner to run Phase 2b in Moderate to Severe Acne 2026-07-01 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/aob-pharma-and-biorasi-to-partner-to-run-phase-2b-in-moderate-to-severe-acne-302816219.html Following encouraging earlier-phase clinical data, the Company is advancing its acne trial ahead of schedule while maintaining atopic dermatitis global Phase 3 timeline. CAMBRIDGE, Mass., July 1, 2026 /PRNewswire/ -- AOB Pharma, Inc. ("AOBiome"), a leading clinical-stage biotechnology... ———————————————————————————————————————————————————————————— Maverrik Launches Build Beyond Referrals One-Day Intensive to Help Expert-Led Businesses Reduce Referral Dependency 2026-07-01 · Pressat · Finance, Healthcare, Energy, Education https://pressat.co.uk/releases/maverrik-launches-build-beyond-referrals-one-day-intensive-to-help-expert-led-businesses-reduce-referral-dependency-b973f81ebe740c2296946472ef5cb340/ Wednesday 1 July, 2026 New one-day intensive gives executive coaches, consultants and expert-led businesses a practical client acquisition system designed to reduce referral dependency and create a more consistent approach to winning new clients. Plymouth, UK - Maverrik has launched the Build Beyond Referrals One-Day Intensive, a new one-day workshop designed to help expert-led businesses reduce referral dependency by building a practical, repeatable client acquisition system. Developed for executive coaches, business coaches, boutique consultants and expert-led businesses across professional services, financial services and technology, the Build Beyond Referrals One-Day Intensive helps delegates build a structured approach to lead generation, client acquisition and business development th ———————————————————————————————————————————————————————————— Cardio Diagnostics Holdings (CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans 2026-07-01 · NewMediaWire · Finance, AI, Healthcare, Retail https://www.newmediawire.com/news/cardio-diagnostics-holdings-cdio-showcases-precision-cardiovascular-solutions-for-employers-health-plans-7087457 LOS ANGELES, CA - July 1, 2026 ( NEWMEDIAWIRE ) - Cardio Diagnostics Holdings (NASDAQ: CDIO) is a precision cardiovascular medicine company leveraging epigenetics, genetics and artificial intelligence. The company discussed innovative approaches to cardiovascular disease prevention, risk assessment and cost management at multiple national benefits conferences this month. Cardio’s presentations highlight how advanced cardiovascular risk assessment and detection tools can support both improved health outcomes and more effective healthcare cost management. “The company’s message centers on the idea that earlier identification of cardiovascular risk and disease can potentially enable more targeted interventions and preventive care. Rather than waiting until symptoms develop or major events occ ———————————————————————————————————————————————————————————— HeartBeam (BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital 2026-07-01 · NewMediaWire · Finance, SaaS, Healthcare, Retail https://www.newmediawire.com/news/heartbeam-beat-advances-modern-cardiac-care-expanding-use-of-ecg-data-outside-of-the-hospital-7087456 LOS ANGELES, CA - July 1, 2026 ( NEWMEDIAWIRE ) - Cardiac monitoring is evolving beyond the routine detection of abnormal heart rhythms toward a future where patients and physicians receive timely actionable insights that can guide clinical decisions outside of a healthcare facility. As healthcare increasingly emphasizes earlier intervention and more personalized care, HeartBeam (NASDAQ: BEAT) is developing technologies designed to transform where and how cardiac data are captured, analyzed and shared, including its proprietary, FDA-cleared HeartBeam System , the first portable, cable-free ECG system capable of synthesizing a 12-lead ECG for assessment of arrhythmias. Advances in digital health, cloud computing and data analytics are making it possible to move beyond episodic monitoring to ———————————————————————————————————————————————————————————— Vadzo Imaging Positions Falcon-544CRS Point of Care Camera with Wake-on-Motion for Portable Diagnostic Applications 2026-07-01 · Newswire.com · Healthcare, Energy, Automotive https://www.newswire.com/news/vadzo-imaging-positions-falcon-544crs-point-of-care-camera-with-wake-22803942 Vadzo's Falcon-544CRS is a 5MP USB 3.2 color camera built on the Onsemi AR0544 HyperLux LP sensor, combining Wake-on-Motion ultra-low power standby, enhanced Dynamic Range eDR, and Line Interleaved HDR with a back side illuminated BSI stacked CMOS architecture and UVC-compliant interface, purpose-built for portable point of care devices, telemedicine peripherals, patient monitoring systems, and battery-powered handheld diagnostic tools where extended battery operation and consistent image quality across variable clinical lighting conditions are simultaneous design requirements, in a compact 38mm x 38mm module that integrates without custom driver development on Windows, Linux, and Android platforms. ———————————————————————————————————————————————————————————— Fertility Sensor Market to Reach USD 2.80 Billion by 2033, Driven by At-Home Reproductive Monitoring Surge and Connected Health Integration - Verified Market Research® 2026-07-01 · PR Newswire · SaaS, Healthcare, Retail https://www.prnewswire.com/news-releases/fertility-sensor-market-to-reach-usd-2-80-billion-by-2033--driven-by-at-home-reproductive-monitoring-surge-and-connected-health-integration---verified-market-research-302815721.html The Global Fertility Sensor Market fueled by rising consumer demand for sensor-enabled ovulation tracking and conception planning tools. Wearable fertility sensors and connected fertility tracking devices are leading adoption as users migrate from single-point testing to continuous,... ———————————————————————————————————————————————————————————— Tooth Replacement Options Explained In HelloNation Article Featuring Dental Expert Dr. Alex Hamilton 2026-07-01 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/tooth-replacement-options-explained-in-hellonation-article-featuring-dental-expert-dr-alex-hamilton-302816151.html The article compares implants, bridges, and dentures to help patients choose the best solution for missing teeth. BRYANT, Ark., July 1, 2026 /PRNewswire/ -- What is the best way to replace missing teeth while maintaining function and long-term oral health? HelloNation has published a... ———————————————————————————————————————————————————————————— NeuroDex ExoSORT Platform Demonstrates Treatment-Responsive Blood-Based Measurement of Neuronal TDP-43 in People Living with ALS 2026-07-01 · Send2Press · SaaS, Healthcare https://www.send2press.com/wire/neurodex-exosort-platform-demonstrates-treatment-responsive-blood-based-measurement-of-neuronal-tdp-43-in-people-living-with-als/ NATICK, Mass., July 1, 2026 (SEND2PRESS NEWSWIRE) -- NeuroDex, a precision diagnostics company specializing in the isolation and analysis of neuron-derived extracellular vesicles (NDEs) from blood, today announced new findings supporting NDE-associated TDP-43 as a treatment-responsive biomarker in amyotrophic lateral sclerosis (ALS). ———————————————————————————————————————————————————————————— National Sleep Foundation Names Mark R. Rosekind, PhD, To Chair Board of Directors 2026-07-01 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/national-sleep-foundation-names-mark-r-rosekind-phd-to-chair-board-of-directors-302816111.html International sleep and fatigue expert will champion NSF's sleep health and safety mission WASHINGTON, July 1, 2026 /PRNewswire/ -- The National Sleep Foundation (NSF) today announced that Mark R. Rosekind, PhD, has assumed the role of Chair of its Board of Directors. As Board Chair, Dr.... ———————————————————————————————————————————————————————————— WallachBeth Capital Announces Closing of Tenon Medical, Inc. $4.2 Million Public Offering 2026-07-01 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/wallachbeth-capital-announces-closing-of-tenon-medical-inc-4-2-million-public-offering-302816085.html JERSEY CITY, N.J., July 1, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Tenon Medical, Inc. (NASDAQ: TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care... ———————————————————————————————————————————————————————————— Tenon Medical, Inc. Announces Closing of $4.2 Million Public Offering 2026-07-01 · PR-Inside · Finance, Healthcare https://pr-inside.com/tenon-medical-inc-announces-closing-of-4-2-million-public-offering-r5196716.htm (PR-inside.com) LOS GATOS, CA / ACCESS Newswire / July 1, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, announced that it has closed its previously announced public offering of securities as described below for aggregate gross proceeds to the Company of $4.2 million, before deducting placement agent fees and other estimated offering expenses payable by the Company. The offering consisted of 11,052,631 shares of our common stock, par value $0.001 per share (or pre-funded warrants in lieu thereof), together with common stock purchase warrants to purchase .. ———————————————————————————————————————————————————————————— UPMC Children's Hospital Foundation Celebrates Historic Community Investment in Children's Health 2026-07-01 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/upmc-childrens-hospital-foundation-celebrates-historic-community-investment-in-childrens-health-302816025.html PITTSBURGH, July 1, 2026 /PRNewswire/ -- UPMC Children's Hospital Foundation announced the successful conclusion of its This Moment: Put a Child's Future First fundraising campaign on June 30, surpassing its ambitious $200 million goal. The campaign is the largest in the hospital's... ———————————————————————————————————————————————————————————— Crispy Quinoa and Chickpea Crunch Recipe is Brain Food from Intermountain Health 2026-07-01 · PRUnderground · Healthcare https://www.prunderground.com/crispy-quinoa-and-chickpea-crunch-recipe-is-brain-food-from-intermountain-health/00387413/ Intermountain Health Registered Dietitians give great Crispy Quinoa and Chickpea Crunch Recipe to help fuel your brain The post Crispy Quinoa and Chickpea Crunch Recipe is Brain Food from Intermountain Health first appeared on ———————————————————————————————————————————————————————————— Extreme Heat is Rising - And so is the Risk to Your Heart 2026-07-01 · NewMediaWire · Healthcare, Retail https://www.newmediawire.com/news/extreme-heat-is-rising-and-so-is-the-risk-to-your-heart-7087455 DALLAS - July 1, 2026 ( NEWMEDIAWIRE ) - As summer heat intensifies across the U.S., the American Heart Association is warning that soaring temperatures don’t just make people uncomfortable - they can put serious strain on the heart and increase the risk of life-threatening complications. Although tragic deaths from major disasters like hurricanes and tornados may get the most news coverage, extreme heat is actually the leading weather-related cause of death in the United States, according to the National Weather Service. A report in the Journal of the American Medical Association found that more than 2,300 people died from heat exposure in the U.S. in 2023 . Research published in the American Heart Association’s journal Circulation projecting that heat-related cardiovascular deaths could ———————————————————————————————————————————————————————————— Car T Cell Therapy For Multiple Myeloma Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Bluebird bio, Cellectis SA, Caribou Biosciences, Luminary Therapeutics 2026-07-01 · GetNews · Healthcare, Automotive https://www.getnews.info/story/2026/07/01/car-t-cell-therapy-for-multiple-myeloma-pipeline-2026-key-companies-moa-roa-and-clinical-trials-evaluation-by-delveinsight-bluebird-bio-cellectis-sa-caribou-biosciences-luminary-therapeutics/?source=barchart ———————————————————————————————————————————————————————————— There Is No Place Like ALYZE: Why Health Experts Say Utah's New Integrated ... 2026-07-01 · PR-Inside · Healthcare, Retail, Gaming https://pr-inside.com/there-is-no-place-like-alyze-why-health-experts-say-utah-s-new-integrated-r5196694.htm (PR-inside.com) Combining a CLIA-certified on-site laboratory, functional medicine, luxury fitness, precision medicine, full recovery services, and aesthetic wellness under one roof, ALYZE opens in Bountiful as something the consumer health market has not seen before BOUNTIFUL, UT / ACCESS Newswire / July 1, 2026 / The wellness industry is full of excellent individual services. Luxury gyms that deliver serious fitness. Functional medicine clinics that go deeper than a standard physical. Recovery studios with world-class equipment. Hormone clinics that specialize in what primary care will not touch. Medspas that handle aesthetics and skin health. Longevity centers focused on the long game. What has never .. ———————————————————————————————————————————————————————————— There Is No Place Like ALYZE: Why Health Experts Say Utah's New Integrated Wellness Club Is in a Category of Its Own 2026-07-01 · Newswire.com · Healthcare, Retail https://www.newswire.com/news/there-is-no-place-like-alyze-why-health-experts-say-utahs-new-integrated Combining a CLIA-certified on-site laboratory, functional medicine, luxury fitness, precision medicine, full recovery services, and aesthetic wellness under one roof, ALYZE opens in Bountiful as something the consumer health market has not seen before ———————————————————————————————————————————————————————————— Cancer Vaccines Market Unlocking New Revenue Opportunities and Strategic Expansion by 2034 – DelveInsight | Dendreon Pharma, Candel Therapeutics, GlaxoSmithKline, Merck, Aduro Biotech, Astrazeneca 2026-07-01 · GetNews · Finance, Healthcare https://www.getnews.info/story/2026/07/01/cancer-vaccines-market-unlocking-new-revenue-opportunities-and-strategic-expansion-by-2034-delveinsight-dendreon-pharma-candel-therapeutics-glaxosmithkline-merck-aduro-biotech-astrazeneca/?source=barchart ———————————————————————————————————————————————————————————— High-Grade Glioma Market Witnesses Strong Momentum During the Forecast Period (2026-2036) with Increasing Clinical Activity and Drug Development | DelveInsight 2026-07-01 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/high-grade-glioma-market-witnesses-strong-momentum-during-the-forecast-period-20262036-with-increasing-clinical-activity-and-drug-development--delveinsight-302815434.html The high-grade glioma market is witnessing steady growth driven by the rising incidence of aggressive brain tumors, increasing awareness, and advancements in diagnostic technologies. The market is further expanding due to the growing adoption of targeted therapies, immunotherapies,... ———————————————————————————————————————————————————————————— Fast, Accurate and Stable: Cloud-Clone Takes the Lead in the Immunofluorescence ... 2026-07-01 · PR-Inside · SaaS, Healthcare https://pr-inside.com/fast-accurate-and-stable-cloud-clone-takes-the-lead-in-the-immunofluorescence-r5196667.htm (PR-inside.com) KATY, TX / ACCESS Newswire / July 1, 2026 / In the wave of precision medicine development and accelerated iteration of life science technology, immunofluorescence (IF) technology has become a core supporting tool in medical diagnostics, basic scientific research and drug development, thanks to its unique advantages including high specificity, high sensitivity, and in-situ precise localization and quantification. However, common pain points such as signal deviation in scientific experiments, efficiency bottlenecks in clinical diagnosis, and batch-to-batch product variation often make researchers and clinical workers miss key results, and waste precious samples and time. As a leading biotechnology enterprise integrating R&D, production .. ———————————————————————————————————————————————————————————— Medical Care Technologies Inc. (OTC Pink:MDCE) Launches Infinite Auctions ... 2026-07-01 · PR-Inside · Healthcare, Gaming https://pr-inside.com/medical-care-technologies-inc-otc-pink-mdce-launches-infinite-auctions-r5196666.htm (PR-inside.com) Star-Studded Lineup Featuring LeBron James, Kobe Bryant, Carmelo Anthony & Allen Iverson Headlines Premium Game-Worn Memorabilia Auction MESA, AZ / ACCESS Newswire / July 1, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced the official opening of its Infinite Auctions Summer 2026 Game Used Flash Auction. Bidding is live today, July 1, 2026, and will run through Saturday, July 18, 2026 at 9:00 PM EST. This high-profile auction showcases an exceptional collection of authentic game-used memorabilia from NBA legends, with all items rigorously authenticated by MDCE's subsidiary Real Game Used (RGU) at www.realgameused.com, the industry leader in photo-match authentication. Standout lots .. ———————————————————————————————————————————————————————————— Desert Oasis Healthcare Celebrates Official 45th Anniversary of Serving ... 2026-07-01 · PR-Inside · Healthcare https://pr-inside.com/desert-oasis-healthcare-celebrates-official-45th-anniversary-of-serving-r5196663.htm (PR-inside.com) Since 1981, Desert Oasis Healthcare has remained dedicated to helping patients live healthier, fuller lives PALM SPRINGS, CA / ACCESS Newswire / July 1, 2026 / Desert Oasis Healthcare (DOHC) proudly celebrates its official 45th anniversary today, marking more than four decades of service, innovation, and commitment to the health and well-being of residents throughout the Coachella Valley and High Desert. Founded in 1981 as one of the first medical groups in the region, DOHC has grown into a multidisciplinary network of compassionate providers and care teams serving more than 60,000 members and patients. While healthcare has evolved dramatically over the past .. ———————————————————————————————————————————————————————————— American Heart Association Announces Volunteer Leaders for 2026-27 2026-07-01 · NewMediaWire · Healthcare, Retail https://www.newmediawire.com/news/american-heart-association-announces-volunteer-leaders-for-2026-27-7087454 DALLAS - July 1, 2026 ( NEWMEDIAWIRE ) - The American Heart Association, a global force changing the future of health for all, has named its volunteer leadership for fiscal year 2026-27. Beginning July 1, Manesh R. Patel, M.D., FAHA , a North Carolina-based interventional cardiologist, will serve as the Association’s new volunteer president and Lee A. Shapiro, J.D., a Florida-based financial expert in health technology, will continue as volunteer chairperson of the board for the second year of a two-year term. Other volunteer officers include Linda Gooden, M.B.A. , volunteer chairperson-elect, who is a retired executive from the aerospace and defense industry, and Robert H. (Bob) Swan, M.B.A. , volunteer treasurer, who is a venture capital and operations executive, both of whom will contin ———————————————————————————————————————————————————————————— Medical Care Technologies Inc. (OTC Pink:MDCE) Launches Infinite Auctions EPIC Summer 2026 Game Used Sports Auction - Bidding Opens Today 2026-07-01 · Newswire.com · Healthcare, Gaming https://www.newswire.com/news/medical-care-technologies-inc-otc-pink-mdce-launches-infinite-auctions-epic Star-Studded Lineup Featuring LeBron James, Kobe Bryant, Carmelo Anthony & Allen Iverson Headlines Premium Game-Worn Memorabilia Auction ———————————————————————————————————————————————————————————— In HelloNation, Home Health Expert Leslie Knopp Shares Guided Activity Plans for Healthy Aging at Home 2026-07-01 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/in-hellonation-home-health-expert-leslie-knopp-shares-guided-activity-plans-for-healthy-aging-at-home-302815921.html TRAVERSE CITY, Mich., July 1, 2026 /PRNewswire/ -- How can everyday routines help older adults stay engaged, capable, and emotionally balanced while living at home? A HelloNation article provides the answer by explaining how guided activity plans bring structure and purpose to daily life.... ———————————————————————————————————————————————————————————— Benign Prostatic Hyperplasia Market Forecast Signals Robust Industry Growth Through 2034 – DelveInsight | AiViva BioPharma, Chong Kun Dang, EMS, Urotronic, Resurge Therapeutics, Antev, Nymox Pharma 2026-07-01 · GetNews · Healthcare https://www.getnews.info/story/2026/07/01/benign-prostatic-hyperplasia-market-forecast-signals-robust-industry-growth-through-2034-delveinsight-aiviva-biopharma-chong-kun-dang-ems-urotronic-resurge-therapeutics-antev-nymox-pharma/?source=barchart ———————————————————————————————————————————————————————————— NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes 2026-07-01 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/01/3320694/0/en/NewcelX-Announces-Successful-FDA-Pre-IND-Meeting-with-Clear-Path-Forward-for-NCEL-101-Toward-Starting-Clinical-Trials-for-Type-1-Diabetes.html FDA feedback supports NewcelX’s planned development strategy for NCEL-101 in combination with Tegoprubart FDA feedback supports NewcelX’s planned development strategy for NCEL-101 in combination with Tegoprubart ———————————————————————————————————————————————————————————— Community First Health Plans and Vheda Health Launch Outcomes-First ... 2026-07-01 · PR-Inside · Healthcare https://pr-inside.com/community-first-health-plans-and-vheda-health-launch-outcomes-first-r5196642.htm (PR-inside.com) SAN ANTONIO, TX / ACCESS Newswire / July 1, 2026 /Community First Health Plans, Inc, (Community First) today announced a new partnership with Vheda Health, the leader in outcomes and analytics through virtual health engagement, to support high-risk mothers living with diabetes and hypertension across Texas. The program is designed to identify mothers with a high-risk pregnancy, engage them early, and deliver full-term babies with decreased complications and improved delivery cost. Through this collaboration, eligible Community First Medicaid members in Atascosa, Bandera, Bexar, Comal, Guadalupe, Kendall, Medina, and Wilson counties will be invited to participate in the Vheda Health Maternity Program. .. ———————————————————————————————————————————————————————————— Community First Health Plans and Vheda Health Launch Outcomes-First Virtual Maternity Program in Texas 2026-07-01 · Newswire.com · Healthcare https://www.newswire.com/news/community-first-health-plans-and-vheda-health-launch-outcomes-first-virtual Community First and Vheda launch a Texas Medicaid virtual maternity program improving outcomes for high-risk pregnancies by early intervention and analytics. ———————————————————————————————————————————————————————————— GeoVax Highlights Continued U.S. Government Investment in Orthopox Preparedness as Strategic Validation of Long-Term Vaccine Readiness 2026-07-01 · NewMediaWire · Finance, Healthcare https://www.newmediawire.com/news/geovax-highlights-continued-u-s-government-investment-in-orthopox-preparedness-as-strategic-validation-of-long-term-vaccine-readiness-7087452 Recent Federal Procurement Reinforces the Importance of Sustained Investment in Domestic Vaccine Manufacturing and Diversified Medical Countermeasures ATLANTA, GA - July 1, 2026 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies against infectious diseases and solid tumors, today commented on the U.S. government's recent procurement of additional ACAM2000® (Emergent BioSolutions) smallpox vaccine, noting that the award reinforces the continued strategic importance of maintaining robust orthopoxvirus preparedness capabilities. The procurement reflects the U.S. government's ongoing commitment to maintaining the Strategic National Stockpile and sustaining multiple medical countermeasures against smallpox and mpox ———————————————————————————————————————————————————————————— Daré Bioscience Announces Flora Sync LF5™ Is Now Available Through Its Direct-to-Consumer Platform 2026-07-01 · GlobeNewswire · Finance, SaaS, Healthcare, Retail https://www.globenewswire.com/news-release/2026/07/01/3320620/30757/en/Dar%C3%A9-Bioscience-Announces-Flora-Sync-LF5-Is-Now-Available-Through-Its-Direct-to-Consumer-Platform.html Commercial Launch Begins Company's First Consumer Revenue Stream, Bringing Science-Backed Women's Health Solutions Directly to Consumers Commercial Launch Begins Company's First Consumer Revenue Stream, Bringing Science-Backed Women's Health Solutions Directly to Consumers ———————————————————————————————————————————————————————————— Coalition for Metabolic Health Launches First in Series of Congressional Briefings on Nutrition and Chronic Disease 2026-07-01 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/coalition-for-metabolic-health-launches-first-in-series-of-congressional-briefings-on-nutrition-and-chronic-disease-302815355.html WASHINGTON, July 1, 2026 /PRNewswire/ -- On Wednesday, June 24, the Coalition for Metabolic Health hosted its first Capitol Hill briefing with a panel of experts examining how nutrition can help address chronic disease and reduce healthcare costs in the United States. This initial session... ———————————————————————————————————————————————————————————— Aimwell Partners Inc. Publishes the Adversarial Validation Standard, ... 2026-07-01 · PR-Inside · AI, Healthcare https://pr-inside.com/aimwell-partners-inc-publishes-the-adversarial-validation-standard-r5196639.htm (PR-inside.com) MIAMI, FL / ACCESS Newswire / July 1, 2026 / Aimwell Partners Inc. (OTCID:AIMN) ("Aimwell" or the "Company"), the parent company of AimwellBio, today announced the publication of the Adversarial Validation Standard, v1, a versioned, open methodology framework designed to establish a transparent reference for decision integrity in AI-generated biopharmaceutical intelligence. As artificial intelligence becomes increasingly embedded in regulatory, clinical, and strategic decision-making across the biopharmaceutical industry, one question has remained largely unanswered: by what published methodology are AI-generated intelligence outputs validated? AimwellBio's Adversarial Validation Standard, v1 seeks to answer that question by introducing a transparent, versioned framework in ———————————————————————————————————————————————————————————— LataMed AI Executes Strategic Commercial Alliance With Telecom Provider to Expand Digital Healthcare Accessibility Across Venezuela 2026-07-01 · NewMediaWire · AI, Healthcare, Retail https://www.newmediawire.com/news/latamed-ai-executes-strategic-commercial-alliance-with-telecom-provider-to-expand-digital-healthcare-accessibility-across-venezuela-7087451 CARACAS, VENEZUELA - July 1, 2026 ( NEWMEDIAWIRE ) - LataMed AI Corp. (OTC: LMED) (the “Company”), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets, today announced that its Venezuelan operating affiliate, LataMed AI VE, has entered into a strategic commercial alliance with CANTV, a Venezuelan based and state-run telecommunications provider, to support the continued expansion of digital healthcare services throughout the country. Under the agreement, the parties intend to work toward making the LataMed AI mobile application and selected digital healthcare services available through CANTV's products and digital service offerings as part of a broad ———————————————————————————————————————————————————————————— Stemtech Corporation Declares July 2026 "Cellular Health Awareness ... 2026-07-01 · PR-Inside · AI, Healthcare, Education https://pr-inside.com/stemtech-corporation-declares-july-2026-cellular-health-awareness-r5196634.htm (PR-inside.com) Spotlighting Two Decades of Natural Regenerative Support, Anti-Aging and Longevity Science, AI-Recognized Pioneer-Leader in Stem Cell Nutrition Marks 20 Years of All-Natural, Plant-Based Stemceuticals™ With a Company-Wide Education Initiative NAPLES, FL / ACCESS Newswire / July 1, 2026 /Stemtech Corporation (OTCID:STEK), the global pioneer and leader in stem cell nutrition, today announced that it has designated July 2026 as Cellular Health Awareness Month, a company-wide initiative dedicated to educating consumers, Independent Business Partners (IBPs), and the wellness community on the science of natural regenerative support, healthy aging, and longevity. "Live Longer - Live Better - Live Younger" For two decades, Stemtech has championed .. ———————————————————————————————————————————————————————————— AIAI Holdings' MediGuide Launches Digital Platform 2026-07-01 · PR-Inside · Finance, AI, SaaS, Healthcare https://pr-inside.com/aiai-holdings-mediguide-launches-digital-platform-r5196631.htm (PR-inside.com) Digital Transformation Initiative Establishes Operational Foundation for Innovation in Diagnostics, Prevention and Precision Medicine DALLAS, TX / ACCESS Newswire / July 1, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today announced that its portfolio company, MediGuide International, has launched a new enterprise digital platform. MediGuide's digital platform is an API-first, interoperable layer that connects insurers, payors, and digital health partners to MediGuide's clinical services, Medical Second Opinion, virtual urgent/primary/behavioral/specialty care, and chronic condition programs, through a single, configurable integration. ———————————————————————————————————————————————————————————— AL Amyloidosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Sorrento Therapeutics, Prothena Therapeutics, Spectrum Pharma, Takeda 2026-07-01 · GetNews · Healthcare https://www.getnews.info/story/2026/07/01/al-amyloidosis-pipeline-2026-therapies-under-investigation-clinical-trials-milestones-and-fda-approvals-by-delveinsight-sorrento-therapeutics-prothena-therapeutics-spectrum-pharma-takeda/?source=barchart ———————————————————————————————————————————————————————————— Lake Emergency Partners to Provide Emergency Medicine Services at St. Bernard Hospital in Chicago 2026-07-01 · Newswire.com · Healthcare https://www.newswire.com/news/lake-emergency-partners-to-provide-emergency-medicine-services-at-st-bernard Lake Emergency Partners joins St. Bernard Hospital in Chicago to provide high-quality emergency medicine services. Read about the new partnership. ———————————————————————————————————————————————————————————— Modular Medical Announces FDA Submission of Pivot Tubeless Insulin ... 2026-07-01 · PR-Inside · Finance, SaaS, Healthcare https://pr-inside.com/modular-medical-announces-fda-submission-of-pivot-tubeless-insulin-r5196614.htm (PR-inside.com) Submission Covers Software Enhancements for Patient Flexibility and Customization of Pivot SAN DIEGO, CA / ACCESS Newswire / July 1, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery technology, today announced submission to the U.S. Food & Drug Administration (FDA) of a series of software enhancements to its PivotTM insulin delivery system, providing users with more customization options and user-interface (UI) improvements, as well as other software upgrades. "This submission is the first of a series of further improvements and upgrades planned for the Pivot platform, now that our core form factor .. ———————————————————————————————————————————————————————————— Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements 2026-07-01 · Newswire.com · Healthcare https://www.newswire.com/news/modular-medical-announces-fda-submission-of-pivot-tubeless-insulin-patch-pump Submission Covers Software Enhancements for Patient Flexibility and Customization of Pivot ———————————————————————————————————————————————————————————— AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans 2026-07-01 · PR Newswire · SaaS, Healthcare https://www.prnewswire.com/news-releases/adjane-reports-first-clinical-validation-of-its-omv-vaccine-platform-inducing-mucosal-immunity-in-humans-302815790.html Phase I results provide platform-level validation supporting AdJane's broader development programs in pandemic preparedness, respiratory infectious diseases and antimicrobial resistance DELFT, Netherlands, July 1, 2026 /PRNewswire/ -- AdJane, a clinical-stage vaccine platform company... ———————————————————————————————————————————————————————————— Author Health Brings Specialized Behavioral Health Services to Pennsylvania and New Jersey 2026-07-01 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/author-health-brings-specialized-behavioral-health-services-to-pennsylvania-and-new-jersey-302815783.html PHILADELPHIA, July 1, 2026 /PRNewswire/ -- Author Health (the "Company"), a specialized provider of comprehensive mental health and dementia care for Medicare, Medicare Advantage, and Special Needs Plan recipients, announced today its expansion into Pennsylvania and New Jersey. By... ———————————————————————————————————————————————————————————— Germany's ePA Rollout Puts Europe's Health-Data Supply Chain to the ... 2026-07-01 · PR-Inside · SaaS, Healthcare https://pr-inside.com/germany-s-epa-rollout-puts-europe-s-health-data-supply-chain-to-the-r5196584.htm (PR-inside.com) Survey of 137 German hospital IT leaders, clinical executives and provider stakeholders finds national patient-record success hinges on data quality, medication safety and workflow integration MUNICH, DE / ACCESS Newswire / July 1, 2026 / Black Book Research today released findings from a Germany provider pulse survey of 137 hospital IT leaders, clinical executives, ambulatory IT leaders, pharmacy and medication-management stakeholders, and digital transformation executives, examining whether Germany's electronic patient record, known as the ePA, is moving from national infrastructure deployment to usable clinical data supply chain. Black Book initiated the Germany survey following its Q2 2026 European interoperability and EHDS readiness .. ———————————————————————————————————————————————————————————— The Mortgage Collaborative launches TMC Healthcare Cooperative to give lender members and preferred partners control over rising healthcare costs 2026-07-01 · Send2Press · Healthcare, Real Estate, Finance https://www.send2press.com/wire/the-mortgage-collaborative-launches-tmc-healthcare-cooperative-to-give-lender-members-and-preferred-partners-control-over-rising-healthcare-costs/ SAN DIEGO, Calif., July 1, 2026 (SEND2PRESS NEWSWIRE) -- The Mortgage Collaborative (TMC), the nation's largest independent cooperative network for mortgage lenders, has launched the TMC Healthcare Cooperative, a self-funded medical program open to all TMC lender members and preferred partners. Developed in partnership with CCIG, a Colorado-based employee benefits firm, the program gives vendors, community banks, credit unions and independent mortgage bankers a way to fund their own health claims as a group. ———————————————————————————————————————————————————————————— Germany's ePA Rollout Puts Europe's Health-Data Supply Chain to the Test, Black Book Provider Pulse Finds 2026-07-01 · Newswire.com · SaaS, Healthcare https://www.newswire.com/news/germanys-epa-rollout-puts-europes-health-data-supply-chain-to-the-test-black Survey of 137 German hospital IT leaders, clinical executives and provider stakeholders finds national patient-record success hinges on data quality, medication safety and workflow integration ———————————————————————————————————————————————————————————— Micropos Medical Announces Initial Clinical Treatments at Johns Hopkins Medicine Using Raypilot System 2026-07-01 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/micropos-medical-announces-initial-clinical-treatments-at-johns-hopkins-medicine-using-raypilot-system-302815715.html GOTHENBURG, Sweden, July 1, 2026 /PRNewswire/ -- Micropos Medical AB today announced that the first five (5) patients in the United States have been treated using the Raypilot® System as part of an early clinical evaluation at Johns Hopkins Medicine, one of the world's leading academic... ———————————————————————————————————————————————————————————— Who Does Gender Affirming Surgery Without a Weight Limit? 2026-07-01 · PR-Inside · Healthcare https://pr-inside.com/who-does-gender-affirming-surgery-without-a-weight-limit-r5196507.htm (PR-inside.com) Gender Affirming Surgery Without a BMI Limit Is Done by Dr. Javad Sajan SEATTLE, WA / ACCESS Newswire / July 1, 2026 / As gender affirming surgery becomes increasingly accessible across the United States, body mass index (BMI) requirements continue to be one of the most significant barriers preventing some transgender and nonbinary patients from getting a gender affirming surgery. While many surgical programs continue to use BMI thresholds when evaluating candidates, a growing number of surgeons are adopting individualized medical assessments that consider a patient's overall health rather than relying on a universal weight cutoff. Among those surgeons isDr. Javad Sajan .. ———————————————————————————————————————————————————————————— Recent Release, "Song of a Dromedary," from Page Publishing Author Jason Mahoney, Explores the Supernatural Battle Between Faith & Darkness Threatening a Gifted Young Boy 2026-07-01 · PR.com · Healthcare https://www.pr.com/press-release/972023 Jason Mahoney has completed his sophomore novel, "Song of a Dromedary," a haunting exploration of one family's descent into paranormal terror. When Vernon Rivers, a musically talented child, begins displaying inexplicable symptoms that baffle medical professionals, his desperate parents turn to the Church as their final option. What unfolds is a chilling account of an exorcism and the cryptic warnings that [PR.com] ———————————————————————————————————————————————————————————— Recent Release, "Speaking Without Words," from Page Publishing Author Jessi Lucio, Offers a Candid Glimpse Into the Reality of Raising a Nonverbal Autistic Child 2026-07-01 · PR.com · Healthcare https://www.pr.com/press-release/972025 Jessi Lucio has completed a new book, titled, "Speaking Without Words: A mother's experience with nonverbal autism," which chronicles her intimate journey as a parent navigating life with children on the autism spectrum. Rather than presenting clinical guidance or formulaic advice, this work captures authentic moments from everyday life: the unexpected humor, the quiet victories, the overwhelming days, and the [PR.com] ———————————————————————————————————————————————————————————— Can GLP-1 Medications Improve Health in People With Type 2 Diabetes and PAD? 2026-07-01 · NewMediaWire · Healthcare, Retail https://www.newmediawire.com/news/can-glp-1-medications-improve-health-in-people-with-type-2-diabetes-and-pad-7087450 Research Highlights: GLP-1RA (glucagon-like peptide-1 receptor agonist) medications, which are prescribed to treat Type 2 diabetes and to help with weight loss, were found to reduce the number of deaths, amputations and hospitalizations among people with Type 2 diabetes and narrowed leg arteries associated with PAD (peripheral artery disease). People who had severely blocked arteries in their legs and those with obesity were most likely to benefit from taking a GLP-1RA. In addition, people taking GLP1-RAs needed fewer procedures to restore blood flow to their legs. DALLAS - July 1, 2026 ( NEWMEDIAWIRE ) - GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations among people with Type 2 diabetes who also had narrowed leg arte ———————————————————————————————————————————————————————————— Coastal Medical Transportation Systems Selected as New Emergency Ambulance Provider for Marlborough 2026-07-01 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/coastal-medical-transportation-systems-selected-as-new-emergency-ambulance-provider-for-marlborough-302815125.html MARLBOROUGH, Mass., July 1, 2026 /PRNewswire/ -- Coastal Medical Transportation Systems (CMTS) is proud to announce its selection as the new provider of emergency ambulance services for the City of Marlborough, Massachusetts. "We are honored to have been selected by the City of... ———————————————————————————————————————————————————————————— Physitrack Announces Five-Year Enterprise Agreement with Leading UK ... 2026-07-01 · PR-Inside · Finance, SaaS, Healthcare https://pr-inside.com/physitrack-announces-five-year-enterprise-agreement-with-leading-uk-r5196502.htm (PR-inside.com) Under the agreement, the customer will implement Physitrack across its clinical services on an enterprise-wide basis. Five-year contract valued at approximately £255k over the full term. LONDON, GB / ACCESS Newswire / July 1, 2026 / Physitrack plc (STO:PTRK) today announced a five-year enterprise agreement valued at approximately £255k, including approximately £54k of first-year revenue, deploying 400+ licences across a UK private hospital group of more than 30 hospitals. Highlights: Five-year contract valued at approximately £255k; approximately £54k first-year revenue (including a £36k PhysioTools-to-Physitrack upsell) 400+ Physitrack licences across 30+ hospitals Branded patient applications and EMR/PMS integration Phased migration and revenue recognition through 2026 An ———————————————————————————————————————————————————————————— SkylineDx's Merlin CP-GEP Granted FDA Breakthrough Device Designation, Building on Exclusive NCCN Recognition in Melanoma Care 2026-07-01 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/skylinedxs-merlin-cp-gep-granted-fda-breakthrough-device-designation-building-on-exclusive-nccn-recognition-in-melanoma-care-302813429.html First and only melanoma gene expression profiling test that is both: Designated as an FDA Breakthrough Device and included in the NCCN guidelines for T1b and T2a cutaneous melanoma patients. FDA Breakthrough Designation acknowledges Merlin CP-GEP's ability to address a significant unmet... ———————————————————————————————————————————————————————————— The $27 Trillion Anti-Aging Gold Rush Is Here: California Trim Clinic Exposes the Billionaire Race to Reprogram the Human Body 2026-07-01 · PRUnderground · Healthcare https://www.prunderground.com/the-27-trillion-anti-aging-gold-rush-is-here-california-trim-clinic-exposes-the-billionaire-race-to-reprogram-the-human-body/00387244/ The world's wealthiest technology investors are placing billion-dollar bets on a possibility that once belonged almost entirely to science fiction: aging may not be an untouchable force of nature, but a collection of biological processes that science could eventually measure, influence, or partially reverse. The broader global longevity economy has been projected to reach approximately... Read more » The post The $27 Trillion Anti-Aging Gold Rush Is Here: California Trim Clinic Exposes the Billionaire Race to Reprogram the Human Body first appeared on ———————————————————————————————————————————————————————————— SciBase Submits FDA 510(k) to Expand Nevisense into the Largest Skin Cancer Market 2026-07-01 · PR Newswire · AI, Healthcare https://www.prnewswire.com/news-releases/scibase-submits-fda-510k-to-expand-nevisense-into-the-largest-skin-cancer-market-302815517.html STOCKHOLM, July 1, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB) a leader in AI-based devices for detection and prevention in dermatology, today announced the submission of a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) seeking to expand... ———————————————————————————————————————————————————————————— Update on 2026 Outlook and Company Progress 2026-07-01 · PR-Inside · Healthcare https://pr-inside.com/update-on-2026-outlook-and-company-progress-r5196500.htm (PR-inside.com) COPENHAGEN, DK / ACCESS Newswire / July 1, 2026 / FluoGuide A/S ("FluoGuide" or the "Company")(STO:FLUO) , a clinical-stage biotech company focused on precision cancer surgery, is pleased to share an update on the 2026 Outlook and ongoing progress. As part of this update, FluoGuide has refined timing of some milestones. There are no changes to the overall development. "FluoGuide has made substantial progress during the first half of 2026. We are proud having reported positive results on all milestones with only minor adjustment in timing that has no impact on the corporate development. We remain committed to setting ambitious milestones .. ———————————————————————————————————————————————————————————— DentScribe Introduces AI Patient Profiles and Treatment Coordinator Intelligence for DSOs and Multi-Location Dental Groups 2026-07-01 · PR Newswire · AI, SaaS, Healthcare https://www.prnewswire.com/news-releases/dentscribe-introduces-ai-patient-profiles-and-treatment-coordinator-intelligence-for-dsos-and-multi-location-dental-groups-302815463.html New capabilities connect SOAP-note ground truth with financial conversations to help dental organizations standardize communication, coach treatment coordinators, and improve case acceptance across locations. SUNNYVALE, Calif., July 1, 2026 /PRNewswire/ -- DentScribe, the AI platform for... ———————————————————————————————————————————————————————————— State Licensed Cannabis Companies Move To Intervene In MMJ's D.C. Circuit ... 2026-07-01 · PR-Inside · Healthcare https://pr-inside.com/state-licensed-cannabis-companies-move-to-intervene-in-mmj-s-d-c-circuit-r5196499.htm (PR-inside.com) "This isn't about opposing legitimate business success. It's about asking whether companies that chose the state marijuana pathway should receive federal advantages while MMJ companies spent years and millions of dollars complying with the FDA and DEA pathway are still waiting for equal treatment under the law."- Duane Boise, CEO MMJ International Holdings. WASHINGTON, D.C. / ACCESS Newswire / July 1, 2026 /MMJ International Holdings, Inc. together with its subsidiaries MMJ BioPharma Cultivation, Inc. and MMJ BioPharma Labs, Inc. (collectively, "MMJ"), today announced that two state-licensed medical marijuana operators have moved to intervene in the consolidated marijuana rescheduling litigation currently pending .. ———————————————————————————————————————————————————————————— State Licensed Cannabis Companies Move To Intervene In MMJ's D.C. Circuit Litigation To Stop Rescheduling 2026-07-01 · Newswire.com · Healthcare https://www.newswire.com/news/state-licensed-cannabis-companies-move-to-intervene-in-mmjs-d-c-circuit "This isn't about opposing legitimate business success. It's about asking whether companies that chose the state marijuana pathway should receive federal advantages while MMJ companies spent years and millions of dollars complying with the FDA and DEA pathway are still waiting for equal treatment under the law." - Duane Boise, CEO MMJ International Holdings. ———————————————————————————————————————————————————————————— AlzeCure Pharma Enters an Out-Licensing and Collaboration Agreement ... 2026-07-01 · PR-Inside · SaaS, Healthcare https://pr-inside.com/alzecure-pharma-enters-an-out-licensing-and-collaboration-agreement-r5196498.htm (PR-inside.com) STOCKHOLM, SE / ACCESS Newswire / July 1, 2026 / AlzeCure Pharma AB (publ) ("AlzeCure")(STO:ALZCUR)(FRA:AC6), which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer's disease and pain, announced today that the company has entered into an out-licensing and collaboration agreement with QuantumCell ApS, a Danish tech-enabled biotech company, regarding the global rights to AlzeCure's Alzheimer's platform NeuroRestore, including the leading drug candidate ACD856. AlzeCure will receive an total upfront payment of USD 12 million, of which USD 5 million constitutes a direct investment in AlzeCure, at a 30% premium to the average share price of SEK .. ———————————————————————————————————————————————————————————— French Optical Fashion, Inc. announces same-week eyeglass exam access for manhattan commuters 2026-07-01 · PressReleaseNews · Healthcare https://pressreleasenews.org/pressroom/french-optical-fashion-inc-announces-same-week-eyeglass-exam-access-for-manhattan-commuters French Optical Fashion, Inc. has launched a same-week eyeglass exam program in Midtown Manhattan, adding online booking and commuter-friendly scheduling for local patients. ———————————————————————————————————————————————————————————— Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus antibody, expanding rare disease portfolio 2026-07-01 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/01/3320317/0/en/Ipsen-to-acquire-Memo-Therapeutics-AG-adding-first-in-class-BK-polyomavirus-antibody-expanding-rare-disease-portfolio.html PARIS, FRANCE AND SCHLIEREN/ZURICH, SWITZERLAND , 01 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) and Memo Therapeutics AG announced today they have entered into a definitive share purchase agreement under which Ipsen has agreed to acquire all issued and outstanding shares of Memo Therapeutics AG. The anticipated acquisition is focused on potravitug, which is a Phase II clinical-stage antibody against the BK polyomavirus (BKPyV). BK polyomavirus associated nephropathy (BKPyVAN) is a serious and frequent clinical complication in renal transplanted patients that can lead to graft loss and transplant failure. Potravitug was granted fast-track designation from the U.S. Food and Drug Administration (FDA) in May 2023 and orphan drug designation in the European Union in December 2025. ———————————————————————————————————————————————————————————— Ipsen va acquérir Memo Therapeutics AG, élargissant son portefeuille de maladies rares grâce à l’ajout d’un anticorps premier de sa classe ciblant le polyomavirus BK 2026-07-01 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/01/3320317/0/fr/Ipsen-va-acqu%C3%A9rir-Memo-Therapeutics-AG-%C3%A9largissant-son-portefeuille-de-maladies-rares-gr%C3%A2ce-%C3%A0-l-ajout-d-un-anticorps-premier-de-sa-classe-ciblant-le-polyomavirus-BK.html PARIS, FRANCE ET SCHLIEREN/ZURICH, SUISSE , 1 JUILLET 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) et Memo Therapeutics AG ont annoncé aujourd’hui avoir conclu un accord définitif d’acquisition d’actions en vertu duquel Ipsen a accepté d’acquérir l’intégralité des actions émises et en circulation de Memo Therapeutics AG. L’acquisition envisagée est centrée sur le potravitug, un anticorps au stade clinique de phase II ciblant le polyomavirus BK (BKPyV). La néphropathie associée au polyomavirus BK constitue une complication clinique grave et fréquente chez les patients ayant bénéficié d’une transplantation rénale, pouvant conduire à la perte du greffon et à l’échec de la transplantation. Le potravitug a obtenu la désignation « Fast Track » de la Food and Drug Administration (FDA) des États-Unis ———————————————————————————————————————————————————————————— Santhera Notes Topline Results from Catalyst Pharmaceuticals’ Phase 1 Clinical Study of AGAMREE® 2026-07-01 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/07/01/3320313/0/en/Santhera-Notes-Topline-Results-from-Catalyst-Pharmaceuticals-Phase-1-Clinical-Study-of-AGAMREE.html Data support AGAMREE®’s potential use as a treatment across a broad range of chronic inflammatory rare diseases ———————————————————————————————————————————————————————————— Lubbock Business Tackles a Hidden Pollution Problem — One Yard at a Time 2026-07-01 · PressReleaseNews · Healthcare https://pressreleasenews.org/pressroom/lubbock-business-tackles-a-hidden-pollution-problem-one-yard-at-a-time Hub City Scoop Dawgs launches a pet waste removal service in Lubbock, Texas, addressing dog waste's overlooked role in local water pollution. The company offers weekly and twice-weekly residential cleanup with optional pet-safe yard disinfecting, aiming to improve public health and water quality while giving dog owners their weekends back. ———————————————————————————————————————————————————————————— AAHRPP Accredits Five More Research Entities 2026-07-01 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/aahrpp-accredits-five-more-research-entities-302815301.html 21 more organizations earn reaccreditation WASHINGTON, June 30, 2026 /PRNewswire/ -- The Association for the Accreditation of Human Research Protection Programs has awarded full accreditation to five more entities, including the U.S. health professions academy and one of the world's... ———————————————————————————————————————————————————————————— Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs 2026-07-01 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/07/01/3320270/0/en/Mesoblast-Receives-BLA-Filing-Number-and-Requests-Modular-Review-for-Rexlemestrocel-L-in-Patients-with-End-Stage-Heart-Failure-and-LVADs.html NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received a Biologics License Application (BLA) filing number from the U.S. Food and Drug Administration (FDA) and has requested a modular review of its BLA for rexlemestrocel-L in prevention of life-threatening gastrointestinal bleeding due to right ventricular dysfunction in end-stage heart failure patients with a left ventricular assist device (LVAD). Rexlemestrocel-L has received Orphan Drug Designation for prevention of life-threatening major mucosal bleeding events and has Regenerative Medicine Advanced Therapy (RMAT) designation for this patient population, providing eligibility for rolling and prio ———————————————————————————————————————————————————————————— Heart to Heart Hospice Strengthens Cybersecurity Through Partnership with CyberMaxx 2026-06-30 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/heart-to-heart-hospice-strengthens-cybersecurity-through-partnership-with-cybermaxx-302814703.html Collaboration enhances protection of patient and employee information PLANO, Texas, June 30, 2026 /PRNewswire/ -- Heart to Heart Hospice, one of the country's largest private providers of hospice care, has partnered with CyberMaxx to strengthen the organization's cybersecurity... ———————————————————————————————————————————————————————————— Dental Expert Dr. Marisa Clifford of Cortland, NY Shares How Small Daily Habits Keep Your Teeth Healthy for HelloNation 2026-06-30 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/dental-expert-dr-marisa-clifford-of-cortland-ny-shares-how-small-daily-habits-keep-your-teeth-healthy-for-hellonation-302815137.html CORTLAND, N.Y., June 30, 2026 /PRNewswire/ -- How much of your oral health really depends on daily habits? That question is explored in a HelloNation article featuring insights from Dr. Marisa Clifford of Dental Arts Group in Cortland, NY. The feature explains how small, consistent... ———————————————————————————————————————————————————————————— Helix BioPharma Corp. Strengthens Executive Leadership to Support U.S. Listing Strategy and Next Phase of Clinical Development 2026-06-30 · NewMediaWire · Healthcare https://www.newmediawire.com/news/helix-biopharma-corp-strengthens-executive-leadership-to-support-u-s-listing-strategy-and-next-phase-of-clinical-development-7087446 VANCOUVER, BC - June 30, 2026 ( NEWMEDIAWIRE ) - Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company” ), a clinical-stage oncology company shaping a near future where today’s hard-to-treat cancers are vincible, today announced the appointments of Helen Middleton as General Counsel and David Browning as Vice President of Clinical Operations . The appointments further strengthen Helix’s executive leadership team as the Company prepares for its planned U.S. securities exchange listing, advances the next stage of development for L-DOS47 through LDOS007, the Company’s planned Phase IB/Randomized Phase II study in first-line non-small cell lung cancer (NSCLC), and continues building the legal, governance and operational infrastructure required to ———————————————————————————————————————————————————————————— XTL Completed the Acquisition of Psyga Bio Ltd. 2026-06-30 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/06/30/3320211/0/en/XTL-Completed-the-Acquisition-of-Psyga-Bio-Ltd.html expands its IP portfolio to clinical-stage biopharmaceutical assets ———————————————————————————————————————————————————————————— The Inner Circle acknowledges Mary Carter Robinson, DDS as a Pinnacle Lifetime Member 2026-06-30 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/the-inner-circle-acknowledges-mary-carter-robinson-dds-as-a-pinnacle-lifetime-member-302814944.html COLLEGE PARK, Md., June 30, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Mary Carter Robinson, DDS is acknowledged as a Pinnacle Lifetime Member for her contributions to Advancing Patient-Centered Care in Oral and Maxillofacial Surgery. With a strong commitment to... ———————————————————————————————————————————————————————————— ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules 2026-06-30 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/06/30/3320159/0/en/ALX-Oncology-Reports-Inducement-Grant-as-permitted-by-the-Nasdaq-Listing-Rules.html SOUTH SAN FRANCISCO, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology," Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, announced that the Compensation Committee of the Board of Directors of ALX Oncology approved the granting of an inducement stock option to purchase a total of 500,000 shares of ALX Oncology’s common stock to Michael Listgarten, General Counsel, on June 29, 2026 in connection with the commencement of his employment. Mr. Listgarten’s inducement stock option is subject to the terms of the ALX Oncology Holdings Inc. 2025 Inducement Equity Incentive Plan and related forms of agreements, and was granted as an inducement material to Mr. Listgarten ———————————————————————————————————————————————————————————— Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline 2026-06-30 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/06/30/3320137/0/en/Liminatus-Pharma-Amends-Definitive-Merger-Agreement-with-InnocsAI-to-Expand-Oncology-Cell-Therapy-Pipeline.html Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline ———————————————————————————————————————————————————————————— HeartBeam (BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study 2026-06-30 · NewMediaWire · Finance, Healthcare, Retail https://www.newmediawire.com/news/heartbeam-beat-completes-enrollment-ahead-of-schedule-in-heart-attack-detection-pilot-study-7087440 LOS ANGELES, CA - June 30, 2026 ( NEWMEDIAWIRE ) - HeartBeam (NASDAQ: BEAT) announced it has completed patient enrollment ahead of schedule in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection. The study enrolled 120 patients presenting with chest pain at two clinical sites in Belgrade, Serbia, with participants evaluated using both a standard 12-lead ECG and the company’s 3D ECG technology. Data analysis is underway, and HeartBeam plans to present the results at a major cardiology conference later this year. The company said the study results are expected to support discussions with the FDA on the design of a planned U.S. pivotal trial and a future submission to expand the HeartBeam System’s indication beyond arrhythmia assessment to include heart attack ———————————————————————————————————————————————————————————— In HelloNation, Audiology Expert Dr. Elizabeth Welch of Franklin, TN Addresses Tinnitus and When to Seek Help 2026-06-30 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/in-hellonation-audiology-expert-dr-elizabeth-welch-of-franklin-tn-addresses-tinnitus-and-when-to-seek-help-302814973.html FRANKLIN, Tenn. , June 30, 2026 /PRNewswire/ -- What causes ringing in the ears, and when should adults seek medical advice? A HelloNation article offers clear guidance for understanding tinnitus, its potential causes, and how adults in Franklin, TN, can take proactive steps to manage... ———————————————————————————————————————————————————————————— Cardio Diagnostics Holdings (CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks 2026-06-30 · NewMediaWire · Finance, Healthcare, Retail https://www.newmediawire.com/news/cardio-diagnostics-holdings-cdio-leverages-epigenetics-to-reveal-hidden-heart-disease-risks-7087439 LOS ANGELES, CA - June 30, 2026 ( NEWMEDIAWIRE ) - When most people think about their risk for heart disease, they think about family history. Did a parent or grandparent have a heart attack? Is heart disease “in their genes”? It’s an understandable assumption, and genetics does play a role in cardiovascular risk. But a growing body of research suggests that DNA sequence alone tells only part of the story, and increasingly, scientists believe it may be the smaller part. The rest of the story is largely written in epigenetics, a field of biology that examines how genes are switched on or off, turned up or down, without any change to the underlying DNA code itself. Cardio Diagnostics Holdings (NASDAQ: CDIO) , a medical technology company built around epigenetics-based cardiovascular testing, ———————————————————————————————————————————————————————————— Trustpoint Xposure Releases Landmark AEO Research Report, Revealing ... 2026-06-30 · PR-Inside · AI, Healthcare https://pr-inside.com/trustpoint-xposure-releases-landmark-aeo-research-report-revealing-r5196359.htm (PR-inside.com) The most comprehensive AI citation authority research conducted on New York's professional services market reveals that 88% of audited brands are either absent or inaccurately cited in AI-generated answers despite significant investment in traditional digital marketing. AMHERST, NY / ACCESS Newswire / June 30, 2026 / Trustpoint Xposure, the AEO-certified PR and digital authority agency headquartered in New York, today released its landmark AEO Research Report, the most comprehensive study of AI citation authority ever conducted on professional service brands revealing that 88% of the 200 professionals audited across legal, medical, financial, and technology sectors were either completely absent from or .. ———————————————————————————————————————————————————————————— Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds 2026-06-30 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/06/30/3320064/0/en/Creative-Medical-Technology-Holdings-Announces-Agreements-for-Exercise-of-Warrants-for-4-5-Million-Gross-Proceeds.html PHOENIX, June 30, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. , (Nasdaq: CELZ) (the “Company”), a biotechnology company dedicated to the advancement of regenerative therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedic, today announced that it has entered into agreements with certain holders of its existing warrants for the immediate exercise of outstanding warrants to purchase up to an aggregate of 2,790,340 shares of common stock of the Company originally issued in October 2025, at a reduced exercise price of $1.60 per share. The shares of common stock issuable upon exercise of the existing warrants are registered pursuant to an effective registration statement on Form S-3 (File No. 333-291713). The aggregate gross proceeds ———————————————————————————————————————————————————————————— Dr. Janak Parikh Featured on Fox 26 Houston to Discuss FoLix, the First ... 2026-06-30 · PR-Inside · Healthcare https://pr-inside.com/dr-janak-parikh-featured-on-fox-26-houston-to-discuss-folix-the-first-r5196353.htm (PR-inside.com) Houston plastic surgeon shares insights on non-surgical hair restoration, early intervention, and the growing role of laser-based treatment for thinning hair. HOUSTON, TX / ACCESS Newswire / June 30, 2026 / Dr. Janak Parikh, MD, FACShas been featured onFox 26 Houstonto discuss FoLix Hair Restoration, an innovative non-invasive laser treatment for hair loss now available through the practice. "Being featured on Fox 26 is a reflection of the growing conversation around non-surgical hair restoration in Houston. FoLix is the first FDA-cleared fractional laser designed specifically for hair loss, and I'm proud to bring that technology to our patients; no chemicals, no downtime, .. ———————————————————————————————————————————————————————————— Dr. Janak Parikh Featured on Fox 26 Houston to Discuss FoLix, the First FDA-Cleared Fractional Laser for Hair Loss 2026-06-30 · Newswire.com · Healthcare https://www.newswire.com/news/dr-janak-parikh-featured-on-fox-26-houston-to-discuss-folix-the-first-22812363 Houston plastic surgeon shares insights on non-surgical hair restoration, early intervention, and the growing role of laser-based treatment for thinning hair. ———————————————————————————————————————————————————————————— Vadzo Imaging Explains Wake-on-Motion USB Camera Technology: Falcon-544CRS Based on Onsemi AR0544 HyperLux LP for Event-Triggered, Low-Power Embedded Vision 2026-06-30 · Newswire.com · AI, Healthcare, Energy https://www.newswire.com/news/vadzo-imaging-explains-wake-on-motion-usb-camera-technology-falcon-22803944 Vadzo Imaging's Falcon-544CRS is a 5MP color USB 3.2 camera built on the Onsemi AR0544 HyperLux LP sensor, combining Wake-on-Motion event-triggered activation with super low power standby mode, purpose-built for battery-operated embedded vision deployments in IoT sensor networks, smart surveillance systems, medical monitoring devices, wearable platforms and edge AI applications. ———————————————————————————————————————————————————————————— FDA Sets Peptide Impurity Thresholds as Low as 0.10%, Oath Research Analysis Finds 2026-06-30 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/fda-sets-peptide-impurity-thresholds-as-low-as-0-10-oath-research-analysis-finds-302814908.html FDA guidance for synthetic peptide drugs requires identification of impurities above 0.10% and caps new impurities at 0.5% — U.S. FDA, 2021 GILBERT, Ariz., June 30, 2026 /PRNewswire/ -- Oath Research, a Gilbert, Arizona–based research peptide supplier, today released an analysis of the... ———————————————————————————————————————————————————————————— New U.S. study finds assistive communication improves lives by 65% and delivers 3.3x return 2026-06-30 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/new-us-study-finds-assistive-communication-improves-lives-by-65-and-delivers-3-3x-return-302814905.html A new U.S. health economic study commissioned by Dynavox Group finds that high-tech assistive communication can significantly improve quality of life for people with disabilities while delivering clear economic benefits to society. STOCKHOLM, June 30, 2026 /PRNewswire/ -- The study,... ———————————————————————————————————————————————————————————— PARADIGM HEALTH SUBMITS RESPONSE TO FDA'S REAL-TIME CLINICAL TRIALS INITIATIVE RFI, INFORMED BY BIOPHARMA SPONSORS AND PROVIDERS 2026-06-30 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/paradigm-health-submits-response-to-fdas-real-time-clinical-trials-initiative-rfi-informed-by-biopharma-sponsors-and-providers-302814900.html COLUMBUS, Ohio, June 30, 2026 /PRNewswire/ -- Paradigm Health, the sole technology provider operationalizing the U.S. Food and Drug Administration's (FDA) Real-Time Clinical Trials (RTCT) proof-of-concept studies, has formally submitted its response to the FDA's Request for Information... ———————————————————————————————————————————————————————————— Advance ER Urges World Cup Visitors & DFW Residents to Prioritize Sexual Health 2026-06-30 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/advance-er-urges-world-cup-visitors--dfw-residents-to-prioritize-sexual-health-302814886.html "Take Home the Memories, Not the Health Concerns" DALLAS, June 30, 2026 /PRNewswire/ -- As Dallas welcomes thousands of international and domestic visitors for FIFA World Cup-related events, Advance ER physicians are encouraging travelers and local residents to remember a very important... ———————————————————————————————————————————————————————————— Intermountain Foundation Adds 5 Leaders to Board of Trustees, Adding Momentum to Healthcare Campaigns 2026-06-30 · PRUnderground · Healthcare https://www.prunderground.com/intermountain-foundation-adds-5-leaders-to-board-of-trustees-adding-momentum-to-healthcare-campaigns/00387203/ Prominent leaders Scott Anderson, Christian Gardner, Gail Miller, Sandy Modersitzki, and Dr. Neal Sorensen join Intermountain Foundation The post Intermountain Foundation Adds 5 Leaders to Board of Trustees, Adding Momentum to Healthcare Campaigns first appeared on ———————————————————————————————————————————————————————————— Sanofi's Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study 2026-06-30 · WebWire · Healthcare https://www.webwire.com/ViewPressRel.asp?aId=356962 - - • Nexviazyme met its primary endpoint, participants alive and free of invasive ventilation, in treatment-na�ve infants zero to six months of age in the Baby-COMET phase 3 study - • Sanofi intends to submit the data to support a regulatory application in the US for the treatment of infantile-onset Pompe disease - - - Positive results from the Baby-COMET phase 3, single-arm, open-label study (clinical study identifier: NCT04910776 ), demonstrated that Nexviazyme (avalglucosidase alfa) m... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=356962 ———————————————————————————————————————————————————————————— Medical Clothing Market to reach USD 250.8 Billion by 2035 at 7.6% CAGR 2026-06-30 · GetNews · Healthcare https://www.getnews.info/story/2026/06/30/medical-clothing-market-to-reach-usd-2508-billion-by-2035-at-76-cagr/?source=barchart ———————————————————————————————————————————————————————————— Software as a Medical Device Market to reach USD 80.12 Billion by 2035 at 34.5% CAGR 2026-06-30 · GetNews · Healthcare https://www.getnews.info/story/2026/06/30/software-as-a-medical-device-market-to-reach-usd-8012-billion-by-2035-at-345-cagr/?source=barchart ———————————————————————————————————————————————————————————— Cosmos Health Authorizes Up to $5 Million Share Repurchase Program 2026-06-30 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/06/30/3319977/0/en/Cosmos-Health-Authorizes-Up-to-5-Million-Share-Repurchase-Program.html Cosmos Health announces stock buyback program of up to $5 million. ———————————————————————————————————————————————————————————— Alafair Biosciences Announces Launch of VersaCoat™ Flowable Hydrogel 2026-06-30 · PR Newswire · SaaS, Healthcare https://www.prnewswire.com/news-releases/alafair-biosciences-announces-launch-of-versacoat-flowable-hydrogel-302814767.html Syringe-deliverable hydrogel expands soft-tissue protection platform for tendons and nerves AUSTIN, Texas, June 30, 2026 /PRNewswire/ -- Alafair Biosciences, a medical device company redefining soft-tissue protection in orthopedic surgery, today announced the launch of VersaCoat™ Flowable... ———————————————————————————————————————————————————————————— When Distance Determines Survival: Avel eCare Makes the Case for Virtual ... 2026-06-30 · PR-Inside · Finance, Healthcare, Education https://pr-inside.com/when-distance-determines-survival-avel-ecare-makes-the-case-for-virtual-r5196315.htm (PR-inside.com) The nation's most experienced Virtual Health System says access to care should never be defined by zip code - and federal Rural Health Transformation funding is creating a historic opportunity to prove it. SIOUX FALLS, SD / ACCESS Newswire / June 30, 2026 / In rural America, the distance to the nearest emergency room isn't just an inconvenience. It's a matter of life and death. A cardiac event in a farming community. A child with a life-threatening allergic reaction in a school 30 minutes from the nearest ambulance. A trauma patient arriving at a Critical Access Hospital where, at 2 a.m., .. ———————————————————————————————————————————————————————————— Report from the Annual General Meeting 2026 of IRLAB Therapeutics AB 2026-06-30 · PR-Inside · Healthcare https://pr-inside.com/report-from-the-annual-general-meeting-2026-of-irlab-therapeutics-ab-r5196314.htm (PR-inside.com) GOTHENBURG, SE / ACCESS Newswire / June 30, 2026 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - IRLAB Therapeutics AB held its Annual General Meeting today, Tuesday 30 June 2026, at Biotech center in Gothenburg. The following main resolutions were made at the Annual General Meeting. Adoption of income statement and balance sheet as well as consolidated income statement and consolidated balance sheet The Annual General Meeting adopted the income statement and the balance sheet as well as the consolidated income statement and the consolidated balance sheet for the financial year 2025. Disposition of the company's results The disposition of the company's results proposed by the Board of .. ———————————————————————————————————————————————————————————— Physitrack Agrees Deal to Launch Digital Rehabilitation Across Major ... 2026-06-30 · PR-Inside · Finance, Healthcare https://pr-inside.com/physitrack-agrees-deal-to-launch-digital-rehabilitation-across-major-r5196305.htm (PR-inside.com) The deal entails enterprise-wide standardisation across 37 clinical sites and approximately 400 practitioner licences nationwide. Approximately £77,000 in annual recurring subscription revenue, representing an initial deployment with expansion potential as the network grows. LONDON, UK / ACCESS Newswire / June 30, 2026 / Physitrack plc (Nasdaq First North:PTRK) today announced an agreement generating approximately £77,000 in annual recurring revenue, standardising digital rehabilitation across 37 clinical sites and approximately 400 practitioner licences for one of the UK's largest independent healthcare providers, with expansion potential as the network grows. Highlights: Approximately £77,000 in annual recurring revenue, with expansion potential 37 clinical sites and appr ———————————————————————————————————————————————————————————— Neuro20 Technologies and The Walk Foundation Partner to Launch Home-Based Neurorehabilitation Initiative 2026-06-30 · Newswire.com · Healthcare https://www.newswire.com/news/neuro20-technologies-the-walk-foundation-launch-patient-access-initiative-for Veteran-founded MedTech pioneer aligns with non-profit to bridge the medical "Care Cliff" for stroke, SCI, MS, amputees, and individuals facing complex neurological conditions while expanding a fully IRB-approved clinical trial pipeline for advanced electroceutical neurorehabilitation. ———————————————————————————————————————————————————————————— Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz & ... 2026-06-30 · PR-Inside · Finance, Healthcare https://pr-inside.com/hims-hers-health-inc-hims-investigation-bronstein-gewirtz-r5196288.htm (PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / June 30, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE:HIMS). Investors who purchased Hims & Hers securities prior to April 1, 2025, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/HIMS. Hims & Hers Investigation Details The investigation concerns whether Hims & Hers and certain of its officers and/or directors have engaged in corporate wrongdoing. What's Next for Hims & Hers Investors? If .. ———————————————————————————————————————————————————————————— SCWorx Announces New Not-for-Profit Teaching Hospital Customer for Data Management Services Supporting Workday Integration 2026-06-30 · GlobeNewswire · Finance, SaaS, Healthcare https://www.globenewswire.com/news-release/2026/06/30/3319901/0/en/SCWorx-Announces-New-Not-for-Profit-Teaching-Hospital-Customer-for-Data-Management-Services-Supporting-Workday-Integration.html Company Continues Expansion of Healthcare Data Management Platform as Hospitals Modernize ERP Infrastructure ———————————————————————————————————————————————————————————— Maison Luxe, Inc. (OTC: MASN) Expands Strategic Review to Include AI-Enabled Business Opportunities 2026-06-30 · NewMediaWire · Finance, AI, Healthcare https://www.newmediawire.com/news/maison-luxe-inc-otc-masn-expands-strategic-review-to-include-ai-enabled-business-opportunities-7087431 FORT LEE, NJ - June 30, 2026 ( NEWMEDIAWIRE ) - Maison Luxe, Inc. (OTC: MASN) ("Maison Luxe," "MASN," or the "Company") today announced that, as part of its ongoing corporate development strategy, management continues to evaluate strategic merger and acquisition opportunities designed to complement the Company's long-term business objectives and enhance shareholder value. Over recent months, management has reviewed opportunities across several industries, including health and wellness. Following this evaluation, the Company has expanded its review to include businesses that leverage artificial intelligence, intelligent automation, and advanced data technologies as part of established operating models. Management believes that companies successfully integrating AI into proven commercial bus ———————————————————————————————————————————————————————————— Klarify Launches AI Operating System for Therapists as Mental Health Industry Faces Workforce and Insurance Crisis 2026-06-30 · NewMediaWire · AI, Healthcare, Retail, Education https://www.newmediawire.com/news/klarify-launches-ai-operating-system-for-therapists-as-mental-health-industry-faces-workforce-and-insurance-crisis-7087430 Backed by Y Combinator, Klarify Launches Publicly With 8,300 Therapists Across Five Countries as Therapists Face Rising Burnout, Administrative Overload, and a Growing AI Imbalance Against Insurers SAN FRANCISCO - June 30, 2026 ( NEWMEDIAWIRE ) - Therapists have become one of the most operationally overwhelmed professions in healthcare. Demand for mental health services has surged, reimbursement pressure continues to intensify, and clinicians increasingly spend as much time operating small businesses as treating patients. Klarify today launched publicly, unveiling an AI native operating system built specifically for therapists. At launch, Klarify boasts more than 8,300 therapists across five countries and is part of Y Combinator’s Spring 2026 batch. Klarify’s position is intentionally firm ———————————————————————————————————————————————————————————— The Eye Drink Achieves Verified Brand Status on RangeMe, Expanding ... 2026-06-30 · PR-Inside · SaaS, Healthcare, Retail https://pr-inside.com/the-eye-drink-achieves-verified-brand-status-on-rangeme-expanding-r5196242.htm (PR-inside.com) As an Incubated Client of Fast Moving Consumer Goods, The Eye Drink Strengthens Its Retail Readiness and Buyer Exposure Through RangeMe's Leading Retail Discovery Platform SAN DIEGO, CA / ACCESS Newswire / June 30, 2026 / The Eye Drink, the innovative functional beverage brand focused on making eye health simple and accessible, announced today that it has achieved Verified Brand status on RangeMe, the leading product discovery platform used by major retailers including Walmart, Albertsons, CVS, Walgreens, Sprouts, Kroger, Whole Foods Market, and thousands of regional retail buyers nationwide. The Eye Drink is an incubated client of Fast Moving Consumer Goods .. ———————————————————————————————————————————————————————————— Peytant Solutions Announces First-in-Human Use of AMStent® Tracheobronchial Covered Stent System 2026-06-30 · PRWeb · Healthcare, Education https://www.prweb.com/releases/peytant-solutions-announces-first-in-human-use-of-amstent-tracheobronchial-covered-stent-system-302812819.html Peytant Solutions, Inc., a medical technology innovator that is the first to combine human biologic material with an existing implantable device, today announced the first-in-human implantation of its AMStent® Tracheobronchial Covered Stent at Fairview East Bank University Hospital, known... ———————————————————————————————————————————————————————————— Children's Hospital Colorado helps improve growth outcomes for children living with dwarfism 2026-06-30 · PR Newswire · Healthcare, Education https://www.prnewswire.com/news-releases/childrens-hospital-colorado-helps-improve-growth-outcomes-for-children-living-with-dwarfism-302814614.html Findings from a global trial show significant increases in height and proportionality among children AURORA, Colo., June 30, 2026 /PRNewswire/ -- New findings from a trial conducted at Children's Hospital Colorado (Children's Colorado) and University of Colorado (CU) Anschutz School of... ———————————————————————————————————————————————————————————— Flux Power Releases SkyEMS® 3.0, Transforming Fleet Data with AI-Powered Insights and Personalized Dashboards 2026-06-30 · GlobeNewswire · Finance, AI, Healthcare, Energy https://www.globenewswire.com/news-release/2026/06/30/3319830/24114/en/Flux-Power-Releases-SkyEMS-3-0-Transforming-Fleet-Data-with-AI-Powered-Insights-and-Personalized-Dashboards.html With customizable AI-powered dashboards, predictive battery health insights, and real-time alerts, SkyEMS 3.0 transforms fleet data into a strategic asset, helping customers optimize operations while strengthening Flux Power's intelligent energy ecosystem. With customizable AI-powered dashboards, predictive battery health insights, and real-time alerts, SkyEMS 3.0 transforms fleet data into a strategic asset, helping customers optimize operations while strengthening Flux Power's intelligent energy ecosystem. ———————————————————————————————————————————————————————————— Tribun Health Announces CaloPix(R) 6, Its First IVDR-Certified Version ... 2026-06-30 · PR-Inside · AI, SaaS, Healthcare https://pr-inside.com/tribun-health-announces-calopix-r-6-its-first-ivdr-certified-version-r5196236.htm (PR-inside.com) A major new milestone in the digital transformation of pathology, benefiting laboratories, clinicians, and patients. Following FDA clearance in 2025,CaloPix's®IVDR certification confirms Tribun Health's ability to serve the global digital pathology market. PARIS, FRANCE / ACCESS Newswire / June 30, 2026 / Tribun Health, a global leader in digital pathology and artificial intelligence orchestration software solutions, today announced the availability of CaloPix® 6, the first version of its platform certified under the European In Vitro Diagnostic Medical Devices Regulation (IVDR) for routine diagnostic use. This new milestone marks the culmination of several years of investment in quality, cybersecurity, risk management, and regulatory .. ———————————————————————————————————————————————————————————— Tribun Health Announces CaloPix(R) 6, Its First IVDR-Certified Version for Routine Diagnostic Use 2026-06-30 · Newswire.com · Healthcare https://www.newswire.com/news/tribun-health-announces-calopix-6-its-first-ivdr-certified-version-for-routine A major new milestone in the digital transformation of pathology, benefiting laboratories, clinicians, and patients. Following FDA clearance in 2025, CaloPix's® IVDR certification confirms Tribun Health's ability to serve the global digital pathology market. ———————————————————————————————————————————————————————————— Tenon Medical, Inc. Announces Pricing of $4.2 Million Public Offering 2026-06-30 · PR-Inside · Finance, Healthcare https://pr-inside.com/tenon-medical-inc-announces-pricing-of-4-2-million-public-offering-r5196235.htm (PR-inside.com) LOS GATOS, CA / ACCESS Newswire / June 30, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, announced that it has priced a public offering of securities as described below for aggregate gross proceeds to the Company of approximately $4.2 million, before deducting placement agent fees and other estimated offering expenses payable by the Company. The offering consists of up to 11,052,631 shares of our common stock, par value $0.001 per share (or pre-funded warrants in lieu thereof), together with common stock purchase warrants to .. ———————————————————————————————————————————————————————————— Modular Medical Delivers Insulin to First Patients on Pivot Tubeless ... 2026-06-30 · PR-Inside · Finance, Healthcare https://pr-inside.com/modular-medical-delivers-insulin-to-first-patients-on-pivot-tubeless-r5196233.htm (PR-inside.com) First Patients Began Device Training and Insulin Delivery Today, Marking Transition to a Commercial Company Pivot is the First Insulin Pump Designed to Address the Large, Underserved Population of Insulin-Dependent Adults Still Relying on Multiple Daily Injections, a Multibillion-Dollar Market SAN DIEGO, CO / ACCESS Newswire / June 30, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery technology, today announced that the first patients have completed onboarding and training and are now actively using the Pivot™ tubeless insulin patch pump in real-world settings. This milestone marks the transition of the Pivot pump from .. ———————————————————————————————————————————————————————————— Arcutis Launches New Virtual Health Platform Supporting Access to Care for Individuals Living with Chronic Inflammatory Skin Diseases, Including Approved ZORYVE® (roflumilast) Indications 2026-06-30 · GlobeNewswire · Finance, SaaS, Healthcare https://www.globenewswire.com/news-release/2026/06/30/3319793/0/en/Arcutis-Launches-New-Virtual-Health-Platform-Supporting-Access-to-Care-for-Individuals-Living-with-Chronic-Inflammatory-Skin-Diseases-Including-Approved-ZORYVE-roflumilast-Indicati.html Arcutis Launches New Virtual Health Platform Supporting Access to Care for Individuals Living with Chronic Inflammatory Skin Diseases ———————————————————————————————————————————————————————————— Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump 2026-06-30 · Newswire.com · Healthcare https://www.newswire.com/news/modular-medical-delivers-insulin-to-first-patients-on-pivot-tubeless-insulin First Patients Began Device Training and Insulin Delivery Today, Marking Transition to a Commercial Company Pivot is the First Insulin Pump Designed to Address the Large, Underserved Population of Insulin-Dependent Adults Still Relying on Multiple Daily Injections, a Multibillion-Dollar Market ———————————————————————————————————————————————————————————— Medical Care Technologies Inc. (OTC PINK:MDCE) Rolls Out Visually Stunning ... 2026-06-30 · PR-Inside · AI, Healthcare, Retail https://pr-inside.com/medical-care-technologies-inc-otc-pink-mdce-rolls-out-visually-stunning-r5196232.htm (PR-inside.com) Photograph Your Open Refrigerator for Instant Personalized Recipes - Faster, More Beautiful and Built for Scale MESA, AZ / ACCESS Newswire / June 30, 2026 /Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a comprehensive redesign and upgrade to its flagship consumer wellness app, Snapshot Recipes, transforming it into a visually stunning, high-speed AI culinary powerhouse. Learn more about the app at https://snapshotrecipes.app. The complete visual overhaul introduces a bold, artistic, and modern creative design that elevates the user experience with mouth-watering imagery, intuitive navigation, and immersive aesthetics. Paired with significantly faster recipe generation speeds and a massively expanded library spanning all .. ———————————————————————————————————————————————————————————— Medical Care Technologies Inc. (OTC PINK:MDCE) Rolls Out Visually Stunning Super-Charged Version of Snapshot Recipes Mobile App 2026-06-30 · Newswire.com · Healthcare https://www.newswire.com/news/medical-care-technologies-inc-otc-pink-mdce-rolls-out-visually-stunning-super Photograph Your Open Refrigerator for Instant Personalized Recipes - Faster, More Beautiful and Built for Scale ———————————————————————————————————————————————————————————— NCQA Names Dr. Ari Robicsek as Inaugural Chief Medical Officer 2026-06-30 · PR-Inside · Healthcare https://pr-inside.com/ncqa-names-dr-ari-robicsek-as-inaugural-chief-medical-officer-r5196230.htm (PR-inside.com) Physician-scientist and healthcare analytics leader joins NCQA to advance digital quality measurement, data-driven innovation and patient-centered outcomes. WASHINGTON, D.C. / ACCESS Newswire / June 30, 2026 / The National Committee for Quality Assurance (NCQA) today announced the appointment of Ari Robicsek, MD, as its inaugural Chief Medical Officer (CMO). Dr. Robicsek joined the organization on June 29, 2026, bringing more than two decades of experience at the intersection of clinical medicine, data science, healthcare analytics and innovation to deepen NCQA's clinical leadership and accelerate its quality modernization agenda. "The creation of the CMO role reflects NCQA's commitment to meeting this moment in .. ———————————————————————————————————————————————————————————— Matic AI Boldly Declares Independence for Primary Care Providers - "We Are Not Going Back!" 2026-06-30 · PRWeb · AI, Healthcare https://www.prweb.com/releases/matic-ai-boldly-declares-independence-for-primary-care-providers---we-are-not-going-back-302814259.html Matic declares independence for primary care providers everywhere, shouting "never again!" to burnout, missed care gaps, after-hours charting, downcoding, ill-informed diagnoses, inbox overload and the mountain of other non-clinical tasks and repetitive obligations that take doctors away... ———————————————————————————————————————————————————————————— Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications ... 2026-06-30 · PR-Inside · Finance, Healthcare https://pr-inside.com/sonoma-pharmaceuticals-receives-fda-510-k-clearance-expanding-indications-r5196228.htm (PR-inside.com) BOULDER, CO / ACCESS Newswire / June 30, 2026 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced it has received a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Microdacyn® Wound Irrigation Solution, including expanded claims, clearance for multiple use, and additional packaging configurations. Under this new clearance, Microdacyn Wound Irrigation Solution can be used under the supervision of a healthcare professional for cleansing, irrigating, moistening, debridement and removal of foreign material including microorganisms from exudating and/or dirty wounds, acute and chronic dermal lesions, such as Stage I-IV .. ———————————————————————————————————————————————————————————— Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results ... 2026-06-30 · PR-Inside · Finance, Healthcare https://pr-inside.com/presentation-at-espghan-2026-describes-additional-groundbreaking-results-r5196227.htm (PR-inside.com) Company remains sharply focused on its ongoing global development program for crofelemer for rare IF diseases Near-term milestones for IF program buttressed by continuing groundbreaking results of study, which demonstrate reduction of parenteral support normalized to body weight of up to 48% in patient with the ultrarare pediatric microvillus inclusion disease (MVID) SAN FRANCISCO, CA / ACCESS Newswire / June 30, 2026 /Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar") family company Napo Pharmaceuticals (Napo) today provided a recap of presentations of the oral liquid crofelemer as adjunctive therapy in pediatric intestinal failure (IF) patients at the 58th Annual European Society for Pediatric Gastroenterology, .. ———————————————————————————————————————————————————————————— Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF) 2026-06-30 · Newswire.com · Healthcare https://www.newswire.com/news/presentation-at-espghan-2026-describes-additional-groundbreaking-results-of Company remains sharply focused on its ongoing global development program for crofelemer for rare IF diseases Near-term milestones for IF program buttressed by continuing groundbreaking results of study, which demonstrate reduction of parenteral support normalized to body weight of up to 48% in patient with the ultrarare pediatric microvillus inclusion disease (MVID) ———————————————————————————————————————————————————————————— Sagility Named a Leader in Avasant's Clinical and Care Management Business Process Transformation 2026 RadarView™ 2026-06-30 · PRWeb · Healthcare https://www.prweb.com/releases/sagility-named-a-leader-in-avasants-clinical-and-care-management-business-process-transformation-2026-radarview-302813913.html Sagility has secured its position as a Leader in the Clinical and Care Management Business Process Transformation RadarView for the second year in a row. • Under Avasant's new, differentiated scoring framework, Sagility achieved high ranking in Future-proofing and Practice Maturity. • The... ———————————————————————————————————————————————————————————— Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution 2026-06-30 · Newswire.com · Healthcare https://www.newswire.com/news/sonoma-pharmaceuticals-receives-fda-510-k-clearance-expanding-indications-and ———————————————————————————————————————————————————————————— Dazos SamurAI to change the way behavioral health pros make decisions 2026-06-30 · PR Newswire · Finance, AI, Healthcare https://www.prnewswire.com/news-releases/dazos-samurai-to-change-the-way-behavioral-health-pros-make-decisions-302813937.html BOCA RATON, Fla., June 30, 2026 /PRNewswire/ -- Dazos has launched SamurAI, an AI-native product line built on top of the Dazos CRM, to give behavioral health operators instant answers and insight into to any question about admissions, referral conversion, revenue metrics and more by... ———————————————————————————————————————————————————————————— FHIMA Celebrates 50th Annual Convention with "Reach for the Stars" Theme, Nationally Recognized Keynote Speakers, and Interactive Healthcare Innovations 2026-06-30 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/fhima-celebrates-50th-annual-convention-with-reach-for-the-stars-theme-nationally-recognized-keynote-speakers-and-interactive-healthcare-innovations-302814388.html Florida's premier health information management conference welcomes hundreds of healthcare professionals to Orlando, July 12–15, 2026. ORLANDO, Fla., June 30, 2026 /PRNewswire/ -- The Florida Health Information Management Association (FHIMA) will celebrate its 50th Annual Convention July... ———————————————————————————————————————————————————————————— LataMed AI Executes Strategic Commercial Alliance With Vrtice Seguros to Expand Digital Healthcare and Insurance Ecosystem 2026-06-30 · NewMediaWire · AI, Healthcare, Retail https://www.newmediawire.com/news/latamed-ai-executes-strategic-commercial-alliance-with-vrtice-seguros-to-expand-digital-healthcare-and-insurance-ecosystem-7087427 CARACAS, VENEZUELA - June 30, 2026 ( NEWMEDIAWIRE ) - LataMed AI Corp. (OTC: LMED) (the “Company”), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets, today announced that its Venezuelan operating affiliate, LataMed AI VE, has entered into a strategic commercial alliance agreement with Vértice Seguros C.A., a Venezuelan insurance company regulated by the Superintendence of Insurance Activity (SUDEASEG). The agreement establishes a collaborative commercial relationship designed to integrate selected insurance-related services into the Company's developing healthcare ecosystem while expanding digital healthcare accessibility for patients throughout ———————————————————————————————————————————————————————————— Rivia Mind Opens Montclair Office to Support Continued Access to Mental ... 2026-06-30 · PR-Inside · Healthcare https://pr-inside.com/rivia-mind-opens-montclair-office-to-support-continued-access-to-mental-r5196216.htm (PR-inside.com) MONTCLAIR, NJ / ACCESS Newswire / June 30, 2026 / Rivia Mind , a mental health practice committed to compassionate, evidence-based care, today announced the continued expansion of its New Jersey services through its Montclair office. The new location represents the next stage of Rivia Mind's commitment to increasing access to outpatient mental health care and psychiatric medication management through a flexible hybrid model that combines in-person and virtual services. The new Montclair office expands access to medication management and therapy for patients across New Jersey. By offering both in-person and virtual appointments, Rivia Mind provides patients with greater flexibility in .. ———————————————————————————————————————————————————————————— Rivia Mind Opens Montclair Office to Support Continued Access to Mental Health Care in New Jersey 2026-06-30 · Newswire.com · Healthcare https://www.newswire.com/news/rivia-mind-opens-montclair-office-to-support-continued-access-to-22814049 Rivia Mind expands access to mental health care in New Jersey with its new Montclair office, offering in-person and virtual therapy and psychiatric care. ———————————————————————————————————————————————————————————— The FDA Publishes Its Supplement Warning Letters, NutraVeri Built the ... 2026-06-30 · PR-Inside · SaaS, Healthcare, Retail https://pr-inside.com/the-fda-publishes-its-supplement-warning-letters-nutraveri-built-the-r5196214.htm (PR-inside.com) A new platform screens supplement formulas and claims against the public FDA and FTC enforcement record, so founders see potential problems before a co-packer, a regulator, or a competitor does. The first readiness score is free. MIAMI, FL / ACCESS Newswire / June 30, 2026 /Nitches Inc. (OTC PINK:NICH) - Every warning letter the FDA issues to a supplement company is public. It is searchable. It does not expire. It names the company, the product, and the exact language that crossed the line, and it stays online for anyone-an investor, a retail buyer, a journalist, or a litigator-to find years later. Most .. ———————————————————————————————————————————————————————————— The FDA Publishes Its Supplement Warning Letters, NutraVeri Built the Tool That Reads Them Before You Receive One 2026-06-30 · Newswire.com · SaaS, Healthcare https://www.newswire.com/news/the-fda-publishes-its-supplement-warning-letters-nutraveri-built-the-tool-that A new platform screens supplement formulas and claims against the public FDA and FTC enforcement record, so founders see potential problems before a co-packer, a regulator, or a competitor does. The first readiness score is free. ———————————————————————————————————————————————————————————— Protagenic Therapeutics' Lead Candidate PT00114 Attenuated Chronic ... 2026-06-30 · PR-Inside · Healthcare https://pr-inside.com/protagenic-therapeutics-lead-candidate-pt00114-attenuated-chronic-r5196208.htm (PR-inside.com) As published in Behavioural Pharmacology, two days of PT00114 treatment reduced corticosterone levels and attenuated anxiety-like behavior in chronically stressed rats; a known CRF₁ receptor antagonist did not show activity in the same model. NEW YORK, NY / ACCESS Newswire / June 30, 2026 / Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company focused on novel neuropeptide therapies for stress-related disorders, today announced the publication of new preclinical data for its lead candidate, PT00114, in the peer-reviewed journal Behavioural Pharmacology. In a well-established rodent model of chronic unpredictable stress, PT00114 reduced both physiological and behavioral markers of chronic stress after stress .. ———————————————————————————————————————————————————————————— Children with Achondroplasia Treated with TransCon CNP Showed Continued Improvements in Lower Extremity Alignment at Week 104 of the Pivotal ApproaCH Trial 2026-06-30 · GlobeNewswire · Finance, Healthcare, Education https://www.globenewswire.com/news-release/2026/06/30/3319671/0/en/Children-with-Achondroplasia-Treated-with-TransCon-CNP-Showed-Continued-Improvements-in-Lower-Extremity-Alignment-at-Week-104-of-the-Pivotal-ApproaCH-Trial.html COPENHAGEN, Denmark, June 30, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new radiographic data from Week 104 from the completed pivotal ApproaCH Trial of once-weekly TransCon CNP (navepegritide) in children with achondroplasia. In the trial, TransCon CNP-treated children demonstrated continued improvements in lower extremity alignment through up to two years of treatment, including improvements in tibial-femoral angle (TFA). As previously reported, improvements in annualized growth velocity were maintained and ACH-specific height Z-score increased with TransCon CNP treatment through Week 104. The data were presented by Leanne M. Ward, M.D., FRCPC, Professor of Pediatrics at the University of Ottawa and Children's Hospital of Eastern Ontario, during the 12 t ———————————————————————————————————————————————————————————— Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader 2026-06-30 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/06/30/3319669/0/en/Microbot-Medical-Increases-Manufacturing-Capacity-as-Demand-for-the-LIBERTY-System-Rises-Enters-into-Strategic-Agreement-with-Sanmina-a-Global-Manufacturing-Leader.html Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina ———————————————————————————————————————————————————————————— The UK’s first-ever mass nature bathe on a rewilding site taking place in July 2026-06-30 · Pressat · Healthcare https://pressat.co.uk/releases/the-uks-first-ever-mass-nature-bathe-on-a-rewilding-site-taking-place-in-july-a6a925b6d67da53006aaf769850d45c9/ Tuesday 30 June, 2026 People of all ages are being invited to join the UK's first-ever mass nature bathe on a UK rewilding site. The Great Pause is a free event being run by the national charity Heal Rewilding, taking place at their flagship nature recovery project near Frome in east Somerset on Sunday 19 July from 3pm onwards. The event will see people coming together in the heart of Heal Somerset's rewilding landscape for a collective period of silence and nature immersion, offering a rare opportunity to pause, slow down and reconnect with the natural world alongside others. Taking place on a summer afternoon surrounded by birdsong, wild grasses and recovering habitats, The Great Pause will invite people simply to lie back on a blanket and become fully present in nature. Participants can ———————————————————————————————————————————————————————————— BioElectronics Issues Chairman's Update Highlighting Sales Growth, and Strategic Progress 2026-06-30 · NewMediaWire · Finance, Healthcare, Retail https://www.newmediawire.com/news/bioelectronics-issues-chairman-s-update-highlighting-sales-growth-and-strategic-progress-7087424 JEFFERSON, MD - June 30, 2026 ( NEWMEDIAWIRE ) - BioElectronics Corporation ( https://www.bielcorp.com/ ) (OTC: BIEL), a developer of medical technology products, today released an update from its Chairman, Richard Staelin, PhD. Dear Shareholders, It has been some time since my last Chairman's letter. During this period, BioElectronics has remained focused on identifying opportunities to expand revenues and markets while maintaining disciplined cost control. Our cost control efforts included relocating our offices and reducing staff to better align with current operational needs. As a result, the Company reported a small profit for calendar year 2025. We also initiated several programs intended to increase awareness, adoption, and long-term value of our technology platforms. One revenue-ge ———————————————————————————————————————————————————————————— Aptevo Secures $1.5 Million Non-Dilutive Research Grant From the Andy ... 2026-06-30 · PR-Inside · Finance, SaaS, Healthcare https://pr-inside.com/aptevo-secures-1-5-million-non-dilutive-research-grant-from-the-andy-r5196206.htm (PR-inside.com) SEATTLE, WA / ACCESS Newswire / June 30, 2026 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced it has been awarded a $1.5 million non-dilutive research grant from the Andy Hill Cancer Research Endowment (CARE) Fund under its Implementation and Outcomes Research program to support investigational new drug (IND)-enabling work for APVO451, Aptevo's novel trispecific antibody-like immunotherapy candidate for solid tumors. Aptevo believes that obtaining this competitive award, reviewed by subject matter experts and awarded based on merit, provides external validation of APVO451's tumor-directed trispecific .. ———————————————————————————————————————————————————————————— AAA Biotech Expands Global Authorized Distributor Network to Improve ... 2026-06-30 · PR-Inside · Healthcare https://pr-inside.com/aaa-biotech-expands-global-authorized-distributor-network-to-improve-r5196204.htm (PR-inside.com) LA JOLLA, CA / ACCESS Newswire / June 30, 2026 / AAA Biotech, a supplier of high-quality research reagents for life science applications, today announced the expansion of its global authorized distributor network aimed at improving access to antibodies, recombinant proteins, and ELISA kits for researchers across key international markets. This expansion strengthens the company's commitment to supporting biomedical research by ensuring faster and more reliable access to critical laboratory tools. The expanded distribution framework is designed to streamline procurement processes for academic institutions, biotechnology companies, and pharmaceutical researchers by reducing lead times and improving regional availability of essential research products. Strengthening .. ———————————————————————————————————————————————————————————— Black Book Norway Provider Pulse Examines Shared-Record Interoperability, ... 2026-06-30 · PR-Inside · Healthcare https://pr-inside.com/black-book-norway-provider-pulse-examines-shared-record-interoperability-r5196203.htm (PR-inside.com) Survey of 99 Norway clinicians and provider respondents follows Black Book's June 2026 EHDS interoperability research OSLO, NO / ACCESS Newswire / June 30, 2026 / Black Book Research today released findings from a focused Norway provider pulse survey of 99 clinicians, care delivery professionals, municipal provider respondents and health IT leaders, examining frontline experience with shared-record modernization, interoperability execution and clinical workflow performance. Black Book initiated the Norway provider pulse following its June 2026 European interoperability and EHDS readiness research, which found that Europe's health systems are increasingly connected but still struggling to achieve structured, reusable, workflow-embedded interoperability. Norway was selected . ———————————————————————————————————————————————————————————— AvevoRx Launches National Nutrition Education and Patient Engagement Initiative, Expands Access for Patients with Complex Nutrition Needs 2026-06-30 · PRWeb · SaaS, Healthcare, Education https://www.prweb.com/releases/avevorx-launches-national-nutrition-education-and-patient-engagement-initiative-expands-access-for-patients-with-complex-nutrition-needs-302811688.html New digital outreach strategy, educational resources, virtual support offerings, and patient engagement platform aim to connect underserved patients and providers with specialized nutrition expertise nationwide GREENSBORO, N.C., June 30, 2026 /PRNewswire-PRWeb/ -- AvevoRx, a national,... ———————————————————————————————————————————————————————————— Kairos Meridian Launches an Independent, Shorter Path From Problem to Impact 2026-06-30 · PRWeb · Healthcare https://www.prweb.com/releases/kairos-meridian-launches-an-independent-shorter-path-from-problem-to-impact-302812776.html Big-agency thinking with boutique agility, and impact you can measure. Independent firm sharpening decisions for life sciences marketers, the vendors selling to them, and the private equity firms weighing pharma assets. Where strategy meets the moment. MILLSTONE TOWNSHIP, N.J., June 30,... ———————————————————————————————————————————————————————————— Blue Impact Grant Awarded to Healthconnect Texas, Strengthening Housing Access in Houston 2026-06-30 · PR Newswire · Finance, Healthcare, Real Estate https://www.prnewswire.com/news-releases/blue-impact-grant-awarded-to-healthconnect-texas-strengthening-housing-access-in-houston-302812505.html Funding from Blue Cross and Blue Shield of Texas will help the statewide health information exchange streamline connections to housing, healthcare, and social services for vulnerable populations across Greater Houston. HOUSTON, June 30, 2026 /PRNewswire/ -- Leaders from Blue Cross and... ———————————————————————————————————————————————————————————— KidneyIntelX® Delivers Unprecedented Two-Year Real-World Outcomes in Diabetic Kidney Disease: No Comparable Risk Assessment Tool Exists 2026-06-30 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/kidneyintelx-delivers-unprecedented-two-year-real-world-outcomes-in-diabetic-kidney-disease-no-comparable-risk-assessment-tool-exists-302813930.html Landmark study of 2,470 patients across two U.S. health systems demonstrates sustained risk-stratified improvements in kidney function, increases in guideline-directed therapy uptake, and - for the first time - measurable reduction in individual patient risk trajectories over 24 months... ———————————————————————————————————————————————————————————— Wellgistics Health Executive Chairman and President Exercise Warrants 2026-06-30 · PR-Inside · Finance, AI, SaaS, Healthcare https://pr-inside.com/wellgistics-health-executive-chairman-and-president-exercise-warrants-r5196188.htm (PR-inside.com) Executives exercise previously issued warrants to acquire 200,000 common shares Shares issued in connection with exercise added to existing lock-up agreements TAMPA, FL / ACCESS Newswire / June 30, 2026 /Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™ , today announced that its Executive Chairman Suren Ajjarapu and President & Interim Co-CEO Prashant Patel have exercised all warrants previously issued to them in connection with the conversion of their outstanding salaries into common shares at $10 per share. The exercise of the warrants resulted in the issuance of .. ———————————————————————————————————————————————————————————— Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors 2026-06-30 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/06/30/3319550/0/en/Palvella-Therapeutics-Appoints-Accomplished-Rare-Disease-Biotech-Executive-and-Commercial-Leader-Matt-Pauls-J-D-M-B-A-to-Board-of-Directors.html Brings more than 25 years of experience advancing and commercializing high-impact therapies for serious diseases, including those with limited or no approved treatment options ———————————————————————————————————————————————————————————— Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones 2026-06-30 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/06/30/3319560/0/en/Pyxis-Oncology-Announces-Up-to-114-Million-Private-Placement-Financing-to-Advance-MICVO-Through-Key-Clinical-Milestones.html Expected to extend cash runway into the second quarter of 2027, supporting additional follow-up for 2L+ R/M HNSCC patients treated with MICVO at or below a dose cap ———————————————————————————————————————————————————————————— Ascelia Pharma Expands Orviglance IP Portfolio with New Patent Filing 2026-06-30 · PR-Inside · Healthcare https://pr-inside.com/ascelia-pharma-expands-orviglance-ip-portfolio-with-new-patent-filing-r5196159.htm (PR-inside.com) MALMÖ, SE / ACCESS Newswire / June 30, 2026 / Ascelia Pharma AB (publ) (STO:ACE), a biotech company focused on improving the life of people living with rare cancer conditions, today announced the filing of a new patent application for its first-in-class liver imaging drug Orviglance®. The patent application covers innovations related to packaging and manufacturing of Orviglance, which includes improving the usability for patients and healthcare professionals. Subject to approval and grant, the patent is expected to further strengthen the market position and future potential of Orviglance. "This patent application reflects our strategy to strengthen our Orviglance franchise and maximize long-term .. ———————————————————————————————————————————————————————————— New Kitten at Home? Stevenson Village Veterinary Hospital Offers Expert Guidance for First-Time Cat Owners 2026-06-30 · Express Press Release · Healthcare https://express-press-release.net/news/2026/06/30/1761151 Baltimore, USA, 2026-06-30 — /EPR Network/ — Bringing home a new kitten is an exciting milestone, but it also comes with important responsibilities that help [read full press release...] ———————————————————————————————————————————————————————————— Gadi Lachman, Founder of TriNetX, Joins Srotas Health Board of Directors 2026-06-30 · PR Newswire · AI, Healthcare https://www.prnewswire.com/news-releases/gadi-lachman-founder-of-trinetx-joins-srotas-health-board-of-directors-302814378.html SAN FRANCISCO, June 30, 2026 /PRNewswire/ -- Srotas Health, an AI Health tech company streamlining clinical trial recruitment, feasibility, and patient engagement through their Agentic AI, today announced the appointment of Gadi Lachman, founder and former CEO of TriNetX, to its Board of... ———————————————————————————————————————————————————————————— Caring Hands Animal Hospital – Ashburn Welcomes Dr. Kira Pointon, DVM, to Its Veterinary Team 2026-06-30 · Express Press Release · Healthcare https://express-press-release.net/news/2026/06/30/1761079 Ashburn, VA, 2026-06-30 — /EPR Network/ — Caring Hands Animal Hospital – Ashburn is pleased to announce the addition of Dr. Kira Pointon, DVM, as [read full press release...] ———————————————————————————————————————————————————————————— Cytonics Completes First-In-Human Phase 1 Clinical Study Report for CYT-108, Advancing Program Toward Next Phase of Development. 2026-06-30 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/cytonics-completes-first-in-human-phase-1-clinical-study-report-for-cyt-108-advancing-program-toward-next-phase-of-development-302814067.html Completion of Clinical Study Report marks conclusion of first-in-human development stage for CYT-108 JUPITER, Fla., June 30, 2026 /PRNewswire/ -- Cytonics Corporation, a clinical-stage biopharmaceutical company developing novel Alpha-2-Macroglobulin (A2M)-based therapeutics for... ———————————————————————————————————————————————————————————— Want Hair Ltd Shares Expert Insights on Achieving Natural Results with Hair Transplant Turkey 2026-06-30 · Express Press Release · Healthcare https://express-press-release.net/news/2026/06/30/1761049 Istanbul, Turkey, 2026-06-30 — /EPR Network/ — Hair restoration continues to evolve, with patients seeking results that look natural, suit their facial features, and last [read full press release...] ———————————————————————————————————————————————————————————— WHO FCTC at 20: Global Tobacco Control Efforts Protect 6.1 Billion People, but Industry Interference Threatens Progress 2026-06-30 · Express Press Release · Healthcare https://express-press-release.net/news/2026/06/30/1761035 Helena, Montana, 2026-06-30 — /EPR Network/ — Twenty years after the adoption of the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) — [read full press release...] ———————————————————————————————————————————————————————————— Green Hills Veterinary Clinic Welcomes Dr. Hailey Mann to Its Veterinary Team in Moberly, MO 2026-06-30 · Express Press Release · Healthcare https://express-press-release.net/news/2026/06/30/1760899 Moberly, MO, 2026-06-30 — /EPR Network/ — Green Hills Veterinary Clinic, a trusted full-service veterinary medical facility serving Moberly and the surrounding communities, welcomes Dr. [read full press release...] ———————————————————————————————————————————————————————————— Dr. Richa Kumar Helps Patients Achieve Smooth, Hair-Free Skin with Innovative Laser Technology 2026-06-30 · Express Press Release · Healthcare https://express-press-release.net/news/2026/06/30/1760868 New Delhi, India, 2026-06-30 — /EPR Network/ — Unwanted hair can be frustrating, time-consuming, and difficult to manage with traditional methods like shaving, waxing, or threading. [read full press release...] ———————————————————————————————————————————————————————————— Transportation of Patients via Panchmukhi Air Ambulance in Patna is Completely Protected 2026-06-30 · Express Press Release · Healthcare https://express-press-release.net/news/2026/06/30/1760850 Patna, India, 2026-06-30 — /EPR Network/ — If you are traveling with the protection of a skilled team, the availability of the latest equipment, and [read full press release...] ———————————————————————————————————————————————————————————— Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases 2026-06-30 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/06/30/3319441/0/en/Nxera-Pharma-to-Receive-US-10-Million-Milestone-Payment-from-AbbVie-under-Collaboration-Targeting-Neurological-Diseases.html Tokyo, Japan and Cambridge and London, UK, 30 June 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that it has reached a fourth R&D milestone under its multi-target discovery collaboration with AbbVie focused on neurological diseases, resulting in a payment of US$10 million to Nxera. ———————————————————————————————————————————————————————————— Salt Medical Achieves ISO 13485 Certification, Reinforcing Its Position as a Full-Lifecycle Partner for Medical Device Companies 2026-06-30 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/salt-medical-achieves-iso-13485-certification-reinforcing-its-position-as-a-full-lifecycle-partner-for-medical-device-companies-302813113.html GALWAY, Ireland, June 30, 2026 /PRNewswire/ -- Salt Medical today announced it has achieved ISO 13485:2016 certification, the internationally recognised standard for quality management systems for the medical device industry. The certification marks a significant milestone in the... ———————————————————————————————————————————————————————————— Salt Medical erhält die Zertifizierung nach ISO 13485 und festigt damit seine Position als Full-Lifecycle-Partner für Medizinproduktehersteller 2026-06-30 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/salt-medical-erhalt-die-zertifizierung-nach-iso-13485-und-festigt-damit-seine-position-als-full-lifecycle-partner-fur-medizinproduktehersteller-302813763.html GALWAY, Irland, 30. Juni 2026 /PRNewswire/ -- Salt Medical gab heute bekannt, dass das Unternehmen die Zertifizierung nach ISO 13485:2016 erhalten hat, der international anerkannten Norm für Qualitätsmanagementsysteme in der Medizinproduktebranche. Die Zertifizierung stellt einen... ———————————————————————————————————————————————————————————— WTW speeds strategic life insurer decisions with addition of GPU-support in RiskAgility Financial Modeller 2026-06-30 · GlobeNewswire · Finance, SaaS, Healthcare https://www.globenewswire.com/news-release/2026/06/30/3319423/0/en/WTW-speeds-strategic-life-insurer-decisions-with-addition-of-GPU-support-in-RiskAgility-Financial-Modeller.html LONDON, June 30, 2026 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company, today announced the newest version of RiskAgility Financial Modeller (FM), its flagship platform for life and health insurers. The release adds advanced graphics processing unit (GPU) execution as a complementary technology that further extends the market-leading performance of RiskAgility FM, enabling insurers to generate insights faster, more cost-effectively and with greater flexibility. ———————————————————————————————————————————————————————————— Sleep Apnea Market Expected to Experience Accelerated Growth and Market Evolution by 2034 – DelveInsight | Apnimed, Eli Lilly, Incannex Healthcare, Axsome Therapeutics, Jazz Pharma, Bioprojet 2026-06-30 · GetNews · Healthcare https://www.getnews.info/story/2026/06/30/sleep-apnea-market-expected-to-experience-accelerated-growth-and-market-evolution-by-2034-delveinsight-apnimed-eli-lilly-incannex-healthcare-axsome-therapeutics-jazz-pharma-bioprojet/?source=barchart ———————————————————————————————————————————————————————————— Myotonic Dystrophy Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Dyne Therapeutics, Avidity Biosciences, Harmony Biosciences, AMO Pharma, Lupin, AMO Pharma 2026-06-30 · GetNews · Healthcare https://www.getnews.info/story/2026/06/30/myotonic-dystrophy-pipeline-2026-key-companies-moa-roa-and-clinical-trials-evaluation-by-delveinsight-dyne-therapeutics-avidity-biosciences-harmony-biosciences-amo-pharma-lupin-amo-pharma/?source=barchart ———————————————————————————————————————————————————————————— Wet Age-related Macular Degeneration (Wet AMD) Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight 2026-06-30 · GetNews · Healthcare https://www.getnews.info/story/2026/06/30/wet-agerelated-macular-degeneration-wet-amd-pipeline-2025-fda-updates-therapy-innovations-and-clinical-trial-landscape-analysis-by-delveinsight/?source=barchart ———————————————————————————————————————————————————————————— As Health Care Moves From Volume to Value, SCU Highlights Integrative, Whole-Person Healthcare 2026-06-30 · PR Newswire · Healthcare, Education https://www.prnewswire.com/news-releases/as-health-care-moves-from-volume-to-value-scu-highlights-integrative-whole-person-healthcare-302814027.html WHITTIER, Calif., June 30, 2026 /PRNewswire/ -- As the U.S. health care system continues moving from fee-for-service models toward value-based care, Southern California University of Health Sciences (SCU) is preparing future healthcare professionals to deliver integrative, whole-person... ———————————————————————————————————————————————————————————— New clinical and real-world evidence on Lecanemab to be presented at AAIC conference 2026 2026-06-30 · PR Newswire · Finance, Healthcare https://www.prnewswire.com/news-releases/new-clinical-and-real-world-evidence-on-lecanemab-to-be-presented-at-aaic-conference-2026-302814196.html STOCKHOLM, June 30, 2026 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai will present new clinical and real-world evidence on lecanemab (Leqembi®) at the Alzheimer's Association International Conference (AAIC) in London, July 12-15, including data on its... ———————————————————————————————————————————————————————————— FDA grants Priority Review to Roche’s Enspryng, the first and only at-home subcutaneous treatment option for thyroid eye disease (TED) 2026-06-30 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/06/30/3319373/0/en/FDA-grants-Priority-Review-to-Roche-s-Enspryng-the-first-and-only-at-home-subcutaneous-treatment-option-for-thyroid-eye-disease-TED.html Basel, 30 June 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has accepted and granted priority review to a supplemental Biologics License Application (sBLA) for Enspryng® (satralizumab) for the treatment of thyroid eye disease (TED). The filing acceptance is based on results from the two randomised, placebo-controlled global phase III SatraGO studies assessing the safety and efficacy of Enspryng in patients with moderate to severe TED. The data were presented at the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) in October 2025. 1 The FDA is expected to make a decision on approval by 15 October 2026. ———————————————————————————————————————————————————————————— Orion Pharma announces agreement with Shilpa Medicare for nivolumab biosimilar for European market 2026-06-30 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/06/30/3319378/0/en/Orion-Pharma-announces-agreement-with-Shilpa-Medicare-for-nivolumab-biosimilar-for-European-market.html ORION CORPORATION PRESS RELEASE 30 JUNE 2026 at 8.00 EEST ———————————————————————————————————————————————————————————— Orion Pharma ja Shilpa Medicare sopimukseen nivolumabi-biosimilaarituotteen oikeuksista Euroopassa 2026-06-30 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/06/30/3319378/0/fi/Orion-Pharma-ja-Shilpa-Medicare-sopimukseen-nivolumabi-biosimilaarituotteen-oikeuksista-Euroopassa.html ORION OYJ LEHDISTÖTIEDOTE 30.6.2026 KLO 8.00 ———————————————————————————————————————————————————————————— Remote Patient Monitoring Market to Reach $66.33 Billion by 2031, Driven by Aging Population, Chronic Disease Burden, and Rise of Connected Healthcare 2026-06-30 · GetNews · Healthcare https://www.getnews.info/story/2026/06/30/remote-patient-monitoring-market-to-reach-6633-billion-by-2031-driven-by-aging-population-chronic-disease-burden-and-rise-of-connected-healthcare/?source=barchart ———————————————————————————————————————————————————————————— International Alcohol Control Online Symposium Held: Focusing on Global and Low- and Middle-Income Country Response Strategies 2026-06-30 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/international-alcohol-control-online-symposium-held-focusing-on-global-and-low--and-middle-income-country-response-strategies-302814017.html MACAU, June 30, 2026 /PRNewswire/ -- The International Alcohol Control Online Symposium, organized by experts from the World Health Organization (WHO), the International Agency for Research on Cancer (IARC) Biobank and Cohort Building Network (BCNet), and other institutions, has... ———————————————————————————————————————————————————————————— Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock 2026-06-30 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/06/30/3319364/0/en/Nuvectis-Pharma-Announces-Pricing-of-100-Million-Public-Offering-of-Common-Stock.html FORT LEE, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative therapies for the treatment of immune complement-related conditions and oncology, today announced the pricing of its previously announced underwritten public offering of 5,000,000 shares of its common stock at a price of $20.00 per share, with expected gross proceeds to Nuvectis of $100 million. Nuvectis has also granted the underwriters a 30-day option to purchase up to 750,000 additional shares of its common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about July 1, 2026, subject to satisfaction of customary closing conditions. ———————————————————————————————————————————————————————————— From Products to Solutions: Linuo Pharma Packaging Charts a New Global Path Through AI-Driven Intelligent Manufacturing 2026-06-30 · PressReleaseNews · AI, Healthcare https://pressreleasenews.org/pressroom/from-products-to-solutions-linuo-pharma-packaging-charts-a-new-global-path-through-ai-driven-intelligent-manufacturing ———————————————————————————————————————————————————————————— TherapyGo Announces Milestone as AI-Powered Mental Health Platform Expands Access to Licensed Psychologists 2026-06-30 · GetNews · AI, SaaS, Healthcare https://www.getnews.info/story/2026/06/29/therapygo-announces-milestone-as-aipowered-mental-health-platform-expands-access-to-licensed-psychologists/?source=barchart ———————————————————————————————————————————————————————————— MedMira Reports Third Quarter Results FY2026 2026-06-30 · PR-Inside · Healthcare https://pr-inside.com/medmira-reports-third-quarter-results-fy-r5196036.htm (PR-inside.com) HALIFAX, NS / ACCESS Newswire / June 29, 2026 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended April 30, 2026. Corporate update During Q3 FY2026, the Company continued to advance the regulatory approval process for its Multiplo® Complete Syphilis (TP/nTP) Antibody Test (Multiplo® TP/nTP). The Company received its initial feedback from Health Canada and remains confident that the new regulatory submission pathway will facilitate more efficient review timelines. Following the quarter, the second phase of clinical trials was completed, and the resulting data will be submitted to support the existing regulatory application. The test is .. ———————————————————————————————————————————————————————————— Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026 2026-06-30 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/devonian-health-group-reports-financial-and-operating-results-of-its-three-and-nine-months-ended-april-30-2026-302813854.html (all amounts are in Canadian dollars) Quarter ended April 30, 2026, net loss of $1.9 million dollars, ($0.70) per share Nine months ended April 30, 2026, net loss of $5.7 million dollars, ($2.07) per share Cash as of April 30, 2026, $0.7 million Company remains debt-free QUÉBEC, June 29,... ———————————————————————————————————————————————————————————— FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2 2026-06-29 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/06/29/3319348/0/en/FDA-Approves-Arcutis-ZORYVE-roflumilast-Cream-0-3-for-the-Treatment-of-Plaque-Psoriasis-in-Children-as-Young-as-Age-2.html FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2 ———————————————————————————————————————————————————————————— Laplace Announces FDA IDE Approval of TRIUMPH Pivotal Trial of Its Transcatheter Tricuspid Valve Replacement System 2026-06-29 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/laplace-announces-fda-ide-approval-of-triumph-pivotal-trial-of-its-transcatheter-tricuspid-valve-replacement-system-302813749.html MINNEAPOLIS, June 29, 2026 /PRNewswire/ -- Laplace Interventional today announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) for TRIUMPH, the company's pivotal trial evaluating its Transcatheter Tricuspid Valve Replacement... ———————————————————————————————————————————————————————————— High Patient Volume Expected at New Surgery Center for Specialized Healthcare Provider Expanding Throughout Southeast and Mid-Atlantic Region: Cardiff Lexington Corporation (Stock Symbol: CDIX) 2026-06-29 · GetNews · Finance, Healthcare https://www.getnews.info/story/2026/06/29/high-patient-volume-expected-at-new-surgery-center-for-specialized-healthcare-provider-expanding-throughout-southeast-and-midatlantic-region-cardiff-lexington-corporation-stock-symbol-cdix/?source=barchart ———————————————————————————————————————————————————————————— 1933 Industries Reports Third Quarter 2026 Financial Results 2026-06-29 · PR-Inside · Healthcare https://pr-inside.com/industries-reports-third-quarter-2026-financial-results-r5195971.htm (PR-inside.com) VANCOUVER, BC / ACCESS Newswire / June 29, 2026 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its third quarter financial results for the six and nine months ended April 30, 2026 and 2025 ("fiscal 2026"). All amounts expressed are in Canadian dollars. The Company owns 100%1 of Alternative Medicine Association (AMA), the Company's cultivation and production subsidiary centred on the medical and adult-use cannabis market in the state of Nevada. Focusing on quality and value offerings, the Company wholesales cannabis flower, pre-rolls and boutique concentrate products under its proprietary .. ———————————————————————————————————————————————————————————— Why Local Leadership is the Ultimate Remedy for Rural Healthcare 2026-06-29 · PR-Inside · Healthcare https://pr-inside.com/why-local-leadership-is-the-ultimate-remedy-for-rural-healthcare-r5195967.htm (PR-inside.com) When Those Who Care Most Get Proper Support, Everyone Wins WATKINSVILLE, GA / ACCESS Newswire / June 29, 2026 / It was mid-2023. Staff at Monroe County Hospital (MCH) in Forsyth, Georgia, population 4,384, had been told by their corporate management leaders that the hospital was going through their reserves quickly. Closing down was not only possible, they said, but likely. MCH wasn't ready to let this happen. So, in November 2023, they chose Aletheia Health Partners, a hospital management company focused on serving rural communities, to try to turn the situation around. The Work Begins, and a Name Emerges As Aletheia began their .. ———————————————————————————————————————————————————————————— PetVivo Reports Financial and Operational Results for Fiscal 2026 2026-06-29 · GlobeNewswire · AI, Healthcare https://www.globenewswire.com/news-release/2026/06/29/3319332/0/en/PetVivo-Reports-Financial-and-Operational-Results-for-Fiscal-2026.html MINNEAPOLIS, MN, US, June 29, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, reported operational results for the fourth quarter of its fiscal year ended March 31, 2026, and financial results for the full fiscal year. ———————————————————————————————————————————————————————————— Gerresheimer Publishes 2025 Annual and Consolidated Financial Statements: Stable Revenue in a Challenging Financial Year 2026-06-29 · NewMediaWire · Finance, Healthcare https://www.newmediawire.com/news/gerresheimer-publishes-2025-annual-and-consolidated-financial-statements-stable-revenue-in-a-challenging-financial-year-7087416 Revenue of EUR 2.3 billion, adjusted EBITDA of EUR 384 million Organic revenue growth of +0.3%, adjusted EBITDA margin at 16.8% Closing of the sale of Centor and comprehensive debt refinancing planned for this year Implementation of the transformation program (gto) for gradual margin improvement DUSSELDORF, GERMANY - June 29, 2026 ( NEWMEDIAWIRE ) - Gerresheimer, an innovative systems and solutions provider and global partner to the pharma, biotech, and cosmetics industries, today published its 2025 annual and consolidated financial statements, which were issued with an unqualified audit opinion. The publication had been postponed due to internal investigations - now completed - regarding revenues and accounting practices in financial years 2024 and 2025. Incorrect entries have been thorou ———————————————————————————————————————————————————————————— “Eccrine Power” by Giacomo Fasano, is the Breakthrough the World Needs Now 2026-06-29 · WebWire · Healthcare https://www.webwire.com/ViewPressRel.asp?aId=356840 For more than 30 years, scientific images have shown something extraordinary: visible bloodline connections surrounding the pore sacs, sweat glands, and capillary networks of the skin. Yet for decades, these images have been overlooked, underexplained, and disconnected from the bigger picture of human health. - - Now, Giacomo Fasano's “Eccrine Power” brings that hidden connection into focus. - - This is not simply a book about sweating. It is a bold re-examination of the body Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=356840 ———————————————————————————————————————————————————————————— Medios Optimizes Its Manufacturing Network and Closes Its Aschaffenburg Facility 2026-06-29 · NewMediaWire · Healthcare https://www.newmediawire.com/news/medios-optimizes-its-manufacturing-network-and-closes-its-aschaffenburg-facility-7087415 BERLIN - June 29, 2026 ( NEWMEDIAWIRE ) - Medios AG is closing the facility of its wholly owned subsidiary, Medios Solutions Aschaffenburg GmbH, and consolidating patient-specific manufacturing at the remaining locations in its Germany-wide network. Production has already been relocated, and supplies to pharmacies and hospitals are guaranteed. Aschaffenburg most recently accounted for approximately 10% of the production volume of the Medios Group’s German manufacturing facilities. The measure affects 32 employees, for whom Medios is seeking to provide fair compensation. The business of patient-specific formulations is under sustained margin pressure – particularly due to price regulatory adjustments – which the company is now countering with measures to increase efficiency. In Germany, Med ———————————————————————————————————————————————————————————— Tilray Brands Strengthens Global Medical Cannabis Platform and Canadian Patient Access Through HelloMD Acquisition 2026-06-29 · GlobeNewswire · Finance, SaaS, Healthcare https://www.globenewswire.com/news-release/2026/06/29/3319322/0/en/Tilray-Brands-Strengthens-Global-Medical-Cannabis-Platform-and-Canadian-Patient-Access-Through-HelloMD-Acquisition.html Acquisition Will Expand Patient Access, Strengthen Digital Healthcare Capabilities, and Create a Fully Vertically Integrated Medical Cannabis Framework for Tilray in Canada Acquisition Will Expand Patient Access, Strengthen Digital Healthcare Capabilities, and Create a Fully Vertically Integrated Medical Cannabis Framework for Tilray in Canada ———————————————————————————————————————————————————————————— Did You Lose Money Investing in Embecta Corp.? Robbins LLP Urges Investors ... 2026-06-29 · PR-Inside · Finance, Healthcare https://pr-inside.com/did-you-lose-money-investing-in-embecta-corp-robbins-llp-urges-investors-r5195951.htm (PR-inside.com) SAN DIEGO, CA / ACCESS Newswire / June 29, 2026 /Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Embecta Corp. (NASDAQ:EMBC) securities between November 25, 2025 and May 4, 2026. Embecta Corp., is a medical device company, that provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Embecta Corp. (EMBC) Misled Investors Regarding .. ———————————————————————————————————————————————————————————— Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies 2026-06-29 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/06/29/3319308/0/en/Praxis-Precision-Medicines-Announces-Extension-Period-for-Relutrigine-for-Treatment-of-SCN2A-and-SCN8A-Developmental-and-Epileptic-Encephalopathies.html FDA sets updated PDUFA date of December 27, 2026 ———————————————————————————————————————————————————————————— Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request 2026-06-29 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/06/29/3319292/0/en/Silo-Pharma-Advances-SPC-15-PTSD-Therapeutic-with-Drug-Device-Robustness-Study-Ahead-of-Planned-FDA-Type-C-Meeting-Request.html Study designed to evaluate performance and formulation stability of proprietary nose-to-brain delivery system ———————————————————————————————————————————————————————————— Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss -- HBSS 2026-06-29 · PR Newswire · Finance, Healthcare, Real Estate https://www.prnewswire.com/news-releases/erasca-inc-eras-faces-securities-class-action-amid-patient-death-intellectual-property-questions-2-8-billion-market-cap-loss----hbss-302813490.html SAN FRANCISCO, June 29, 2026 /PRNewswire/ -- Erasca, Inc. (NASDAQ: ERAS) faces a securities class action after the stock tanked $9.25 (-48%) on news that Revolution Medicines (RevMed) accused Erasca of patent infringement concerning Erasca's pan-RAS molecular glue targeting solid tumors... ———————————————————————————————————————————————————————————— Quantum BioPharma (QNTM) Reaches Key Midpoint Milestone in Multiple Sclerosis Imaging Study 2026-06-29 · NewMediaWire · Healthcare, Retail https://www.newmediawire.com/news/quantum-biopharma-qntm-reaches-key-midpoint-milestone-in-multiple-sclerosis-imaging-study-7087413 Before any new drug or diagnostic technology can be used widely, it must pass through a series of structured studies designed to answer specific questions. The milestone highlighted in Quantum BioPharma’s announcement is that patient enrollment in a key pilot study has reached its halfway mark. Preliminary analyses show a robust signal in acute MS lesions, along with potential sensitivity to gray matter lesions. LOS ANGELES, CA - June 29, 2026 ( NEWMEDIAWIRE ) - Clinical studies are among the most demanding and consequential undertakings in medicine. They require years of planning, careful patient selection, rigorous data collection and ongoing regulatory oversight, all in pursuit of a single goal - generating reliable evidence that a new drug, device or diagnostic tool is both safe and ef ———————————————————————————————————————————————————————————— Neutra Corp’s Subsidiary Neutra Life Sciences Executes New Women’s Health Joint Venture and Expands Trial Portfolio 2026-06-29 · GlobeNewswire · Healthcare https://www.globenewswire.com/news-release/2026/06/29/3319254/0/en/Neutra-Corp-s-Subsidiary-Neutra-Life-Sciences-Executes-New-Women-s-Health-Joint-Venture-and-Expands-Trial-Portfolio.html Neutra Corp’s Subsidiary Neutra Life Sciences Executes New Women’s Health Joint Venture and Expands Trial Portfolio ———————————————————————————————————————————————————————————— How Millions in Political Donations Push for DEA Marijuana Rescheduling ... 2026-06-29 · PR-Inside · Healthcare https://pr-inside.com/how-millions-in-political-donations-push-for-dea-marijuana-rescheduling-r5195925.htm (PR-inside.com) While DEA's marijuana rescheduling hearing proceeds with participants for and against rescheduling, MMJ International Holdings highlights publicly disclosed political spending by major state licensed cannabis companies-and a federal cultivation application that has remained unresolved since 2018. WASHINGTON, D.C. / ACCESS Newswire / June 29, 2026 / MMJ International Holdings, Inc. (MMJIH), a pharmaceutical cannabinoid development company pursuing FDA-regulated treatments for Huntington's disease and multiple sclerosis, today called attention to publicly disclosed political spending by major state licensed cannabis companies as theDrug Enforcement Administration's (DEA) marijuana rescheduling hearing opened today in Arlington, Virginia. For nearly eight years, MMJIH has purs ———————————————————————————————————————————————————————————— Trinity Biotech Terminates Standby Equity Purchase Agreement with Yorkville 2026-06-29 · GlobeNewswire · Finance, Healthcare https://www.globenewswire.com/news-release/2026/06/29/3319248/8624/en/Trinity-Biotech-Terminates-Standby-Equity-Purchase-Agreement-with-Yorkville.html DUBLIN, June 29, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on human diagnostics and the development of innovative solutions addressing unmet clinical and industrial needs, today announced that it has formally provided notice of termination to YA II PN, LTD., an affiliate of financing partner Yorkville Advisors Global, in respect of its Standby Equity Purchase Agreement (the “SEPA”) for an equity line of credit facility. ———————————————————————————————————————————————————————————— Northside Hospital expands cardiac safety at iconic race 2026-06-29 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/northside-hospital-expands-cardiac-safety-at-iconic-race-302813609.html SAN FRANCISCO, June 29, 2026 /PRNewswire/ -- Northside Hospital is investing in cardiac safety at the 57th Northside Hospital Peachtree Road Race through a collaboration with Atlanta Track Club and Avive Solutions. 50 Avive Connect AED®s will be carried by trained volunteer runners across... ———————————————————————————————————————————————————————————— Dr. John Spencer Ellis Launches Comprehensive Longevity Coaching Program Designed to Help Men Over 40 Slow — and Even Reverse — the Biological Markers of Aging 2026-06-29 · PR.com · Healthcare https://www.pr.com/press-release/972268 Dr. John Spencer Ellis has launched a comprehensive Men's Health and Longevity Coaching program designed to help men over 40 measurably slow and reverse biological markers of aging through integrated work across hormones, sleep, inflammation, body composition, skin, and hair. [PR.com] ———————————————————————————————————————————————————————————— Dr. John Spencer Ellis Expands AI Search Visibility Services for Medical Doctors Seeking Sustainable Patient Acquisition 2026-06-29 · PR.com · Finance, AI, Healthcare https://www.pr.com/press-release/972262 Dr. John Spencer Ellis has expanded Reputation Return's AI search visibility services to help medical doctors across all specialties maintain patient acquisition as over 52 percent of patients now use artificial intelligence platforms to find healthcare providers. The comprehensive solutions address the specific signals AI platforms evaluate when recommending physicians, ensuring doctors remain prominent and discoverable [PR.com] ———————————————————————————————————————————————————————————— Dr. John Spencer Ellis Launches Escape the Rat Race Coaching Program to Address the Growing Burnout Crisis Among Professional Men 2026-06-29 · PR.com · Healthcare https://www.pr.com/press-release/972260 Dr. John Spencer Ellis has launched his Escape the Rat Race Coaching program to help professional men over 40 break free from the burnout affecting roughly four in ten American men. The personalized program guides accomplished men through monetizing their expertise, building location-independent income, and redesigning their lives around freedom, simplicity, restored health, and mental clarity. [PR.com] ———————————————————————————————————————————————————————————— Vadzo Imaging Positions Falcon-821CRS as Precise Dermatology Camera Module with 4K HDR for Skin Tone Accuracy 2026-06-29 · Newswire.com · SaaS, Healthcare https://www.newswire.com/news/vadzo-imaging-positions-falcon-821crs-as-precise-dermatology-camera-22804654 The Falcon-821CRS is an 8MP 4K HDR dermatology camera module built on the Onsemi AR0821 HyperLux sensor. Positioned for dermoscopy, skin lesion assessment, teledermatology platforms, and clinical dermatology workflows, this color-accurate USB camera module delivers 4K output with on-chip High Dynamic Range, precise color reproduction, and USB 3.2 connectivity. It supports Windows, Linux, and Android in an S-Mount form factor, offering OEM dermatology device designers and clinical imaging engineers a production-ready platform built specifically for skin tone accuracy. ———————————————————————————————————————————————————————————— Study Reveals How Leukemia Cells Enter and Damage Lungs 2026-06-29 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/study-reveals-how-leukemia-cells-enter-and-damage-lungs-302813546.html Results Recommend Steroids as Standard Treatment for Respiratory Distress and Suggest New Drug Targets NEW YORK, June 29, 2026 /PRNewswire/ -- Led by NYU Langone Health researchers, a new study shows how blood cancer cells enter the lungs, damage tissue, and cause severe breathing... ———————————————————————————————————————————————————————————— Better Care and Lower Costs: The Provider-Aligned Model of Care 2026-06-29 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/better-care-and-lower-costs-the-provider-aligned-model-of-care-302813545.html Annual Report on Affordability highlights how integrated care models improve quality while lowering health care spending WASHINGTON, June 29, 2026 /PRNewswire/ -- As health care spending rises and midterm elections come into focus, policymakers are searching for ways to improve... ———————————————————————————————————————————————————————————— Plopii bringt nikotinfreie „Focus"-Beutel mit nootropischer Wirkung auf den Markt, deren Wirkstoff Paraxanthin ist 2026-06-29 · PR Newswire · Healthcare https://www.prnewswire.com/news-releases/plopii-bringt-nikotinfreie-focus-beutel-mit-nootropischer-wirkung-auf-den-markt-deren-wirkstoff-paraxanthin-ist-302813519.html Ein Biotech-Unternehmen aus Brooklyn bringt eine Produktreihe von Nootropika-Beuteln für mehr Konzentration und Energie auf den Markt, deren Wirkstoff Paraxanthin ist – der wichtigste aktive Metabolit von Koffein. Die nikotinfreien Beutel sind in fünf Geschmacksrichtungen erhältlich und... ———————————————————————————————————————————————————————————— New San Diego Marketing Firm Bets on Patience Over Hype and Has Early Results to Show for It 2026-06-29 · PR.com · Healthcare https://www.pr.com/press-release/972303 The Boring Digital Co., a new San Diego firm, works with small professional-service businesses — lawyers, chiropractors, physical therapists, accountants — on the durable, unglamorous side of search marketing. Its promise: skip the noise, do the patient work, and let the rankings speak. One early client reached the top three citywide for its core search term within a month, on a single backlink. [PR.com] ———————————————————————————————————————————————————————————— Four Seasons Hotel New York Downtown Unveils Club 27, the Next Evolution of Wellness Memberships 2026-06-29 · WebWire · Healthcare https://www.webwire.com/ViewPressRel.asp?aId=356904 Four Seasons Hotel New York Downtown is pleased to unveil Club 27, the Hotel's private wellness membership program, designed for discerning individuals seeking unparalleled access to one of Lower Manhattan's most coveted spa destinations. - - Set within the award-winning Spa at Four Seasons Hotel New York Downtown, the top luxury lifestyle hotel located in the heart of Tribeca, Club 27 offers a discreet sanctuary where members can prioritize health, recovery, and wellbeing while enjoying... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=356904 ———————————————————————————————————————————————————————————— Physicians for You Recruitment Launches Dedicated Canada Online Resource for International Physicians 2026-06-29 · PRWeb · Healthcare https://www.prweb.com/releases/physicians-for-you-recruitment-launches-dedicated-canada-online-resource-for-international-physicians-302811603.html A leading physician recruitment firm publishes a comprehensive guide to Canadian life and medical careers for internationally trained doctors. VANCOUVER, BC, June 29, 2026 /PRNewswire-PRWeb/ -- Physicians for You, a recognized leader in physician recruitment and placement across Canada,... ———————————————————————————————————————————————————————————— SUIC and VisionRenu Sign Strategic MOU to Accelerate AI Biotechnology, Precision Medicine, and U.S. Capital Market Expansion 2026-06-29 · NewMediaWire · AI, Healthcare https://www.newmediawire.com/news/suic-and-visionrenu-sign-strategic-mou-to-accelerate-ai-biotechnology-precision-medicine-and-u-s-capital-market-expansion-7087409 NEW YORK, NY and TAIPEI, TAIWAN - June 29, 2026 ( NEWMEDIAWIRE ) - SUIC Worldwide Holdings Ltd. (OTC Markets: SUIC) ("SUIC"), a technology-enabled investment and business acceleration company, and VisionRenu Biomedical Technology Co., Ltd. ("VisionRenu"), a Taiwan-based medical technology company specializing in brain health and ophthalmic medical devices, today announced the signing of a Strategic Memorandum of Understanding (MOU). The agreement establishes a framework for collaboration in AI-powered biotechnology, precision medicine, and international capital market initiatives, positioning both companies to participate in one of the world's fastest-growing technology sectors. Driving Global Commercialization and Capital Market Expansion Under the MOU, SUIC and VisionRenu will combine th ———————————————————————————————————————————————————————————— Growing Scientific Evidence Links E-Cigarette Chemicals to Heart Health Risks 2026-06-29 · NewMediaWire · Healthcare, Retail https://www.newmediawire.com/news/growing-scientific-evidence-links-e-cigarette-chemicals-to-heart-health-risks-7087408 DALLAS - June 29, 2026 ( NEWMEDIAWIRE ) - Is vaping bad for my health? As people who use e-cigarettes and their loved ones pose questions like this, growing scientific evidence shows that the answer is yes. Research studies show that several chemicals found in e-cigarettes and produced when used as intended may harm heart health. As policymakers evaluate the rapidly evolving market of tobacco and nicotine products, the American Heart Association, a global force changing the future of health for all, says everyone should be aware of the scientific evidence pointing to potential cardiovascular harms. Often misrepresented and misunderstood as harmless water vapor, e-cigarette aerosol often contains a mix of chemicals, additives, sweeteners and flavoring agents, according to the U.S. Food and